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Class 1 integrons are genetic elements of bacteria that contribute to the 
abundance of antibiotic resistance. Poultry products are thought to be one of the 
most important reservoirs for transmission of antimicrobial resistance bacteria 
(AMR) via foodborne zoonotic pathogens reducing the effectiveness of 
antimicrobial treatments. Prebiotics have attracted attention as an aid to reduce 
pathogen loads and support the intestinal health of poultry. However, whether 
prebiotics directly reduce the expansion of bacterial populations carrying antibiotic 
resistance genes (ARG) or reduce their transmission from livestock, is not known. 
This thesis investigates the potential role of prebiotic galactooligosaccharides 
(GOS) in the mitigation of ARG prevalence in the microbiomes of broiler chickens 
reared under biosecure or commercial conditions.  
 
This study identified and estimated the prevalence of three conserved genes 
present in class 1 integrons (intI1, sul1 and qacEΔ1) from broiler chicken caecal 
contents reared in biosecure and commercial condition. The prevalence of gene 
cassettes (GCs) featuring ARGs were examined from birds fed either standard 
control or an isocaloric diet supplemented with GOS. Six GC types were identified 
by sequencing long-range PCR products: GCs-A (aadA2, linF), GCs-B-1 (dfrA1, 
ORF1, aadA24), GCs-B-2 (dfrA1, aadA1), GCs-C-1 (aadA1), GCs-C-2 (aadA1), and 
GCs-F (aadA9). The predominant GC in biosecure birds was GC-B2, whilst GC-A 
was more prevalent in commercial birds. Phenotypic antimicrobial resistance of 
the caecal microbiota was estimated by evaluation of trimethoprim coliform 
resistant populations and parallel determination of integrase gene copy number 
for birds fed either control or GOS diets. Alpha and beta diversities of the caecal 
bacterial communities were also determined using a 16S rRNA sequencing 
approach. Differences in the caecal communities were calculated using AMOVA and 
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differentially abundant Operational Taxonomic Units (OTUs) identified by LEfSe 
(Linear discriminant analysis effect size).  
 
Feeding prebiotic GOS to 22 days of age mitigated the expansion of 
antibiotics resistance populations observed in the control microbiome composition 
for broiler chickens reared in a biosecure environment. Colonization by zoonotic 
Salmonella Enteritidis demonstrated that both Salmonella and GOS feed influence 
the structure of the gut microbiome. GOS treatment altered the proportions of 
specific OTUs in infected bird compared to non-infected. These important changes 
resulted in a faster clearance of Salmonella infection in GOS-fed birds compared 
to control fed birds, which was associated with a significant increase on 
Negativicutes at the expense of Clostridiales. It is hypothesized that this change 
restricts the abundance of Proteobacteria carrying antimicrobial resistance due to 
the depletion of oxygen. Thus, GOS feed modulates the broiler microbiome, which 
can have a positive impact on the safety of poultry products by reducing the 
incidence of foodborne pathogens, mitigating the antibiotic resistance load, and 
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CHAPTER 1  




1.1 Introduction  
The high plasticity of bacterial genomes that enables bacteria to adapt to 
most ecosystems, has meant that bacterial evolution has been widely investigated. 
This feature that allows bacteria to re-arrange and exchange genomic sequences 
to acquire new characteristics, has been widely demonstrated with antibiotic 
resistant bacteria (Stalder et al., 2012). Human impact extends to the change of 
microbial distribution and abundance of species and dynamics of microbial genome 
evolution. One of the most important groups that have flourished in the modern 
world, are antimicrobial resistant bacteria. Thus, to control this process, 
understanding the dissemination and evolutionary selection is important in order 
to identify the reasons for the success this phenomenon. Currently, the growing 
rate of antibiotic resistant bacteria is a major public health issue (Davies and 
Davies, 2010). In addition, many studies have highlighted the source of resistance 
genes of clinical interest, as an environmental resistome (D'Costa et al., 
2006;Aminov and Mackie, 2007;Martínez, 2008;Wright, 2010). While the 
occurrence of mutations involved in bacterial adaptation is partially responsible, 
horizontal gene transfer seems to be the more frequent cause of the rapid 
dissemination of antibiotic resistance genes (ARGs) across a wide range of 
bacteria. Horizontal gene transfer is prevalent in natural ecosystems (Aminov, 
2011). One mechanism of horizontal gene transfer is through mobile genetic 
elements (MGEs) which are diverse and prevalent in bacteria (Wozniak and 
Waldor, 2010;Bertels and Rainey, 2011). During horizontal gene transfer, they act 
as functional platforms which can be acquired or lost, contributing a significant 
part to the processes of rapid bacterial adaptation and resistance development 







There are various genetic elements that are involved in the adaptation of 
bacteria. The most significant contributor in dissemination of antibiotic resistance 
is the class 1 integron. The way in which they have spread shows similarities to 
the way in which virulent species invade new environments. Many have been 
isolated from clinically important human pathogens. More than 70 clinically 
relevant bacterial species have been invaded by class 1 integrons including 
common human gut resident bacteria and those from domesticated animals. They 
possess an invasive nature that have facilitated their dispersal to every continent 
of the world and every environment. Therefore, they are considered now as 
significant environmental pollutants (Gillings, 2017).  
Poultry production for both meat and eggs has been increasing speedily 
worldwide (Scanes, 2007). It is thought to be one of the most important reservoirs 
for transmission of antimicrobial resistance bacteria (AMR) via foodborne zoonotic 
pathogens reducing effectiveness of antimicrobial treatments (Kaakoush et al., 
2014;Card et al., 2017). Dietary interventions have been described as promising 
approach for modulating chicken microbiome (Ranjitkar et al., 2016). 
Galactooligosaccharide (GOS) prebiotic has attracted attention in poultry 
production for its role in reducing pathogen loads and supporting body health 
(Pourabedin and Zhao, 2015). However, whether they directly reduce expansion 
of bacterial population carried antibiotic resistance genes (ARGs) or reduce their 
transmission from livestock foodborne pathogens into the food supply is not 
known. This thesis describes the investigation of the potential role of GOS in the 
mitigation of the prevalence of ARGs in the broiler chicken microbiome, via a 16S 
rRNA sequencing approach in order to track changes in abundance of 
Enterobacteriaceae. In addition to reducing AMR, understanding the role of GOS 
on the microbiome may have a positive impact on the safety of poultry products 
by reducing the incidence of foodborne pathogens thus improving overall public 
and animal health. 
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1.2 literature review 
1.2.1 Antibiotics   
Antibiotics remain the most effective treatment to deal with infectious 
diseases caused by bacteria and are considered the cornerstones of modern 
medicine (Surette and Wright, 2017). They are biologically active molecules with   
diversife structures and different origins. Antibiotics are natural products, semi-
synthetic derivatives, or chemically synthetic compounds possessing different 
modes of action (Molinari, 2014). They are used to treat both humans and animals 
for several purposes such as disease treatment, disease prevention, and (animals) 
as growth promotion in livestock animals (Rolain, 2013). Today, most of the 
antibiotics used are generated from the phylum Actinobacteria with nearly 80% of 
actinobacterial antibiotics derivates produced by soil resident bacteria of the genus 
Streptomyces (Barka et al., 2016). 
Antibiotics are classified, based on their structure and degree of affinity to 
target sites, into Penicillin’s, Cephalosporins, Tetracyclines, Aminoglycosides, 
Macrolides, Sulfonamides, Quinolones, Diaminopyrimidines, Polymyxin and 
Carbapenems  (Sengupta et al., 2013;Bi et al., 2015;Liu et al., 2016). The majority 
of antibiotics have a specific effect toward different bacterial species that impact 
essential microbial functions either by: (i) inhibiting cell wall synthesis (-lactams), 
(ii) by affecting protein synthesis machinery by interacting with ribosomal subunits 
(Tetracycline, Chloromphenicol, Aminoglycosides), (iii) targeting nucleic acid 
machinery (Rifampcin, Fluoroquinolones), (iv) interfering with metabolic pathways 
(Folic acid analogues, sulfonamides), and (v) by damaging bacterial membrane 
structure such as Polymyxins (Sultan et al., 2018). 
The widespread distribution of multi-drug resistant pathogens to the major 
classes of antibiotics have become increasingly prevalent worldwide (Stalder et 
al., 2019). Drug resistance flourishes because of the injudicious use of 
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antibacterials in human medicine, extensive veterinary usage of antibacterials in 
the livestock food industry as growth promoters, and the presence of resistant 
microbes in the environment and food (Molinari, 2014). Selection pressure due to 
the overuse of antibiotics in clinical and agricultural settings is thought to have 
promoted the evolution and prevalence of antibiotics resistance genes (ARGs) that 
confer resistance, regardless of their origins (Allen et al., 2010). 
The emergence of bacterial resistance mechanisms such as; mutations in 
topoisomerase including all fluoroquinolones (Jacoby, 2005), metallo- and beta-
lactamases (comprising all β-lactams) (Bush, 2010), 16S rRNA methylases 
(including nearly all aminoglycosides) (Zhou et al., 2010) and up-regulation of 
resistance nodulation and division (RND) efflux pumps compromising multiple drug 
classes (Nikaido and Takatsuka, 2009), has left few to no antibiotics active against 
multi-resistant bacteria.  A serious concern is the recent worldwide rise of  
resistant bacterial pathogens like Klebsiella pneumoniae expressing 
carbapenemase-2(KPC-2), New Delhi metallo-β-lactamase-1 (NDM-1), and 
plasmid-mediated colistin resistance MCR-1 (Xiong et al., 2018b). This rise in 
antimicrobial resistance is much faster than the development of and approval of 
new antibiotics, creating an urgent need for new antibiotics (Molinari, 2014).  
 
1.2.2 Antibiotic resistance  
The increasing levels of  AMR is threatening the health progress achieved by 
antibiotics and is recognized as a global crisis (Ventola, 2015). During the period 
of 2011–2014 in Europe, a significant increase has been observed in the 
percentage of both Klebsiella pneumoniae and Escherichia coli infections that were 
found to be resistant to fluoroquinolones, third-generation cephalosporins or 
aminoglycosides, as well as multiple resistance to all three antibiotic groups 
(ECDC, 2015). Currently, AMR is estimated to be responsible for 50 000 deaths 
annually across the US and Europe (O'Neill, 2014), and by 2050, the estimated 
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annual deaths number of AMR bacteria could reach 10 million, surpassing the 
deaths associated with cancer (Tagliabue and Rappuoli, 2018). 
Antibiotic resistance (AR) is a natural phenomenon developed by bacteria that are 
protecting themselves from antibiotic-producing bacteria in order to increase their 
survival chances in highly competitive environments (D’Costa et al., 2011). The 
organisms that produce antibiotics have self-resistance mechanisms against their 
own antibiotics. Additionally, co-existence of antibiotic producing and non-
producing bacteria is also thought to have led to co-evolution of resistance 
mechanisms in non-producer environmental bacteria (Kaur and Peterson, 2018) 
and both groups are thought to have led to the emergence of resistance in 
pathogenic clinical isolates (Surette and Wright, 2017;Kaur and Peterson, 2018). 
An enormous diversity of resistance mechanisms have been identified in both 
antibiotic-and non-antibiotic producing bacteria to practically all antibiotic families 
(D'Costa et al., 2006;Bhullar et al., 2012).  
Bacteria that have encoded antibiotic resistance determinants obviously 
have a selective advantage over those antibiotic-sensitive bacteria in presence of 
antibiotics (Sengupta et al., 2013). However, some of the multidrug resistance 
genes confer resistance to a number of structurally unrelated compounds such as, 
quaternary ammonium compounds, ethidium bromide, the DNA-intercalating 
mutagen acridine, the anionic detergent sodium dodecyl sulfate and uncouplers 
such as carbonyl cyanide m-chlorophenyl hydrazone. Hence, it seems that ARGs 
have a greater role in bacterial physiology than just antibiotic resistance. 
Furthermore, they may also confer resistance to some chemical substances 
generated by the host, like bile acids or may being  a part of some unknown 
physiological roles (Martínez and Rojo, 2011;Sengupta et al., 2013). 
Resistance to antibiotics can be categorised into three main groups: intrinsic, 
adaptive, and acquired resistance (Fernández et al., 2011;Blair et al., 2015). The 
intrinsic resistance is ancient in origin and has complex mechanisms that are have 
been adapted through evolution (Rolain, 2013). Additionally, these antibiotics 
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naturally produced by organisms can act as signalling molecules in nature and 
homeostasis of bacterial communities (Martínez and Rojo, 2011;Baquero et al., 
2013). Thereby, production of antibiotics by naturally resistant organisms 
maintains an ecological balance in the environment (Cordero et al., 2012). For 
instance, the natural low permeability of the bacterial cell wall of Gram-negative 
bacteria is an example of the intrinsic antibiotic resistance, which limits the uptake 
of many antimicrobials including aminoglycosides (Garneau-Tsodikova and Labby, 
2016).  
Adaptive antibiotic resistance takes place due to an environmental trigger 
(for example, changes in nutrient concentration or sub-inhibitory levels of 
antibiotics) that leads to temporary genetic changes and/or changes in protein 
expression levels involving in the antibiotic tolerance (Garneau-Tsodikova and 
Labby, 2016). Bacterial growth on surfaces as biofilms creates an adaptive 
resistance (often referred to as tolerance) to antibiotics  (de la Fuente-Núñez and 
Hancock, 2015). Finally, acquired antibiotic resistance may occur by the 
integration of exogenous genetic element such as a plasmid, conferring multiple 
resistance genes, or by mutation of existing genes. Both intrinsic and acquired 
resistances are carried by genetic elements that are passed vertically during 
bacterial reproduction, while adaptive resistance is transient, which typically 
means reverting upon when the environmental trigger has been removed. 
Additionally, resistance genes carried on plasmids may be transmitted horizontally 
from one bacterium to another which is the main mechanism of the dissemination 
of antibiotic resistance genes among various bacterial species (Garneau-Tsodikova 
and Labby, 2016). 
Recently, genomic and metagenomic researche in humans, animals, food 
and in the environment have revealed that there is a huge reservoir of ARGs 
named the “intrinsic resistome” which represents a large subset of non-acquired 
ARGs that have multiple and complex functions in nature (Rolain et al., 




1.2.3 The mobile resistome  
The continuous appearance of resistance genes present in the 
environmental, antibiotic producing, and pathogenic bacteria, led to the concept 
of the ‘resistome’ which is defined by Wright (2007) as “the collection of all the 
antibiotic resistance genes, including those usually associated with pathogenic 
bacteria isolated in the clinics, non-pathogenic antibiotic producing bacteria and 
all other resistance genes”. Mobilisation of resistance genes can be driven between 
distantly related bacteria by their association with mobile genetic elements 
(MGEs). These MGEs that seem vary in their appearance or absence within a 
bacterial population, hence they are not encoding essential genes for cell function. 
Figure 1.1 shows how resistance genes can be acquired from any source 
(Wellington et al., 2013). 
Mobilisation of MGEs are associating with the stress response, which means 
their mobility can be activated by exposure to antibiotics and environmental 
pollutants (Wellington et al., 2013). When bacteria are exposed to sublethal doses 
of antibiotics, whether in a clinical setting due to treatment of an infection being 
not completed  (patient non-compliance), or when there is limitation in the drug’s 
accessibility to certain tissues such as bone or cerebrospinal fluid (Bryskier, 
2005a). Outside the clinical setting, bacteria may be exposed to sublethal doses 
of antibiotics when manure of livestock fed diet supplemented with antibiotics are 
then released into soil and aqueous environment. All these mechanisms of 
exposure, have highly influenced the dissemination of multidrug resistance 
(Sengupta et al., 2013). Additionally, low antibiotic doses are likely to be 
associated with enhancing horizontal gene transfer (HGT) by MGEs that mediate 
the dissemination of antibiotic resistance genes such as sub-minimum inhibitory 
concentrations of tetracycline (Celli and Trieu‐Cuot, 1998;Sengupta et al., 2013).  
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Finally, transmission of genetic material between bacterial populations is also 
potentially triggered by stressors like metals and biocides (Seier-Petersen et al., 














Figure 1.1 The mobilome of ARGs between closely and distantly related bacteria 
of mobile genetic elements shared resistance gene pool. The ARGs (red) evolving on 
the chromosome and moving by transposition to the plasmid. Narrow host range plasmids 
(α) permitting spread between strains whereas broad host range plasmids (β) allowing 
transfer to distantly related bacteria. R–=sensitive phenotype. R+=resistant phenotype 
(Wellington et al., 2013). 
 
Many antibiotic resistance genes have been shown, by having a perfect 
nucleotide sequence homology, to have been transferred between environmental 
bacteria and clinical pathogens including those that confer resistance to β-lactams, 
aminoglycosides, tetracyclines, sulfonamides, and phenicoles (Forsberg et al., 
2012). These genes orthologous to ARGs have been recognised on MGEs in 
resistant pathogenic bacteria which make up the environmental resistome; a 




However, some phylogenetic studies have suggested that current clinical 
resistance genes cannot be determined in antibiotic producers, and their 
emergence in clinical pathogens are not explained by recent horizontal gene 
transfer from these organisms (Baquero et al., 2013). It is suggested that they 
may have undergone gene duplications and frequent horizontal gene transfer that 
predate the industrial release of antibiotics (Baquero et al., 2013). Anthropogenic 
action (the amount of released antibiotics into microbial environments by human 
action), has certainly increased the amount of antimicrobials that enter the 
environment and interact with bacteria (Baquero et al., 2013), but its involvement 
in the dissemination of antibiotic resistance remains controversial (Bhullar et al., 
2012). Evidence of the occurrence of antibiotic resistance in environments that 
are apparently antibiotic-free suggests the situation is more complex (Sengupta 
et al., 2013). For example, bacteria from a region of the Lechuguilla Cave, New 
Mexico, that has been isolated for over 4 million years, were resistant to 14 
different commercially available antibiotics (Bhullar et al., 2012). 
Phylogenetically related gut microbiota are known to frequently transfer 
resistance genes between commensals and pathogens. Surprisingly, some studies 
indicated that fairly large numbers of resistance genes harboured in human 
microbiome have not (yet) been transmitted to human pathogens (Sommer et al., 
2009;Sommer et al., 2010;Bengtsson-Palme et al., 2018). The main causes for 
this are unknown, however, it seems there are strong barriers preventing 
transmission. One of these barriers could be the oxygen requirements. For 
instance, many uncultured, anaerobic microorganisms in the human gut 
microbiota have a higher proportion of undiscovered genes that give resistance to 
aminoglycosides, amphenicols, beta-lactams and tetracyclines, that have not been 
transmitted to human pathogen due to difference in oxygen needs (Sommer et 
al., 2009). Resistance genes found in the cultivable human gut bacteria, have 
homologues to resistance genes in aerobic bacterial human pathogens 




1.2.4 The use of antibiotics in poultry  
Poultry production is one of the most important worldwide food industries, 
with over 90 million tons of chicken meat produced per year (FAO, 2017;Nhung et 
al., 2017). Several different antimicrobials are still used to raise poultry in most 
countries (Agunos et al., 2012;Landoni and Albarellos, 2015), generally by the 
oral administration, to prevent and treat disease, as well as to enhance growth 
and productivity (Page and Gautier, 2012;Nhung et al., 2017).  The use of 
antibiotics in growth promotion (GP) has been banned by the European Union (EU) 
in 1999 (Casewell et al., 2003). Numerous studies have linked the ban of antibiotic 
usage in food animal production with a decrease of AR prevalence (Marshall and 
Levy, 2011). However, the use of antibiotics as growth promoters and therapeutics 
in animals is not monitored in some countries in the world such as China and 
United States, despite a high occurrence of AR bacteria (Zhu et al., 2013). The 
large number of antibiotics used in food animal production have been used also in 
the treating of human bacterial infections. Thereby, the usage of one specific 
antibiotic in animal farms can accelerate the development of AMR in both 
pathogens and commensal organisms (Nhung et al., 2017). Furthermore, it also 
causes cross-resistance with antibiotics used in medicine and possibly that could 
select for multiple ARs to functionally unrelated antibiotics because ARGs could be 
associated with transferable plasmids and transposons (Marshall and Levy, 2011). 
Additionally, residues of  antibiotics used in poultry production are also of concern 
to human health (Nhung et al., 2017). 
 
1.2.5 Food animals as source of antibiotic resistance in human 
pathogen  
The interplay between food animals, the environment, pathogenic bacteria 
and humans have been involved in shaping the evolution of infectious diseases. 
Livestock play a crucial role in the dissemination and development of antibiotic 
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resistance in pathogenic bacteria (Surette and Wright, 2017). The relationships 
between antibiotic usage in animals and the emerging of AR bacteria in animal 
and human infections was studied during the previous decades (Marshall and Levy, 
2011). Administration of antimicrobial agents in food-animals as prophylaxis 
(growth promoters) or as treatment has been recognised to act as selector for AR 
bacteria that might be transmitted to clinical human pathogens since the 1970s. 
Utilisation of oxytetracyclines as growth promoters in chickens showed an 
increased selection of tetracycline-resistant Escherichia coli colonisation in the 
poultry and in the gut of the farm family (Levy et al., 1976a;Levy et al., 1976b). 
Another example of bacterial cross-resistance through antibiotic usage in animal 
feed production and those used in humans is vancomycin-resistant enterococci 
(VRE) which has emerged as a result of using avoparcin with dramatic increases 
in this resistance amongst human pathogens (Hammerum et al., 2010). The use 
of avoparcin as a growth promoter has been banned in the EU since 1997, which 
subsequently caused a decrease in the carriage of glycopeptide-resistance in 
Enterococcus faecium (Kazimierczak and Scott, 2007). However, although 
resistance has  generally decreased, persistence was observed in some cases: for 
example, in Denmark in pigs administered tylosin (a macrolide antibiotic). As a 
consequence, the ermB and vanA genes were found to be encoded on the same 
mobile genetic elements  (Aarestrup, 2000). Thus AR bacteria are selected in 
chickens, pigs, and cattle or food animals and are likely to be transmitted to the 
human intestinal microbiota via the food chain (Salyers et al., 2004). Moreover, 
along with the detection of numerous AR genes, Aziz et al. (2010) found most of 
these genes were carried on transposons with some of them acquiring by mobility 
of ARGs, posing an increased risk of LGT of ARGs from livestock animals to human 
pathogens (Zhu et al., 2013).  
Recently, foodborne urinary tract infections (FUTIs) has been considered as 
a new source for antimicrobial-resistant foodborne illness (Nordstrom et al., 
2013). For instance, the multidrug resistant extra-intestinal pathogenic E. coli 
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(ExPEC) causes community-acquired urinary tract infections (Vincent et al., 2010). 
These include a trimethoprim–sulfamethoxazole-resistant E. coli UTI outbreak in 
women from the United States (Manges et al., 2001), as well as the community-
outbreak of clonally related extended-spectrum beta-lactamases (ESBLs) type 
CTX-M infections worldwide (Pitout et al., 2005;Pitout and Laupland, 2008). These 
outbreaks have been linked to contaminated meat and other foods as a reservoir 
of the strains causing UTI; suggesting that the use of antimicrobials in food animal 
production can select for AR strains of ExPEC. Furthermore, a widespread 
contamination by AMR ExPEC in retail foods has been detected, specifically in 
turkey products obtained from grocery stores in retail markets from the United 
States (Johnson et al., 2005a).  
There are several examples of foods that act as source of AR bacteria and 
could be transfered to humans via the food chain. Johnson et al. (2005b) have 
reported that retail foods may be a proxy for community transmission of AR ExPEC, 
which are recently considered as clinically significant foodborne pathogens. This 
has also been found in Canada in retail chicken, meat, and pork (Manges et al., 
2007;Vincent et al., 2010). Antibiotic resistance in E. coli isolated from chicken 
have also been founded in Spain, Barcelona, Minnesota, Wisconsin and the United 
States, suggesting that foodborne AR ExPEC transmission is a very predominant 
phenomenon acting as a reservoir of ARGs transmissible to the human microbiome 
via the food chain (Johnson et al., 2006;Johnson et al., 2007).  
 
1.2.6 Resistance mechanisms 
The mechanisms of action and resistance of the major antimicrobial agents’ 
categories are described below. 
 
1.2.6.1 Aminoglycosides (AGs) 
Since streptomycin was first isolated from Streptomyces griseus and 
introduced for clinical use in 1944, this class of antibiotics has become a 
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cornerstone of antibacterial chemotherapy. Aminoglycosides are broad-spectrum 
agents targeting protein synthesis. They exhibit activity against various Gram-
positive and Gram-negative organisms (Krause et al., 2016). They are particularly 
potent against members of the Enterobacteriaceae family which include E. coli, K. 
pneumoniae and K. oxytoca, Enterobacter cloacae and E. aerogenes, Providencia 
spp., Proteus spp., Morganella spp., and Serratia spp. (Ristuccia and Cunha, 
1985;Aggen et al., 2010;Landman et al., 2010).  
The mechanism of action of AGs involves inhibition of protein synthesis by 
high affinity binding to the A-site on the 16S ribosomal RNA of the 30s ribosome 
(Kotra et al., 2000). Different classes of AGs have different specificities for 
different regions on the A-site, most of them altering its conformation. As a 
consequence of this interaction, the antibiotic induces mistranslation by promoting 
codon misreading on delivery of the aminoacyl transfer RNA. As a result of this 
error prone protein synthesis allowing the wrong amino acids to assemble into a 
polypeptide, the cell membrane becomes damaged (Davis et al., 1986;Mingeot-
Leclercq et al., 1999;Ramirez and Tolmasky, 2010;Wilson, 2014). Some AGs can 
also disrupt protein synthesis by blocking elongation or by direct inhibition of 
initiation (Davis, 1987;Kotra et al., 2000;Wilson, 2014). 
 
Mechanisms of aminoglycoside resistance include enzymatic modification, 
target site modification via an enzyme or chromosomal mutation, and efflux 
pumps. Each mechanism has different effects on the various AG classes and often 
several mechanisms are involved in the resistant phenotype (Krause et al., 2016). 
The most common mechanism of AG resistance is inactivation by a family of 
enzymes named aminoglycoside modifying enzymes (AMEs). These enzymes are 
classified into three types according to the kind of modification involved. They are 
the acetyltransferases (AAC), adenyl transferases or the nucleotidyl transferases 
(ANT), and the phosphotransferases (APH;(Kotra et al., 2000;Ramirez and 
Tolmasky, 2010)). The ANT group of enzymes, products of the aadA gene, 
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encoded by integrons and are commonly found in streptomycin resistant Gram-
negative bacteria (Sultan et al., 2018). Resistance to AGs may also occur by 
decreasing antibiotic uptake through outer membrane proteins (intrinsic barrier). 
This is achieved by a decrease in membrane permeability by acquiring lipid 
modifications which causes repulsion of AGs. Furthermore, even if some AG 
molecules enter the bacterial cell, their intercellular concentrations may still be 
low because of the active ejection of AGs out of the cell by efflux pumps 
(Fernández and Hancock, 2012;Garneau-Tsodikova and Labby, 2016). 
Resistance to AGs can be gained by mutations of the ribosomal target of 
aminoglycoside antibiotics. This may occur by modification  of the ribosome by a 
family of ribosomal methyltransferase enzymes (Wilson, 2014). Most pathogenic 
bacteria develop resistance to AMEs via horizontal gene transfer (HGT). This is due 
to the high mobility of AMEs because their genes are transferred on mobile genetic 
elements like plasmids, integrons, transposons, and other integrative genetic 
elements. Genes involved in resistance to AGs are often associated with other 
resistance genes such as β-lactamases, “bla” genes (Garneau-Tsodikova and 
Labby, 2016).  
 
1.2.6.2 Lincosamides  
Lincomycin was the first lincosamide isolated from soil in 1962 in Lincoln, 
Nebraska.  It was produced by Streptomyces lincolnensis ssp. Lincolnensis 
(MacLeod et al., 1964;Bryskier, 2005b;Schwarz et al., 2016). Lincosamides have 
a wide antimicrobial spectrum, against Gram-positive bacteria, most anaerobes, 
but not Gram-negative aerobes, and some mycoplasmas and protozoa 
(Greenwood, 2010). Lincosamides may act as bacteriostatic agents, which slow or 
inhibit the growth of bacteria but do not kill them, or as bactericidal antibiotics, 
which actively kill bacteria, based on drug concentration, bacterial species, and 
pathogen concentration (Das and Patra, 2017). The mechanism of lincosamides 
action is by protein synthesis inhibition in sensitive bacteria. This is achieved by 
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blocking the activation of amino acid monomers by aminoacyl-tRNA synthesis, 
elongation, and chain termination of the grown polypeptides on the ribosome. 
Therefore, this class of antibiotics cause interruption to the timing and specificity 
of these steps, leading to either deceleration of growth or death of the 
microorganism (Spížek and Řezanka, 2017). Clindamycin is the main prescribed 
lincosamide antibiotic in clinical practice (Spížek and Řezanka, 2017). 
The main route of resistance to lincosamides is achieved by modifying the 
23S rRNA in the 50S ribosomal subunit, which is the same resistance mechanism 
to macrolides and streptogramin B. Resistance to lincosamides can occur through 
three different mechansims: (1) mutation in the antibiotic ribosomal target that 
prevents its binding or by modification of the target-site by methylation, (2) efflux 
of the antibiotic, and (3) by inactivation of the drug. These mechanisms have been 
observed in lincosamide producer microorganism to protect themselves against 
the antimicrobial products that they produce. However, in pathogenic 
microorganisms, the effectiveness of these three mechanisms is not equal in terms 
of incidence and clinical implications. The broad-spectrum of lincosamides 
resistance is caused by modification of the ribosomal target whereas efflux and 
inactivation affect only some of the molecules in this class  (Leclercq, 2002). 
Bacterial outer membrane permeability is an important factor for the intrinsic 
resistance of Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp. 
(Kwon, 2017). Hence, Gram-negative microorganisms are generally resistant to 
lincomycin and clindamycin (Spížek and Řezanka, 2017) so the use in human 
medicine is limited. In veterinary use, lincomycin is approved for therapeutic use 
of various infections in dogs, cats, and swine, in combination with spectinomycin, 





Resistance to quinolones has emerged since nalidixic acid was used in clinical 
medicine (Jacoby, 2005). The mode of quinolone action is by targeting two 
essential bacterial enzymes. These are DNA gyrase and DNA topoisomerase IV, 
inhibition of which lead to impairment of DNA synthesis (Jacoby, 2005). 
Mechanisms of resistance occurred by mutation and acquisition of resistance-
conferring genes. Resistance through mutations in one or both enzymes commonly 
taken place in a specific domain of the GyrA and ParE subunits leading to reduced 
drug binding to the enzyme-DNA complex (Hooper and Jacoby, 2015). The other 
mechanism of resistance is mediated by mutations in proteins that encode the 
regulatory genes controlling the transcription or expression of native efflux pumps 
or porin genes located in the bacterial membrane (Hooper and Jacoby, 2015). 
These efflux pumps have a broad substrate range including quinolones, other 
antimicrobials, disinfectants, and dyes. Mutations of both types can increase with 
the presence of selection pressure and produce highly resistant strains. Resistance 
genes that are acquired on plasmids are likely to confer low-level resistance that 
induces the selection of mutational high-level resistance (Hooper and Jacoby, 
2015). The chromosome-encoded resistance causes a decline in outer-membrane 
permeability which is linked with loss of porins. While over expression of the 
naturally present efflux pumps causes antimicrobials to be pumped out of cells. 
Additionally, mutations in the molecular targets of quinolones: DNA gyrase and 
topoisomerase IV confer resistance to them (Hooper, 2000;Jacoby, 2005;Sultan 
et al., 2018).  
 
1.2.6.4 Sulfonamides and Trimethoprim  
Sulfonamides were first effectively used as antibacterial agents, in the United 
States, during the 1930s, whereas trimethoprim was introduced to clinical 
medicine at the end of the 1960s (Sköld, 2010). The spectrum of activity of each 
agent is bacteriostatic alone however the combination (synergistic effect) between 
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both of them (sulfamethoxazole) is bactericidal (Sykes and Papich, 2013). Both 
antibiotics affect bacterial folic acid synthesis. Sulfonamides target the inhibition 
of dihydropteroate synthetase (DHPS), which act as a catalyst for forming of 
dihydrofolate from para-aminobenzoic acid in metabolic pathway of folic acid 
biosynthesis. In the next step of this pathway, trimethoprim acts as an inhibitor 
for dihydrofolate reductase (DHFR), which catalyses the formation of 
tetrahydrofolate from dihydrofolate. These steps follow each other and result in a 
sequential blockade. Resistance to both these drugs can be transferable, thus, 
they are often linked to each other, an example of which are the transposons of 
the Tn21 family (Eliopoulos and Huovinen, 2001).  
Several mechanisms mediate resistance to sulfonamides and trimethoprim 
as follows: (1) efflux pumps and or their impermeability to the drugs, (2) intrinsic 
lack of the enzymes target, (3) spontaneous chromosomal mutations leading to 
overproduction of the host DHFR caused by promoter mutation, a consequence of 
this is that a greater concentration of trimethoprim is required for the inhibition 
(found in Enterobacteriaceae), (4) mutations in structural gene of the DHFR 
(streptococci, staphylococci). The last two mechanisms often occur in 
Enterobacteriaceae and Haemophilus influenzae causing high-level resistance. The 
acquisition of exogenous dfr genes horizontally, that encode resistant DHFRs, are 
also involved in resistance (Eliopoulos and Huovinen, 2001;Bergmann et al., 
2014;Rossolini et al., 2017).  
Enterobacteria that possess a high-level of resistance to trimethoprim is 
often due to acquisition of a genetic element encoding trimethoprim resistant 
DHFR with an alteration of the active site. To date, many different trimethoprim 
resistant DHFRs have been described in Gram-negative organisms that belong to 
at least two groups encoding the dfrA and dfrB genes. These genes are commonly 
carried on mobile gene cassettes embedded in integrons described in 
Enterobacteriaceae (Brolund et al., 2010;Rossolini et al., 2017).  
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Campylobacter jejuni and Helicobacter pylori are naturally resistant to 
trimethoprim because they lack the chromosomal gene for dihydrofolate reductase 
and therefore, the target for trimethoprim is absent (Myllykallio et al., 2003). Many 
pathogenic bacteria such as Escherichia coli have been detected that carry 
chromosomal resistance to trimethoprim that is due to 100-fold overproduction of 
chromosomal dihydrofolate reductase. This overproduction is caused by several 
types of mutations, which contribute to an increase in the expression of the 
enzyme gene via increased promoter efficiency, optimization of ribosome binding 
and more efficient codon usage (Sköld, 2010). 
Resistance to sulfonamides is acquired by a single amino acid chromosomal 
mutation in the dhps gene. This mutation is naturally prevalent among many 
clinical pathogens (Eliopoulos and Huovinen, 2001). Resistance may lead to an 
increase of para-aminobenzoic acid production as well as to alteration of DHPS 
which reduces the enzyme affinity for sulphonamides (Rossolini et al., 2017). 
Resistance is also commonly associated with harbouring plasmids that encode a 
drug-resistant DHPS (Chen, 2004). There are three types of DHPS resistance, 
encoded by the sulI, sulII and sulIII genes. These genes have been identified in 
Gram-negative enteric bacteria (Rossolini et al., 2017). The sulI gene is frequently 
associated with other resistance genes and is locating in conserved segments of 
integrons in Tn21-like elements carried by large conjugative plasmids (Eliopoulos 
and Huovinen, 2001). The sulII gene is genetically linked to a streptomycin 
resistance gene that moves around on broad host-range plasmids and on small 
non-conjugative plasmids (Chen, 2004). These genes encoding DHPS confer high-
levels of resistance (Rossolini et al., 2017). 
 
1.2.7 Resistance mediated by mobile genetic elements (MGEs) 
The acquisition of antibiotic resistance in bacteria occurs through two 
principal routes: chromosomal mutation and the acquisition of MGEs by horizontal 
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gene transfer (Alekshun and Levy, 2007;San Millan, 2018). However, the 
acquisition of ARGs frequently takes place via mobility of DNA which can be loosely 
defined as any segment of DNA that is able to translocate from one part of a 
genome to another or between genomes (Van Hoek et al., 2011). This includes a 
wide range of mobile genetic elements that are described below. 
 
1.2.7.1 Resistance mediated by plasmids 
A plasmid is a circular DNA molecule replicating independently of the 
chromosome and can be transmited horizontally between bacteria via conjugation. 
This DNA segment (plasmid) plays a vital role in both bacterial evolution and 
distribution of antibiotic resistance genes among the most serious clinical 
pathogens (Alekshun and Levy, 2007;Carattoli, 2013). Conjugative plasmids are 
the most important drivers of ARGs dissemination among bacterial population such 
as Enterobacteriaceae and Enterococcaceae including some of the most significant 
nosocomial pathogens (Vincent, 2003;Boucher et al., 2009;Rozwandowicz et al., 
2018).  
Plasmids which have been detected in almost all bacteria, include an origin 
of replication as well as genes that encode replication functions as their simplest 
elements (Chambers et al., 1988). Some other plasmids commonly harbour an 
origin of transfer and genes encoding functions that allow them to transmit to new 
hosts via conjugation (Smillie et al., 2010). Thus, plasmids that contain 
conjugation genes are called conjugative while plasmids that are only composed 
of an origin of transfer (oriT) without conjugation genes are called mobilizable 
plasmids (Van Hoek et al., 2011). Conjugative plasmids are either broad host 
range, being not restricted to host within their division, or narrow host range being 
limited to a small number of related bacterial groups (Sultan et al., 2018). 
Moreover, some plasmids have the ability to transfer to a specific host, but they 
are unable to replicate in the new host or cannot replicate well. Consequently, this 
type of plasmid is likely to be lost, but if this plasmid contains resistance genes on 
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a transposon, this genetic element can contribute to translocation of this 
resistance to the bacterial chromosome and be preserved in the absence of the 
plasmid. Consequently, plasmids do not necessarily need to be maintained in a 
specific host to be involved in the spread of resistance (Van Hoek et al., 2011). 
Additionally, functions in replication and transfer plasmids commonly encode 
antibiotic resistance. Therefore, resistance genes carried by a conjugative or 
mobilizable plasmid have the potential to transfer to new hosts (Van Hoek et al., 
2011). The association between plasmids and bacterial clones is ubiquitous, with 
certain AR plasmids that strongly linked to specific bacterial lineages (San Millan, 
2018). 
 
1.2.7.2 Resistance mediated by transposons 
Transposable elements (TEs) or conjugative transposons, are also called 
integrative conjugative elements (Roberts et al., 2008). They are similar to 
conjugative plasmids, in that transposons have an origin of transfer and the 
required genes for the conjugation apparatus but they do not carry an origin of 
replication. They need to be incorporated into a replicon that can be either a 
plasmid or chromosome, in order to be maintained. This gives transposons an 
advantage over plasmids because they do not need to have replication machinery, 
therefore, they tend to have a larger host range than plasmids (Van Hoek et al., 
2011). 
TEs are divided into two classes: composite transposons and complex 
transposons. Composite transposons have a range of resistance genes possessing 
identical structural and functional characteristics, but little DNA homology to each 
other. Complex transposons comprise three dissimilar but interrelated families; 
Tn3, Tn21 and Tn2501 (Schmitt, 1986;Wiedemann et al., 1986;Lafond et al., 
1989;Sultan et al., 2018). Composite transposons, Tn5, Tn9, Tn10, Tn903, 
Tn1525, and Tn2350 are found in Gram-negative bacteria while Tn1, Tn3, Tn21, 
Tn501, Tn1721, and Tn3926, found among both Gram-negative and Gram-
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positive bacteria, are classed as complex resistance transposons. These 
components are capable of “jumping” within a DNA molecule or from one DNA 
molecule to another (Bennett, 2008). The most studied example is Tn21 which 
carries OXA (a carbapenems, possessing oxacillinase activity) and PSE (β-lactam 
gene with Pseudomonas specific enzyme) determinants that confer resistant to 
aminoglycoside antibiotics (Sultan et al., 2018). Tn21 also encodes resistance to 
mercury compounds (Brown et al., 1986) and trimethoprim, imparted by dhfr II 
and V (Sundström et al., 1988).  
 
1.2.7.3 Resistance mediated by integrons 
1.2.7.3.1 Properties of integrons  
Integrons are genetic elements that in conjunction with transmissible 
plasmids and transposons, can integrate and express various genes including 
resistance genes increasing antibiotic resistance in bacteria. Screening for their 
presence may therefore be used as an indicator for the presence of antibiotic 
resistance genes. They are non-mobile themselves, but they can be carried within 
mobile genetic elements like transposons and plasmids, facilitating their horizontal 
transfer into a broad range of pathogens. They are ancient elements that can be 
recovered from all parts of the environment. More than 15% of bacteria that have 
been sequenced have integrons in their genomes (Gillings, 2017). They are 
classified to five different types based on the integrase gene sequence (class I-V). 
The most studied and prevalent integrons among commensal and pathogenic 
bacteria are the class I integrons. They possess a high conserved sequence of the 
intI1 gene which is classed among mobile integrons in clinical isolates however; it 
has variability in environmental mobile integrons (Gillings et al., 2008b). They are 
found widely in clinical isolates that are resistant to commonly used antibiotics 
(Gillings et al., 2008b;Gillings, 2017). Hence, integrons enable bacteria to face the 
challenge of antibiotic treatment by aiding rapid adaptation. They can be 
categorised into two main categories. The first are the resistance integrons or 
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mobile integrons (MIs) which are located either on the chromosome or on plasmids 
that carry gene cassettes that encode resistance to antibiotics. The second 
category are the super-integrons (SIs), which are located on the chromosome and 
carry gene cassettes with a variety of functions (Fluit and Schmitz, 2004). Figure 
1.2 summarised different mechanisms of antibiotics resistance  
 Figure 1.2 Different routes of resistance mechanisms to face effect of antibiotics. 
Lateral gene transfer is involved in transferring and exchanging of genetic elements among 
bacterial cells. Transformation participates in direct uptake of DNA segments from the 
surrounding environment by competent recipient carrying chromosomal set of proteins. 
Transduction allows DNA insertion into chromosome as a prophage which then replicates, 
packages host DNA alone or in combination with the host cell chromosome. Conjugative 
plasmids use a conjugative pilus to form a connection with the recipient cell to transfer 
these plasmids into the recipient cell that is eventually transferred and copied with the 
entire bacterial chromosome, multicopy plasmid or a small DNA piece to a recipient cell. 
These genetic elements are embedded into the chromosome or independently replicated if 
compatible with the inhabitant plasmids. Integrons possess site specific recombination 
mechanism which it encodes a promoter for gene cassettes for genetic exchange and 
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dissemination. Transposons and insertion sequences integrate into new sites on the 
chromosome or plasmids by non-homologous recombination and increase the copy number 
of transferred genes giving rise to chromosomal mutations, deletions and rearrangements 
(Sultan et al., 2018). 
 
1.2.7.3.2 Class 1 integrons 
The class 1 integron is the most ubiquitous platform and remains the main 
focus of numerous studies (Deng et al., 2015). Class 1 integrons located are on 
MGEs are called mobile integrons (MI) which are widely distributed in 22% to 59% 
of Gram-negative bacterial pathogens in clinical settings (Labbate et al., 
2009;Cambray et al., 2010). They are often involved in carrying and disseminating 
antibiotic resistance genes (Naas et al., 2001;Gillings, 2014;Li et al., 2017;Kaur 
and Peterson, 2018). They originated from Tn402 and their stable structure 
consists of two conserved sequence regions, called 5'-CS region and 3'-CS region, 
with a variable gene cassette (GCs) region between them (Cambray et al., 2010). 
The 5'-CS region consists of three key sequences; the integrase gene (intI) 
controlled by Pint promoter, the specific site for recombination of gene cassettes 
(attI) and a cassette promoter region that is located within int1. This common 
promoter (Pc) of integrase, controls the expression of all cassettes that are 
incorporated within the integrons (Gillings, 2017). Each GCs carrying DNA 
sequences is associated with a recombination site (attC), and these cassettes are 
promoterless (Nivina et al., 2016). The Int1 genes encode the integrase protein 
which is a member of tyrosine recombinase family and is closely related to Xer 
proteins (Cury et al., 2016). The 3'-CS region carries resistance to sulphonamides 
(sul1), the quaternary ammonium compound resistance gene (qacE∆1) which 
provides detergent resistance, and two open reading frames, orf5 and orf6, 
encoding unknown functions proteins (Karah, 2008) Figure 1.3 shows the 











Figure 1. 3 The structure and activity of the class 1 integron (Nivina et al., 2016). 
Schematic representation of the class 1 integron. The stable platform consists of a gene 
coding for the integron-integrase gene (intI) and its promoter Pint, a cassette promoter 
(Pc), and an integron recombination site (attI). Circular, mobile gene cassettes encoding 
DNA sequences can be excised through an intramolecular attC×attC reaction mediated by 
the integrase to regenerate circularized gene cassette, which may insert through an 
attI×attC reaction mediated by the integrase to form an array of GCs of variable size.  
 
1.2.7.3.3 Gene cassette structures 
Gene cassettes  (GCs) exist as circular, non-replicating DNA molecules when 
moving from one genetic site to another (Bennett, 1999). They are only considered 
to be part of the integron after the integration event. They usually consist of a 
single gene and a short sequence of 59 bases, located downstream of the gene 
termed attC. The function of attC is a specific recombination site capable of binding 
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with the integron at the attI site. The attachment site of cassettes has imperfect 
inverted repeats.  
Each integrated cassette is flanking by two boundaries with the sequence 
GTTRRRY, that are recognised by integrase (intI), for the recombination process 
to proceed. Two sites with different structures are used by integrase to exchange 
DNA between the non-palindromic attI and palindromic attC. The process of 
integration is carried out by integrase between the attC site in a closed circular 
cassette and the attI site of the integron. The excision process of the captured 
cassettes occurs between two attC sites; one of them associated with the previous 
cassette located upstream and the other one downstream of the excised cassette, 
which regenerate to form a circular structure of the cassette. The consequence of 
integration is a chimeric product between the attI/attC sites upstream the GC gene 
on one side and chimeric attC/attC sites downstream of the gene on the other side 
of the cassette. This results in a clusters of resistance genes with chimerical attC 
sites, with similar palindromic structures. The size of the cassettes is small, around 
500–1000 bp, and the genes carried on the gene cassettes are usually promoter-
less and are expressed from a common promoter on the integron (Karah, 
2008;Larouche and Roy, 2011). Distant cassettes from the Pc promoter may not 
be expressed (Collis and Hall, 1995;Jové et al., 2010), however they can be 
excised and reintegrated at the attI site in which their expression is increased 
(Barraud and Ploy, 2015). Hence, several cassettes can be stockpiled in an array 
to constitute a low-cost memory reservoir of functions for the host cell (Escudero 
et al., 2018). Thus, this activity that enables integrons to create genomic and 
phenotypic diversity (Ghaly et al., 2020). 
Specifically, the cassettes are composed of the inverse core site which carries 
two domains 1L (RYYYAAC) and 2L (GTTRRRY) sequences and the core site which 
contains 2R (RYYYAAC) and 1R sequence (G  TTRRRY), where R is G or A (a 
purine), Y is C or T (a pyrimidine). GCs are generally defined by the presence of 
sequence between the RYYYAAC inverse core site 1L and the GTTRRRY core site 
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R1 (Stokes et al., 1997;Larouche and Roy, 2011). While the attI sites of class 1 
integrons carry non palindrome sequences at R and L regions as well as two further 
integrase binding sites which consist of direct repeats, termed DR1 and DR2 
presented in Figure 1.4 A (Gillings, 2014). The incorporation point of incoming GCs 
occurs either between the G and TT in the right core site or between the AA and 
C on the complement strand of DNA (Hansson et al., 1997) the vertical arrows 
show the site of recombination point (Figure 1.4 A and B). 
These two pairs (1L-2L and 2R-1R) of the inverted repeat binding sites are 
in opposite directions and form simple putative integrase binding sites termed LH 
and RH. They are recognised depending on the type of tyrosine recombinase, 
recombination sites and are described as conserved sequences in several 
resistance cassette attC sites (Stokes et al., 1997;Biskri et al., 2005). These sites 
are separated by a central sequence region of variable length. This internal 
homology enables attC to form secondary structures or enclosed hairpin DNA 
which play a vital role in recognition and recombination by Int1 as shown in Figure 
1.4C (Gillings, 2014). 
The size of the attC recombination sites ranging from 57 to 141 bp and it is 
currently the main feature for attCs classification (Recchia and Hall, 1995;Recchia 
and Hall, 1997). The insertion of several cassettes in tandem in the same integron 
always in the same orientation creates an array of cassettes (Partridge et al., 
2009). Furthermore, the marked base in 2L (the fourth base; asterisk in Figure. 
1.4 B) act to direct the orientation of the inserted strand to ensure that cassettes 
are inserted in the right orientation (Cambray et al., 2010;Bouvier et al., 2005). 
Integration between att1 and attC takes place in the bottom strand only of the 
captured attC, and the single stranded recombination structure is then resolved 
by replication (Bouvier et al., 2009;Loot et al., 2012). The activity of Int1 is 
dependent on the Int1 protein structure, not on the sequence, which is why Int1 
proteins are able to mobilize diverse gene cassettes with very different attC 
sequences (MacDonald et al., 2006). 
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GCs are frequently associated with resistance to a variety of antibiotics 
including the aadA gene that encodes streptomycin-spectinomycin resistance and 
trimethoprim resistance (Deng et al., 2015). Moreover, Lu et al. (2003b) 
highlighted that class 1 integrons commonly carried the streptomycin resistance 
gene cassette (aadA1) in avian E. coli. Interestingly, the therapeutic use of this 
drug has stopped in both human and veterinary medicine. Therefore, streptomycin 
resistance could be maintained even in the absence of a selection pressure 
(Ochman et al., 2000). Additionally, Ebner et al. (2004) suggested that the high-
level prevalence of streptomycin resistance could act as an interesting model in 
studying how predominance of antibiotic resistance did not always correlate with 
withdrawal of the antibiotic from the bacterial environment.  
 Resistance to trimethoprim determinants is also found frequently (Fluit and 
Schmitz, 2004;Mazel, 2006;Cambray et al., 2010). These resistance genes 
determinants show prevalence of 22–59%, and reported among various groups of 
Gram-negative bacteria including Escherichia, Klebsiella, Aeromonas, 
Enterobacter, Providencia, Mycobacterium, Burkholderia, Alcaligenes, 
Campylobacter, Citrobacter, Stenotrophomonas, Acinetobacter, Pseudomonas, 
Salmonella, Serratia, Vibrio, and Shigella  (Ramírez et al., 2005;Crowley et al., 
2008;Partridge et al., 2009;Xu et al., 2009;Xu et al., 2011;Sultan et al., 2018). 
The study by Heir et al. (2004) was conducted on 192 clinically relevant 
Enterobacteriaceae of blood culture isolates, indicating that the most common 
gene cassette types determined were trimethoprim resistance genes dfrA followed 
by aminoglycoside resistance aadA genes.  
Despite much research the regulatory control and dynamics of cassette 
recombination remain unclear. Several studies reported that the expression of 
class 1 mobile integron was controlled by the SOS response (Guerin et al., 2009). 
This response controlled by a repressor protein termed (LexA) and induced by the 
presence of damaged ssDNA fragments that can arise from various environmental 
factors. These DNA segments non-specifically bind to universal recombination 
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protein (RecA) that induce LexA inactivation by autocatalytic cleavage (Sassanfar 















Figure 1.4 Structure of recombination sites of attI1 and attC of class 1 Integron. 
(A) Represents the sequence of the double strand (ds) attI1 site. (B) represents sequence 
of the ds attCant(3'')-Ia site. (C) Secondary structure of the folded bottom strand of 
the attCant(3'')-Ia site, according to MFOLD (http://mfold.bioinfo.rpi.edu/cgi-bin/dna-
form1.cgi). The inverted repeats regions (L, 1L, and 2L, R, 1R and 2R) are marked by 
horizontal black arrows whereas the attI1 direct repeats are shown by horizontal lines with 
an empty arrowhead. The recombination positions are indicated by vertical arrows and the 
extrahelical bases are identified by asterisks (Larouche and Roy, 2011). 
 
1.2.8 Role of horizontal gene transfer (HGT) in transmission of 
antibiotic resistance genes ARGs  
The genetic exchange mechanisms that are involved in transmission of ARGs 
between bacterial populations are: transformation of free DNA, transduction by 
bacteriophages, and conjugation via plasmids (Wright, 2007;Hu et al., 2017), 
collectively named as the mechanisms of HGT (Kaur and Peterson, 2018). These 
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HGT mechanisms occur widely in nature, although certain bacterial species are 
likely to use one mechanism more exclusively than others (Barlow, 2009). For 
instance, transformation is an effectively utilized mechanism in streptococci 
because they can become naturally competent whereas enterobacteria commonly 
use conjugative plasmids for exchanging of genetic information. Johnston et al. 
(2014) indicated that the most efficient method in Gram-positive Streptococcus 
pneumoniae and Bacillus subtilis is transformation although many Gram-negative 
bacteria also become competent. The bacterial nutrition status (Claverys et al., 
2006) and environmental stressors, such as antibiotics or DNA damaging agents  
(Prudhomme et al., 2006) are considered the main factors that control 
competence. However, genetic transfer mechanisms mediated by conjugative 
plasmids are likely to be more prevalent in the spreading of resistance genes in 
nature than either transformation or transduction. This is because of plasmids are 
able to autonomously replicate, and they carry ARGs against all major classes of 
antibiotics (Kaur and Peterson, 2018). Plasmids can encode a collection of ARGs 
as part of transposons, thus simultaneously confer resistance to various classes of 
antibiotics and metal ions (Nikaido, 2009). Therefore, they can disperse ARGs over 
long genetic distances to different species, genera, and even kingdoms relying on 
plasmid host range (Kaur and Peterson, 2018). 
A study by Volkova et al. (2014) showed that conjugation seems to be 1000-
fold more common than transduction as a mechanism for the transfer of resistance 
genes. Carattoli (2013) demonstrated that the transmission of ARG determinants 
by conjugation is responsible for their contribution to worldwide prevalence in both 
community and hospital environments. The process of genetic exchange can be 
encouraged in “hot-spot” environments, such as wastewater treatment plants and 
sewage, agricultural and slaughterhouse waste and hospital effluents, due to the 
high density of bacteria, phages, and plasmids in these settings (Kenzaka et al., 
2010;von Wintersdorff et al., 2016). 
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The three mechanisms of HGT each have limitations including: the host 
range of the incoming plasmid or the phage, the host restriction modification 
systems, formation of cell-to-cell contacts, fitness cost of acquired new gene, as 
well as the ability of incoming DNA recombination with DNA of the host (Thomas 
and Nielsen, 2005;Domingues et al., 2012). Furthermore, the capability of MGEs 
to incorporate into a population is also dependent on its ability to autonomously 
replicate and achieve vertical transmission. For instance, the incompatibility group 
IncP, are the most successful conjugative plasmids that have a broad host range 
(Davies and Davies, 2010) facilitating their dissemination and maintenance in 
distantly related phyla (Klümper et al., 2015). Also, HGT exhibits success in the 
persistence of MGEs or DNA to in the environment (Kaur and Peterson, 2018). 
Recently, a novel mechanism termed ‘carry-back’ was proposed for inter-
phylum genetic exchange (Jiang et al., 2017). This mechanism involves 
conjugation mediated by a broad-host range conjugative plasmid (Klümper et al., 
2015) that may transfer a DNA fragment from commonly spread class 1 integrons 
of Proteobacteria to Actinobacteria, followed by recombination, consequently 
creating actinobacterial DNA flanked by proteobacterial DNA. Dead cells of 
Actinobacteria can release these actinobacterial DNA molecules flanked by 
proteobacterial DNA into the environment, and Proteobacteria can incorporate this 
DNA into their genome by transformation and homologous recombination (Kaur 
and Peterson, 2018).  
 
1.2.9 Chicken gut microbiota 
1.2.9.1 Chicken gut microbiota as sources of AR 
The system of animal production has been linked to the prevalence and 
evolution of AMR of organisms such as E. coli (Tadesse et al., 2012;Simoneit et 
al., 2015;Luna-Galaz et al., 2016), Enterococcus spp., Staphylococcus aureus 
(Bortolaia et al., 2016) and other foodborne zoonotic pathogens, like non-
typhoidal Salmonella (Luna-Galaz et al., 2016;Vickers, 2017;Nhung et al., 2017) 
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and Campylobacter spp. (Richter et al., 2015). Comparatively, little is known 
regarding the dissemination and mechanisms of AMR in pathogenic bacteria in 
food animal production including poultry. As reviewed previously (1.2.4) there is 
an increasing global consumption of poultry meat and eggs (Mishra and Jha, 
2019), thereby poultry production is one of the fastest growing  animal industries 
involved in nutrition and global food security. 
Some important human pathogens such as Campylobacter and Salmonella 
are commonly detected within the chicken microbiota where they are largely non-
pathogenic to chickens (Newell et al., 2011). However, they can be a source for 
disseminating pathogens to humans as well as a pool for transferring antibiotic 
resistance (Nhung et al., 2017). Since the commensal bacteria share the same 
habitat as pathogens, commensals may act as reservoir of multidrug resistance 
genes that are acquired by conjugative transfer from pathogenic bacteria.  
Poultry products are one of the most significant reservoirs for transmission 
of foodborne disease such as Campylobacter (Kaakoush et al., 2014). The 
abundance of this organism on poultry farms and in the surrounding environment 
is not surprising because the majority of warm-blooded domestic animals, wild 
animals and birds shed viable Campylobacter species in their faeces. Colonisation 
of broiler flocks by Campylobacter spp takes place at between 2–3 weeks of age 
and positive birds often remain colonised until slaughter (Kaakoush et al., 2014). 
  
1.2.9.2 Gastrointestinal tract of chicken  
The gastrointestinal (GI) tract of chickens is densely populated by a diverse 
microbiota that plays a vital role in digesting and absorbing nutrients, developing 
the immune system, and reducing the opportunity of pathogenic bacteria 
colonisation via attachment to the epithelial walls of the enterocytes acting as a 
protective barrier (Yeoman et al., 2012;Pan and Yu, 2014;Wang et al., 2016). The 
bacterial microbiota produces vitamins (e.g., vitamin K and vitamin B groups), 
short chain fatty acids (acetic acid, butyric acid and propionic acid), organic acids 
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(e.g., lactic acid) and antimicrobial agents (such as bacteriocins), lower 
triglyceride, and induction non-pathogenic immune responses, which all provide 
both nutrition and protection for the host (Jeurissen et al., 2002;Apajalahti, 
2005;Dibner and Richards, 2005;Yegani and Korver, 2008;Shang et al., 2018b). 
The GI tract of the chicken consists of the crop, proventriculus, gizzard, 
duodenum, jejunum, ileum, caeca, large intestine, and cloaca (Yeoman et al., 
2012). Each part of GI tract has different metabolic functions that are shaped by 
the resident microbial communities and thereby it is important to determine 
sampling location and study design (Shang et al., 2018b). Generally, the most 
representative phylum in GI tract of the chicken microbiota is Firmicutes followed 
by a small abundance of Proteobacteria and Bacteroidetes phyla, and a low 
abundance of Actinobacteria and Tenericutes members (Waite and Taylor, 2014).  
Microbial colonisation in the GI tract of chickens is highest in the caecum 
with a much greater bacterial diversity than found in the upper GI tract (Oakley 
et al., 2014). The caecum is considered the key site for bacterial fermentation of 
non-digestible carbohydrates as well the organ most targeted by pathogens for 
colonisation. In chickens this organ consists of two paired caeca, both harbouring 
similar bacterial communities (Stanley et al., 2015). The caecum microbiota is a 
stable, rich and diverse microbial community including many anaerobes (Salanitro 
et al., 1974;Videnska et al., 2013).  
The predominant residents of the caecal microbiota are members of the  
Clostridia genus followed by the genera Lactobacillus and Ruminococcus (Gong et 
al., 2007). Most Clostridia found in the caecum belong to three main families which 
are Clostridiaceae, Lachnospiraceae and Ruminococcaceae (Danzeisen et al., 
2011). Enterococcaceae, Enterobacteriaceae and Bacteroidaceae are also  
abundant families in the caecal microbiota  (Yin et al., 2010), which is also 
dominated by unknown and unclassified bacterial members (Stanley et al., 2013). 
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Factors which affect the chicken gut microbiota include: diet (Torok et al., 
2008), gender (Lumpkins et al., 2008), genetic background (Zhao et al., 2013), 
housing condition (Nordentoft et al., 2011), litter managements (Torok et al., 
2009;Cressman et al., 2010), feed restriction (Callaway et al., 2009) and density 
of rearing birds (Guardia et al., 2011).   
Research in recent years has focussed on the way in which the caecal 
microbiota develops with time from hatching to adult birds. A study by Oakley et 
al. (2014) documented significant shifts in caecal microbial communities from first 
day of hatching until 6 weeks of age in commercial broilers (Oakley et al., 
2014;Oakley and Kogut, 2016). Typically, the cecum richness and diversity 
increase through these 6 weeks, and the taxonomic composition of these microbial 
communities quickly changes from Proteobacteria, Bacteroides, and Firmicutes, to 
almost entirely Firmicutes by 3 weeks of age (Oakley et al., 2014;Oakley and 
Kogut, 2016). On the other hand, Kumar et al. (2018) found that Firmicutes were 
the most abundant phylum in both caeca and ileum at all the ages (day 0 to day 
42) except d 42 in the caeca where Bacteroidetes were abundant. The variation in 
reported bacterial composition can be explained because of differences in 
extraction of the nucleic acids, protocol used, primers, sequencing approach, 
environmental factors, dietary types/ composition, breed, and geographical 
conditions between different studies (Shang et al., 2018b).  
Some bacterial population may appear or disappear over time in the GI 
microbiota of older chickens whereas others remain stable during the life. Young 
chickens are dominated by Firmicutes species while adult birds (older than 7 
months) commonly colonised by Bacteroidetes (Callaway et al., 2009;Videnska et 




1.2.9.3 16S RNA Genes Technology  
Culture based microbial studies have provided a limited understanding of 
microbial communities, because less than 1% microbial organisms can be easily 
cultured (Kellenberger, 2001). The sequences of the small unit of ribosomal RNA 
gene in prokaryotes has become the most widely used technique for deducing the 
phylogenetic evolution among microbial species (Lane et al., 1985;Sharpton et al., 
2011). Ribosomal RNA genes are an ideal tool for studying microbial phylogeny 
because they contain both highly conserved regions across all bacteria and 9 
hypervariable regions which vary in terms of length, position and taxonomic 
discrimination (Van de Peer et al., 1996). The amplification of the hypervariable 
regions is carried out using the polymerase chain reaction with universal primers 
designed to bind to the conserved regions (Klindworth et al., 2013). These variable 
regions have different power levels of discrimination dependent on the microbial 
group and the short target regions (<300 bp). The most hypervariable informative 
part is the V4 region (Soergel et al., 2012).  
The nucleotide sequences of these amplified products can distinguish among 
bacteria to the genus or species level (Weisburg et al., 1991;Flint et al., 2006). 
The relative abundance of each sequence reflects the abundance of the bacterium 
in the original sample. Thus, the 16S rRNA genes sequencing gives a true census 
of a bacterial community by identifying the bacterial types present in a sample 
with its relative abundances. DNA sequencing technology has developed in the last 
few years, to the point that can enable complete census of the richness and 
diversity of complex communities (Shang et al., 2018b). This revolution of 
molecular sequencing biotechnology has shaped the view of microbial diversity 
and composition of various environments including the human gut, soil, and salt 
lakes as well as prediction function and interaction in various sections of the GI 
tract (Chen et al., 2013;Shang et al., 2018b). The Illumina Miseq is one of the 
high-throughput sequencing technologies that has allowed gene amplicon 
sequencing in microbial ecology studies where millions of paired-end reads can be 
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sequenced directly from the relevant environments (Chen et al., 2013;Wen et al., 
2017). This next generation sequencing (NGS) platform has offered an accurate, 
convenient, rapid, and inexpensive method for genomic research (Pettersson et 
al., 2009;Park et al., 2013). Likewise, it is the most frequently utilised system  
used in recent chicken gut microbiome and metagenomic research (Shang et al., 
2018b). However, this platform suffers from some limitations such as short read 
assembly and high cost (Kumar and Pitta, 2015). 
 
1.2.10 Modulation chicken gut microbiota by prebiotics 
To cope with the need for reducing the usage of antimicrobial growth 
promoters (AGPs) after their use was banned in poultry in the EU since 2006, 
several strategies involving different feed additives have been evaluated (Teng 
and Kim, 2018). Ideally these should promote growth but without encouraging 
antimicrobial resistance (AMR) and the transfer of ARGs from animal to human 
microbiota (Castanon, 2007;Yadav and Jha, 2019;Richards et al., 2020). Addition 
of prebiotics into broiler diets are one of these approaches that have been studied 
(Teng and Kim, 2018).  
Prebiotics have been defined as non-digestible food ingredients that when 
metabolised by gut microorganisms, modulates the composition or activity of the 
gut microbiota, thereby conferring a beneficial physiological effect on the host 
(Bindels et al., 2015;Pourabedin and Zhao, 2015). The main characteristics of 
prebiotics described by Patterson and Burkholder (2003). This includes the 
definition that prebiotics should be considered nondigestible food ingredients, not 
capable of being hydrolysed by host enzymes or even directly absorbing by host 
cells in GIs. Prebiotics should selectively stimulate one or limited numbers of 
health promoting bacteria, have the ability to change the intestinal microbiota and 




The potential advantages of dietary supplemention with prebiotic 
oligosaccharides in the gut microbiota are summarised in Figure 1.5, which 
includes: reduction of pathogens by competitive exclusion (Callaway et al., 2008); 
improving gut morphological structure (Pourabedin et al., 2014;Chee et al., 
2010b) and increasing the production of SCFA which modulates host immune 
response and metabolism (Saulnier et al., 2009;Roberfroid et al., 2010).  
Additionally, the formation of SCFA in the intestines involves: lowering pH, 
bioavailability of calcium and magnesium, and inhibiting of potentially harmful 
bacteria (Teitelbaum and Walker, 2002;Wong et al., 2006).  
Figure 1.5 Potential mechanisms of prebiotics action. 
Metabolisation of prebiotics by the gut commensal microbiota. Prebiotics can be fermented 
into short-chain fatty acids (SFCA) by the action of gut microbiota, mainly acetate, 
propionate, and butyrate. SCFA lowering the luminal pH, providing energy sources for 
epithelial cells, and have deep effects on inflammation modulators and metabolic 
regulations. Intestinal mucosal structure can also be improved by a well-balanced bacterial 
community. Some bacterial strains produce antimicrobial factors or induce the immune 
system by signalling dendritic cells. Both monosaccharides and oligosaccharides can 
decrease pathogen colonisation by blocking the receptor sites utilised by pathogens for 
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attachment to the epithelial cell surface. This figure is taken from  (Pourabedin and Zhao, 
2015). 
Generally fermented prebiotics in the intestine produce SCFAs which include 
butyrate that are considered as significant fuel for colonocytes, enhancing the 
growth and absorptive capacity of the epithelium in the colon and to suppress the 
growth of colonic carcinoma cells (Van Craeyveld et al., 2008;Pourabedin and 
Zhao, 2015;Teng and Kim, 2018). Additionally, fermentation of prebiotics produce 
lactic acid and some antibacterial substances, such as bacteriocin against 
pathogenic bacteria (Bogusławska-Tryk et al., 2012). 
In the gut microbiome, bacterial population that are thought to be specifically 
induced by prebiotic supplemented diet are lactobacilli and bifidobacteria. As in 
the intestine of young broilers, the administration of prebiotics in diets shows 
enhancement of the abundance of lactobacilli and bifidobacteria as well as 
reducing the titers of coliforms (Yang et al., 2008;Chee et al., 2010a). The 
enhancement of the populations of these beneficial bacteria leads to suppression 
of levels of pathogenic bacteria, such as Clostridium pefringens and E. coli, in the 
intestinal microbiome of broiler chickens (Xu et al., 2003;Kim et al., 2011;Ricke, 
2015). The increased availability of sequencing information regarding the 
microbial community means there may be other unidentified bacteria that are also 
selectively stimulated  by certain prebiotics (Kaplan and Hutkins, 2000;Hutkins et 
al., 2016). Furthermore, inhibition of pathogen colonisation by prebiotics can 
decrease harmful molecules produced by pathogens, which have been recognised 
as exogenous signals (Tizard, 2013). These signal molecules are known as 
pathogen-associated molecular patterns (PAMPs) which can be identified by 
pattern recognition receptors (PRR), such as toll-like receptors (TLRs) and NOD-
like receptors (NLRs), that are expressed on the surface of sentinel cells (Kogut, 
2013). When the PRRs recognise PAMPs, sentinel cells including epithelial cells, 
macrophages, mast cells, and dendritic cells, are activated, thereby cytokines 
produced for regulation of further innate immune responses. Likewise, prebiotics 
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themselves can act as non-pathogenic antigens which means they can be detected 
by receptors of immune cells leading to beneficial modulation of host immunity 
(Teng and Kim, 2018). 
Galacto-Oligosaccharide (GOS) is a valuable product that can be produced 
from the cheese whey industry. Whey is considered the most significant by-
product waste from the dairy industry because it can cause significant 
environmental pollution problems (Smithers, 2008). This by-product corresponds 
to 85–95% of the milk volume and comprises of 55% of milk nutrients with a 4.5-
5% w/v abundance of lactose (Chandrasekaran, 2012;Geiger et al., 2016). The 
process of bioconversion of lactose hydrolysates by using the catalytic activity of 
β-galactosidases to form valuable products is known as transgalactosylation. This 
reaction leads to the formation of oligosaccharides of different chain lengths and 
glycosidic linkages that act as prebiotics and possess structural similarity to 
oligosaccharides in human breast milk (Fischer and Kleinschmidt, 2018). 
Therefore, they are widely used in infant formulas because bovine milk contains 
only very small amounts of oligosaccharides (Sangwan et al., 2011). GOS are non-
digestible carbohydrates (lactose‐derived compounds) with known prebiotic 
activity. GOS generally consists of one or more galactose units that are usually 
linked to a terminal glucose. It shows variable degrees of polymerisation ranging 
from 2 to 8 monomeric units (Geiger et al., 2016). Thus, GOS can act as 
fermentable substrates for some members of the gut microbiota that have been 
determined to modulate the colonic flora by promoting of beneficial bacteria, such 
as bifidobacteria and lactobacilli, and inhibition of less desirable bacteria (Holzapfel 
and Schillinger, 2002;Rastall et al., 2005;Macfarlane et al., 2008;Geiger et al., 
2016).  
Studies have reported that the injection of GOS in ovo broilers 34 days after 
hatching is likely to increase body weight (Pruszynska-Oszmalek et al., 2015). In 
addition, GOS administration also modulated the intestinal microbiota as Park et 
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al. (2017a) found that GOS treatment showed higher abundance of Alistipes 
genus, Lactobacillus intestinalis and Faecalibacterium prausnitzii in broilers caeca 
compared with the control group. It has been reported that adding GOS to broiler 
diets could increase counts of Bifidobacteria members in faeces (Jung et al., 
2008;Teng and Kim, 2018). 
  
1.2.11 Salmonella 
1.2.11.1 Salmonella Background   
Salmonella is a genus of Gram-negative bacteria, usually motile, facultative 
anaerobic and non-spore forming bacilli, which belong to the Enterobacteriaceae 
family (Coburn et al., 2007;Dunkley et al., 2009;Agbaje et al., 2011). It grows at 
temperatures between 5–45°C in a pH range of 4–9 and with water activity above 
0.94 (Guthrie, 1992). These bacteria are sensitive to heat and are killed at 
temperatures of 70°C or above. Salmonellae are resistant to drying and may 
survive for years in dust and dirt. This genus includes two species, Salmonella 
bongori and Salmonella enterica. S. enterica has six subspecies: salamae, 
arizonae, diarizonae, houtenae, indica, and enterica (Wisner, 2011;Hooton et al., 
2014). These subspecies can be further classified based on their lipopolysaccharide 
(LPS) O antigen component and flagellar (H) antigen into more than 2500 serovars 
(Sabbagh et al., 2010;Wisner, 2011). Salmonella are capable of colonizing the GI 
tracts of many mammals, birds and reptiles and can persist in the environment as 
well (Callaway et al., 2008). Most Salmonella serovars are host-restricted, but 
some are not. Host-restricted serovars tend to cause systemic disease that 
threatens the life of the host, while non-host-restricted strains often produce 
gastroenteritis in many different host species (Wisner, 2011). 
Salmonella enterica is a leading cause of foodborne human diseases with 
poultry considered as the main source of human illnesses (Havelaar et al., 
2015;Hughes et al., 2017). Annually, Salmonellosis is responsible for 78 million 
incidences and 59 thousand foodborne-related deaths (Havelaar et al., 2015). 
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Yearly, in the United States, non-typhoidal Salmonellosis is responsible for 1 
million cases, 19 thousand hospitalizations, and 378 deaths (Scallan et al., 2011). 
Most susceptible to Salmonella infection are children (≤5 years) and the elderly 
whom frequently require medical treatment (Bythwood et al., 2019).  
The severity and length of illness can be treated by antibiotic therapeutics 
(Hu et al., 2014). However, the emergence of antimicrobial-resistant Salmonella 
has reduced the efficacy of commonly prescribed antimicrobials that treat 
salmonellosis  (Wasyl et al., 2015;Iwamoto et al., 2017;Tyson et al., 2017;Duong 
et al., 2018). The documented cases of treatment failure (nontyphoidal 
Salmonella) have become a significant public health concern (Collard et al., 
2007;Tribble, 2017;Duong et al., 2018). 
Contaminated meat and eggs are frequently associated with salmonellosis. 
The acquisition of Salmonella by chicks takes place via vertical transmission from 
parents as well as horizontal transfer from the rearing environment and feed 
(Rothrock Jr et al., 2015). The majority of the initial infection occurs at an early 
stage of life (post-hatch); however, Salmonella infection can happen during any 
stage of the production cycle (Byrd et al., 1999;Shanmugasundaram et al., 2019). 
Salmonella prevention within poultry flocks is difficult since cleaning and 
disinfection fail to eradicate Salmonella in poultry (Davies and Wray, 
1996;Shanmugasundaram et al., 2019). Therefore, it is important to control 
Salmonella infection within poultry products to increase the safety of human 
consumed food. 
S. Enteritidis is considered the most predominant Salmonella serovar in 
human cases associated with the contamination of poultry products in US 
(Morningstar-Shaw et al., 2016). S. Enteritidis has historically been linked to 
poultry and it has been proposed to succeed due to niche displacement of the 
closely related host-specific poultry Salmonella serovars Gallinarum and Pullorum, 
which had previously been removed from commercial flocks (Louis et al., 
1988;Bäumler et al., 2000;Control and Prevention, 2000;Porwollik et al., 
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2005;Martelli and Davies, 2012;Ricke, 2017). Several controlling strategies on-
farm have been evaluated/investigated for preventing Salmonella shedding in 
poultry, include vaccination (Varmuzova et al., 2016). However, these strategies 
have not succeeded in controlling Salmonella contamination in chicken 
(Koutsoumanis et al., 2019), and thereby, it is important to identify alternative 
on-farm approaches to manage Salmonella infection in broilers 
(Shanmugasundaram et al., 2019). 
 
1.2.11.2 Salmonella Enteritidis pathogenicity in the GI tract of chicken  
Although the infection of zoonotic Salmonella in poultry is largely 
asymptomatic (Kogut and Arsenault, 2017), S. enterica serovars, specially S. 
Enteritidis and S. Typhimurium have been shown to colonise the lower part of GI 
tract in the first days of life, and stimulate a low-level systemic infection in 
chickens (Beal et al., 2005). The persistence of Salmonella colonisation may 
extend for several weeks without giving any clinical signs of disease in the GI tract 
of chickens. While the process of pathogenesis by S. enterica serovars includes 
adhesion, colonisation, invasion, and intracellular replication, which can lead to 
the systemic spread of the organism to internal organs such as the liver and 
spleen. The first important step in colonisation and persistence is efficient adhesion 
to the epithelial layer of the GI tract. The cecum is predominantly colonised by S. 
enterica serovars, however, their translocation to internal organs is often limited, 
mainly in adult birds (Van Immerseel et al., 2003;Beal et al., 2005). Generally, 
the primary source of SE infection and transmission in chickens is through the 
faecal-oral route (Shah et al., 2017). SE frequently colonises the crop after 
ingestion, (Hargis et al., 1995;Turnbull and Snoeyenbos, 1974), but less 
frequently in the proventriculus and duodenum. However, the most preferential 
and persistent sites are in the lower ileum, cecum, and cloaca (Turnbull and 
Snoeyenbos, 1974). Subsequently, SE is able to invade the intestinal epithelium 
and localise in the submucosa within 4 hours of infection (Berndt et al., 2007). 
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The process of invasion happens via M-cells that sample the intestinal lumen and 
nonphagocytic cells. The invasion of intestinal prompts inflammation that is 
characterised by the infiltration of heterophils, macrophages, red blood cells, and 
other immune cells into the lamina propia and caecal luminal exudate (Porter Jr 
and Holt, 1993;Macri et al., 1997;Van Immerseel et al., 2002). When inflammation 
proceeds, SE produces virulence factors that support Salmonella survival within 
macrophages, which are thought to be responsible for the systemic spread to 
colonise internal organs including the liver and spleen, and in laying hens this also 
results in colonisation of the reproductive tract organs (Berchieri Jr et al., 
2001;Higgins et al., 2007;He et al., 2010).  
The kinetics of SE infection varies depending on the age or type of chickens 
(Shah et al., 2017). The infection of Salmonella in chickens seems to be dependent 
on age. Early infected birds by Salmonella in day 1 of life have long extended 
periods of carrying Salmonella with high numbers compared to those infected at 
day 8 of life (GAST and Beard, 1989). As Salmonella clearance is slower in early 
challenged birds than those challenged later in life 3–6 weeks (Beal et al., 2004). 
Moreover, detectable changes in the cecum microbiome have been recognised in 
birds that are exposed to Salmonella in the first 4 days post hatching (Juricova et 
al., 2013). 
 
1.2.11.3 Prevalence of antibiotic resistance Salmonella in poultry  
The presence of Salmonella on poultry meat products is associating with their 
prevalence in the poultry farms (Choi et al., 2014). Although several methods 
have been applied to eradicate Salmonella colonisation on breeding farms, 
including vaccination, use replacement systems of all-in/all-out on broiler farms, 
and antimicrobial free approaches, high rates of Salmonella expansion and 
antimicrobial-resistance are still common place on broiler farms (Ishihara et al., 
2009;Rayamajhi et al., 2010). Poultry litter, has been documented as indicator for 
the presence of Salmonella in poultry farms (Shang et al., 2018a). 
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Despite representing a minor population of chicken microbiota and litter, 
poultry sources of zoonotic Salmonella not only represent a source of infection but 
are a repository for antimicrobial resistance in food. Bythwood et al. (2019) 
documented abundant AMR Enterobacteriaceae in poultry and poultry litter in the 
absence of antibiotic treatments. Several studies have reported the similar 
findings (Fairchild et al., 2005;Smith et al., 2007;Agga et al., 2016;Liljebjelke et 
al., 2017).  
As Salmonella that colonise chickens easily acquire antimicrobial resistance 
genes from the resident bacteria present in chickens, even if antimicrobial use is 
absent (Bythwood et al., 2019). Poultry litters are enriched in bacteria with a high 
abundance of class 1 integrons at 1 copy per 1-100 bacterial genomes (Nandi et 
al., 2004). The most prevalent integrons carrying antimicrobial resistance genes 
in poultry litter are remarkably similar to those present in clinical and food isolates 
of Salmonella (Nandi et al., 2004;Liljebjelke et al., 2017).  
The appearance of Salmonella that possess extended-spectrum β-
lactam/cephalosporin resistance has been assigned to acquisition of conjugative 
plasmids (Winokur et al., 2000). These plasmids often carry other resistances, 
such as chloramphenicol, florfenicol, streptomycin, and tetracycline (Winokur et 
al., 2000;Doublet et al., 2004;van Loon et al., 2015). Antimicrobial resistant 
(AMR) Salmonella with high abundances of streptomycin resistance, either alone 
or in combination with other antibiotics (36.3%), has been recovered from 
commercial broiler chicken farms. Streptomycin and sulfadimethoxine resistant 
Salmonella tend to carry the determinants on the transposon Tn21 (Liljebjelke et 
al., 2017). This transposon encodes the merA gene for mercury resistance; aadA1 
resistance gene for streptomycin; and sul1 resistance gene for sulfadimethoxine 
resistance (Liebert et al., 1999). Tn21 is frequently involved in the dissemination 
of mercury and antimicrobial resistance in nature (Liebert et al., 1999), and is 
widespread in poultry Salmonella and E. coli (Bass et al., 1999). The association 
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between the merA and aadA resistance genes and streptomycin/ sulfadimethoxine 
resistance was observed in 17.72% of streptomycin resistant Salmonella 
(Liljebjelke et al., 2017). 
 
1.2.11.4 Prebiotics for Salmonella control in poultry 
Controlling Salmonella proliferation in poultry is a key element to reduce the 
contamination of poultry products consumed by humans (eggs and meat). Efficient 
alternative control strategies are required to decrease the hospitality of the cecum 
to Salmonella colonisation (Hughes et al., 2017). Feed additive prebiotic, 
represents one of these strategies that has attracted the attention of the poultry 
industry. Besides its role in promoting bird health, prebiotics can improve the 
safety of poultry products by making intestinal environment unfavourable for 
foodborne pathogens including Salmonella (Micciche et al., 2018). The most 
frequently studied prebiotics used in poultry production are fructo-
oligosaccharides (FOS), mannan-oligosaccharides (MOS) and galacto-
oligosaccharides (GOS) (Mundt et al., 2015;Pourabedin and Zhao, 2015;Ricke, 
2015;Gibson et al., 2017). Despite this, GOS has not received the same level of 
attention for poultry farm use as compared with FOS and MOS (Pourabedin and 
Zhao, 2015). 
Numerous studies have documented the role of increases in short chain fatty 
acids (SCFAs) concentrations with the reduction of Salmonella proliferation 
(Durant et al., 2000b;Durant et al., 2000a), which can be achieved by prebiotic 
administration (Cummings and Macfarlane, 2002;Ricke, 2015). Prebiotic 
protection against Salmonella colonisation is proposed to be accomplished by 
competition for binding sites (Durant et al., 2000b) and increasing the levels of 
the SCFAs concentrations in the intestine (Ricke, 2015).  
The most extensively studied oligosaccharides against Salmonella are MOS 
(Pourabedin, 2015). For instance, a study by Fernandez et al. (2002) on chickens 
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challenged with S. Enteritidis showed a reduction in caecal Salmonella 
concentration. While Lourenço et al. (2015) elucidated that feed supplemented 
with MOS boosted lymphocyte counts (CD4+ and CD8+) in the ileum and cecum, 
and reduced Salmonella shed in chicken faeces when challenged with S. 
Enteritidis. Stanley et al. (2016)  also demonstrated a 1-3 log reduction of caecal 
Salmonella counts in 21-day old chicks supplemented 0.05% MOS and MgSO4. 
Fructooligosaccharides supplements have been demonstrated to enhance 
Lactobacillus and Bifidobacterium populations, resulting in an increasing in SCFAs 
and lactate that are presumed to improve the immune system and the reduce 
Salmonella colonisation (Cummings and Macfarlane, 2002;Bogusławska-Tryk et 
al., 2012;Emami et al., 2012;Ricke, 2015). The elucidated mechanism of FOS 
action is achieved by fermentation of FOS by Lactobacillus and Bifidobacterium, 
which leads to increase both SCFAs and lactate in the cecum resulting in a reduced 
Salmonella population (Cummings and Macfarlane, 2002;Ricke, 2015). 
The influence of the GOS on the caecal microbiome and the carriage of 
Salmonella was reported by Hughes et al. (2017) indicated that Salmonella counts 
were reduced in the GOS treated birds challenged with a cocktail of Salmonella 
Typhimurium and Salmonella Enteritidis. They found that the prebiotic GOS could 
modify caecal tonsil immune gene expression and the caecal microbiome, 
proposing that this treatment could be a useful tool for lowering the carriage of 
Salmonella in poultry. Azcarate-Peril et al. (2018) also identified the role of GOS 
in acceleration of Salmonella clearance via modifying the gut microbiome. 
Moreover, a study by Searle et al. (2010) indicated that the existence of GOS 
within the GI tract has been shown to decrease the adherence and invasion of 
Salmonella in human enterocytes. Thus, modulation of the microbiome through 
the using prebiotics has been shown to have an effective impact in the gut 






1.3 Aims and Objectives 
This research aimed to test the hypothesis that GOS supplemented feed can 
alleviate the expansion of antibiotic resistance gene carriage in the bacterial 
populations of the broiler chicken microbiome in addition to the established role of 
maintaining gut health.  
Particularly, the aims of the current study are to investigate the overall 
prevalence of ARGs in the caecal contents of broiler chickens reared in controlled 
biosecure conditions and to compare these with birds reared for commercial 
production by using class1 integrons as a bioindicator for antibiotic resistance. In 
this context, the gene cassette (GCs) contents of class 1 integrons will be reported 
from birds reared under the different regimes. Profiles of the 16S rRNA genes of 
the caecal microbiota of these birds will be investigated and the patterns of 
resistance evaluated with respect to the relative abundance of the intestinal 
bacterial populations. Phenotypic antimicrobial resistance will be estimated by 
examining trimethoprim coliform resistant populations. The effect of prebiotic 
galactooligosaccharide feed on microbiome composition will be carried out in order 
to investigate the prebiotic’s role in modifying the gut microbiota and whether 
there was any reduction in resistance gene carriage by comparing control and GOS 
diets. In addition, the involvement of GOS in the overall reduction of intestinal 
colonization of zoonotic Salmonella Enteritidis (PT4) 125109 will be assessed with 










































2.1 General bacterial growth and storage media preparation  
All details for the preparation of media and antibiotics described in this thesis 
are presented in Appendix 1. The suppliers for all media and chemical substances 
are listed in Table 2.1. 
 
Table 2.1 Media and chemical substances that were used in this study 
Compound Supplier 
Agar Bacteriological (Agar No.1) LPOOII 
Oxoid, UK Ltd 
 
 
Maximum Recovery Diluent (MRD) (CM0733) 
Xylose-Lysine-Desoxycholate (XLD) agar (CM0469) 
Modified Semi-solid Rappaport Vassiliadis (MSRV) agar CM1112 
MacConkey agar No 3 (Mac_03) CM115 
De man, Rogosa and Sharpe (MRS) agar CM0361 
Nutrient Agar (NA) 
Nutrient broth No. 2 CM0067 











Dimethyl sulphoxide (DMSO) 
Sodium chloride 
Fisher Scientific, UK 
Ltd 
Ethanol absolute 




2.2 Salmonella  
2.2.1 Salmonella growth conditions 
Salmonella enterica 125109 was selected to be the model strain used to 
colonise broiler chickens, as it is nalidixic acid resistant and this could be used to 
easily select and enumerate it. Salmonella were cultured on m-XLD plates (Oxoid, 
UK) or nutrient agar in aerobic incubator at 37°C for 24 h or 50 in YT broth 
(Appendix 1.1.10) incubated at shaker incubator at 200 rpm for 24h. Salmonella 
enterica U288 was used as positive control in PCR usually cultured on m-XLD and 
then on nutrient agar plates for DNA extraction.  
2.2.2 Salmonella serotype test 
Three types of Salmonella antisera (Poly O, O9 and O4 antisera; Pro-Lab 
Diagnostics, USA) were used to confirm Salmonella serotype. The slide 
agglutination test was performed by adding two separate loopfuls (10 l each) of 
PBS (Appendix 1.2.3) on a clean glass slide. Then, one or two bacteria colonies 
were emulsified in one of the drops, while the positive control Salmonella was 
emulsified in the other drop. A 10 l aliquot of PBS was added to the first test 
subject (a negative control). Then, 10 l of antisera was added to the remaining 
test subject and 10 l of Poly O antisera was added to the positive control 
Salmonella drop. The glass slide was gently rocked for a minute and agglutination 
was checked. Negative results showed no agglutination while positive results 
showed agglutination with Poly O. Salmonella enterica 125109 is serotype O9 so 
agglutinated with the O9 serum, the Poly O serum but not the O4 serum. 
 
2.2.3 Preparation of Salmonella inoculum 
To prepare the inoculum, Salmonella Enteritidis 125109 was grown on m-
XLD and LB agar plates (Appendix 1.1.1 and 1.1.6) and incubated for 24 h at 37 
ºC. A colony was inoculated into 50 ml of LB broth in a 250 ml conical flask and 
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incubated at 37°C with shaking at 200 rpm for 16 h. The cells were washed twice 
with 50 ml of MRD.  
The suspension was diluted 1:10, then the OD600 was adjusted to 0.34 
(approximately 108 CFU /ml).  The actual dose is determined by decimal dilution 
of the suspension 10-6 with 0.1 ml spread on XLD in triplicate using the 10-4 to 10-
6 dilutions. 
 
2.3 Experimental birds 
Two trials involving experimental chickens are described in this thesis. The 
first trial was conducted under biosecure conditions in the Bio-Support Unit (BSU) 
at the University of Nottingham, Sutton Bonington Campus. The trial started from 
hatching until 35 days of age (da), with four sampling days (22, 24, 28, 35 da). 
The second trial was conducted using birds reared under commercial conditions 
with two sampling days at 30 and 37 da. Both trials were designed and carried out 
according to the ARRIVE (Animal Research: Reporting of in Vivo Experiments) 
guidelines (Kilkenny et al., 2010) which is a system to improve the design, analysis 
and reporting of research using animals. 
 
2.3.1 Ethics statement   
The use of birds in experiments were subjected to an approval process under 
national guidelines by the United Kingdom Home Office. This project was approved 
under United Kingdom Government Home Office Project Licensing ASPA 86. The 
University Ethics Committee internally reviewed all project licenses prior to 
submission to the Home Office. This includes the handling of animals, scrutiny of 




2.3.2 Selection of broilers and Salmonella free test 
The male Ross 308 birds were selected because they are a modern broiler, 
and their growth rate is in accordance with Home Office regulation in terms of size 
restrictions of pens for experimental birds. All male birds were supplied at one day 
old from P.D. Hook Ltd.  
In order to ensure that the birds were Salmonella free, a test was performed 
by collecting all the papers on which the birds had been transported. The papers 
were shredded and added to BPW for Salmonella enrichment as described below 
in 2.4.1.3 to check that the birds were Salmonella free. 
 
2.3.3 Pre-trial test for selecting antibiotic resistance genes and its 
concentration  
One sample of caecal contents from a chicken, reared under commercial 
conditions, was randomly selected for the pilot study. Approximately 0.2 g of 
caecal contents was weighed and MRD was added to give a 10% suspension. The 
suspension was mixed, and then serial dilutions were prepared to 10-4. Three types 
of media were used: MRS, Mac-03 and m-XLD. The agar plates were supplemented 
with trimethoprim or lincomycin used in three different concentrations. For 
trimethoprim these were 5, 10 and 20 µg/ml. For lincomycin these were 30, 50, 
70 µg/ml. Each serial dilution was inoculated on to each of the three different 
media, with three different concentrations, of the two different antibiotics. The 
workflow illustrated in Figure 2.1. 
 
2.3.4 Trial 1 design (Biosecure or controlled housing birds, CH) 
On arrival at the BSU, the 112 birds were randomly penned at two rooms. 
Control birds (non-infected) in Room 1 in two groups, G1 (standard feed or non-
GOS feed) and G2 (standard feed supplemented by GOS). Birds to be colonised 
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with Salmonella were penned in Room 2 also in two groups, G3 (standard feed) 
and G4 (GOS feed). Feed and water were supplied ad libitum with alternating light 
and dark regimes of 12 hours. 
The birds were fed starter standard diet (G1 and G3) or standard diet with 
3% w/w GOS (G2 and G4), until day 10 da. Groups G1 and G3 were then changed 
to standard grower diet while groups G2 and G4 were fed GOS grower diet, where 
the amount of GOS in the diet was reduced to 1.5% w/w, for economic reasons. 
At 22 da all birds in G1, G2, G3 and G4 were fed a standard finisher diet until 35 
da. Birds in groups G3 and G4 were given 4.6 x108 CFU/ml Salmonella Enteritidis 
125109 (nalidixic acid resistant), at 20 da, by oral gavage, while birds in G1 and 
G2 were given an equivalent mock dose of MRD. Each group contained at least 
seven birds per sample point to be able to measure a significant 1 log10 reduction 
in intestinal Salmonella colonisation at 95% confidence. During the experiment, 
temperature and humidity were controlled in both rooms. Euthanasia of birds were 
carried out by exposure to rising CO2 gas according to Schedule 1 of the UK 













Table 2.2 Experimental design of Trial 1  
Groups Diet 
Sampling date and Bird 
number 
Group 1 Uninfected / standard feed 
(n = 7 at 22, 24, 28 
and 35 da, total n = 35 
birds) 
Group 2 Uninfected/GOS feed 
(n = 7 at 22, 24, 28 





(n = 7 at 22, 24, 28 
and 35 da, total n = 35 
birds) 
Group 4 
Salmonella challenge/ GOS 
feed 
(n = 7 at 22, 24, 28 





















2.3.5 Trial 2 design using commercial birds 
A total of 40 Ross 308 broiler chickens were obtained from a commercial 
source (Moy Park, UK), 20 birds fed standard control diet (ctl), and 20 fed galacto-
oligosaccharides diet (GOS). Birds were placed in the barn as day olds and 
brooded at a temperature of 32°C and relative humidity of 60% to 70%. During 
rearing, starter GOS diet (3% w/w) or starter control diet was given until 11 da 
then the diet was changed to grower control or a GOS diet with less GOS (1.5% 
w/w). At 22 da all birds were fed control diet until 37 da. The chickens were raised 
in barns in commercial conditions and GOS fed birds kept separately from control 
birds. The thinning process (reducing the number of birds to allow for more space 
or a proportion of birds are transported or taken from the main flock to lower 
stocking density before birds are finally removed for slaughter) was carried out at 
30 da and 20 birds collected at random. The birds were transferred to The 
University of Nottingham where the chickens were humanely euthanized by  
carbon dioxide asphyxiation. Caecal content and tissue samples were collected for 
further analysis. The samples were stored at -80°C until processed. Both 
experiments were performed according to the guidance of The Institutional Animal 
Care and Use Committee at the UK, and it was approved by the Local Ethics 










Table 2.3 Trial 2 commercial chicken experiment design  
Groups Diet 
Sampling date and Bird 
number 
G1 standard feed (n = 10 birds, at 30 da) 
G2 GOS control feed (n = 10 birds, at 30 da) 
G3 standard feed (n = 10 birds, at 37 da) 
G4 GOS control feed (n = 10 birds, at 37 da) 
 
 
2.3.6 Feed composition and quality control 
The starter diet comprised of wheat (59.9% [wt/wt]), soya meal (32.5% 
[wt/wt]), soyabean oil (3.65% [wt/wt]), limestone (0.6% [wt/wt]), calcium 
phosphate (1.59% [wt/wt]), sodium bicarbonate (0.27% [wt/wt]), the enzymes 
phytase and xylanase (dosed according to the manufacturer’s instructions; DSM 
Nutritional Products Ltd., Basel, Switzerland), and a vitamin mix containing salt, 
lysine hydrochloride, DL-methionine, and threonine. The wheat content has 
increased in both the grower and finisher diets at the expense of soya meal by 2 
and 5% (wt/wt), respectively. The prebiotic GOS was supplied as Nutrabiotic 
(GOS, 74% [wt/wt] dry matter, Dairy Crest Ltd., Davidstow, Cornwall, UK). The 
preparations of GOS contained a mixture of monosaccharides (glucose and 
galactose) and oligosaccharides (DP2 to DP8). The disaccharide lactose, a reactant 
in the manufacture of galacto-oligosaccharides, is not a galacto-oligosaccharide 
otherwise all other disaccharides and longer oligosaccharides (DP3+) are galacto-
oligosaccharides and nondigestible. The starter feed was supplemented with 
3.37% (wt/wt) GOS and isocaloric adjustments made in the wheat (54% [wt/wt]) 
and soybean oil (4.88% [wt/wt]) contents. The grower and finisher feeds 
contained 1.685% GOS with respective adjusted wheat contents of 57.7% (wt/wt) 
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and 63.3% (wt/wt) and soybean oil contents of 6.14% (wt/wt) and 6.22% (wt/wt). 
The final feeds were isocaloric (metabolizable energy including enzyme 
contribution) and contained the same crude protein levels and Degussa poultry 
digestible amino acid values which are lysine, methionine, methionine plus 
cysteine, threonine, tryptophan, isoleucine, valine, histidine, and arginine 
(Richards et al., 2020). 
 
2.4 Sample collection and treatment   
The procedure of treating all samples is summarised in Figure 2.2. 
 
2.4.1 Caecal contents  
Approximately one gram of caecal content was immediately transferred into 
cryovial tubes, frozen in liquid nitrogen and then stored at -80°C for genomic DNA 
extraction. Another one gram of fresh material was collected from caeca combined 
into pre-weighed universals. Each collected sample was diluted in MRD to give a 
10 % w/v suspension. The sample was then serially 10-fold diluted (20 µl to 180 
µl) in the same medium to 10−5 in 96 well plates. Aliquots of 100 µl of appropriate 
dilutions (detailed below) were spread on the appropriate different agar plates 
(detailed below) in triplicate and incubated under the appropriate conditions 
(detailed below). The average values of colony-forming units (CFU) were used for 
the statistical analysis. Colonies was counted after overnight incubation by coulter 
counter (Digital colony counter, Stuart SC6 Colony counter 
- Stuart Equipment, protected by BioCote, UK). The CFU/ml was calculated using 
following formula,  




2.4.1.1 Enumeration of coliforms and trimethoprim resistant coliforms in 
caecal contents  
For coliform enumeration (this include counts of lactose fermenters and non-
lactose fermenting bacteria), 100 μl of serial dilutions 10-4-10-6 were spread on 
Mac-03. For trimethoprim resistant coliforms, 100 μl of dilutions 10-1-10-4 were 
spread on Mac-03 with trimethoprim (20 µg/ml). Both types of plate were 
incubated under aerobic conditions at 37°C for 24 h before colonies were counted. 
Mac-03 media contain crystal violet and bile salts as selective agents for 
preventing the growth of Gram-positive bacteria. 
 
2.4.1.2 Salmonella enumeration in caecal contents modified from 
Atterbury et al. (2007) 
For Salmonella enumeration, 100 μl of serial dilutions 10-2 to 10-5 were 
spread in triplicate onto m-XLD plates (XLD with 1 µg/ml of Novobiocin and 12.5 
µg/ml Nalidixic acid added) and incubated at 37°C for 24 h. Before counting, a 
confirmation test was done on representative Salmonella colonies (typically black) 
by slide agglutination tests with Poly O, and O9 serotype-specific antisera (Pro-
Lab Diagnostics, Cheshire, United Kingdom).  
 
2.4.1.3 Salmonella enrichment from caecal contents  
To ensure Salmonella were not present in the non-infected control groups, 
pooled swabs of approximately 0.1 g of caecal contents were transferred to 50 ml 
BPW (Appendix 1.2.1) for Salmonella enrichment for 16-20 h at 37 oC. Three 100 
µl aliquots of the incubated BPW suspension were dispensed on to MSRV plates 
and incubated without inversion at 42C for 24 h. Any growth was sub-cultured to 
XLD plates (with no nalidixic acid or novobiocin added) and incubated at 37°C. If 
any suspected colonies were identified they were checked with Poly O antiserum 




 2.4.2 Liver and spleen  
Approximately 1-5 g of liver and spleen tissues were added to weighed 
stomacher bags, reweighed and BPW to 10 % w/v was added. The bag was sealed, 
and the contents stomached for 1 min on medium speed, in a Seward Stomacher® 
80 (Seward Biomaster; UK). All bags were incubated at 37oC for 16-20 h. For 
enumeration, 100 µl of the 10 % tissue suspension was spread on m-XLD 
incubated at 37°C for 24 h. For enrichment three 100 µl aliquots of the incubated 
tissue BPW suspension were dispensed onto MSRV plates and incubated without 




























XLD+ 5 µg Trimethoprim 
MacConkey No 3 + 5 µg Trimethoprim 
MRS + 5 µg Trimethoprim 
XLD+ 10 µg Trimethoprim 
MacConkey No 3 + 10 µg 
Trimethoprim MRS + 10 µg Trimethoprim 
XLD+ 20 µg Trimethoprim 
MacConkey No 3 + 20 µg Trimethoprim 
MRS + 20 µg Trimethoprim 
XLD+ 30 µg Lincomycin 
Mac 3 + 30 µg Lincomycin 
MRS + 30 µg Lincomycin 
XLD+ 50 µg Lincomycin 
MRS + 50 µg Lincomycin 
Mac 3 + 50 µg Lincomycin 
XLD+ 70 µg Lincomycin 
MRS + 70 µg Lincomycin 

























500 ml of each media was made. 25 ml of molten agar was transferred to universals kept war in water 
bath, and antibiotics at different were added and quickly media pour into Petri dish. 
 
Mac 3 plates incubated at 37°C 
XLD plates incubate at 42°C 
MRS plated incubated at 37°C 
anaerobic 






Moy Park caecal contents 
Start with 1 sample Spread 100 µl 






 Figure 2.2 Summary of workflow in Trial 1 (controlled housed birds) for studying the effect of GOS diet on Salmonella 




2.5 Nucleic acid extraction and analysis  
 
2.5.1 Gel electrophoresis  
 
2.5.1.1 Agarose gel electrophoresis  
Agarose gel electrophoresis was used for routine analysing of DNA fragments 
produced from PCR in this thesis. To prepare an agarose gel, 0.8% or 1% w/v 
agarose (Sigma-Aldrich) was firstly added to 100ml of 1x TAE buffer (40 mM tris-
acetate adjusted with glacial acetic acid to pH 8, 1 mM disodium ethylene-diamine-
tetra-acetic acid) in a 250ml sterile conical flask. This mixture was completely 
melted by microwave and kept until it cooled to approximately 50°C with gentle 
mixing every 5 min. Ethidium bromide (Fisher) was added at a final concentration 
of 0.4 μg/ml and gently mixed by swirling the flask. This mixture was poured into 
a pre-assembled casting tray provided with desired comb. The gel was allowed to 
solidify at room temperature for approximately 20-30 min, and the rubber dams 
and comb were carefully removed from the casting tray. The tray with gel was 
then placed in a gel electrophoresis tank containing TAE buffer, and DNA samples 
were loaded into the wells. In order to estimate the size of DNA samples either a 
100 bp or 1 kb DNA ladder (New England Biolabs, UK) were also loaded to wells. 
These samples were run at 75V-80V for approximately 45-60 min until 
bromophenol blue dye reached ¾ length of the gel. Finally, samples were 
visualised under UV light using gel documentation system (Gel Doc XR+ System, 




2.5.2 Genomic DNA isolation 
  
2.5.2.1 GenElute Bacterial Genomic DNA kit  
Genomic DNA of gram-negative bacteria (S. enterica U288, S. enterica, 
P125109 and E. coli J53 pMG101 and trimethoprim resistance isolates) were 
extracted from cells using GenElute Bacterial Genomic DNA kit (Sigma-Aldrich) 
according to manufacturer’s instructions. The overnight growth of bacterial cells 
was harvested from LB agar plates or nutrient ager (Appendix 1.1.6 and 1.1.8) 
and suspended in 1.5 ml sterile RO water using a sterile cotton swab. The 
suspension was centrifuged in a bench top centrifuge (HETTICH MIKRO 185; 
Germany) at 12,000 x g for two min. The supernatant was removed, and the pellet 
was thoroughly re-suspended in 180 μl of Lysis Solution T followed by addition of 
20 μl of 20 mg/ml DNase-free RNase. Then, 20 μl of 20 mg/ml proteinase K 
(Sigma-Aldrich / Appendix 1.1.13) was added and this suspension was incubated 
in heat block (Grant QBT2; UK) for 30 min at 55°C. After incubation, 200 μl of 
Lysis Solution C was added to the mixture and thoroughly vortexed for 15 s 
followed by re-incubating at 55°C for 10 min. During incubation, 500 μl of column 
preparation solution was added to the column to maximize DNA binding to the 
membrane and centrifuged at 12,000 x g and the flow-through was discarded. 
After incubation of lysed suspension, 200 μl of 100% ethanol was added and 
thoroughly vortexed for 10 s. Then, the homogenous suspension was transferred 
into the binding column by using a wide-bore pipette to avoid shearing DNA and 
the column was then centrifuged at 6,500 x g for 1 min. The flow-through was 
discarded and 500 μl of First Wash Solution was transferred into the column. The 
column was then centrifuged at 6,500 x g for 1 min and the flow-through was 
discarded. Then, 500μl of Second Wash Solution was added into the column and 
it was centrifuged at 12,000 x g for3 min. The collection tube was discarded and 
was replaced with a new tube. An aliquot of 100 μl of Elution Solution was loaded 
into the centre of column and left for 1-5 min to elute the DNA. The column was 
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then centrifuged at 12,000 x g for 1 min and the flow-through was collected. 
Extracted DNA concentration was measured using a Nano-drop ND1000 
spectrophotometer (ThermoScientific, Wilmington, USA). Finally, isolated genomic 
DNA was stored in a-20°C freezer for long term storage. 
 
2.5.2.2 DNA extraction from poultry caecal contents (Trial 2) by MP 
Biomedicals Fast DNA SPIN Kit  
Total genomic DNA was extracted from approximately 250 mg of total caecal 
contents samples using the Fast DNA Spin extraction kit (MP Biomedicals; USA) 
according to manufacturer’s instructions protocol. Approximately 250 mg of caecal 
contents was weighted into a 2 ml Lysing Matrix E tube, 825 μl of Sodium 
Phosphate Buffer was added followed by 275 μl of PLS solution. The mixture was 
then vortexed for 10-15 s. Sample tubes were centrifuged at 14,000 x g for 5 min 
and the supernatant aseptically decanted. An aliquot of 978 μl of sodium 
phosphate buffer was added followed by 122 μl of MT Buffer. The mixture was 
vigorously mixed by vortexing, and samples homogenized in the FastPrep® 24 5G 
instrument set at 6.0 m/s for 40 s. Samples were centrifuged at 14,000 x g for 5 
min and supernatant transferred to a clean 2.0 ml centrifuge tube. Then, 250 μl 
of PPS solution was added, vigorously mixed (not vortexed), and incubated at 4°C 
for 10 min. After incubation, samples were centrifuged at 14,000 x g for 15 min. 
During centrifuging, 1 ml of binding matrix solution was mixed and added to a 
clean 2 mL conical tube (not supplied). The supernatants from the samples were 
then transfered to the binding matrix solution in the 2 mL conical tube, then tubes 
gently mixed by hand for 3-5 min. All tubes were centrifuged at 14,000 x g for 2 
min and the supernatant decanted. The binding mixture pellet was washed by re-
suspending with 1 ml Wash Buffer 1. The following step required two centrifugation 
steps. First, approximately 600 μL of the binding mixture was transferred to a 
SPIN Filter tube and centrifuge at 14,000 g for 1 min. The Catch tube was emptied, 
and the remaining binding mixture was added to the SPIN Filter tube and 
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centrifuged as before. The Catch tube was emptied again and 500 μl of prepared 
Wash Buffer 2 was added to the SPIN Filter tube and gently re-suspend using the 
force of the liquid from the pipette tip to re-suspend the pellet without vortexing 
tubes. Samples were centrifuged at 14,000 x g for 2 min and flow-through 
discarded. Residual ethanol was extracted by centrifuging the sample again for 2 
min to dry the sample from the binding matrix. The SPIN Filter was transferred to 
a clean 1.9 ml Catch tube. The pellet was suspended in 60-100 l of TES. Samples 
were centrifuged at 14,000 x g for 2 min to elute the purified DNA into the clean 
Catch tube. The SPIN filter was discarded, and DNA stored at -20°C (for extended 
periods) or 4°C until use. The purity and concentration of the extracted DNA was 
measured on the Nanodrop spectrophotometer. 
  
2.5.2.3 DNA extraction from poultry caecal contents (Trial 1) by QIAcube 
HT 
The majority of DNA samples in Trial 1 were extracted by QIAcube® HT 
(Qiagen; UK) using the QIAamp Power Faecal protocol. In brief, 100 mg of caecal 
sample was weighed into a Pathogen Lysis Tube L (cat. no.19092). Then, 650 μl 
pre-warmed Buffer PW1 was added to each sample. Each sample was thoroughly 
homogenized twice by FastPrep® 24 5G instrument (MP, USA) set at 6.5m/s for 
45 s separated by 5 min. Then samples were centrifuged at 14,000 x g for 1 min. 
Approximately 400-μl supernatant from previous step was pipetted into a new 
tube, avoiding transferring any solid material, re-centrifuged the sample again. 
Then, 150 μl of Buffer C3 was added to the supernatants and mixed thoroughly 
by carefully vortexing or pipetting and incubated for 5 min at 4 °C. All samples 
were centrifuged at 14,000 x g for 1 min. For each sample, 20 μl Proteinase K was 
added to a new S-Block well. Then, 300 μl of each supernatant from previous step 
was transferred to these wells, mixed and incubated for 10 min at room 
temperature (15–25°C). Finally, the S-Block was placed in the QIAcube HT and 




2.5.2.4 Manual DNA isolation for poultry caecal contents (Trial 1) by 
QIAamp® PowerFecal® DNA Kit. 
Some samples fail to yield DNA by the QIAcube HT method, therefore DNA 
from these samples was manually isolated. Approximately 0.10 g of caecal 
contents were weighted into the Bead Tube. Then, 750 μl of Power Bead Solution 
was added. followed by addition of 60 μl of Solution C1 and vortexed briefly. Then, 
the tubes were heated at 65°C for 10 min. Secured tubes were horizontally 
Vortexed using an adapter (cat. no. 13000–V1–24) at maximum speed, for 10 
min. The tubes then were centrifuged at 13,000 x g for 1 min. The supernatant 
(between 400 to 500 μl) was transferred to a clean 2 ml Collection Tube. Then, 
250 μl of Solution C2 was added and mixing by brief vortexing. The tubes were 
incubated at 2–8°C for 5 min. The tubes then were centrifuged at 13,000 x g for 
1 min. Supernatant (600 μl) was transferred to a clean 2 ml Collection Tube 
avoiding disturbing the pellet. Then, 200 μl of Solution C3 was added and vortexed 
briefly. The tubes were incubated at 2–8°C for 5 min. The tubes were centrifuged 
at 13,000 x g for 1 min. The supernatant was transferred (not more than 750 μl) 
to a clean 2 ml collection tube, avoiding the pellet. An aliquot of 1200 μl of Solution 
C4 was added to the supernatant and vortexed for 5s. Then, 650 μl of each 
supernatant was loaded onto an MB Spin column and centrifuged at 13,000 x g 
for 1 min. The flow-through was discarded and this was repeated until all the 
supernatants had been finished. After that, 500 μl of Solution C5 was added and 
centrifuged for 1 min at 13,000 x g. The flow-through was discarded and 
centrifuged again for 1 min at 13,000 x g. The MB Spin Column were placed in a 
clean 2 ml collection tube. An aliquot of 100 μl of Solution C6 was added to the 
centre of the white filter membrane and centrifuged at 13,000 x g for 1 min and 




2.5.2.5 Wizard genomic DNA purification Kit  
PCR amplification products of gene cassettes were isolated using Wizard 
Genomic DNA purification kit (Promega, UK) according to manufacturer’s 
instructions. After running the PCR products on 0.8% agarose gel, the required 
size bands (Approximately 2000 bp) were excised in a minimal amount of agarose 
on a UV wavelength transilluminator, and then placed into weighed 1.5 ml 
microcentrifuge tube. All tubes were re-weighed, and the weight of the excised 
DNA gel slices calculated. Then an equal volume of membrane binding solution 
was added (approximately 10 µl of membrane Binding Solution was added per 10 
mg of agarose gel fragment) then vortexed and incubated at 50–65°C in heat 
block (Grant QBT2; UK) for 10 min or until the gel slice was thoroughly dissolved. 
During incubation, all tubes were briefly vortexed to maximize the rate of agarose 
gel melting. After incubation, all samples were briefly centrifuged to ensure that 
the DNA particles were at the bottom of the tube. Dissolved DNA was transferred 
into SV Minicolumns in a single Collection Tube for each dissolved gel slice and 
incubated for 1 min at room temperature. 
The SV Minicolumn was centrifuged at 16,000 × g for 1 min and flow-through 
collection tubes discarded. The column was washed by adding 700 µl of previously 
diluted membrane wash solution (with 95% ethanol) to the SV Minicolumn. The 
SV Minicolumn was centrifuged for 1 min at 16,000 × g and the collection tube 
was emptied. A second wash was performed by adding 500 µl of Membrane Wash 
Solution to the SV Minicolumn and centrifuging for 5 min at 16,000 × g. The SV 
Minicolumn and the Collection Tube was emptied and re-centrifuged for 1 min with 
opened lid to allow evaporation of any residual ethanol. The SV Minicolumn was 
transferred to a clean 1.5 ml microcentrifuge tube and 50 µl of Nuclease-Free 
Water was added directly into the centre of the column without touching the 
membrane with the pipette tip. The column was incubated at room temperature 
for 1 min and then centrifuged for 1 min at 16,000 × g. The SV Minicolumn was 
68 
 
discarded, and the elution containing DNA in the microcentrifuge tube was stored 
at 4°C or –20°C. All genomic DNAs were stored at -20°C for long term storage. 
 
2.5.3 Polymerase Chain Reaction (PCR)  
 
2.5.3.1 PCR Primers  
The PCR oligonucleotides designed in this thesis are listed in Tables 2.5 and 
2.6.  Generally,  the  length of all designed oligonucleotides was in ideal range of 
18–22 base pairs, melting temperature in the range from 48 to 66°C, the content 
of GC between 40 and 70%, and usually termination of primers was either a 
guanine or cytosine residue at the 3’ end unless they were obtained from another 
resource. After designing the primers, all primers were checked by oligo analyser 
(Integrated DNA Technologies) for possible formation of stable primer secondary 
structures, self-dimer and hairpins. For calculating the melting temperature for 
each primer, the equation below is used,  
Tm = 4°C (G+C) + 2°C (A+T)   
Primers applied in this thesis were synthesised by Eurofins MWG Operon 
(Ebersberg, Germany). All oligonucleotides for GCs listed in this thesis were 
designed based homogeneity of the majority of sequence data reads obtained from 
first primer reads and then divided into groups based on that.   
 
2.5.3.2 PCR running conditions  
The DreamTaq Green 2x PCR Master Mix (ThermoScientific) was used in all 
PCR reactions carried out in a BIOER XP thermal cycler. The DreamTaq DNA Master 
Mix containing of 2 U of polymerase, 2x DreamTaq Green buffer, 0.4 mM of dNTPs 
each and 4 mM of magnesium chloride. Each PCR reaction (25 μl) contained 12.5 
μl of 2× DreamTaq Green PCR Master Mix (ThermoScientific) mixed with 
approximately 1 µl of ±50 ng DNA template; 0.5 µM forward and reverse primers; 
and 9 µl water. In general, the PCR setting conditions for each reaction were 
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carried out as follows: initial denaturation at 95°C for 5 min; 35 cycles of PCR 
amplification including denaturation at 95°C for 30 s, annealing routinely set at 
64°C unless otherwise indicated for 30 s, extension at 72°C for 1 or 3 min; and 
the reaction ended with a final extension at 72°C for 5 min. The extension time 
through PCR amplification cycles was adjusted depending on the size of amplified 
product, with 1 min per kilo base pair of PCR product. Agarose gel electrophoresis 
(Section, 2.5.1.1) for running amplified PCR products was carried out to verify 
product size either using a DNA standard ladder and taking a digital image or to 
cut out desired bands for purification. PCR products were stored in -20°C. 
 
2.5.3.3 Real time quantitative PCR (RT-qPCR)  
The Quantitative PCR was preformed using PowerUp SYBR Green Master Mix 
(ThermoFisher) according to manufacturer’s instructions. In brief, a mixture of 
(0.5 µl, 1x) 10pmol forward (ACGAGCGCAAGGTTTCGGT) and reverse 
oligonucleotides (CGTTCCATACAGAAGCTGG) target specific location in integrase 
gene added to (5 µl, 1x) PowerUp SYBR Green Master Mix (ThermoFisher) and (3 
µl, 1x) PCR water (Invitrogen) in a total volume of 10 μl, then 9 µl of this mixture 
was dispensed into 384-Well white qPCR Plate. One µl of extracted DNA samples 
(described in 2.5.2.3) transferred into required well into the plate. The plate then 
was sealed and mixed briefly three times for few second by mini spinner centrifuge 
(Axygen; ThermoFisher). The q-PCR reaction was carried out using a Light Cycler 
480 instrument (Roche). The qPCR conditions are setting as follow: denaturation 
programme at 95°C for 5 min; followed by amplification programme including 45 
repeated cycles of denaturation at 95°C for 15 s, annealing at 66°C for 1 min; and 
then one cycle of melting curve including incubation at 95°C for 5 s, 65°C for one 
minute and 97°C for 30 s with a continuous fluorescence measurement; and finally 
the run was finished by cooling programme to 40°C for 10 s. All results were 
analysed using Light Cycler 480 software for detecting the cycle threshold value 
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(Ct value) as well as absolute quantification of integrase expression value which 
was then calculated based on control results. 
 
2.5.4 Class 1 integron gene detection  
The presence of class 1 integrons were determined using PCR primers that 
detect three conserved sequences of class 1 integrons which are: intI1, qacEΔ1 
and sul1. The oligonucleotides pairs were chosen using data from published papers 
which are outlined in Table 2.4 (Holmes et al., 2003;Ebner et al., 2004;Gillings et 
al., 2015;Ravi et al., 2015) and purchased from Eurofins (Ebersberg; Germany). 
Each PCR reaction (total volume 25 μl) contained 2× DreamTaq Green PCR Master 
Mix (ThermoScientific, Wilmington, USA); 0.5 µM forward and reverse primers; 1 
µl of sample DNA and the remainder PCR grade water (Roche; 03315959001; 
Germany). The PCR reaction was run on XP Thermocycler, (Bio-Rad, UK). The 
control template DNA was prepared by extracting DNA from S. typhimurium U288 
that carries class 1 integrons, using the GenEluteTM Bacterial Genomic DNA Kit 
for gram-negative bacteria (Sigma–Aldrich, UK) in accordance with the 
manufacturer’s instructions (see 2.5.2.1). The extracted DNA was diluted to 50 
ng/ul and were used immediately for PCR. The PCR conditions were: 95 °C for 5 
min and 35 cycles of 95 °C for 30 s, 64 °C for 30 s, 72 °C for 30 s and final 
extension at 72 °C for 5 min. The PCR products separated by agarose gel 
electrophoresis using 1 % agarose (Pharmacia Fine Chemicals, UK) in TAE buffer 




Table 2.4 Primers used for detecting three conserved sequences of class 1 
integrons 
 
2.5.5 Amplification and mapping of gene cassettes (GCs) 
The amplification of inserted gene cassettes was performed by long range 
PCR (XP Thermocycler, BioRad; UK). Firstly, four primer pairs were tested to start 
the amplification of GCs with gradient PCR to detect optimum conditions 
summarised in Table 2.5. Secondly, specific walk primers, that flanking the 
integrated gene cassettes from the 5′ and 3′ conserved ends of class 1 integrons, 
were designed and are shown in Table 2.6 and 2.7. Each PCR reaction (25 μl) 
contained 2× DreamTaq Green PCR Master Mix (ThermoScientific); 0.5 µM forward 
and reverse primers; 1 µl of sample DNA and PCR grade water (Roche). The S. 
enterica Typhimurium U288 genomic DNA was used as a positive control and water 
as a negative control. PCR conditions were 95 °C for 5 min and 35 cycles of 95°C 
for 30 s, 64 °C for 30s, 72 °C for 3 min and final extension 72 °C for 5 min. PCR 
products were purified using the Wizard® SV Gel and PCR Clean-Up System kit 




























































(2.5.2.5) and then the purified DNA sequenced by the Eurofins MWG Value Read 
service. The resulting sequences reads were organised and grouped by using 
BioEdit (Sequence Alignment Editor version 7.0.5.3), then the reads were 
assembled into contigs using CLC Work Bench by Prof Ian Connerton, under the  
default settings and then submitted to the NCBI database using the BlastN search 




Table 2.5 Primers tested for identifying integrated gene cassette sequences of 


























(Gillings et al., 
2009) 
R-MRG285 CCAGAGCAGCCGTAGAGC 
F-ntf2  ACACCGTGGAAACGGATGAAG 
n/a 





(Ravi et al., 
2015) 
R-qacE∆1     ATACCTACAAAGCCCCACGC 




Table 2.6 Primers used for walking in integrated gene cassette sequences of class 





F-ntf2  ACACCGTGGAAACGGATGAAG n/a Ebner et al., 2004 
F2-GCs-B CTGTTGGTTGGACGCAAGAC n/a This study 
F2-GCs-F ACCATGCGAAAGCTCAATACTC n/a This study 
F2-GCs-C ATTCTTGCAGGTATCTTCGAGC n/a This study 
F3-GCs-B-1      AGGTTTGCGATCCGCTGTG n/a This study 
F3-GCs-B-2 GAGCTTTGATCAACGACC  n/a This study 
F3-GCs-C GCTGGCTTTTTCTTGTTATC  n/a This study 
R2-GCs-B-1 CAAATTGCAGTTCTCGCT n/a This study 






Table 2.7 Primers used for walking in integrated gene cassette sequences of class 





F-ntf2 ACACCGTGGAAACGGATGAAG n/a 
Ebner et al., 
2004 
F2-GCs-A CAGCCATGATCGACATTGATC n/a This study 
F2-GCs-B GTTAACCTCTGAGGAAGAATTG n/a This study 
F2-GCs-C CAACGATGTTACGCAGCAGG n/a This study 
F3-GCs-A1 GTTCTCTGATATCGAATTCGC n/a This study 
F3-GCs-A2 AGAAGATCACTTGGCCTCAC n/a This study 
F3-GCs-B CATCATGAGGGAAGCGGTG n/a This study 
F3-GCs-C CCACGATCGACATTGATCTG n/a This study 
F4-GCs-B ATCGCTTGGCCTCGCGCGC n/a This study 
R-qcr2 ACCGATTATGACAACGGCGG n/a 





2.5.6 16S rRNA Gene sequences and analysis 
The amplification of 16S rRNA was carried out by using specific primers: 515f 
(50 GTGCCAGCMGCCGCGGTAA 30) and 806r (50 GGACTACHVGGGTWTCTAAT 30) 
that are designed to flank the hypervariable V4 region of the bacterial 16S rRNA 
genes (Caporaso et al., 2011). Amplicons were sequenced on the Illumina MiSeq 
platform using 2 × 250 bp cycles according to the manufacturer’s instructions by 
Source Bioscience, Nottingham UK. All sequences data of the 16S rRNA gene were 
quality filtered and then clustered into operational taxonomic units (OTUs) by 
Mothur (V1.39.5, Schloss et al., 2009) through the Schloss lab. MiSeq SOP2 
(Kozich et al., 2013). 
The functions required to perform analysis pipeline are available on the 
Mothur website (http://www.mothur.org/wiki/MiSeq_SOP) 22 and it was carried 
out following the approach of (Kopylova et al., 2016) and (Schloss, 2016). In brief, 
sequences paired reads was assembled into contigs and ambiguous bases of any 
contigs was removed or picked out. Then, sequences were aligned against the 
SILVA reference database, and any incorrect alignment (non-bacterial origin) of 
sequences were picked out. The ends of the sequences were trimmed in order to 
start and end at the same alignment position of all sequences (Schloss, 2013). 
Then, identification of the unique sequences and their frequency per each amplicon 
was carried out. De-noise sequences of each amplicon were performed by using 
pre-clustering algorithm (Schloss et al., 2011). To decrease sequences errors, the 
sequences were checked for chimeras using VSEARCH. Classification of each 
sequence was implemented against the Ribosomal Database Project (RDP) 16S 
rRNA gene training set by a naive Bayesian classifier used to classify (version 14) 
which required 80% confidence score (Schloss et al., 2011). This classifier was 
customised to cover rRNA gene sequences of mitochondria and Eukaryota in order 
to exclude any undesirable sequences that classified as Archaea, Eukaryota, 
chloroplasts, or mitochondria. Finally, sequences were categorised into groups 
according to their taxonomic level of phylum and assigned to operational 
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taxonomic units (OTUs) at a 3% dissimilarity level. Coverage was calculated in 
mothur by Good’s coverage at 98%. Bacterial sequences were normalised to equal 
sequence counts, and these normalised OTU tables were used in all further 
analysis (Westcott and Schloss, 2017). 
The α- and β-diversity were analysed using Mothur (V1.39.5). The alpha 
diversity was assessed by Chao index for OTU richness, while the overall diversity 
(evenness) was measured with the inverse Simpson's index. Differences in α -
diversity was tested using Wilcoxon rank sum test. For the Beta-diversity, 
assessed by metric calculated by Mothur and significance was tested by using 
analysis of molecular variance (AMOVA) implemented also by Mothur. Distribution 
of gene cassettes was presented by phylogenetic tree of Gram-negative bacteria 
(Proteobacteria) and rarefaction curve was constructed by Mothur. Linear 
discriminant analysis effect size (LefSe) was also performed by Mothur.  
 
2.5.7 Bioinformatics software utilised  
To assemble and analyse all sequencing data generated from 16S RNA as 
well as whole metagenome sequence, several bioinformatics techniques were 
used. Bioinformatics software utilised throughout the study are listed Table 2.8.  
 
2.5.8 Statistical analysis 
All data that related to bacterial count first converted to log 10 (cfu/ml) for 
bacterial counts and treated by parametric statistics using T. test. All the results 
related to profiling microbiota were tested for normality using the Shapiro-Wilk 
test and expressed as bar charts by using median or percentage or box plots. 
Analysis of significance was carried out based on normality test results by non-
parametric tests (Mann Whitney U test for unpaired data or Wilcoxon test). Each 
data was compared to another to show if there are any differences between the 
mean or ranks. Statistical analysis was carried out using GraphPad Prism V8 
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(GraphPad Software, Inc, CA, USA) and Microsoft® Excel 2016/XLSTAT©-Pro 
(2013.4.03, Addinsoft, Inc., Brooklyn, NY, USA) statistical package at 95 % 
confidence level. The values were considered as statistically significant when p 







Software Use Citation Link 
BLAST 
Basic Local Alignment Search Tool 
that was used to search genes or 
proteins against the NCBI database 
or against specified sequences. 
(Altschul et al., 1990) http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Clustal 
Omega 
General multipurpose alignment 
program for nucleotides and 
proteins; finds the best alignment 
over the entire length of each 
sequence submitted. 













Powerful software package for 











Data organization and visualization 
 
(SnapGene®) http://www.snapgene.com 






2.5.8.1 Statistical analysis for quantification of integrase copy number  
The cycle of threshold (Ct) of reaction is value at which the fluorescence can 
be emitted appropriately above the background fluorescence and then this value 
can be detected. The baseline signal and threshold signal of fluorescence were 
determined automatically by the PCR machine. The Ct values for each reaction 
were detected and the calculation was carried out in Microsoft Excel 2016. 
According to Higuchi et al. (1993) method, the absolute quantification of integrase 
copy number was calculated based on standard curve of positive control S. 
Typhimurium U288. Fivefold serial dilution was done (100-10-7) and then log10 gene 
numbers were plotted versus Ct values and straight line was generated (the 
standard curve). In brief, the number of copies for template was calculated by 
using this website (https://cels.uri.edu/gsc/cndna.html) for determining the 
number of copies of a template and then log10 was used to plot values against Ct 
value. Then, quantitation of the amount of integrase copy in the ‘unknown’ 
samples of interest is conducted by measuring Ct and using the standard curve to 
determine starting copy number (Arya et al., 2005). T-test was performed in 
GraphPad Prism 8.0 and Microsoft Excel 2016 to compare the difference of copy 
number between G1 and G2, G3 and G4 for each sampling points. 
 
2.5.8.2 16S RNA PCR 
The 16S RNA sequence was used to select coliform isolates for whole genome 
sequencing. The PCR conditions and reactions were carried out as described in 
2.5.3.2. According to Hugerth et al. (2014) the optimum oligonucleotides for 
amplifying 16S RNA are: forward primers was (341F:CCTACGGGNGGCWGCAG) 
and reverse primer (R805: GGACTACHVGGGTWTCT) which target amplification of 
the V3-V4 region (Hugerth et al., 2014). Prior whole genome sequence, 16S RNA 
sequence of approximately 35 bacterial isolates that collected from CH birds 
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(Trial1) were used to select different isolates of coliforms based on sequence data 
for whole genome sequencing. PCR conditions of 30 cycles of amplification include: 
denaturation 95°C for 5 min, 95°C 20s, annealing 51°C 20s, extension 72°C 20s, 
final extension 72°C 1 min. In addition, this step was followed by PCR for both 
screening integrase and gene cassettes presence. 6 sample then were selected for 
whole genome sequence.   
 
2.5.9 DNA sequencing  
 
2.5.9.1 PCR product sequencing  
In order to get sequence reads for GCs obtained from broiler caecal contents 
of biosecure housed and commercial birds, the concentrations of purified PCR 
products (2.5.2.5) were measured by Nano drop and diluted if needed to 10 ng/μl 
in total volume 15μl of required PCR product. In addition, another 15μl of required 
primer at 10pmol μl-1 was transferred to 1.5 ml microcentrifuge tube with extra 
5μl volume of required primer for each additional sequencing reaction. PCR 
samples and primers were sent to Eurofins genomics for sequencing. 
 
2.5.9.2 Whole genome sequencing of gDNA samples  
Bacterial DNA was first isolated as described in 2.5.2.1. After extraction, 
approximately 10 µl of bacterial DNA sample was transferred into 1.5 ml 
microcentrifuge tubes. Selected samples were sequenced by illumina Sequencing 
(Food science, Sutton Bonington, Nottingham, UK) for whole genome sequencing 
via the MiSeq platform.  
Briefly, genomic DNA fragments are sheared into 200-300 bp fragments. A 
sequencing library is generated by mixing the adapters with its complements and 
allowing DNA to attach on the surface of flow cell oligonucleotides. Each DNA 
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fragment molecule was iso-thermally amplified to simulate generation of millions 
of clusters in a flow cell, and this process is known as bridge amplification. The 
flow cell is a glass slide containing lanes which are coated with a lawn consisted 
of two types of oligonucleotides to allow template fragment binding. The process 
of sequencing is initiated by binding of the first primer to generate the sequence 
reading. Then, the fluorescent tagged nucleotide that is integrated into the 
synthesised complementary chain of the template fragment in each sequencing 
cycle. The fluorescent labels also act as the terminator for polymerisation. After 
insertion of one nucleotide, the fluorescent dye is triggered by a laser and the 
fluorescent signal is emitted. These signals produce images which are then 
analysed by the MiSeq image control software. To enable the incorporation of the 
next nucleotide the fluorescent label is enzymatically cleaved, and the fragment 
length is detected by the number of the sequencing cycles, and the base calling is 
done based on the emission wavelength together with the signal intensity. The 
previous steps are summarised in Figure 2.3. All data or paired end reads were de 


























Figure 2.3 Next generation sequencing basic steps of Illumina MiSeq.  
A. Fragmentation of gDNA sample and ligation with specialised adaptors to both fragment 
ends. B. loading library into flow cell to hybridise the fragments to the flow cell surface. 
Amplification of each bound fragment into a clonal cluster through bridge amplification. C. 
sequencing biosynthesis through sequencing reagent (fluorescently labelled nucleotides) 
are added and the first base is incorporated, and the flow cell is imaged. The emission from 
each cluster is recorded. The emitted wavelength and intensity are used to identify the 
base. The repeated cycle ‘’n’’ times create a read length of ‘’n’’ bases. D. reads are aligned 
to reference sequence with bioinformatics software. Differences between reference genome 













                                     CHAPTER 3 
INVESTIGATION OF THE PREVALENCE OF CLASS 1 
INTEGRONS IN BROILER CHICKEN CAECAL CONTENTS 









Mobile genetic elements are one of the most significant factors that influence 
the spread of antibiotic resistance genes (ARGs) by the acquisition, expression, 
and dissemination of these ARGs in clinical settings and environmental habitats. 
Class 1 integrons are bacterial genetic elements that widely contribute to the 
emergence the multidrug resistance in human medicine, which themselves are 
frequently located on mobile genetics elements including plasmids and 
transposons (Ruiz et al., 2003;Nardelli et al., 2012;Jechalke et al., 2014). This 
has facilitated integron mobility and dispersal among similar or different species 
within bacterial communities (Escudero et al., 2015). Indeed, mobile integrons 
(MIs) are evolvable elements for the rapid adaptation of bacteria to environmental 
changes shaped by humans. In the 1960s, MIs played a significant role in the early 
rise of multidrug resistance among clinically important bacteria, leading to the 
discovery of integrons in the late 1980s (Escudero et al., 2015). Integron classes 
1 and 3 (Arakawa et al., 1995) are found to be correlated with Tn402 (Collis et 
al., 2002;Xu et al., 2007), whereas class 2 integrons are almost exclusively 
associated with Tn7 derivatives (Ramírez et al., 2010). 
The embedded gene cassettes (structure of GCs, Chapter 1, Section 
1.2.7.3.3) are frequently associated with a variety of resistances for almost all 
antibiotic families, including trimethoprim, aminoglycosides, lincosamides, beta-
lactams, chloramphenicol, fosfomycin, macrolides, rifampicin, and quinolones 
(Stalder et al., 2012). Besides antibiotics that have played vital roles in selection 
and dissemination of class1 integrons, the selective pressure of resistance to 
quaternary ammonium compounds (QACs) used in cleaning and disinfection 
products, has also been reported to be a contributory factor in their dissemination. 
The qac gene encoding resistance determinants to QACs is commonly observed on 
class 1 integrons (Jechalke et al., 2014;Stalder et al., 2012). QACs are commonly 
used in food processing because of their biocidal effect in addition to their non-
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toxic, non-tainting, and non-corrosive properties (Holah et al., 2002). Morente et 
al. (2013) stated that there is a potential concern with regard to the cross-
resistance observed between antibiotics and QACs in environmental and food-
associated bacteria.  
Poultry meat production faces a range of challenges to satisfy growing 
demand. To meet the demand the world poultry production would need to grow 
by 2.5% per year up to 2030, and as much as 3.4% in developing countries (Ricke, 
2016). Consumption in the UK is reported as 83 million birds per year (GOV.UK, 
2020). Thus, the poultry industry is important part in human food chain that 
requires careful monitoring with respect to AMR in order to achieve desirable 
outcomes for food safety and quality. 
However, livestock are considered a significant reservoir for AMR expansion 
due to the possible horizontal spread between commensal bacteria and zoonotic 
pathogens, which is real concern to human health (Munk et al., 2017). Several 
studies have demonstrated that the use of antimicrobials in domestic animals, 
often as growth promoters, leads to an increase in the occurrence of AMR and 
reductions in their use positively decreases the observed resistance (Munk et al., 
2017).  In commercial broiler chicken production birds are typically reared in barns 
of 20,000 birds or more, which allow the dispersion of microorganisms throughout 
the flock representing an important source of microbiota to other flocks on the 
farm (Connerton et al., 2018). Therefore, class I integrons encoding ARGs can 
easily disseminate between flocks, which enter the human food chain for 
acquisition by human commensal and pathogenic bacterial populations. Human 
interaction with the environment can recycle the ARGs to create a continuous 
process of acquiring new gene cassettes with sequential rearrangements of host 
mobile elements. These events make the natural environment a prolific reservoir 
for the acquisition of new resistance genes to the advantage of opportunistic 
pathogens (Waldron and Gillings, 2015). Moreover, differences in agricultural 
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practice have the potential to effect class 1 integron carriage and gene cassette 
arrangements (GCs). Monitoring how human activities (anthropogenic pollutants) 
participate in recycling resistance to food chain animals and how these activities 
contribute to worldwide crisis in the management of bacterial infections are critical 
to our understanding (Gillings et al., 2008a). 
Due to limited knowledge of the gene flow in these environments or the 
genetic platforms that support the mobility of class 1 integrons, making predictions 
of their impact on food-associated bacterial communities is difficult. The broiler 
chicken caecal microbiome is an important reservoir of class 1 integrons, where 
three conserved genes are frequently observed: class 1 integrase (intI1), heavy 
metal or quaternary ammonium compounds (qacE∆1) and sulphonamides 
resistance (sul1). This chapter therefore aims to use the class 1 integron as a 
biomarker for the acquisition and spread of antibiotic resistance in commercially 
















3.2 Results  
3.2.1 Detection of class 1 integrons in biosecure chicken flocks  
In order to determine the prevalence of class 1 integrons, genomic DNAs 
were extracted from a total of 111 caecal samples from broiler chickens reared in 
controlled housing from one-day old chicks. Three conserved genes of the 
integron-integrase system (intI1, qacEΔ1 and sul1) were PCR amplified and the 
products analysed using standard agarose gel electrophoresis. The intl1 Ravi 
primer (Ravi et al., 2015) was selected as main indictor for presence of class 1 
integrons from four different primers used for detecting the prevalence of intl1 
noted in Table 2.4 (Chapter 2). The locations of the integrase primers within intl1 
are indicated in Table 3.1 and 3.2. Validation of the primers for these three genes 
was performed using Salmonella enterica Typhimurium strain U288 as a positive 
control for the intI1 gene and E. coli J53 (pMG101, obtained from Dr Jon Hobman’s 
group, University of Nottingham) as a positive control for the qacEΔ1 and sul1 
genes. S.T.U288 was PCR negative for the sul1 gene and also it gives undeniable 
band with qacEΔ1 results shown in Figure 3.1. Gradient PCR was used to optimise 
annealing temperature Figure 3.2 (A, B and C).  
The PCR conditions for each reaction were carried out as follows: initial 
denaturation at 95°C for 5 min; 35 cycles of PCR amplification including 
denaturation at 95°C for 30 s, annealing routinely set at 64°C (one degree reduced 
from above optimisation) for 30 s, extension at 72°C for 1 and the reaction ended 
with a final extension at 72°C for 5 min. Generally, the results show that 99 % 
(110/111) of biosecure chicken caecal samples were positive for integrase gene 
based on the intl1 Ravi and intl1 HS464 primers, whereas qacEΔ1 and sul1 genes 
were detected in 93.7% (104/111) and 94.5% (105/111) of chicken caecal 
genomic DNA samples respectively. Only one sample appeared to be negative for 
the class 1 integron. The full results are shown in Appendix 2.1 Table 2.1.1 and 




Table. 3.1 Sequence of class 1 integron gene clarify positions of used 










Sequence of class 1 integrons obtained from positive control Salmonella 
Typhmurium U288 
>STU288_RS24150 STU288_RS24150 class 1 integron integrase  




































































































Figure 3.1 Positive control verification of PCR primers. 
Agarose gels (Chapter 2, Section 2.5.1.1) showing target genes 
amplification products of PCRs from positive controls bacteria 
(S.U288 for IntI1 genes and E.coli J53 for sul1 and qacEΔ1 
genes) electrophoresed on a 1 % TAE gel. The annealing 
temperature was 64 °C. All odd numbered lanes respective 
negative controls. 
Lane 1 100 bp ladder, Lane 2 the 546 bp PCR product of Ravi 
intl1, Lane 4 the 254 bp gene amplicon of EB intl1, Lane 6 the 
471 bp of intl1 HS464, Lane 8 the 311 bp clinical intI1 (C), Lane 
10 346 bp the sul1 gene (J53), Lane 12 the 200 bp qacEΔ1 gene 
(J53). The PCRs were carried out using the primers listed in Table 
2.4, Chapter 2. The DNA molecular weight markers (100-1,517 

























Figure 3.2 Gradient PCR products amplified under three different annealing 
temperatures A 65 °C, B-61.4 °C, C 55 °C. Agarose gels (Chapter 2, Section 2.5.1.1) 
demonstrate target genes amplification products of PCRs electrophoresed on a 1 % TAE 
gel. 
Lane 1 100 bp ladder, lane2 intl1 Ravi S.E.125109, lane 3 Intl1 Ravi sample1, lane 4 Intl1 
Ravi S.T.U288, lane 5 int1 Ravi –ve control, lane 6 int1 EB S.E.125109, lane 7 int1 EB 
sample1, lane 8 intl1 EB S.T.U288, lane 9 int1 EB –ve control, lane 10 sul1 S.E.125109, 
lane 11 sul1 S.E. sample1, lane 12 sul1 S.T.U288, lane 13 sul1–ve control, lane 14 qacE∆1 
S.E.125109, Lane 15 qacE∆1 samples1, lane 16 qacE∆1 S.T.U288 Lane 17 qacE∆1–ve 
control, lane 18 100 bp ladder DNA. The primers used listed in Table 2.4, Chapter 2 and 
DNA obtained from different salmonella isolates used in this gradient PCR. The DNA 




IntI1 Ravi IntI1 EB sul1 qacE∆1 
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3.2.2 Detection of class 1 integrons in commercial chicken flocks  
A similar approach was performed with animals reared under normal 
commercial conditions to investigate how prevalent these genes are in commercial 
setting. A total of 40 broiler chicken caecal samples, fed either control or GOS 
diets were harvested at two different sampling times from the same barns at 
thinning (30 da) and depopulation (37 da) as frequently practiced in broiler 
production. The birds were transported to the University of Nottingham before 
euthanasia and sampling of the caecal contents for genomic DNA isolation and 
investigation of the three conserved genes (intI1, qacEΔ1 and sul1). 
 The prevalence of intl1 was determined by using four different primers as 
noted in Table 2.4 (Chapter 2). The IntI1 Ravi primer was selected as the main 
primer for detecting the presence of class 1 integrons. In this trial S.T.U288 was 
used as a positive control for detecting integrons genes and as negative control 
for sulphonamide resistance (sul1). The amplicon products of the PCR results are 
shown in Appendix 2.7 (Table 2.7.1) and the corresponding Figures presented in 
Appendices 2.8-2.11, which illustrate that 92.5% (37/40) of the commercial 
chicken faecal samples were positive for the integrase gene whereas the qacEΔ1 
and sul1 genes were detected in 100% (40/40) and 97.5% (39/40) of the broiler 
chicken caecal samples respectively. It appears that only three samples were 








3.2.3 Characterisation of antibiotic resistance gene cassettes of class 
1 integrons of caecal content microbiota of biosecure birds 
Further investigation was performed to determine the distribution of 
antibiotic resistance gene cassettes (GCs) in the class 1 integrons.  A total of 111 
luminal caecal samples, including samples negative for the class 1 integrase gene, 
were investigated for GCs using long range PCR. Four different primers (long range 
Ravi, MRG 284/285, ntf2/qcr2 and F-Ravi/R-qacEΔ1) for the gene cassettes arrays 
are noted in Table 2.5 (Chapter 2), and were tested at different extension times(1 
min and 3 min) to select the optimum primers for amplifying the gene cassettes 
and determine the optimal PCR conditions (Appendix 2.12 Figure 2.12 1A, 2A, and 
2.12 1B, 2B). The primers F-ntf2/R-qcr2 were chosen for amplifying GCs of both 
trials with annealing temperature of 64 oC because this primer pairs give one clear 
band compared to the others. The extension time was selected at 3 min because 
expected maximum size of GCs proximality 1.5-2kb.   
The contents of all the PCR positive amplicons for the GCs were characterised 
at nucleotide sequence level by primer walking through the amplified fragment 
using the Eurofins dye-terminator sequence service. In general, the results of DNA 
sequencing data from primer walking of the GCs (in most cases 3 forward reads 
and one reverse read with the exception of gene cassettes type B-1 for which two 
reverse primers were used) were first, classified based on similarity of sequence 
data via Bioedit, second, by assembling all reads from which consensus contigs 
were created and then verified to each GC, and finally the  integron embedded 
GCs were annotated and verified using Basic Local Alignment Search Tool (BlastN). 
The results revealed that five different types of gene cassettes arrays were present 
in the biosecure reared broilers that could be categorised into four groups or types: 





In respect of totals, the most predominant cassette was type GCs-B-2 at 
50.45 % (56/111) that contained dfrA1, and confers resistance to dihydrofolate 
reductase (trimethoprim-resistant dihydrofolate reductase type I) and 
aminoglycoside 3’’ adenylyltransferase (aadA1). The next most frequent type was 
group C-1, which contained the aadA1 gene alone (6.3 %; 7/111), whilst GCs 
placed in group C-2 were detected in 3 samples with 2.7% (3/111). The GC group 
F was found in only 4.5% (5/111), which contained the aadA9 gene alone. The 
GCs group B-1 were present at 3.6% (4/111). The B-1 GCs were found in only 
four samples (3.22.5-1, 3.28.5-1, 4.22.7-1 and 4.24.7-1), and this gene cassette 
shared sequence identity to GCs-B-2 but with an insertion of approximately 500 
bp between the dfrA1 and aadA1 genes. The relative abundance of each gene is 
presented in Tables 3.4 A and B.  
The PCR amplicons for the GCs were analysed by gel electrophoresis and are 
shown in Figures 3.3-3.6. What was notable in this trial was that 12 samples had 
2 integrase cassette bands, and from these samples 4 had GCs-B-1 & GCs-B-2, 3 
had GCs-B-2 & GCs-C1, 2 GCs-B-2 & GCs-C-2 and 3 had GCs-B-2 & GCs-F. 
Moreover, there was a band of 700 bp that was analysed and found not to be 
related to class 1 integrons as indicated in Figure 3.4 by the yellow arrow.  











Agarose gel electrophoresis of PCR amplified GC products. 
Each group is represented by one image, the first row contains samples 
of 22 and 24 da old birds, whereas the second row contains samples 


















Figure 3.3 The GC amplicon products of caecal DNA samples of birds 
fed the standard control diet (Group1). The agarose gel electrophoresis 
performed at 3 min extension time, 64 C° annealing temperature and primer 
used was F-ntf2/R-qcr2 electrophoresed on 0.8% TAE agarose gel.  
Row 1, Lane 1 Kb bp ladder (BioLab), Lane 2 GCs sample 1.22.1, Lane 3 GCs sample 
1.22.2, Lane 4 GCs  sample 1.22.3, Lane 5 GCs sample 1.22.4, Lane 6 GCs sample 
1.22.5, Lane 7 GCs sample 1.22.6, Lane 8 GCs sample 1.22.7, Lane 9 GCs  sample 
1.24.1, Lane 10 GCs sample 1.24.2, Lane 11 GCs  sample 1.24.3, Lane 12 GCs 
sample 1.24.4, Lane 13 GCs  sample 1.24.5, Lane 14 GCs sample 1.24.6, Lane 15 
GCs  sample 1.24.7,  Lane 16 GCs -ve control, Lane 17 GCs +ve control, Lane 18 
100 bp ladder (BioLab). 
 Row 2, Lane 1 100 bp ladder (BioLab), Lane 2 GCs sample 1.28.1, Lane 3 GCs 
sample 1.28.2, Lane 4 GCs sample 1.28.3, Lane 5 GCs sample 1.28.4, Lane 6 GCs 
sample 1.28.5, Lane 7 GCs sample 1.28.6, Lane 8 GCs sample 1.28.7, Lane 9 GCs  
sample 1.35.1, Lane 10 GCs sample 1.35.2, Lane 11 GCs  sample 1.35.4, Lane 12 
GCs sample 1.35.5, Lane 13 GCs  sample 1.35.6, Lane 14 GCs sample 1.35.7, Lane 
15 GCs -ve control, Lane 16 GCs +ve control, Lane 17 100 bp ladder (BioLab).  
1      2      3    4    5       6     7     8    9      10   11    12   13   14   15   16   17   18 
1     2     3    4       5     6     7     8     9    10   11   12    13   14   15    16   17    
Suspect band not wanted  





















Figure 3.4 The GC amplicon products of caecal DNA samples of birds 
fed the GOS supplemented diet (Group2). The agarose gel electrophoresis 
performed at 3 min extension time, 64 C° annealing temperature and primer 
used was F-ntf2/R-qcr2 electrophoresed on 0.8% TAE agarose gel. The pointed 
orange bands were only the identified GCs in this group. 
Row1, Lane 1 Kb bp ladder (BioLab), Lane 2 GCs sample 2.22.1, Lane 3 GCs sample 
2.22.2, Lane 4 GCs sample 2.22.3, Lane 5 GCs sample 2.22.4, Lane 6 GCs sample 
2.22.5, Lane 7 GCs sample 2.22.6, Lane 8 GCs sample 2.22.7, Lane 9 GCs sample 
2.24.1, Lane 10 GCs sample 2.24.2, Lane 11 GCs sample 2.24.3, Lane 12 GCs 
sample 2.24.4, Lane 13 GCs sample 2.24.5, Lane 14 GCs sample 2.24.6,  Lane 15 
GCs sample 2.24.7, Lane 16 GCs -ve control, Lane 17 GCs +ve control,  Lane 18 
100 bp ladder (BioLab).                             
Row 2, Lane 1 100 bp ladder (BioLab),  Lane 2 GCs sample 2.28.1, Lane 3 GCs 
sample 2.28.2  Lane 4 GCs sample 2.28.3, Lane 5 GCs sample 2.28.4, Lane 6 GCs 
sample 2.28.5 Lane 7 GCs sample 2.28.6, Lane 8 GCs sample 2.28.7 , Lane 9 GCs 
sample 2.35.1, Lane 10 GCs sample 2.35.2, Lane 11 GCs sample 2.35.4,  Lane 12 
GCs sample 2.35.5, Lane 13 GCs sample 2.35.6, Lane 14 GCs sample 2.35.7, Lane 
15 GCs -ve control,  Lane 16 GCs +ve control, Lane 17 100 bp ladder (BioLab).   
 
1      2    3      4     5     6     7     8     9    10    11   12           13   14   15   16   17   18    















Figure 3.5  The GC amplicon products of caecal DNA samples of birds 
fed the standard control diet challenged by Salmonella (Group3). The 
agarose gel electrophoresis performed at 3 min extension time, 64 C° annealing 
temperature and primer used was F-ntf2/R-qcr2 electrophoresed on 0.8% TAE 
agarose gel. 
Lane 1 Kb bp ladder (BioLab), Lane 2 GCs sample 3.22.1, Lane 3 GCs sample 
3.22.2, Lane 4 GCs sample 3.22.3, Lane 5 GCs sample 3.22.4, Lane 6 GCs sample 
3.22.5, Lane 7 GCs sample 3.22.6, Lane 8 GCs sample 3.22.7, Lane 9 GCs sample 
3.24.1, Lane 10 GCs sample 3.24.2, Lane 11 GCs sample 3.24.3, Lane 12 GCs 
sample 3.24.4, Lane 13 GCs sample 3.24.5, Lane 14 GCs sample 3.24.6, Lane 15 
GCs sample 3.24.7, Lane 16 GCs -ve control, Lane 17 GCs +ve control, Lane 18 
100 bp ladder (BioLab).   
Row 1 Lane 1 100 bp ladder (BioLab), Lane 2 GCs sample 3.28.1, Lane 3 GCs 
sample 3.28.2, Lane 4 GCs sample 3.28.3, Lane 5 GCs sample 3.28.4, Lane 6 GCs 
sample 3.28.5, Lane 7 GCs sample 3.28.6, Lane 8 GCs sample 3.28.7, Lane 9 GCs 
sample 3.35.1, Lane 10 GCs sample 3.35.2, Lane 11 GCs sample 3.35.4, Lane 12 
GCs sample 3.35.5, Lane 13 GCs sample 3.35.6, Lane 14 GCs sample 3.35.7, Lane 
15 GCs -ve control, Lane 16 GCs +ve control, Lane 17 100 bp ladder (BioLab).    
                            
Predicts bands 
 1      2      3     4      5      6      7      8      9     10   11   12    13    14   15    16    17    18    

















Figure 3.6 The GC amplicon products of caecal DNA samples of birds fed 
the GOS supplemented diet challenged by Salmonella (Group 4). The 
agarose gel electrophoresis performed at 3 min extension time, 64 C° annealing 
temperature and primer used was F-ntf2/R-qcr2 electrophoresed on 0.8% TAE 
agarose gel  
Row 1, Lane 1 Kb ladder (BioLab), Lane 2 GCs sample 4.22.1, Lane 3 GCs sample 
4.22.2, Lane 4 GCs sample 4.22.3, Lane 5 GCs sample 4.22.4, Lane 6 GCs sample 
4.22.5, Lane 7 GCs sample 4.22.6, Lane 8 GCs sample 4.22.7, Lane 9 GCs sample 
4.24.1, Lane 10 GCs sample 4.24.2, Lane 11 GCs sample 4.24.3, Lane 12 GCs sample 
4.24.4, Lane 13 GCs sample 4.24.5, Lane 14 GCs sample 4.24.6, Lane 15 GCs sample 
4.24.7, Lane 16 GCs -ve control, Lane 17 GCs +ve control, Lane 18 1 Kb ladder 
(BioLab).  
Row 2, Lane 1 kb ladder (BioLab), Lane 2 GCs sample 4.28.1, Lane 3 GCs sample 
4.28.2,  Lane 4 GCs sample 4.28.3, Lane 5 GCs sample 4.28.4, Lane 6 GCs sample 
4.28.5, Lane 7 GCs sample 4.28.6, Lane 8 GCs sample 4.28.7, Lane 9 GCs sample 
4.35.1, Lane 10 GCs sample 4.35.2, Lane 11 GCs sample 4.35.3, Lane 12 GCs sample 
4.35.4, Lane 13 GCs sample 4.35.6, Lane 14 GCs sample 4.35.7, Lane 15 GCs sample 
4.35.5, Lane 16 GCs -ve control, Lane 17 GCs +ve control, Lane 18 kb ladder 
(BioLab).  
1     2      3     4     5       6     7      8      9     10   11   12     13    14   15   16     17   18  
18    
  1      2      3     4      5      6     7      8      9     10   11    12    13   14     15   16    17   18  
18    
G4 
3kb 




Table 3.3 Genetic content of GCs arrays identified by long range PCR  
of DNA caecal samples of birds reared in biosecure condition 
Sample feed type age Gene cassette 
1.22.1 ctl-nonc 22 GroupB-2 
1.22.2 ctl-nonc 22 GroupB-2 
1.22.3 ctl-nonc 22 GroupB-2 
1.22.4 ctl-nonc 22  ND 
1.22.5 ctl-nonc 22 GroupB-2 
1.22.6 ctl-nonc 22 GroupB-2 
1.22.7 ctl-nonc 22 ND 
1.24.1 ctl-nonc 24 GroupB-2 
1.24.2 ctl-nonc 24 ND 
1.24.3 ctl-nonc 24 GroupB-2 
1.24.4 ctl-nonc 24 ND 
1.24.5 ctl-nonc 24  ND 
1.24.6 ctl-nonc 24  ND 
1.24.7 ctl-nonc 24 GroupB-2 
1.28.1 ctl-nonc 28 ND 
1.28.2 ctl-nonc 28 ND 
1.28.3 ctl-nonc 28 ND 
1.28.4 ctl-nonc 28 ND 
1.28.5 ctl-nonc 28 ND 
1.28.6 ctl-nonc 28 ND 
1.28.7 ctl-nonc 28 GroupB-2 
1.35.1 ctl-nonc 35 ND 
1.35.2 ctl-nonc 35 ND 
1.35.4 ctl-nonc 35 ND 
1.35.5 ctl-nonc 35 GroupB-2 
1.35.6 ctl-nonc 35 ND 
1.35.7 ctl-nonc 35 ND 
2.22.1 GOS-nonc 22  ND 
2.22.2 GOS-nonc 22  ND 
2.22.3 GOS-nonc 22  ND 
2.22.4 GOS-nonc 22  ND 
2.22.5 GOS-nonc 22  ND 
2.22.6 GOS-nonc 22  ND 
2.22.7 GOS-nonc 22  ND 
2.24.1 GOS-nonc 24  ND 
2.24.2 GOS-nonc 24 GroupB-2 
2.24.3 GOS-nonc 24  ND 
2.24.4 GOS-nonc 24  ND 
2.24.5 GOS-nonc 24  ND 
2.24.6 GOS-nonc 24 GroupB-2 

























Sample feed type age Gene cassette 
2.28.1 GOS-nonc 28 ND 
2.28.2 GOS-nonc 28 ND 
2.28.3 GOS-nonc 28 ND 
2.28.4 GOS-nonc 28 ND 
2.28.5 GOS-nonc 28 ND 
2.28.6 GOS-nonc 28 ND 
2.28.7 GOS-nonc 28 ND 
2.35.1 GOS-nonc 35 ND 
2.35.2 GOS-nonc 35 ND 
2.35.3 GOS-nonc 35 Group C-1 
2.35.4 GOS-nonc 35 Group C-1 
2.35.5 GOS-nonc 35 ND 
2.35.6 GOS-nonc 35 ND 
2.35.7 GOS-nonc 35 ND 
3.22.1 ctl-sal 22 GroupB-2 
3.22.2 ctl-sal 22 GroupB-2 
3.22.3 ctl-sal 22 GroupB-2 
3.22.4 ctl-sal 22 GroupB-2 
3.22.5 ctl-sal 22 GroupB-1& GroupB-2 
3.22.6 ctl-sal 22 GroupB-2 
3.22.7 ctl-sal 22 GroupB-2 & groupC-2 
3.24.1 ctl-sal 24 GroupB-2 
3.24.2 ctl-sal 24 GroupB-2 
3.24.3 ctl-sal 24 GroupB-2 
3.24.4 ctl-sal 24 GroupB-2 
3.24.5 ctl-sal 24 GroupB-2 
3.24.6 ctl-sal 24 GroupB-2 
3.24.7 ctl-sal 24 GroupB-2 
3.28.1 ctl-sal 28 GroupB-2 
3.28.2 ctl-sal 28 GroupB-2 
3.28.3 ctl-sal 28 GroupB-2 & group F 
3.28.4 ctl-sal 28 GroupB-2 
3.28.5 ctl-sal 28 groupB-1 & GroupB-2 
3.28.6 ctl-sal 28 GroupB-2 
3.28.7 ctl-sal 28 GroupB-2 
3.35.1 ctl-sal 35 Group C-2 
3.35.2 ctl-sal 35 Group B-2 & groupC-2 
3.35.3 ctl-sal 35 GroupB-2 
3.35.4 ctl-sal 35 GroupB-2 
3.35.5 ctl-sal 35 GroupB-2 
3.35.6 ctl-sal 35 GroupB-2& groupC-1 
3.35.7 ctl-sal 35 GroupB-2& Group F 
Continued Table 3.3 Genetic content of GCs arrays identified by long range PCR  




Continued Table 3.3 Genetic content of GCs arrays identified by long range PCR of 























*Sample identifier key : ex, 1.22.1 The first digit refers to diet type (G1=1, standard control 
diet; G2=2, GOS supplemented diet; G3=3, standard control diet challenged by 
Salmonella; and G4 =4,GOS supplemented diet challenged by Salmonella). The second 
digit refers to sampling day (22,24,28 and 35). The third digit refers to sample number (1-
7 for each feed type at one sampling point in total 28 birds / sampling point). 
 
 
Sample feed type age Gene cassette 
4.22.1 GOS_sal 22 Group B-2 
4.22.2 GOS_sal 22 Group B-2 
4.22.3 GOS_sal 22 Group B-2 
4.22.4 GOS_sal 22 Group B-2 
4.22.5 GOS_sal 22 Group C-1 
4.22.6 GOS_sal 22 Group B-2 
4.22.7 GOS_sal 22 Group B-1 & Group B-2 
4.24.1 GOS_sal 24 ND 
4.24.2 GOS_sal 24 Group B-2 
4.24.3 GOS_sal 24 Group B-2 
4.24.4 GOS_sal 24 Group B-2 
4.24.5 GOS_sal 24 ND 
4.24.6 GOS_sal 24 GroupB-2 
4.24.7 GOS_sal 24 Group B-1& Group B-2 
4.28.1 GOS_sal 28 ND 
4.28.2 GOS_sal 28 ND 
4.28.3 GOS_sal 28 Group C-1 
4.28.4 GOS_sal 28 GroupB-2 
4.28.5 GOS_sal 28 Group F 
4.28.6 GOS_sal 28 ND 
4.28.7 GOS_sal 28 Group B-2 
4.35.1 GOS_sal 35 Group F 
4.35.2 GOS_sal 35 Group B-2 
4.35.3 GOS_sal 35 ND 
4.35.4 GOS_sal 35 Group B-2& Group F 
4.35.5 GOS_sal 35 ND 
4.35.6 GOS_sal 35 Group B-2 & group C-1 




Table 3.4 Total numbers of GCs recovered across time of biosecure birds (7 birds 
per barn). 
 

































B-1 - - - - - - - - - - - 
B-2 5 3 1 1 10/27=37% - 2 - - 2/28=7.14 12/55=21.81 
C-1 - - - - - - - - 2 2/28=7.14 2/55=3.63% 
C-2 - - - - - - - - - - - 
F - - - - - - - - - - - 
ND 2 4 6 5 17/27=62.96 7 5 7 5 24 41/55=74.54 
Total/da  5 3 1 1 10/27=37% 0 2 0 2 4/28=14.28 14/55=25.45 
GCs 
type 




















B-1 1 - 1 - 2/28=7.14 1 1 - - 2/28=7.14 4/56=7.14 
B-2 7 7 7 6 27/28=96.4 6 5 2 4 17/28=60.71 44/56=78.6 
C-1 - - - 1 1/28=3.57 1 - 1 2 4/28=14.2 5/56=8.92 
C-2 1 - - 2 3/28=10.71 - - - - - 3/56=5.35 
F - - 1 1 2/28=7.14 - - 1 2 3/28=10.71 5/56=8.9 
ND - - - - - - 2 3 2 7 7/56=12.5 
Total
/da 
9 7 9 10 35/28=125 8 6 4 8 26/28=92.85 
63/56=112.
5 



















Figure 3.7 The structure of class 1 integron GCs identified from the genomic DNAs 
of broiler caecal samples of birds reared under biosecure conditions. In all different 
cassettes arrays, the grey boxes represent a partial sequence of integron (intI1), and the 
black diamond is attachment site of integron (attI). Orange box is trimethoprim resistant 
gene (dfrA1), green boxes are another kind of streptomycin (aadA1), dark pink and blue 
boxes are streptomycin resistance gene (aadA9 and aadA24), and dark green coloured 
boxes are quaternary ammonium compound (qacE∆1). Small, coloured diamonds represent 
different attachment sites for antibiotic resistance gene which are chimeric sequences 
between attI and attC. The location and the direction of transcription of genes are indicated 
by bold arrow. Primers named F1, F2, F3, R1 and R2 are listed in Table 2.6 Chapter2. All 
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3.2.4 Characterisation of the antibiotic resistance gene cassettes of 
class 1 Integrons from caecal samples of commercial chicken flocks. 
The distribution of integron gene cassettes in 40 luminal caecal samples was 
determined by long range PCR. Three types of gene cassettes arrays were found 
in commercial broiler caecal samples that were categorised into three groups: 
GCs-A, GCs-B-2, and GCs-C-2. All resulted summarised in Table 3.5.  
The most prevalent gene cassettes observed in this trial was GCs-group A, 
at 75% (30/40), which confers resistance to aminoglycoside 3''-
adenylyltransferase (streptomycin and spectinomycin; aadA2) and lincosamide 
resistance (linF). The next most prevalent type was GCs-group B-2 at 22.5% 
(9/40), which contains dfrA1 that confers resistance to dihydrofolate reductase 
(trimethoprim-resistant dihydrofolate reductase type I) and aminoglycoside 3''-
adenylyltransferase (aadA1). This gene cassette shared a similar sequence to that 
obtained from biosecure broiler caecal samples, however this cassette was less 
prevalent than those identified in birds reared under biosecure conditions. The 
third type of GC was group C-2, which contains the aadA1 gene alone (2.5%; 
1/40). Results are presented in Table 3.6. Although, the GC group C-2 obtained in 
this trial displayed homologous sequence to GC-C-1 obtained from the controlled 
housing flock, the insertion of three Gs was found in the Lex A box of the integrase 
sequence at the position of the Pint promoter (Appendices 2.13.4 and 2.14), as 
was observed in the DNA of few samples of both biosecure and the commercial 
chicken flocks. PCR of the GC products resolved by agarose gel electrophoresis are 
presented in Figures 3.9, 3.10 and 3.11. All the GCs obtained are illustrated in 
Figure 3.11. The approximate position of designed primers pointed in each gene. 
Furthermore, all sequence reads are categorised and assembled, then consensus 
sequence of each GCs was created by CLC. All gene cassettes sequences data are 
represented in Appendix 2.13 (Figures 1-5) with used oligonucleotides and each 




PCR GCs gel pictures. 
Figure 3.8 The PCR amplicon products of GCs found in chicken caecal DNA samples 
of commercial birds (samples 1-18). The agarose gel electrophoresis performed at 3 min 
extension time, 64 C° annealing temperature and primer used was F-ntf2/R-qcr2 
electrophoresed on 0.8% TAE agarose gel.  
Lane 1 1 kb ladder (BioLab), Lane 2 GCs sample 1, Lane 3 GCs sample 2,  Lane 4 GCs 
sample 3, lane 5 GCs sample 4, Lane 6 GCs sample 5, Lane 7 GCs sample 6, Lane 8 GCs 
sample 7, Lane 9 GCs sample 8, Lane 10 GCs sample 9, Lane 11 GCs sample 10, Lane 12 
GCs sample 11, Lane 13 GCs sample 12, Lane 14 GCs sample 13, Lane 15 GCs sample 14, 
Lane 16 GCs sample 15, Lane 17 GCs sample 16, Lane 18 GCs sample 17, Lane 19 GCs 
sample 18, Lane 20 1 kb ladder (BioLab). 
Figure 3.9 The PCR amplicon products of GCs found in chicken caecal DNA samples 
of commercial birds (samples 19-36). The agarose gel electrophoresis performed at 3 
min extension time, 64 C° annealing temperature and primer used was F-ntf2/R-qcr2 
electrophoresed on 0.8% TAE agarose gel.  
Lane1 1 kb ladder (BioLab),  Lane 2 GCs sample 19, Lane 3 GCs sample 20   Lane 4 GCs 
sample 21, Lane 5 GCs sample 22, Lane 6 GCs sample 23, Lane 7 GCs sample 24,  Lane 8 
GCs sample 25, Lane 9 GCs sample 26, Lane 10 GCs sample 27, Lane 11 GCs sample 28, 
Lane 12 GCs sample 29, Lane 13 GCs sample 30, Lane 14  GCs sample 31, Lane 15  GCs 
   1     2     3      4     5     6      7     8      9    10   11   12   13   14    15   16   17   18   19   20 
   1     2      3     4      5      6     7      8     9    10    11   12   13   14   15    16   17    18    19   20 
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sample 32, Lane 16  GCs sample 33, Lane 17  GCs sample 34, Lane 18  GCs sample 35, 
Lane 19  GCs sample 36, Lane 20 1 kb ladder (BioLab). 
 
 







Figure 3.10 The PCR amplicon products of GCs found in chicken caecal DNA 
samples of commercial birds (samples 37-40). The agarose gel electrophoresis 
performed at 3 min extension time, 64 C° annealing temperature and primer used was F-
ntf2/R-qcr2 electrophoresed on 0.8% TAE agarose gel.  
Lane 1 1 kb ladder (BioLab), Lane 2 GCs sample 37, Lane 3 GCs sample 38, Lane 4 GCs 















Table 3.5 Genetic content of GCs arrays identified by long range PCR of DNA caecal 
samples of birds reared in commercial condition 
sample type age Gene cassette 
mpS 1 ctl 30d GroupA 
mpS 2 ctl 30d GroupA 
mpS 3 ctl 30d GroupA 
mpS 4 ctl 30d GroupA 
mpS 5 ctl 30d GroupB 
mpS 6 ctl 30d GroupA 
mpS 7 ctl 30d GroupA 
mpS 8 ctl 30d GroupB-2 
mpS 9 ctl 30d GroupB-2 
mpS 10 ctl 30d GroupA 
mpS 11 GOS 30d GroupA & B-2 
mpS 12 GOS 30d GroupA 
mpS 13 GOS 30d ND 
mpS 14 GOS 30d GroupA 
mpS 15 GOS 30d GroupA 
mpS 16 GOS 30d GroupA 
mpS 17 GOS 30d ND 
mpS 18 GOS 30d GroupA 
mpS 19 GOS 30d GroupB-2 
mpS 20 GOS 30d GroupA 
mpS 21 GOS 37d GroupA 
mpS 22 GOS 37d GroupA 
mpS 23 GOS 37d GroupA 
mpS 24 GOS 37d GroupB 
mpS 25 GOS 37d GroupA 
mpS 26 GOS 37d GroupA 
mpS 27 GOS 37d GroupB-2 
mpS 28 GOS 37d GroupA 
mpS 29 GOS 37d GroupA&B-2 
mpS 30 GOS 37d GroupA 
mpS 31 ctl 37d GroupA 
mpS 32 ctl 37d GroupA 
mpS 33 ctl 37d GroupA 
mpS 34 ctl 37d GroupA 
mpS 35 ctl 37d ND 
mpS 36 ctl 37d GroupA 
mpS 37 ctl 37d GroupB-2 
mpS 38 ctl 37d GroupA 
mpS 39 ctl 37d GroupA 




Table 3.6 Total numbers of GCs recovered across time of commercial birds (10 
birds per barn).  
 
 

























A 7 8 15/20=75% 7 8 15/20=75% 30/40=75 
B-2 3 1 4/20=20% 2 3 5/20=25% 9/40=22.5 
C-2 0 1 1/20=5% 0 0 0 1/40=2.5 
ND 0 1 1 2 0 2 3/40=7.5 













Figure 3.11 The structure of class 1 integron GCs identified from genomic  
DNAs of broiler caecal samples of birds reared under commercial conditions. In all 
the different cassettes arrangements, the grey boxes represent a partial sequence of 
integron (intI1) and the black diamond is the attachment site of integron (attI). Dark red 
boxes represent the streptomycin resistance gene (aadA2), orange boxes the trimethoprim 
resistant gene (dfrA1), tiffany blue boxes a second kind of streptomycin resistance (aadA1), 
dark blue boxes lincosamide resistance (linF) genes and dark green coloured boxes 
represent the resistance determinant for quaternary ammonium compounds (qacE∆1). 
Coloured diamonds represent different attachment sites for antibiotic resistance genes. The 
location and the direction of transcription of genes are indicated by bold arrows. All 
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F1 R F2 F3 
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The findings demonstrate that all the GCs obtained from chickens’ caecal 
contents (Tables 3.3 and  3.5) of both trials, are considered to be small GCs arrays 
that are likely located within mobile genetic elements (transposons and plasmids), 
which are possibly spread by LGT to facilitate the high prevalence observed within 
the broiler chicken gut microbiota. The amplicon sizes of the gene cassettes were 
2218, 2394, 1911, 1332, 1335 and 1355 bp (Table 3.7). In general, by comparing 
the diversity of the antibiotic resistance patterns in these experiments, it is evident 
that each trial was dominated by one type of GC, the controlled housing birds 
exhibited high prevalence of GC-group B-2, and in the commercial birds the GC-
group A was predominant being present in more than half of the samples. 
 
3.2.5 Attachment site attC structure 
All the gene cassette types (A, B-1, B-2, C-1,C-2 and F) were investigated 
for the presence of two GTTRRRY sequences, which act as the initiation sequence 
for the recombination process by integrase (intl1), and are located at the 
boundaries of each inserted gene cassette to define the entry point. Thus, GCs are 
categorised by the existence of essential palindromic sequences of different 
lengths between the RYYYAAC inverse core site and the GTTRRRY core site. In 
addition, the sequences were screened for integron integrase specific domains that 
are required in integration activity (L, R) as described in Figure 1.4 (Chapter1). 
Analysis of the attachment site (attC) sequences of various aadA cassettes 
indicated that the aadA2, aadA1 and aadA24 genes share similar palindromic 
sequences at inverse core site (1L, 2L) and core site (2R) regions. However, the 
1R core site features a substitution in the last four bases but retains the GTTRRRY 
consensus sequence, whereas the L2 region was different to the other aadA genes. 
The variable region shows 1% dissimilarity between aadA1 and aadA24. However, 
6% dissimilarity between aadA2 genes compared to aadA1. For the palindrome 
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sequence of attC in the linF gene, the inverse core site (GCACAAC, 1L) was located 
upstream the stop codon within the linF gene.  
However, the dfrA1 palindromic sequences were compatible (Biskri et al., 
2005). The different sizes of attC length observed are shown in Table 3.7 and the 
imperfect inverted repeats are underlined in Table 3.8. 
 
Table 3.7 Summary of genetic content of gene cassette arrays identified by long 
range PCR (F-ntf2, R-qcr2) 
 
Table 3.8 Summary of attachment site sequence (attC) of GCs obtained from 

























A aadA2 792 60 linF 821 58 - - - 2218 
B-1 dfrA1 473 94 Orf1 519  aadA24 702 60 2394 
B-2 dfrA1 473 94 aadA1 792 60 - -  1911 
C-1 aadA1 792 60 - - - - -  1332 
C-2 aadA1 792 60 - - - - -  1335 
F aadA9 834 60 - - - - -  1355 











&Roy,2011) aadA2 >TGTCTAACAATTCGTTCAAGCCGACCGCGCTACGCGCGGCGGCTTAACTCCGGCGTTGTGC 
aadA24 >TGTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCGAGCGTTAGAT 
aadA9 >CGTCTAACTATTCATTTAAGCCGAAGCCGCTTCGCGGCTCGGCTTAATTCAGGCGTTAGAT 
(Tauch et al., 
2002) 
linF >CGCACAACAAGTAAATCCAGCGGACGCATAAAAACGCGCCGCTGATTTTGACGTTAGAT 















       The abundance and prevalence of class 1 integrons has had a spectacular 
increase in bacterial communities compared to what it was estimated to be 100 
years ago in clinical forms of this element (Ghaly et al., 2017;Gillings, 2017). This 
has meant that these DNA elements have become significant indicators for a wide 
range of environmental pollutants (Pruden et al., 2006;Pruden et al., 2013). The 
gastrointestinal tract of the chicken is highly populated and acts as a key reservoir 
for the transmission of foodborne disease and a fertile environment for the 
exchange of antibiotic resistant genes via LGT (Stalder et al., 2012;Kaakoush et 
al., 2014). In this regard, it is important to investigate load of antibiotic resistance 
genes and associated mobile elements in one of the most common food sources, 
which could act as a vehicle for dissemination in the human food chain and a proxy 
for understanding the spread of ARG amongst bacterial species.   
Previous studies have shown a high abundance of integrons in E. coli isolates 
from broiler chickens (Goldstein et al., 2001;Lu et al., 2003b). In this study 92.5% 
of the commercial broiler caecal contents tested positive for the IntI1 gene (5ꞌCS) 
and 99% of the biosecure broiler caecal samples were positive for integrase. 
Therefore, there was no discrimination between two different conditions in terms 
of the prevalence of class 1 integrons. For clarification, four primers were used for 
targeting different sections of the integrase gene, the primers called int1 Ravi and 
HS464 were used as the main primers. Primers for IntI1 EB were not effective, 
likely due to a substitution observed in the forward primer compared to the IntI1 
sequence that might justify why this primer did not work with the majority of 
samples. Surprisingly, many studies have suggested that integrons were prevalent 
in bacterial communities that had not been directly exposed to antibiotic pressure 
in clinical, agricultural or environmental settings (Stalder et al., 2012). In addition, 
Gillings (2018) suggested that the high abundance of IntI1 is subjected to active 
selection as it confers a survival advantage to the bacteria that carry it.  
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Escudero et al. (2015) highlighted the high frequency of integrases 
depending on the environment in which the integrons were found. Vásquez-Ponce 
et al. (2019) pointed out that this may explain how DNA segments are shared 
sequences across various bacterial samples obtained from different environments 
such as  soil, fresh water, marine and pathogenic bacteria (veterinary and human). 
Liljebjelke et al. (2017) noted that the reservoir of antimicrobial resistance genes 
was larger than previously thought. 
Most of the broiler chicken caecal samples were also positive for the qacEΔ1 
gene (3ꞌCS) with 100% presence in the commercial birds and 93.7 in the biosecure 
caecal DNA samples. Stalder et al. (2012) pointed out that qac GCs are common 
in class 1 integrons. Rådström et al. (1994) reported that the origin of qacE gene 
in the class 1 integron could be identified as emanating from transposons Tn402 
and Tn5090. Moreover, the class 1 integrons containing qacE may act to retain 
antibiotic-resistant bacteria in environments polluted by quaternary ammonium 
compounds because the selection for qac resistance may lead to co-selection for 
antibiotic resistance (Gaze et al., 2005). Gilbert and McBain (2003) and Gillings 
(2014) demonstrated that this gene encodes a versatile efflux pump that confers 
resistance to toxic cationic molecules, and may interpreted as a role in defending 
cells against toxic substances presented in natural ecosystems. Therefore, the 
qacE gene has played a significant role in the emergence of class 1 integrons as it 
provides a survival advantage besides acting as a site for integrative mobile 
elements.  
Similarly, the sul1 gene was observed in almost all samples, 97.5%- 94.5% 
of caecal DNA samples from commercial and in biosecure conditions respectively. 
Although Vásquez-Ponce et al. (2019) reported that no typical structure had been 
found for class 1 integrons among florfenicol FB isolates in his study of multi-
resistant bacterial isolates collected from the gut microbiota of extended antibiotic 
treated Salmo salar fish farms. These authors also reported the absence of the 3’-
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CS of qacEΔ1/sul1 genes in this group (FB), whereas 23% of oxytetracycline (OB) 
isolates showed these structures in the integron system. The sul1 gene confers 
resistance to sulphonamides that target dihydropteroate synthase in the folic acid 
pathway, and it was inserted into the Tn402-class 1 integrons causing deletion at 
the end of the qacE to generate  qacE∆1, and features in clinical class 1 integrons 
as a 3’ conserved segment (Gillings, 2014). 
What is worth mentioning here is that the high stability of the class 1 
integrons sequence was noted among (40+75) 115 sequence data sets of GI of 
broiler chicken microbiota. Dubois et al. (2007) noted high uniformity of the class 
1 integrons from clinical isolates of Shigella spp. Furthermore, Gillings et al. (2015) 
found that the clinical class 1 integrons possessed homologous DNA of the 
integrase (intI1) gene, which is strong evidence that they have a single recent 
common ancestor. In addition, Gillings (2014) could identify a class 1 integrase in 
new clinical pathogens, which could also be found on the chromosomes of non-
pathogenic environmental Betaproteobacteria. Thus, studying the origins of these 
clinical class 1 integrons may facilitate understanding of the dynamics and 
prevalence of antibiotic resistance. Analysis of the integrase sequence revealed 
that various resistance gene cassettes conserve a LexA box motif that overlaps 
with the –10 box of the intI1 promoter. Cambray et al. (2011) indicated that the 
LexA binding motif has been found in a large proportion of database integrase 
sequences, suggesting that the control of integrase expression by the SOS 
response is conserved amongst integron systems. The in vitro assessment of LexA 
box functionality for class 1 integrons indicates that the SOS response increases 
the expression of the class 1 integrase 4.5-fold (Escudero et al., 2015).  
Papagiannitsis et al. (2009) and Guérin et al. (2011) described an insertion 
of three G bases in the intI1 sequence, which they claim as an activator sequence 
in a second promoter (P2) located downstream of Pc that increases the distance 
to 17 bases between the -35 and-10 hexamers. This was observed in few samples 
in this study recovered from genomic DNAs of both biosecure and commercial 
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birds. Despite this, the sequences at -35 and-10 region possessed a weak 
sequence promoter that may be interpreted as the reason for the abundance of 
the gene cassette among microbiota.   
The gene cassettes obtained from both trials show discrimination for 
antibiotics for veterinary use. Gene cassettes encoding lincosamides (linF) that 
confer resistance to lincomycin were found to be the dominant GCs in commercial 
birds with total carriage 75%, (30/40), while the linF gene was completely absent 
under biosecure conditions. It is clear that the previous usage history of lincomycin 
in flock drinking water still enhances mobility of this gene despite the ban of using 
AGPs in the EU since 2006. Maxey and Page (1977) reported that lincomycin 
mitigated necrotic enteritis in broiler chickens caused by Clostridium perfringens, 
which may account for its sustained use. GCs B-1 was only found in the birds 
reared under biosecure conditions. The gene cassette was present in 4 samples, 
which represent atypical copies of GCs B-2 that exhibit an insertion of a gene 
encoding a hypothetical protein between dfrA1 and aadA1. The other gene 
cassettes show similar sequence homology although they are reared under 
different conditions. 
Martinez-Freijo et al. (1999) proposed that the stability of transferred 
variable regions (GCs) often act as part of the integron structure rather than as 
individual cassettes. The study findings of GCs arrays suggest that wide 
dissemination and uniformity among various OTUs across caecal contents of 
several birds may be indicative of the relative stability of these structures 
supporting Martinez-Freijo’s hypothesis. Futher analysis of the strength or 
weakness of the Pc promoters is needed to help to clarify if they contribute to 
satability among microbiota. 
Several studies have documented streptomycin resistance (aadA) as 
commonly mediated by integrons. Ebner et al., (2004) reported that GCs were 
detected from Salmonella enterica serovars isolated from animal environments 
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that contain the aadA GC at low diversity. Similarly, in this study the most 
prevalent gene in all cassettes was aadA, whether a single gene such as (aadA1) 
or in conjunction with either trimethoprim resistance (dfrA1) or lincosamide 
resistance (linF, aadA2). The GCs of group B contained dfrA1 and aadA1 as the 
second most abundant configuration observed within biosecure broiler chicken 
caecal microbiota. Ponce-Rivas et al. (2012) pointed out that the dfrA1 and aadA1 
GCs were the most prevalent genes detected within the class 1 integrons present 
in Escherichia coli isolates from poultry litter, which were located on mega-
plasmids or the chromosome. Martinez-Freijo et al. (1999) also reported these 
resistance genes in Enterobacteriaceae. Although Larouche and Roy (2011) 
reported that IntI1 had weak excision activity for the dfrA1 cassettes.  
In this context the GCs of group C and F may be considered as a deletion of 
the dfrA1 gene from group B, which collectively indicate a greater genetic variation 
of the GCs obtained from group B, whereas the GCs of group A were more stable. 
However, relatively few papers discuss stability of gene cassettes as a function of 
time in the gut microbiome. 
Although attC sites of the gene arrays of integrons are not considered a 
conserved sequence among various genes, the attC sites of similar gene cassettes 
show identical sequences in inverted repeat boxes or palindromic sequences (L1, 
L2, R1 and R2) in most of attC sites of the same resistance gene. These feature in 
chromosomal integrons, which show a high sequence identity of the attC sites 
suggesting a relationship between these fragments and the sequence of the 
recombination site in the host (Rowe-Magnus et al., 2003). 
In summary, comparisons between different reared environments provide 
insights into the dynamics and flow of resistance genes in the absence of antibiotic 
use. Diversity in the lineage of class 1 integrons in these settings suggest they 
remain mobile and able to find their way into the genomes of zoonotic pathogens. 
However, the integrons present in the birds reared under biosecure condition are 
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likely to have arisen from the hatchery and preserved as a component of the gut 


































                                      CHAPTER 4 
INVESTIGATION OF ANTIBIOTIC RESISTANCE IN THE 
CAECAL MICROBIOTA OF BROILER CHICKENS FED STANDARD 



























The microbiomes of food animals have gained antibiotic resistance genes 
over several decades (Allen, 2014). Antimicrobial agents have been extensively 
used in animal production over the past 50 years for several purposes that 
principally include using them as therapeutic agents for treating infection, or as 
prophylactics for preventing illness, and for sub-therapeutic use for improving feed 
efficiency and growth performance. However, as highlighted in Chapter 1 (Section 
1.2.4), the use of antibiotics growth promoters (AGPs) in food producing animals 
has been banned in the European Union due to its contribution to accelerate the 
development of AR and the potential to spread to pathogens (Marshall and Levy, 
2011). Hence, it is mainly the historic use of antibiotics that contribute to the 
continuing presence of antibiotic residues in feed and the environment (Mehdi et 
al., 2018). 
Many studies have highlighted farmed animals and their broader 
environment as proxy of ARGs that can be easily acquired across species (Forsberg 
et al., 2012;Finley et al., 2013;Braykov et al., 2016). Animal faecal microbiota 
harbours a huge reservoirs of these ARGs that might be acquired by human 
commensals and pathogens (Allen, 2014). Antibiotic residues, resistant bacteria 
and ARGs may be transferred into the environment by several mechanisms such 
as directly from manure, leakage from holding tanks, runoff, and airborne 
particulates (Udikovic-Kolic et al., 2014;McEachran et al., 2015;Xiong et al., 
2018a).  
It was shown in the Chapter 3 that despite the difference in rearing 
conditions of broiler chickens, trimethoprim resistance GCs were prevalent in both 
environmental settings associated with other types of resistance determinants 
(streptomycin resistance, aadA1). Trimethoprim resistance was therefore selected 
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for investigating the AMR load in caecal contents of the microbiota of broiler 
chickens. So far, 30 dfr-genes have been identified as determinants for the 
developing trimethoprim resistance, and which are usually associated with 
integrons (Sköld, 2001). This feature results in an effective horizontal 
dissemination mechanism for antibiotic resistance between bacteria (White et al., 
2001;Dionisio et al., 2002;Blahna et al., 2006). Limited studies have investigated 
the epidemiology and frequency of the different dfr-genes and their association 
with integrons or its relationship to other resistance determinants from E. coli or 
coliforms (Brolund et al., 2010). 
The avian GIT microbiota rapidly develops in the early stages of life (in 
particular, within the first 2 weeks) since young chicks are hatched and delivered 
to a chicken house (typically at 1–2 da). Initially, the GI of young chick is very 
simple containing a small number of bacteria belonging to a few different species 
(Fonseca et al., 2011;Cox et al., 2012;Hiett et al., 2013;Wang et al., 2016). 
 Post-hatching the intestinal microbiome becomes dominated by 
Enterobacteriaceae (1 to 3 da) and then Firmicutes around 7 da (Ballou et al., 
2016;Connerton et al., 2018). Through the first week of life, the abundance and 
taxonomic diversity of Gram-positive bacteria become dominated by the 
Clostridiales OTUs, causing a corresponding decrease in the proportion of Gram-
negative bacteria (Ballou et al., 2016). Exogenous sources of bacteria that can be 
incorporated into the microbiota of the immature gut of chicks include litter 
materials, feed, water, and ambient air. Bacteria from these sources can easily 
colonise the young GI tract due to the low numbers of competitors (Wang et al., 
2016). Hence, the microbiome of growing chicks undergoes a series of temporal 
successions (Wielen et al., 2002;Lu et al., 2003a) and the complexity and diversity 
of GI microbiota are increased (Wei et al., 2013), and their interactions 
significantly influence host physiology, immunology and nutritional status (Zhao 
et al., 2013). Thereby, the dynamics and flow of ARGs between farmed animals 
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and their environment are considered an important event in terms of shaping 
animal microbiota and mobilising ARG determinants.  
 
The aim of this study was to elucidate the effect of rearing conditions on the 
avian GI microbiome in terms of estimating the prevalence of ARGs. In order to 
do this, it is important to understand how the chicken microbiome develops in 
chickens fed a standard diet and reared under biosecure or commercial settings. 
Therefore, the aim of the work described in this chapter are to evaluate 
trimethoprim resistance in coliform populations in chickens fed a standard diet. 
This includes an evaluation of the total coliform count; the trimethoprim resistance 
bacteria count and absolute quantification of the copy number of integrase genes 
















4.2 Results  
4.2.1 Pre-trial test optimisation of antibiotic selection method 
Before starting the experiments, it was important to select the most 
appropriate antibiotic and the optimum concentration to add to the selective 
media. Randomly selected samples of chicken caecal contents were handled as 
described in Chapter 2, Section 2.3.3. The antibiotics chosen were trimethoprim 
and lincomycin. Three different concentrations were tested, these were 5, 10, 20 
µg/ml for trimethoprim, and 30, 50, 70 µg/ml for lincomycin. These antibiotics 
were added to three different kinds of selective media (Mac-03, MRS and M-XLD). 
The results are shown in Figures 4.1 and 4.2.  
High counts of Gram-positive bacteria resistant to lincomycin were recorded 
in the samples, so this antibiotic was excluded from the trials. Thus, trimethoprim 
at a concentration of 20 µg/ml was selected as it yielded a countable range of 
trimethoprim resistance bacteria. Selection for coliforms was chosen because of 
their role in the dissemination of antibiotics resistance genes as well as their 























































Figure 4.1 Initial test study for selecting the optimum trimethoprim concentration 
for plating on three types of media (MAC-03, XLD, MRS), at three different 
concentrations (5, 10 and 20 µg/ml) over three dilution factors (-2, -3, -4). The 
purple bar chart groups for enumeration coliforms, red group for Salmonella and grey bar 
chart for Lactic acid bacteria.  




































Lincomycin  Concentration g-1
 
Figure 4.2 Initial test study for selecting the optimum lincomycin concentration 
for plating on three types of media (MAC-03, XLD, MRS), at three different 
concentration (30, 50 and 70 µg/ml) over two dilution factors (-3, -4). The purple 
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bar chart groups for enumeration coliforms, red group for Salmonella and grey bar chart 
for Lactic acid bacteria.  
4.2.2 Enumeration of coliform bacteria recovered from the caecal 
contents of control fed birds reared under biosecure conditions. 
In order to estimate the relative abundance of the caecal coliform counts 
(this includes all bacteria grown on the plate) with age of the chickens, 
enumeration of coliforms on triplicate MacConkey plates was performed as 
described in (Chapter 2, Section 2.4.1.1) with the control diet during 4 sampling 
points 22, 24, 28, 35 da (Trial1 Chapter 2, Section 2.3.4). The results are 
represented in Figure 4. 3.  
 
Figure 4.3 Total coliforms recovered from the caecal contents of 22, 24, 28 and 35 
da old birds fed the control diet and reared in biosecure conditions (G1, trial 1). 
Data are expressed as standard boxplots with medians (solid black line). Outliers are 
represented as dots. The top and bottom Whiskers indicate maximum and minimum values, 
unless these values exceed 1.5x interquartile range. All orange boxes represent control fed 
birds. The number of birds per sampling point is 7 (total =28 birds), counted on Mac-03 
media.  
A significant difference was observed in total coliform counts between 
sampling days 22 vs 35 (p=0.026) as well as 24 vs 35 (p=0.01) with time. 
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Although there was no significant difference (p>0.05) found between 22 vs 24 or 
28 vs 35 da. Therefore, the results show that coliform counts start to decrease at 
28 da and continue to decrease to 35 da. In general, coliform numbers decrease 
with time. 
4.2.3 Enumeration of trimethoprim resistance coliforms obtained from 
the caecal contents of control fed birds reared under biosecure 
conditions (G1, trial1). 
The viable count of trimethoprim resistant bacterial were enumerated on 
MacConkey agar plates containing trimethoprim (20 µg /ml). The results in Figure 
4.4 indicated that the viable counts of trimethoprim resistance bacteria generally 
remained steady across the trial with no significant difference was found (p>0.05) 












Figure 4.4 Viable counts of resistance coliforms bacteria growing on MacConkey 
03 supplemented by 20 µg/ml of trimethoprim obtained from the caecal contents 
of 22, 24, 28 and 35 da old birds fed control diet (G1). Data are expressed as standard 
boxplots with medians (solid black line). Outliers are represented as dots. The top and 
bottom Whiskers indicate maximum and minimum values, unless these values exceed 1.5x 
interquartile range. All orange boxes represent control fed birds. The number of birds per 
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sampling point is 7 (total =28 birds), counted on Mac-03 media supplemented by 20 µg/ml 
of trimethoprim. 
 
4.2.4 Ratio of coliform trimethoprim resistance bacteria from the 
caecal contents  
The ratio of trimethoprim resistance was calculated by dividing the 
concentration of trimethoprim resistance coliforms by the total coliform count 
determined on control plates. There was no significant difference (p> 0.05) 
between the ratio of coliform trimethoprim resistant isolates in G1 when comparing 
between 22 vs 24 da or 28 vs 35 da. However, a significant difference was 
observed between 22 da vs 35 da (p=0.014) and between 24 vs 35 (p=0.028). 
The trend appears to be that the proportion of trimethoprim resistance bacteria 













Figure 4.5 Ratio of trimethoprim resistant coliform population with time of 
controlled housing birds fed a conventional diet. The Figure  shows the ratio of 
trimethoprim resistance in control diets gradually increasing with time. Specifically, the 
growth rate was slower at 22 and 24 da however this rate displayed a greater increase after 
28 da. Data are expressed as standard boxplots with medians (solid black line). Outliers 
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are represented as dots. The top and bottom Whiskers indicate maximum and minimum 
values, unless these values exceed 1.5x interquartile range. All orange boxes represent 
control fed birds. The number of birds per sampling point is 7 (total =28 birds). 
 
4.2.5 Evaluation of the class 1 integron copy number based on the 
integrase genes per gram of caecal content for control diet fed birds 
reared under biosecure conditions (ctl diet). 
A second set of experiments was carried out to determine the integrase copy 
number for the control diet birds reared under controlled conditions. qPCR was 
preformed to evaluate class1 integrons signals across four sampling points (22, 
24, 28, 35 da). The integrase sequence was selected because it is integral to the 
class 1 integron carrying ARGs and considered as an indicator of the antibiotic 
resistance load. Primers designed to target a small region of approximately 200 
bp inside the main sequence. The established Ravi primer set was adopted for this 
purpose. The primary test was done by using the standard PCR for selected 
samples as shown in Figure 4.6, whilst the results of the qPCR assay of integrase 







Figure 4.6 initial test for PCR amplified fragments for RT q-PCR for detecting 
integrase copy number (183bp). Lane 1 100 bp Ladder, Lane 2 sample1 (1.22.3), Lane 
3 sample2 (1.22.7), Lane 4 sample3 (3.28.6), Lane 5 sample4 (4.24.3), Lane 6 sample 5 
   1      2        3      4       5      6       7      8 
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(4.24.6), Lane 7 S.T.U 288, Lane 8 negative control. Key for numbers (1=G1, ctl-bio nonc, 









Figure 4.7 Class 1 integrase copy number quantified by qPCR per gram of caecal 
content for control housed birds. The specific primers were designed (Chapter 2, 
Section 2.5.3.3) to determine copy number of class 1 integrase gene applying Salmonella 
typhimurium U288 as positive template to draw the standard curve (Chapter 2, Section 
2.5.8.1). Comparison shows total copy number of integrases across 4 sampling points in 
control diets birds (Trial1). Data are expressed as standard boxplots with medians (solid 
black line). Outliers are represented as dots. The top and bottom Whiskers indicate 
maximum and minimum values, unless these values exceed 1.5x interquartile range. All 
orange boxes represent control fed birds. The number of birds per sampling point is 7 (total =28 
birds).    
Results demonstrated that there was no significant difference found in 
integrase copy number between the sampling points (t.test p-value= 0.19 at 22 
vs 24 da, p-value 0.11 at 24 vs 28 and p-value=0.37 at 28 vs 35. However, the 
class 1 integrase copy number was significantly reduced at 28 da (control) 




number is to reduce with time for birds fed the ctl diet and reared under biosecure 
conditions.  
 
4.2.6 Evaluation of copy number of class 1 integrase gene per gram of 
caecal content for commercial birds (ctl diet). 
The quantification of copy number of class 1 integrase gene per gram of 
caecal content was carried out by using Salmonella Typhimurium U288 as a 
positive template and to create standard curve for absolute quantification copy 
number of the class 1 integrase gene. Results showed that there was no difference 
in total copy number of integrases between two sampling time in control diets of 











































Figure 4.8 Class 1 integrase copy number quantified by qPCR per gram of caecal 
content of commercial birds. Data are expressed as standard boxplots with medians 
(solid black line). Outliers are represented as dots. The top and bottom Whiskers indicate 
maximum and minimum values, unless these values exceed 1.5x interquartile range. All 
blue boxes represent control fed birds. The number of birds per sampling point is 10 (total 





4.2.7 Development of the caecal microbiome composition of control 
fed diet birds reared in controlled housing and commercial condition.   
The developmental changes in the broiler chicken caecal microbiome were 
investigated by analysing DNA sequences of the 16S rRNA genes of the 
hypervariable region (V4). This allowed an assessment of both the biodiversity of 
caecal microbiota and the relative abundance of the community members from 
the two broiler chickens groups. A total of 1947973 (median: 66586, IQR: 
59287.5) of quality-controlled sequence reads of 28 biosecure housed birds fed 
control diet, and a total of 1112207 quality-controlled sequence reads (median: 
42664, IQR: 62932) obtained from 20 broiler caecal samples of commercial birds. 
These were classified into 4892 OTUs (distance 0.03) that split to 10 phyla. 
Coverage was calculated in mother (V1.39.5) by Good's coverage at 98% (range 
= 0.97 - 0.99%) to estimate the proportion of total OTUs present in each sample 
of the biosecure and commercial birds fed control diets. Rarefaction curves 
indicated the depth of sequencing data was sufficient for the coverage of all OTUs 
present in caecal samples (Appendix 3, Figure 3.1 A and B). The coverage range 
was deemed as sufficient for the sequence depth of all samples. Random 
subsampling of 3511 reads per sample, was undertaken in order to avoid bias 
between communities with different sampling depths for bacterial community 
analysis and abundance. 
Generally, the dominant phyla for the microbiota of birds reared in biosecure 
housing were Firmicutes (Clostridiales_unclassified) with an overall median 
abundance of 93.06% ranging from 91.4%-96.6%, followed by Proteobacteria 
with median 3.26% (ranging from 1.78-6.34%) and smaller contributions from 
Bacteria_unclassified (median:1.2%) and Actinobacteria (median: 0.9%) within 
these phyla. Whilst the dominant phyla in the microbiomes of the commercial birds 
were Firmicutes with an overall median abundance 78.62% (77.96%-79.27%) 
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followed by Actinobacteria at median 7.52%, Bacteroidetes at median 5.70% 
(ranging from 3.93-7.47%), Proteobacteria median 4% (2.97-5.057%) and 
Bacteria_unclassified median 3.39% (4.43-2.35%). However, Bacteroidetes were 
only significant components of the microbiota of the birds from commercial flocks 
however they were absent in the caecal microbiota of birds from biosecure 
conditions across various sampling points. 
At the class level, the results indicated that no significant difference was 
detected in the caecal bacterial communities by comparing the abundant OTUs at 
22 da with birds at 24 da birds within the biosecure housed birds (trial 1). The 
exception to this was the relative abundance of Bacilli showing a decrease at 24 
da (p-value 0.01, median: 7.31, 4.03, IRQ: 3.33, 0.79 at 22 vs 24 respectively). 
No significant change was found between the caecal bacterial communities at 24 
da old birds and 28 da, or between 28 and 35 da old birds fed control diets at class 
level (p-value >0.05). While comparison of the sampling points (30 and 37 da) 
from the commercial birds indicated significant changes in the abundance of Bacilli 
(p-value 0.01, median: 8.07, 3.70%, IRQ: 6.4, 1.89 for the 30 da birds vs 37 da 
respectively), Negativicutes (p-value=0.0007; median: 0.00, 1.55, IRQ: 0.0, 25), 
Epsilonproteobacteria (p-value=0.0001; median: 0.00, 2.42%, IRQ: 0.0, 2.95). 
Indeed, at the class level distinctive OTUs were evident in the caecal bacterial 
communities of commercial birds that were not present in caecal microbiota of 
controlled housed birds. These included the relative abundance of Bacteroidetes 
that were almost completely absent in controlled housing birds while they were 
found at both sampling points for the commercial birds (median: 7.47% at da 30, 
3.94% at da 37, IRQ: 5.92, 3.37 in commercial birds). Betaproteobacteria 
represent approximately 1% (median: 1.21% at da 30, 1.0% at da 37, IRQ: 1.34, 
0.62) in commercial birds whereas there was no presence of this class in controlled 
housed birds. Moreover, Epsilonproteobacteria (median: 0, at 30 da, 2.24% at 37 
da; IRQ:0, 2.95) in the birds from commercial flocks was noted at 37 da and 
131 
 
absent at 30 da in the same trial.  Epsilonproteobacteria were absent in trial1. The 
abundance of Negativecutes was not significantly different with less than 1% 
difference between all sampling points for the control housed birds.  However, 
there was a significant difference in this class for the caecal microbiota of 
commercial birds at 37 da, showing the level of Negativecutes is significantly 






































Figure 4.9 The relative abundance of dominant bacterial phyla of the chicken caecal microbiota of biosecure housed birds 
clustered on the basis of the Ribosomal Database Project taxonomy (phylum level). The results are presented as % and at least 










































































































































































































































































Figure 4.10 The relative abundance of dominant bacterial phyla of the chicken caecal microbiota of commercial birds clustered on 
the basis of the Ribosomal Database Project taxonomy (phylum level). The results are presented as % and at least taxa that include 1% 












































































































































































































































































































































































































Figure 4.11 The relative abundance of dominant bacterial classes of the biosecure housed chicken caecal microbiota clustered 
on the basis of the Ribosomal Database Project taxonomy (class level). The results are presented as % and at least taxa that include 




Figure 4.12 The relative abundance of the dominant bacterial classes of the commercial broiler chicken caecal microbiota clustered on the 
basis of the Ribosomal Database Project taxonomy (class level). The results are presented as % and at least taxa that include 1% community was 







































































4.2.7.1 Relative abundance of Proteobacteria phylum of controlled 
housing (CH) birds and commercial birds fed control diets  
The classification of bacterial taxa is displayed as hierarchal taxonomic 
groups starting with Phylum and ending with OTU (Phylum > Class > Order > 
Family > Genus > OTU). The median of Proteobacteria abundance (OTU003, 
OTU004 in trial1 and trial 2 respectively) was investigated at the phylum level in 
broiler caecal samples of the control fed barns indicated that there was no 
significant change calculated by using Mann Whitney or Wilcoxon test (Figure 
4.13; p-value >0.05). The medians of the relative abundances of Proteobacteria 
at 22 da 3.29%, at 24 da 6.34%, at 28 da 3.23% and at 35 da 1.78% for control 
housed birds. There was no significant difference between the abundance of 
Proteobacteria (Figure 4.13) of commercial birds fed the control diet between 30 
da (2.97%) and 37 da (median: 5.0 %; Wilcoxon test p-value =0.075). The results 
of the Shapiro-Wilk test of normality and quantile-quantile plots indicated that the 
distribution of OTUs of Proteobacteria phylum was not normally distributed across 
cohorts at 22 da in biosecure birds and at 30 da for the commercial birds (Shapiro-
Wilk normality test= 0.0215 at 22 da, p-value=0.0001 at 30 da in commercial 
birds; Appendix 3, Figure 3.2 A and B). 
There was an intra-group variability in the caecal bacterial communities at 
phyla level as observed in the Proteobacteria phylum for the control diet group at 
30 da, (median: 3%, IQR: 1.9%). At the class level the Negativicutes, showed 
variation in composition with an identical bootstrap threshold for control 

















































Figure 4.13 Comparison of the relative abundance of the Proteobacteria phylum 
of controlled housed birds during 4 sampling points and commercial ones through 
two sampling points both fed control diets. Bar charts indicate median of relative 
abundance of the Proteobacteria, Wilcoxon test p value was used because the relative 
abundance of all Proteobacteria phylum not normally distributed across cohorts (Appendix 
3.2 A and B). All orange bars represent control fed birds reared in biosecure condition, while 












4.2.7.2 Distribution of resistance gene cassettes (GCs) arrays in 
Proteobacteria phylum  
Phylogenetic trees of the proteobacterial OTUs identified within the chicken 
caecal microbiota of the biosecure housed bird and those from commercial are 
presented in Figures 4.14. As integron gene cassettes are frequently associated 
with Proteobacteria, the distribution of GCs for each bird within the Proteobacteria 
phylum are indicated adjacent to the identifiers of the phylogenetic trees. These 
show that the distribution of GCs, mainly GCs-B-2 in the CH birds, was associated 
with Gammaproteobacteria  OTU0007 belonging to 
Enterobacteriaceae_unclassified with few contributions associated with OTU0324 
which is also Gammaproteobacteria (Enterobacteriaceae_unclassified) and 
OTU0169 is Gammaproteobacteria (Proteus). Whilst GCs were found more 
prevalent among various Proteobacteria OTUs in commercial birds showing the 
most abundant GCs were mostly detected in OTU0007 
(Enterobacteriaceae_unclassified) and OTU0070  (Betaproteobacteria  
Parasutterella), OTU0276 (Proteobacteria_unclassified), OTU0041 
(Epsilonproteobacteria Campylobacter),  OTU0176 (Alphaproteobacteria    
Aestuariispira) and OTU 0615 (Gammaproteobacteria 
Enterobacteriaceae_unclassified). Generally, A and B2 GC types were distributed 
among all the commercial birds featuring Proteobacteria phyla. However, the 
group A GCs dominated in 37 da birds which coincides with the appearance of 
Campylobacter OTU0041 at 37 da. Appendix 3, Figure 3.3 A and B exhibiting GCs 
distribution per sampling points for each trial. Due to the cut off value adopted ≥ 










Figure 4.14. The phylogenetic tree of Proteobacteria OTUs associated with the 
distribution of GC groups identified in the broiler chicken microbiota. The tree was 
constructed by a neighbour-joining method with Bootstrap value ≥ 20. (A) biosecure birds 
only da 22 and 24 have been presents because with applying cut-off value≥ 20 there was 
no Proteobacteria OTUs found at 28 and 35 da. (B) commercial birds age matched 30 and 
37 da. The scale bar represents a sequence divergence of 3%. The bacterial OTUs are: OTU 
0324 is Gammaproteobacteria (Enterobacteriaceae_unclassified), OTU0007 is 
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Gammaproteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is 
Gammaproteobacteria (Proteus), OTU0041 is Epsilonproteobacteria (Campylobacter), 
OTU0176 is Alphaproteobacteria (Aestuariispira), OTU0471 is Alphaproteobacteria 
(Alphaproteobacteria_unclassified), OTU0565 is Gammaproteobacteria 
(Escherichia/Shigella), OTU0070 is Betaproteobacteria  (Parasutterella), OTU0276 is 
Proteobacteria_unclassified. ND not detected.  
 
4.2.8 Microbial diversity analysis 
To analyse the microbiome composition of the birds on the control diets of 
alpha (α-) and beta (β-) diversity indices were calculated from the data using 
Mothur (V1.39.5). For the α-diversity, the OTUs richness (observed OTUs) were 
calculated using the Chao1 index, while the overall diversity (evenness) was 
measured using the inverse Simpson's index. The Chao1 index evaluates richness 
(the total number) of species present in the community whereas the inverse 
Simpson's index gives more weight to dominant (the abundance) species. The 
Shapiro-Wilk test of normality was performed, which determined that inverse 
Simpson’s index of the trial1 data were normally distributed with the exception 
data for 24 da (Shapiro-Wilk test p-value >0.05; except at da 24 the normality 
test p-value= 0.0279). Likewise, Chao index data of biosecure birds (trial 1) were 
normally distributed across sampling days p-value >0.05 except for 28 da the 
Shapiro-Wilk test p-value= 0.03780. However, the inverse Simpson's index and 
the Chao index were normally distributed for the commercial birds (trial 2; inverse 
Simpson’s index p-value= 0.7348 and 0.2637 at da 30 and 37 da). The Shapiro-
Wilk test of normality of the Chao index of commercial birds were p-value= 0.4431 
and 0.3210 for 30 da and 37 da respectively. The fit of the data using quantile-
quantile plots and frequency distribution plots (all QQ plots of normality test) are 
presented in Appendix 3.4 and 3.5 (A and B). 
 The α-diversity with respect to time are presented in Figure 4.15 for the 
control diets groups of biosecure and commercial birds. For the biosecure reared 
141 
 
birds the inverse Simpson index appears to reduce with age, but a significant 
change was only observed between 24 and 28 da (inverse Simpson index, p-
value= 0.026). The Chao index for community richness of controlled hosing birds 
showed that there was no difference between the 22, 24, 28 and 35 da results as 
presented in Figure 4.16.  
The alpha diversity of broiler chicken microbiota of the commercial birds 
exhibited a significant reduction in inverse Simpson index between 30 and 37 da 
for the control barn (Simpson index, p-value= 0.0002; Figure 4.15).  While the 
Chao index of commercial birds indicated there was no significant change between 
30 and 37 da (Chao index, p-value >0.05; Figure 4.16). 
The β-diversity was estimated by Bray-Curtis dissimilarity, which 
demonstrated variation in species composition on the basis of age. Differences in 
β-diversities were visualised using principal component analysis based on the 
Bray-Curtis distances between each experimental group as presented in Figures 
4.17 and 4.18. The results indicated that there is no significant change in caecal 
microbiota of the control birds (AMOVA test p-value>0.05) when comparing 22 vs 
24 da (AMOVA test p-value= 0.328), da 24 vs 28 da (AMOVA p-value=0.091), 
However, a significant change was found between the microbiota collected at 28 
vs 35 da (AMOVA test p-value=0.015) and when overall comparison of all sampling 
points were considered (AMOVA test p-value = 0.001). Whilst there was a 
significant change was found in commercial birds of microbial communities at 30 
and 37 da (AMOVA test p-value = 0.001).  
The linear discriminant analysis (LDA) effect size (LEfSe) method was used 
in order to identify OTUs with differential relative abundance between the caecal 
microbial communities of biosecure birds with development. The data show 
transitions in the beta diversity of the broiler chicken microbiota between the four 
sampling times (22, 24, 28 and 35) highlighting microbial succession, which is 
marked by the dominant order of Clostridiales, most OTUs belonging to the 
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Lachnospiraceae and Ruminococcaceae. AMOVA indicated a significant difference 
between 28 and 35 da birds for birds reared under biosecure conditions. LEfSe 
identified five differentially abundant OTUs at 35 da, which were Romboutsia 
(OTU0021), Lachnospiraceae_unclassified (OTU0012, OTU0016), Anaerostipes 
(OTU0011) and Blautia (OTU0034) compared to Lachnospiraceae_unclassified 
(OTU0013), Oscillibacter (OTU0068) and Clostridium_IV (OTU0125) that show 
greater abundance at 28 da (Figure 4.19). LEfSe was also performed to determine 
the differentially abundant OTUs between the microbiotas of commercial birds fed 
control diet collected at 30 and 37 da. OTUs identified in seven genera that appear 
at 37 da explain these differences (Figure 4.20): Megamonas (OTU0004), 
Faecalibacterium (OTU0005) Campylobacter (OTU0041), Bacteroides (OTU0115), 















Figure 4.15 Comparison of inverse Simpson’s index for alpha diversity between 
sampling ages for controlled housing (22, 24, 28 and 35 da) and commercial birds 
(30 and 37 da). Data are displayed for each control groups as bar chart with medians and 






























































biosecure condition, while blue bars indicate to birds fed control and reared under 
commercial condition. 
Results showing there was no significant in alpha diversity within different sampling points 
of biosecure birds in trial1, however there was declining observed in inverse Simpson’s 
index of ctl at 28 da old birds compared to ctl-24 old birds. Similarly, within trial 2 (30 vs 
37 da in commercial birds) there was significant reduction in alpha diversity (inverse 
Simpson index, p-value 0.0002) with age. Inverse Simpson’s indices were tested for 
normality distribution by Shapiro-Wilk test indicating data not normally distributed at 24 da 
old cohorts reads (Shapiro-Wilk test p-value=0.0279 at 24 da) therefore significant was 















Figure 4.16 Comparison of Chao index for richness between sampling ages for 
controlled housing (22, 24, 28 and 35 da) and commercial birds (30 and 37 da). 
Results showing there was no significant difference detected between sampling points of 
controlled housing birds (Chao index P-value>0.05) as well as between 30 da and 37 da 
old birds reared in commercial condition (Chao index P-value= >0.05). Although, it 
indicates that richness reduced in CH birds. However, no significant difference was noted 
within each sampling time of each trial. The Chao indices calculated from normalised reads 























































 Comparison of richness indecies for ctl-diets
144 
 
described above. Shapiro-Wilk test indicating that data not normally distributed at 28 da 
old cohorts therefor all data treated the same way by Mann whiney test.   
 
 
Figure 4.17 PCoA plots of Beta diversity based on Bray Curtis dissimilarity of 
controlled housing birds fed control diets. The control diet birds at 22 and 24 da has 
no significant difference between the birds (AMOVA test p-value: 0.328), There was also 
no significant difference between 24 and 28 da (AMOVA p-value 0.091), whilst there was a 


























Figure 4.18 PCoA plots of Beta diversity based on Bray Curtis dissimilarity 
clustering data with respect to age of commercial birds fed a control diet.  
Comparison of caecal microbiota of commercial birds fed control diets at age 30 and 37, 
indicates there is a significant difference between the two barns (p-value: 0.001, AMOVA 
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Figure 4.19 Histogram of the linear discriminant analysis (LDA) effect size (LEfSe) 
of control housed birds over 4 sampling times. LDA scores computed for express the 
differentially abundant of bacterial communities of birds fed ctl and reared in biosecure  
conditions  at 22 da (represented by green bars), 24 da birds (represented as red bars), 
28 da birds (purple bars) and 35 da (grey bars).  LEfSe illustrates which clades amongst 
detected OTUs that are statistically explain the greatest differences between bacterial 
population fed the same diets and reared in similar conditions. All representative OTUs 









































































Figure 4.20 Histogram of the linear discriminant analysis (LDA) effect size (LEfSe) 
between commercial birds at 30 and 37 da. LDA scores computed for express the 
differentially abundant between commercial broiler chickens at 30 da (represented by green 
bars) and 37 da birds (represented as red bars). LEfSe illustrates which clades amongst 
detected OTUs that are statistically explain the greatest differences between bacterial 





4.3 Discussion  
In Chapter 3 the relative abundance of the gene cassettes obtained from the 
broiler chicken caecal microbiota of birds reared in biosecure or commercial 
environments was generally considered. This Chapter highlights diversity in the 
microbiota of the birds from which the gene cassettes were identified. Under 
biosecure rearing conditions 37% (10/27) of the birds were identified as carrying 
GCs-B-2 (dfrA1 and aadA1) across four sampling points but in 17 birds GCs were 
not detectable (see Table 3.4A). To the contrary, in commercial birds with greater 
stocking densities, the GCs were identified in the majority of caecal samples and 
showing a higher diversity in the embedded cassettes: GCs-A contains aadA2 and 
linF resistance genes with 35% (7/20) at 30 da to 40% (8/20) at 37da with 15% 
GCs-B-2 at 30 da, and 5% for GCs-B-2 and GCs-C-2 at 37 da (see Chapter 3, 
Table 3.6). Brolund et al. (2010) researched the distribution of dfr-genes in E. coli 
and K. pneumoniae isolated from hospital patients with UTIs (frequently treated 
with trimethoprim), which demonstrated a disproportionate prevalence of 
integrons in E. coli and K. pneumoniae compared to controls. The dfr-genes were 
carried by narrow host range plasmids, suggesting the need for further studies to 
understand the link between gene-cassettes of plasmids, integrons, and the 
chromosome (Brolund et al., 2010).  
 
As described in this Chapter, trimethoprim resistance was selected to study 
phenotypic antibiotic resistance as it could be discriminated in birds reared in 
biosecure and commercial conditions. The dfr gene that confers trimethoprim 
resistance could be identified in GCs PCR amplified from chicken caecal microbiota 
genomic DNA preparations. Blahna et al. (2006) found that most dfr-genes resided 
in gene cassettes within variable regions of integrons leading to the rapid spread 
of trimethoprim resistance between various bacteria. Additionally, they reported 
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that the most common gene present among uropathogenic Escherichia coli in 
Europe and Canada was dfrA1, making up 37.9% of the dfr containing isolates. 
 Similarly, the current study found dfrA1 the predominant gene in GC-B-1 and 
GC-B-2 in both trials. However, several studies have reported that alternative dfr-
genes including dfrA5, dfrA7, dfrA12, dfrA14, dfrA17, dfrA22 and dfrA27 to be 
located within variable regions of class 1 integrons (Grape et al., 2005;Blahna et 
al., 2006;Kadlec and Schwarz, 2008;Wei et al., 2009;Šeputienė et al., 2010). 
 
Despite the trend of trimethoprim ratios increasing with days of age, the 
integrase gene copy number decreased with time. This finding suggests that the 
resistance genes are not only embedded in class 1 integrons as measured using 
the integrase gene as the target. It is also plausible that there is redundancy in 
the bacterial populations that harbour the class 1 integrons, members of which 
become excluded but not those carrying the functional resistance gene. As a 
consequence, the proportion of the coliforms carrying trimethoprim resistance will 
increase while the total coliforms decline, including those carrying class 1 
integrons.  Yu et al. (2004) pointed out the dfr genes integrated within integrons 
seem to be more prevalent than those genes that are not associated with class 1 
integrons. They suggest that studies should focus on changes in dfr genes 
associated with class 1 integrons over the time.  
The analysis of 16S RNA data provided deep investigation of the diversity 
and abundance of the caecal luminal microbiota for the standard diets of birds 
reared in two different environments. Many studies have indicated that the most 
abundant phylum in the chicken caecal bacteriome are Firmicutes, for example a 
study by Yeoman et al. (2012) reported Firmicutes as the predominant taxa in the 
caecal microbiome. Wei et al. (2016) showed that this phylum formed 57.8% of 
the total bacterial sequences of caecal content samples, whereas the Bacteroidetes 
and Proteobacteria phyla were less abundant, comprising 5.4% and 4.3% of the 
total bacteria sequences respectively. However, Oakley et al. (2014) reported that 
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Firmicutes, Bacteroides, and Proteobacteria are the most common phyla in the 
chicken ceca. Likewise, the analysis of 16S RNA sequences at phyla level for the 
microbiota of the commercial birds was consistent with the study, while the 
composition of the caecal microbiota of the birds reared in controlled housing 
exhibit less diversity including the absence of Bacteroidetes at various sampling 
times. A study conducted by Oakley et al. (2014) highlighted the role of housing 
environment as source of diversity of microbial community in the most commercial 
poultry that carried over from one flock to another acting as an important inoculum 
for the chick gastrointestinal microbiome. Thereby variation between trials may 
be as consequence of rearing conditions or environmental changes that birds face 
but variation within each trial sampling points could be due to temporal succession. 
For example, van der Wielen et al. (2000) proposed a possible reason for the high 
prevalence of Firmicutes a consequence of the need for butyrate in the developing 
the intestine of young chickens but this may be reduced with increased age. While 
Polansky et al. (2016) observed a gradual increase in Bacteroidete numbers in the 
cecum after 3 weeks as consequence of the need to digest polysaccharides, which 
produce propionate and butyrate required for nutrient balance.  
Results at class level revealed that the diversity of OTUs was higher in 
commercial flock than the birds reared in controlled housing. Clear variation was 
highlighted between two trials, most notably the emergence of Campylobacter 
OTUs (Epsilonproteobacteria) at 37 da in the commercial birds concurrent with 
Negativecutes, which were not found at 30 da. This could be an indicative to 
human contact via the thinning process, which took place at 30 da for the 
commercial poultry flock. A recent study by Connerton et al. (2018) noted that 
chickens can be exposed to Campylobacter colonization at any time during the 
rearing period, however the efficiency of transmission and detection of 
campylobacters occur after 2 weeks. The emergence of other OTUs and secondary 
GCs at 37 da could also be correlated with human exposure at thinning process. 
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The majority of previously declared Campylobacter free broilers can become 
contaminated quickly during the thinning process (Sahin et al., 2015). The 
European baseline study (EFSA, 2010) stated that thinning (partial depopulation) 
is significantly contributes to transmission of campylobacters into a poultry house 
considered as key risk factor for flock positivity (Newell et al., 2011).  This because 
catchers travelling from farm to another with their own vehicles, equipment, boots, 
and clothing, often disregarding personal hygiene and biosecurity. This led to use 
these tools in depopulation process with possible contamination with 
campylobacters at the abattoir or other farm sites (Hutchison et al., 2004;Newell 
et al., 2011).  
The α-diversity of the broiler chicken caecal microbiota was calculated by 
inverse Simpsons and used to assess differences in the bacterial populations of 
the developing birds. A significant reduction in the α-diversity was observed 
between 24 and 28 da (p-value 0.02) but otherwise the α-diversity between the 
sampling points for the biosecure birds were not affected.  However, α-diversity 
in commercial birds was significantly reduced (p-value 0.0002) at 37 da, which 
may be for a consequence of Campylobacter colonization or new components of 
the microbiota introduced at thin. A study by Choi et al. (2015) suggested a 
reduction in α-diversity was indicative of an unhealthier status or a tendency 
towards pathogen invasion, which may have contributed to an increase in 
susceptibility upon decreasing α-diversity and the efficient colonisation by 
Campylobacter spp. Despite at 28 da alpha-diversity significantly reduced in CH 
birds there is no observation of pathogen colonization. 
 AMOVA significance tests of Beta diversity using Bray-Curtis indices 
indicated significant variation between the caecal microbiota compositions of 
broiler chickens collected at 30 da compared to those collected at 37 da (p-value 
of AMOVA 0.001). PCoA plots demonstrate partition of microbiota indices at 30 
and 37 da in commercial birds. The caecal microbiota may be subject to natural 
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maturation with age. The composition of caecal microbiota from birds reared in 
controlled housing show are only different between 28 and 35 da (AMOVA p-value 
0.01), which may conform with the timing of the maturation from juvenile to 
mature composition observed for the commercial birds. However, Connerton et al. 
(2018) reported a transition in microbiota of control birds aged 15 and 22 da in 
their study monitoring the development of the gut microbiota and innate immune 
responses of broiler chickens resulting from early and late challenge with C. jejuni. 
They also found that the transition observed in the broiler microbiota was less 
variable at 22 da for Campylobacter colonized birds. This finding suggest that the 
rearing condition may lead to delay maturation of microbiota composition. It has 
been well documented that biosecurity, litter management, feed availability and 
ambient temperature can substantially affect the GIs microbiota composition 
(Shang et al., 2018b). 
The current study found the relative abundance of total coliform numbers to 
decrease with time (35 da) in CH birds (Figure 4.3). This finding corresponds to 
the results at phyla level that show decreases in representative members of the 
Proteobacteria at 35 da (Figure 4.13). This observation also coincides with the 
reduction in copy number of the class 1 integrons in birds reared under controlled 
housing conditions (Figure 4. 7). Awad et al. (2016) reported the transition in the 
broiler chicken caecal microbiota post 14 da coincided with an increase in the 
relative abundance of Firmicutes and Tenericutes at the expense of Proteobacteria.  
They also noted the changes in the abundance of the microbial communities’ post 
C. jejuni colonisation at 14 da, and observed a reduction in Escherichia coli 
abundance at various intestinal sites whereas Clostridium spp. showed a 
significant increase.  
The distribution of GCs among the Proteobacteria phylum (Figure 4.14) 
highlights Gammaproteobacteria (OTU0007_ Enterobacteriaceae_unclassified) as 
the main OTU that coincides with birds containing GCs for both trials. Whilst the 
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wide distribution of GCs observed among several Proteobacteria OTUs in 
commercial birds including Beta-proteobacteria (OTU0070), Epsilonproteobacteria 
(OTU0041_Campylobacter) and Alphaproteobacteria OTUs (OTU0176 and 
OTU0471). Gammaproteobacteria are known as a class of medically important 
groups of bacteria, that include many important pathogens such as the 
Enterobacteriaceae (e.g., E. coli), and Salmonella (enteritis and typhoid fever), 
Vibrio cholerae (cholera), Pseudomonas aeruginosa (lung infections), and 
Klebsiella pneumoniae  (Broszat et al., 2014). Non-pathogenic Betaproteobacteria 
are thought to be a source of class 1 integrons. These environmental bacteria are 
found in water bodies or are associated with plants that can enter the human food 
chain. Therefore, presence of class 1 integrons in this bacterial group facilitate 
their mobilization and environmental spread (Gillings et al., 2008).  
LEfSe indicated an increase in the abundance of clostridial species in the 
biosecure and commercial birds at 30 da. However, Negativicutes, and 
Proteobacteria displayed significant increases at 37da for the commercial birds. 
While OTU0004 (Megamonas) and 0041 (Campylobacter) were emerging OTUs in 
the caecal microbiota of the commercial birds at 37 da. Connerton et al (2018) 
showed that the caecal microbiota of control birds named TEG1 (Trial E Group 1 
were birds administered with a placebo) had a greater abundance of 
Enterobacteriaceae compared to those colonized by C. jejuni (TEG2, Trial E Group 
1 were administered with C. jejuni) at 2 dpi (22 da) with increases in the relative 
abundance of Clostridia in the colonized birds (TEG2). The increase of Clostridiales  
was observed in C. jejuni, which is attributed to the role of Campylobacter in 
hydrogen sink that could prompt growing of clostridial organisms and their 
competitive ability by increasing fermentation, causing increased organic acid 
production which can be utilized by campylobacters as an energy source 
(Kaakoush et al., 2014;Connerton et al., 2018).  
However, variable shifts were also noted by Connerton et al. (2018) in the 
high abundance of several Clostridial OTUs in the absence of C. jejuni. Likewise, 
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the current study also found the most frequently observed OTUs of the 
Clostridiales in CH birds and commercial birds at 30 da were 
Lachnospiraceae_unclassified, Ruminococcaceae_unclassified and Clostridium 
XIVa, which are considered the major butyrate producing bacteria that have 
important roles in maintaining metabolic and immune functions in the gut. The 
genus Bacteroides (Alistipes), which was found to be dominant OTUs in 
commercial birds at 30 da, have been highlighted for their ability to improve the 
absorption of nutrient and provide protection for the host from pathogen 
colonisation. This strong metabolic activity is likely as result of the efficient 
fermentation of polysaccharides to SCFA (Wexler, 2007;Teng and Kim, 2018), as 
well as maintaining the intestinal microecological balance (Hooper et al., 2001).  
 
4.4 Conclusion  
In conclusion, this Chapter highlights the involvement of class 1 integrons 
as mobile genetic elements that contribute to the prevalence of antibiotic 
resistance in the broiler chicken microbiota, which likely become associated with 
the birds at hatch and remain associated regardless of the environment the birds 
are reared under. The results show that although there is variation between two 
environmental settings studied here in terms of the predominant type of antibiotic 
resistance (GCs), similar patterns of gene cassette determinants dominate chick 
gut bacterial communities. The investigation of trimethoprim resistance (dfr-gene) 
in the controlled housing environment with respect to the integrase copy number 
demonstrated a reduction but this did not impact the proportion of trimethoprim 
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5.1 Introduction  
The enforced withdrawal of the prophylactic use of antibiotics in livestock 
production is likely to negatively impact on poultry production because of the 
increasing of disease prevalence such as necrotic enteritis (McDevitt et al., 
2006;Janardhana et al., 2009). Poultry meat is considered the second largest 
global food industry (Manning et al., 2007), and therefore to maintain essential 
poultry production and meet the global demand for reduction of antibiotic use in 
farming, alternative approaches to the use of antibiotics are required (Janardhana 
et al., 2009). Recently, prebiotics have been applied as a potential alternative to 
antibiotics. Modulation of the ecosystem of the gut microbiota by prebiotics is 
multi-faceted, which includes the promotion of alternate components of the 
intestinal microbiota, improvement of epithelial integrity, and to stimulate of the 
immune system, and  regulating the interactions between the host and the 
intestinal microbiota (Teng and Kim, 2018). Hence, prebiotics have been 
extensively researched to optimise the chicken gut microbiota, notably the use of 
non-digestible dietary fibre products in prebiotic interventions aimed at improving 
poultry health and productivity (Pourabedin and Zhao, 2015). However, 
investigation of the influence of prebiotics to modulate gut bacterial populations 
may also have the potential to reduce the antibiotic resistance load in the chicken 
gut microbiome. In this regard, this Chapter indicates a promising role for the use 
of GOS as an effective approach to reduce antibiotic resistance associated bacterial 
communities in the chicken microbiome, and thereby to reduce the risk the 
prevalence of antibiotic resistant bacteria entering the human food chain from 
poultry sources. Furthermore, it can be used as an alternative to antibiotic growth 
promoters that contribute to the antibiotic resistance problem.  
Evidence suggests that when bacteria carrying antibiotic resistance genes 
have been incorporated into an ecosystem, the prevalence and persistence of this 
resistance can remain even in the absence of selection pressure from the 
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antibiotics (Liljebjelke et al., 2017). Nevertheless, some environments act as hot-
spots for genetic exchange including the animal gut microbiome because of the 
high density of bacterial populations, and the presence of gene mobilising 
elements such phages and plasmids in these settings (Kaur and Peterson, 2018). 
 The presence of class 1 integrons aid the mobilisation of ARGs, although 
they are non-mobile themselves, they are mobilised in conjugation with 
transmissible elements enhancing the flow of resistance genes between various 
members of the microbiota (Gillings, 2017;Kaur and Peterson, 2018). Thus, the 
integrated nature of poultry production, was chosen for the observation of 
antimicrobial resistance phenotypes associated with broiler chicken microbiotas, 
reared in either controlled housing or commercial environments in order to 
investigate potential control approaches for restricting resistance development 
through influence of the gut microbiota by dietary GOS supplementation. To assess 
changes in the microbiota requires high-throughput sequencing technologies such 
as used for 16S RNA analysis that have revolutionised microbiology in terms of 
understanding bacterial diversity, and have become powerful tool for analysing 
gut microbial composition (Pourabedin and Zhao, 2015). 
Besides the established roles of prebiotics in modulation of the intestinal 
microbiota, they can decrease exogenous signals produced by pathogenic bacteria 
and resisting pathogen colonization (Kogut, 2013). This includes reduction in 
coliform abundance (Yang et al., 2008;Chee et al., 2010a). As reviewed in Chapter 
1 (Section 1.2.10), prebiotics can be utilised for fermentation in the intestine by 
health-promoting bacteria, producing lactic acid, short-chain fatty acid (SCFA) and 
antimicrobial substances such as bacteriocins directed towards pathogenic 
bacteria (Bogusławska-Tryk et al., 2012). These products do not only improve the 
intestinal microbial structure, but also they can bring about improvements in 
intestinal epithelial cell integrity, which can then lead to an increase in the 
absorption of nutrients to support the growth performance of the animals (Lan et 
al., 2005). Few studies highlighted the role of prebiotics in the reduction of 
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coliforms in the chicken caecal microbiota, however studies in pigs have indicated 
that synbiotic formulations (Bifidobacterium thermophilum RBL67 and prebiotic 
FOS, GOS and MOS) show decreases in the levels of Enterobacteriaceae in pig 
faecal samples (Bomba et al., 2002) as well as the decreased adherence of 
Escherichia coli O8:K88 to the jejunal and colonic mucosa (Nemcová et al., 
2007;Tanner et al., 2014). However, a synbiotic approach was not adopted for 
coliform inhibition in the current study.  
This Chapter aimed to investigate the influence of feeding GOS on the 
profiles of broiler chicken microbiota from birds reared under two different 
conditions (controlled housing and commercial conditions). Four sampling points 
were examined for the controlled trial and two sampling times for the birds reared 
for market. In particular, the effect of GOS feeding on the reduction of antibiotic 
resistant-containing OTUs (Enterobacteriaceae), which contribute to the 
dissemination of antibiotic resistance in the gut microbiota. Class 1 integrons will 














5.2.1 Enumeration of coliform bacteria recovered from the broiler 
chicken caecal contents of control and GOS supplemented diets (G1 
and G2) reared under biosecure conditions (Trial 1)   
In order to detect the impact of GOS on the relative abundance of coliform 
counts, the enumeration of coliform on triplicate MacConkey plates were 
performed as described in (Chapter 2, Section 2.4.1.1) for birds fed the control 
and GOS supplemented diets over 4 sampling points (Trial1 Chapter 2, Section 










Figure 5.1 The comparison of coliform numbers recovered from the caecal 
contents of 22, 24, 28 and 35 da old birds fed control (G1) and GOS supplemented 
diets.  Data are expressed as standard boxplots with medians (solid black line). The orange 
boxes indicate to control diet and tiffany blue boxes represent GOS diets. Outliers are 
represented as dots. The top and bottom Whiskers indicate maximum and minimum values, 
unless these values exceed 1.5x the interquartile range. n=7 birds/sampling da (total 28 
birds/group). 




Although there is no significant difference (p>0.05) observed between the 
two diets, a significant difference was found between ctl-22 da vs ctl-35 da 
(p=0.026) as well between GOS barn at 22 vs 35 da (0.021). The GOS 
supplemented diet showed a reduction in the total coliform counts compared to 
the control diet. In general, the results indicated that the trend line of total coliform 
counts in both control and GOS diet decrease with time. The levels of the total 
number of coliforms tend to be reduced in birds on the GOS diet compared to the 
control diet and this reduction is consistent until day 35. 
 
5.2.2 Enumeration of trimethoprim resistance bacteria obtained from 
the caecal contents of control and GOS supplemented diets (G1 and 
G2) reared under biosecure conditions (Trial 1)   
The viable count of trimethoprim resistant bacteria was enumerated on 
MacConkey-03 agar plates containing trimethoprim (20 µg /ml). The results 
indicated that viable counts of trimethoprim resistance bacteria generally 
remained steady across the trial. However, the level of trimethoprim resistant 




















Figure 5.2 Comparison of resistance coliform bacteria growing on MacConkey-03 
with trimethoprim (20 µg/ml) obtained from the caecal contents of 22, 24, 28 and 
35 da old birds fed control diet (G1) and GOS supplemented diet (G2). Data are 
expressed as standard boxplots with medians (solid black line). The orange boxes indicate 
to control diet and tiffany blue boxes represent GOS diets. Outliers are represented as dots 
(in the style of Tukey). The top and bottom Whiskers indicate maximum and minimum 
values, unless these values exceed 1.5x the interquartile range. n=7 birds / sampling da 
(total 56 birds). 
 
Results clearly demonstrate that the GOS supplemented diet reduced the count of 
the trimethoprim resistant bacteria compared to control. Therefore, although there 
no significant difference (p>0.05) found between two diets, the range of coliform 









5.2.3 Ratio of trimethoprim resistant coliform bacteria recovered from 
the caecal contents of control and GOS diets (G1 and G2) 
The ratio of trimethoprim resistance calculated by dividing the number of 
trimethoprim resistance coliforms on total number of coliforms in control plates at 
selected dilution factor (usually 10-5 or 10-4 for control plates 10-2 or 10-3 for 
trimethoprim resistance bacteria). There was no significant difference (p> 0.05) 
between the ratio of trimethoprim coliforms resistant isolates in birds fed the 
control diet G1 and those fed the GOS diet G2. It seems that the trend line of 
trimethoprim resistance population is increased with time in both feed types. 
However, the growth of the resistant population in the GOS fed birds (G2) was 
slower or less in the 22 and 24 da old birds than in the 28 and 35 da old birds and 
this reduction was absent because effect of GOS disappeared in 28 da old birds 







Figure 5.3 Comparison of the proportion of trimethoprim resistant isolates in the 
bacterial population between two different diets. Showing the proportion of coliforms 
exhibiting trimethoprim resistance in control and GOS diets. At the proportion remains 
similar at 22 and 24 da old birds, however after 28 da the proportion of trimethoprim 
population is increased.  Data are presented as boxplot with medians (The solid black line 
indicates the median and the top and bottom of the shaded boxes indicate the 25th and 
75th percentiles). It indicates maximum and minimum values, unless these values exceed 
1.5-fold the interquartile range. Outlying data are plotted as individual markers. The orange 
boxes indicate to control diet and tiffany blue boxes represent GOS diets. The n=7 birds / 





5.2.4 Evaluation of class 1 integron copy number of control and GOS 
diets obtained from biosecure housed and commercial birds  
A second set of experiments were carried out to test the hypothesis that the 
GOS supplemented diet may restrict antibiotic resistant populations. Total 
genomic DNA was isolated, and qPCR was performed to evaluate the integrase 
copy number selected to discriminate difference between two diets in terms of the 
antibiotic resistance gene content arising from class 1 integrons. Similar primers 
used as described in Chapter 4 Section 4.2.5.  
Figure 5.4 A Class 1 integrase copy number quantified by qPCR per gram of caecal 
content of biosecure birds. The specific primers were designed (Chapter 2, Section 
2.5.3.3) to determine the copy number of class 1 integrase gene applying Salmonella 
typhimurium U288 as a positive template to generate a standard curve (Chapter 2, 
2.5.8.1). Comparison shows control and GOS supplemented diets across 4 sampling points 
(Trial1). Data are presented as boxplot with medians (The solid black line indicates the 
median and the top and bottom of the shaded boxes indicate the 25th and 75th percentiles). 
It indicates maximum and minimum values, unless these values exceed 1.5-fold the 
interquartile range. Outlying data are plotted as individual markers. The orange boxes 
indicate to control diet and tiffany blue boxes represent GOS diets. The n=7 birds / sampling 


















Figure 5.4 B Class 1 integrase copy number quantified by qPCR per gram of caecal 
content of commercial birds. As noted above a standard curve for Salmonella 
typhimurium U288 was used as positive template. Comparison shows the levels of class 1 
integron was not significantly differ between control and GOS supplemented diets in 
commercial production birds. This may as result to high abundance of Proteobacteria in 
Trial 2 as it will mentation below. The orange boxes indicate to control diet and tiffany blue 
boxes represent GOS diets. The n=10 birds / sampling da (total 40 birds). 
   
Figure 5.4A shows that at da 22 there is a statistically significant difference 
(p-value, 0.01 t-test) between the standard and GOS diets, indicating that the 
GOS diet contained less class 1 integrase gene copies per g of caecal content. 
However, this significance is not apparent for the subsequent sampling points (24, 
28 and 35).  What should be noted is that at day 22 feeding with GOS was stopped 
and the control finisher diet supplied thereafter (Chapter 2, Section 2.3.4). In 
addition, the trend line of the integrase copy number reduces with time in the 
control diet, which is consistent with the trend observed for the total coliform 
counts in Figure 5.1, which suggests an association between the class 1 integron 









































Copy number of class 1 integrase per gram of caecal content
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and coliform contents. The question arising is whether the GOS diet has a 
prolonged or legacy effect, or this effect limited to when it in use (temporary 
effect). However, in the commercial birds, results presented in Figure 5.4 B display 
variation in the integrase copy number between birds, and due to difference in trial 
design and sampling time it was difficult to distinguish any effect of the GOS diet 
one week after stopping the prebiotic feed.  
 
5.2.5 Development of the caecal microbiome composition of birds fed 
control and GOS supplemented diets in biosecure housed birds  
DNA sequencing of the V4 region of 16S rRNA genes was used to investigate 
diversity and relative abundance of the caecal luminal microbiota of broiler 
chickens fed two different diets and reared in two different environments. This 
approach allowed the study of changes in composition of the chicken gut 
microbiota in order to evaluate the impact of the two diets on the broiler chicken 
microbiome and to compare the phylogenetic relationships with the distribution of 
antibiotic resistance.  As it mentioned in Chapter 4, the classification of bacterial 
taxa is displayed as hierarchal taxonomic groups starting with phylum and ending 
with OTU (Phylum > Class > Order > Family > Genus > OTU).  
 A total of 3527444 (median: 113283.5, IQR: 137021.8) quality-controlled 
sequence reads were obtained from 56 broilers caecal samples of control housed 
birds fed control (ctl) and GOS diets. These could be classified into OTUs 4892 
(distance 0.03) that fall in to 11 phyla. Coverage was calculated in mothur 
(V1.39.5) by Good's coverage at 98% (range = 0.97 - 0.99%) for estimation the 
proportion of total OTUs present in each sample (Rarefaction curves Appendix 
4.1A). Random subsampling of 3511 reads per sample was performed to avoid 
bias between communities with different sampling depths for bacterial community 
content and relative abundance analyses. 
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The control and GOS diets from biosecure housed chicken caecal samples 
exhibited OTUs falling in to 11 shared phyla binned at 98% similarity. In general, 
the results show that the dominant phyla over all sampling days were Firmicutes 
(Clostridiales_unclassified) with overall mean 92.5% in the birds fed the control 
diet and 92.6% in the GOS fed birds, followed by small proportion of 
Proteobacteria with overall mean abundance 4.56% to 3.28% in control and GOS 
diet respectively. Fewer contributions from the Actinobacteria (Bifidobacterium) 
with mean abundances of 1.11% to 2.46% in control to GOS diets and 
Bacteria_unclassified with mean abundances of 1.81% to 1.27% noted within 
these phyla. Bacteroidetes were notable by their absence throughout. These 
results are illustrated in Figures 5.5 and 5.6.  
The first sampling point (at 22 da) of the caecal microbiota grouped at the 
phylum taxonomic level shows both diets are dominated by Firmicutes 
(Clostridiales_unclassified) at similar abundances. Firmicute abundance in the 
control group had a median of 92.04% (IRQ: 4.78%), and in the GOS diet the 
median was 92.61% (IRQ: 5.36%). The microbiota contained lesser contributions 
of Proteobacteria (median: 3.29% in ctl diet to 1.57% in the GOS diet; IRQ: 1% 
and 3.13% respectively), Bacteria_unclassified (median: 1% in ctl diet to 1.11% 
in the GOS diet; IRQ: 4.5% and 0.8% respectively), and Actinobacteria 
(Bifidobacterium, median:0.8, 0.7; IRQ: 1% and 0.5% respectively) in control and 
GOS diets as indicated. At 24 da, the abundance of Proteobacteria started to 
increase in both diets (median: 6.3% in ctl diet to 2% in the GOS diet; IRQ: 3.12% 
and 4.1% respectively) and Bacteria_unclassified (median: 1.8% in ctl diet to 
1.9% in the GOS diet; IRQ: 1% and 1.4% respectively). At 28 da birds, 
Proteobacteria abundance slightly decreased compared to what it was at 24 da in 
control diet (median: 3.2%, IRQ: 3.6%), however, this abundance is still higher 
than that observed for the GOS diet (median: 2.66%, IRQ, 2.28%). By the end of 
the trial at 35 da the control diet birds were observed to be decreasing in 
168 
 
Proteobacteria abundance (median: 1.78%, IRQ: 1.61%), whereas for the GOS 
diet the abundance of Proteobacteria was increased (median: 3.71%, IRQ: 
1.66%). There was no significant difference in the level of Actinobacteria (P 
value >0.05), which is increased in the birds on the GOS diet compared with 
control. Overall, no significant difference was detected at phyla level p> 0.05).   
At the class level, the results showed that the most abundant bacterial 
classes were Clostridiales_unclassified (mean: 84.2%, 83.3% in control and GOS 
diets respectively), Bacilli  (mean: 7.64% in control fed birds, 8.94% in GOS fed 
birds), Gamma-proteobacteria (mean: 4.54% to 3.28% for control vs GOS diet), 
Actinobacteria (mean:1.11%, 2.46% for control vs GOS diet) and Bacteria-
unclassified (mean:1.81% to 1.27% for control vs GOS diet). These data are 
presented in Figures 5.7 and 5.8.  
The level of Bacilli gradually increased in both diets with abundances at 22 
da in control fed birds compared to GOS fed birds (median 7.31%, IRQ  3.33 in 
control birds compared to 3.35%, IRQ 0.99% in GOS fed birds, p-value Wilcoxon 
test= 0.0175).  However, at 28 da old birds the abundance of Bacilli was higher 
in the GOS diet than the control diet (median of Bacilli: 15.8%, IRQ 10.21% in 
GOS diet compared to 8.5%, IRQ 6.48% in the control diet).   
Additionally, in general the level of Gamma-proteobacteria was increased in 
the control birds until 24 da then this level is declined with age (median: at 22 da, 
3.29%, IRQ 1; median: at 24 da, 6.34%, IRQ 3.12%; median: 3.23% at 28 da, 
IRQ: 3.64; median: 1.78% at 35 da, IRQ: 1.61%) but it was higher than the level 
for the GOS supplemented diets (median: 1.57% at 22 da, IRQ: 3.13; 2% at 24 
da, IRQ: 4.13; median: at 28 da 2.65%, IRQ: 2.28; and median at 35 da, 3.7%, 




5.2.6 Caecal microbiome composition of control and GOS 
supplemented diets in commercial birds.   
The total quality-controlled 16S rRNA amplicon reads for the caecal contents 
of 40 broiler chickens on the control and GOS diets recovered from commercial 
birds was 1912797 (median: 63456.5, IRQ:  89409.25). These were classified into 
4031 OTUs (distance 0.03) that split in to 10 phyla. The coverage was calculated 
in mothur (V1.39.5) by Good's coverage at 98% (range = 0.97 - 0.99%). 
Rarefaction curves presented in Appendix 4.1B show the proportion of the total 
OTUs for each sample. The coverage range was considered an acceptable level of 
sequence depth for all samples. Random subsampling was performed using 3511 
reads per sample, in order to avoid any bias between communities with different 
sampling depths for the bacterial community contents and relative abundance 
analyses. 
In the commercial birds at phyla level, the dominant phyla were Firmicutes 
(Clostridiales_unclassified) and Bacteroidetes with smaller contributions from the 
Actinobacteria (Bifidobacterium), Proteobacteria, Bacteria_unclassified (Figure 
5.9). While the most abundant bacterial classes were Clostridiales_unclassified 
and Bacteroidaceae (Figure 5.10).  
The results at phyla level showed that the was no difference between the 
caecal contents of birds on the two diets at da 30. However,  there was an increase 
in the abundance of Bacteroidetes on the GOS diet compared to the control-diet 
birds (median of Bacteroidetes: 7.47%, IRQ: 5.92% in the control-30 da compared 
to 10.94%, IRQ: 4.65 for the GOS diet), and an increased level of Actinobacteria 
in the control compared to the GOS diet (median of Actinobacteria:  7.52%, IRQ: 
3.36% for the control compared to 5.28%, IRQ 3.62 for the GOS diet). While at 
da 37 there was a significant shift in the abundance of Firmicutes in the GOS 
supplemented group (median: 79.27%, IRQ: 9.56, in the control compared to 
67.15% IRQ: 5.77% for the GOS diet, p value 0.0011). The proportions of 
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Bacteroidetes remained significantly more abundant in broilers given the GOS-
supplemented diet than the control fed birds (median: 3.9%, IRQ:3.37 for the 
control diet compared to 7.52%, IRQ: 7.26 for the GOS diet birds at 37 da, p-
value 0.0232). Similarly, the level of Proteobacteria were increased at 37 da in 
GOS-fed groups compared to control groups (median: 5%, 11.6% IQR: 3.8, 11.3 
for control vs GOS respectively).  
At class level, the comparison between control and GOS diets displayed 
significant increases in the levels of Firmicutes-unclassified for the GOS diet at 30 
da (median:  2.376% vs 3.971%, p-value=0.023). While the abundance of Beta-
proteobacteria were detected in the control group at 30 da (median: 1.21%, 
compared to 0.003% for control vs GOS, p-value 0.0014). At 37 da, the only 
significant differences in abundance were observed for the Firmicutes-unclassified 
(median: 2.68% compared to 3.846 for control vs GOS; p-value 0.001) and 
Bacteroides (median: 3.94% to 7.523 for control vs GOS; p-value 0.023) for the 
GOS diet barns. While the abundance of Negativicutes was detected only in control 
fed birds at 37 da (median: 1.6%, vs 0.0%, IQR: 24.7 to 0.0%; p-value 0.0025 
in the control vs GOS diets respectively). Whilst Epsilonproteobacteria were 
observed for both diets at 37 da but with higher levels in birds on the GOS diet 
compared to the control (median: 2.4%, 5.2%, IQR: 2.95, 13.9% in control vs 
GOS respectively, p-value=0.27). There was an intra-group variability in the 
caecal microbial communities of commercial birds at phyla level, which was 
determined for the Proteobacteria phylum in control diet group at 30 da, (median: 
3%, IQR: 1.9%); and Actinobacteria in the GOS barn communities at 37 da, 























Figure 5.5 Comparison of the relative abundance of dominant bacterial phyla among biosecure housed birds gut microbiota 
fed control and GOS diets clustered based on Ribosomal Database Project taxonomy (phylum level). The results are presented 







































































































































































































































































































































































































































































































Figure 5.6 Comparison of the relative abundance of dominant bacterial phyla among biosecure housed birds gut microbiota 
fed control and GOS diets clustered based on Ribosomal Database Project taxonomy (phylum level). The results are presented 

















































































































































































































































































Figure 5.7 Comparison of the relative abundance of dominant bacterial classes among biosecure housed birds gut microbiota fed 
control and GOS diets clustered based on Ribosomal Database Project taxonomy (class level). The results are presented as %. For 

























































































































































































































































Figure 5.8 Comparison the relative abundance of dominant bacterial classes among biosecure birds gut microbiota fed 
control and GOS diets clustered based on Ribosomal Database Project taxonomy (class level). The results are presented as 















Figure 5.9 Comparison of the relative abundance of dominant bacterial phyla among commercial chicken gut microbiota fed control 
and GOS diets clustered based on Ribosomal Database Project taxonomy (phylum level). The results are presented as % and at least taxa 

















































































































































































































































































































Figure 5.10 Comparison of the relative abundance of dominant bacterial phyla among commercial chicken gut microbiota fed 
control and GOS diets clustered based on Ribosomal Database Project taxonomy (class level). The results are presented as %. For 











































































































































5.2.7 Relative abundance of the Proteobacteria phylum between GOS 
and control diets 
The abundance of the Proteobacteria phylum between the two diets across 
four sampling times for birds in biosecure housing revealed that there was no 
significant change (p value > 0.05) in abundance of Proteobacteria in caecal 
contents of biosecure housed birds. The median values are presented in Figure 
5.11 for control and GOS diets respectively across sampling the points: at 22 da 
(median: 3.29% for control and 1.57% for GOS; IRQ: 1.05, 3.13, p-value 0.2593), 
at 24 da ( median: 6.34% for control and 2.08% for GOS, IRQ: 3.12, 4.15; p-
value 0.1649) o, at 28 da (median: 3.23% for control and 2.66% for GOS, IRQ: 
3.64, 2.28; p-value 0.3829) and at 35 da (median 1.78% for control and 3.71% 
for GOS; IRQ: 1.61, 1.66; p-value 0.2593) 
Figure 5.11 shows similar results were found when investigating 
Proteobacteria abundance at phylum level between caecal samples of commercial 
birds in that there were no significant changes observed. The medians of control 
and GOS supplemented diets: at 30 da old bird (median: 2.97% for control and 
3.41% for the GOS diet, IRQ: 1.91, 9.51; p-value 0.9118) and at 37 da (median: 
5% for control and 11.68% for the GOS diet, IRQ: 3.83 and 11.36; p-value 0.123). 
No change was detected in control diet between the two sampling times for the 
control diet (median: 2.98% in ctl 30 da compared to 5.057% in ctl-37 ;IRQ: 
1.9%, to 3.8%; p-value 0.075) but Proteobacteria were significantly more 
abundant in broilers fed the GOS-supplemented diet at 37 da compared to 30 da 
(median 3.41 compared to 11.68%, IRQ:  9.51 and 11.36; p -value 0.046).  
The results of the Shapiro-Wilk test of normality and quantile-quantile plots 
indicated that the distribution of the Proteobacteria phyla was not normal for birds 
on the control diet at 22 da (p-value = 0.0215), while the other sampling points 
of both feeds indicated that the abundance of Proteobacteria was normally 
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distributed across cohorts for the biosecure birds (Appendix 4.2A). Similarly, data 
of Proteobacteria were not normally distributed (Shapiro-Wilk normality test= 
0.0001) for control birds at 30 da, however for the other sampling point the data 
were normally distributed across the cohorts in the commercial flocks (p-value > 
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Figure 5.11 The relative abundance of the Proteobacteria phylum obtained from 
broiler chicken caecal contents fed control and GOS diets reared in biosecure and 
commercial conditions. Data are expressed as a bar chart with median for each sampling 
point and comparing the abundance of Proteobacteria between the two rearing conditions 
given either control or GOS diet. No significant change was detected within each trial. The 
Wilcoxon test p-value was used because the data not normally distributed, which shows no 
statistical difference in either trial.  All orange bars represent control fed birds while tiffany 
blue represent GOS fed birds reared in biosecure housing condition (n=7 birds/sampling 
point, total /group 28 birds. The blue bars indicate to control fed birds whereas the purple 
bars indicate to GOS fed birds reared in commercial condition (n=10 birds/sampling point 
total 20 birds / group). The proportion of Proteobacteria was reduced at 22 and 24 da in 
GOS-fed birds, however after 28 da (6 days after stopping feeding the GOS-diet) the level 
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of Proteobacteria were increased in the biosecure flocks, while commercial birds showed 
increases in the Proteobacteria abundance at each of the sampling days in the GOS barns.  
 
5.9  The distribution of resistance GC arrays in Proteobacteria OTUs of 
birds in biosecure housing conditions and commercial birds fed control 
and GOS diets. 
Integron gene cassettes are frequently associated with Proteobacteria. 
Phylogenetic trees of the proteobacterial OTUs identified within the chicken caecal 
microbiota of the biosecure housed bird and those from commercial are presented 
in Figure 5.12. The Proteobacteria population in the commercial birds is clearly 
more diverse.  The presence of GCs for each bird in which the OTU was observed 
are indicated with respect the diets the birds were provided. The results 
demonstrate that there were 4 main OTUs present within this phylum that 
coincided with the presence of GCs detected for biosecure birds. The most frequent 
associations of resistance genes were with Proteobacteria OTUs belonging to 
Enterobacteriaceae_unclassified OTUs (OTU0007, OTU0324) with lesser frequency 
determined for Gammaproteobacteria (Proteus, OTU0169) and Betaproteobacteria 
(OTU0097, Sutterella) regardless of the diet. Using the chi-squared test for all 
birds reared under biosecure conditions the proportion with gene cassettes on the 
GOS diet was not different to those on the control diet (χ2 (1, N = 55) = 2.3, p = 
0.13). However, the chi-squared test for the birds at 22 da when the GOS diet was 
first replaced with control indicated the proportion with gene cassettes on the GOS 
diet was significantly different to those on the control diet (χ2 (1, N = 14) = 5.2, 
p = 0.02). For the commercial birds Proteobacteria OTUs associated with high GC 
frequency were OTU0007, OTU0070, OTU0176, OTU0041 and OTU0276.  
Comparing both trials, OTU0007 showed the greatest correlation with the presence 
of the GCs regardless of diet with a weaker association for OTU0169. Notably 
OTU0276 and OTU0471 appeared in control feed birds whilst OTU0474 emerged 
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only in GOS fed birds from commercial flocks. The chi-squared test for the 
proportion of commercial birds with gene cassettes on the GOS diet was not 
different to those on the control diet (χ2 (1, N = 40) = 0.08, p = 0.77).   
The diversity of the recovered GCs per sampling point and dietary type are 
shown in Appendix 4.3 (1-4) and 4.4 (1-2) for both trials. Results indicated that 
three OTUs emerged in biosecure birds at 22 da birds, which remained until the 
end of trial 1 (35 da). The majority of resistance genes identified arose at 22 da. 
In the commercial birds OTU0169 (Proteus) appears displaced by emerging 
OTU0041 (Campylobacter) and OTU0471 (Alphaproteobacteria_unclassified) 
which coincides with a decrease in the distribution of GC-B in the Proteobacteria 
OTUs at 37 da but GC-A persists. The association between the gene cassettes 
identified and the Proteobacterial phylogenetic trees with respect to the diet and 














Figure 5.12 Phylogenetic tree of Proteobacteria phylum illustrates the OTUs present in broiler chicken microbiota fed control and GOS diets 
reared in biosecure and under commercial conditions (constructed with Bootstrap value ≥ 20). (A) biosecure birds at 22 and 24 da have been 
presented because applying a cut-off value ≥20 reads per OTU there was no Proteobacteria OTUs found at 28 and 35 da. (B) commercial birds age matched 
30 and 37 da. The scale bar represents a sequence divergence of 3%. The bacterial OTUs are: OTU 0324 is Gamma-proteobacteria 
(Enterobacteriaceae_unclassified), OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is Gamma-proteobacteria (Proteus), 
OTU0097 is (Beta-proteobacteria) Sutterella, OTU0041 is Epsilonproteobacteria (Campylobacter), OTU0176 is Alpha-proteobacteria (Aestuariispira), 
OTU0474 is Alpha-proteobacteria_unclassified, OTU0471 is Alpha-proteobacteria (Alphaproteobacteria_unclassified), OTU0615 is Enterobacteriaceae 




5.10 Microbial diversity analysis  
The analysis of microbiome composition of caecal contents from controlled 
housed and commercial birds was estimated by using Mothur (V1.39.5). Inverse-
Simpson's measure of alpha (α-) diversity and Chao index estimating the number 
of species richness. The beta (β-) diversity was also calculated within Mothur 
using Bray-Curtis dissimilarity metrics.  
By comparing the inverse Simpsons index of both feed types there was no 
significant differences in alpha diversity detected between the different time 
points of control and GOS diets among biosecure birds. However, birds reared 
under biosecure conditions showed a reduction in alpha diversity for the control 
at 28 da compared to the control at 24 da  (Simpson index, p-value control 24 
vs control 28, Mann Whitney test=0.0262), but this was not evident in the GOS-
fed birds (Simpson index, p-value GOS 24 vs GOS 28, Mann Whitney test 0.62 
respectively). Overall, with time the trend showed a reduction in alpha diversity, 
which slightly lower in the control groups compared to the GOS supplemented 
groups.  
The inverse Simpsons index of both control and GOS diets were tested via 
the Shapiro-Wilk test of normality, which indicated that the inverse Simpson’s 
index was not normally distributed in the control diets (control 24 da) of the 
biosecure birds (Shapiro-Wilk test, p-value = 0.0279 at control-bio-24 da). The 
fit of the data in quantile-quantile plots is represented in Appendix 4.5 A. 
However, the normality tests of the other sampling points of both feed types for 
the biosecure housed birds indicated that the inverse Simpsons index was 
normally distributed across the cohorts for the control and GOS diets (Shapiro-
Wilk test, p-value >0.05).  
In contrast, the alpha diversity of the commercial barn reared birds was 
significantly different between control and GOS supplemented diets at 37 da, 
where the control birds showed a reduction. However, alpha diversity was not 
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affected at 30 da for either feed regime (inverse Simpson, p-value 0.8534). The 
comparison between two diet and trials for the inverse Simpsons is presented in 
Figure 5.13.   
For the commercial birds, the inverse Simpsons indices were normally 
distributed across cohorts for both feeds. The Shapiro-Wilk test for the inverse 
Simpsons indices, p-value = 0.7348, 0.8189 for control and GOS respectively at 
30 da birds, while p-value =0.2637, 0.1736 at 37 da.  All data of quantile-
quantile plots are shown in Appendix 4.6A. 
The Chao index results in Figure 5.14 indicate no differentiation in richness 
index within controlled housed birds for the four sampling times with gradual 
increasing in richness in GOS diet until 24 da old birds (Chao index, p-value = 
0.0728 at 24 da). At 28 da both diets show a decrease in richness (Chao index, 
p-value = 0.804 at 28 da). The normality test of the Chao indexes exhibited that 
the data was not normally distributed in the control birds at 28 da (Chao index, 
p-value = 0.0378), whereas all other sampling points were normally distributed 
(p-value >0.05) Appendix 4.5B.  
For the commercial birds, no significant difference was determined for 
richness between the control and GOS diet at 30 da (Chao index, P-value 0.075) 
and no significant change in richness between the diets at 37 da birds (Chao 
index, p-value 0.63). Similar results were observed also in Chao index for the 
commercial birds, demonstrating that both diets are normally distributed at 
sampling times 30 and 37 da (Shapiro-Wilk test, p-value = 0.4431, 0.3884 at da 
30; p-value of normality test = 0.3210, 0.7609 at 37 da for the control and GOS 
diets respectively). All data of quantile-quantile plots are represented in 







Figure 5.13 Comparison of inverse Simpson’s index for alpha diversity of trial 1 
and 2 during four samplings time (22, 24, 28 and 35 da) for broiler caecal 
communities of biosecure birds and two samplings time (30 and 37) of 
commercial birds fed control and GOS diets. 
Data are expressed as bar chart with medians. Outliers are represented as dots. 
Wilcoxon test p value is used because the Shapiro-Wilk test showed the data were not 
normally distributed (Appendix 4.5 A and 4.6 A). There was no significant difference found 
in biosecure housed birds, however a significant difference in inverse Simpson index was 
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Figure 5.14 Chao index for richness between two diets through different 
sampling points for broilers caecal communities. The Chao indices calculated from 
normalised reads data are displayed for each group 22, 24, 28, and 35 for biosecure 
housed birds while 30 and 37 da for commercial birds. Data are expressed as described 
above bar charts with medians and scatter plots. 
Beta diversity analysis was conducted by calculating Bray-Curtis distances 
using Mothur (V1.39.5). Bray-Curtis distance quantifies compositional 
dissimilarities between the microbiota of the birds fed control and GOS diets. 
Dissimilarity ordination plots were generated demonstrating comparison of 
dissimilarity between two trials. An AMOVA test of significance was calculated 
also using Mothur (V1.39.5) to detect differences between sampling times for 
each diet for each trial. The AMOVA test results (Figures 5.15) indicated that 
within controlled housed birds there was a significant shift between microbiota 
of the two different feeds at 22, 24 and 28 (AMOVA test, p-values: 0.003, 0.001, 
0.014) but no significant difference between the two diets at 35 da (AMOVA test, 
p-value: 0.242).  
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Variation in species composition between the communities representing the 
two diets from commercial birds were also visualised using the Bray-Curtis 
distances in Figure 5.16. The AMOVA test shows a difference in the microbiota at 
30 da between both control and GOS birds (AMOVA test, p-value 0.004) as well 
as between control and GOS birds at 37 da (p-value 0.001). 
Linear discriminant analysis effect size (LEfSe) was applied to identify 
differentially abundant OTUs between control and GOS diets in both trials. Figure 
5.17 shows the significant differentially abundant OTUs for the microbiota from 
all the birds reared under biosecure conditions across various samplings times. 
Differential abundance between the diets was dominated by members of the 
Firmicutes phylum in GOS fed birds at 22 da that include Lachnospiraceae ssp 
OTU0032 and OTU0030, Enterococcus OTU0078 and members of the 
Clostridiales_unclassified class OTU0138. Differences in the abundance of 
Lachnospiraceae ssp OTU0032 and Enterococcus OTU0078 were also found in 
GOS-fed birds at 24 da with high abundance of OTU0015_Subdoligranulum and 
other Lachnospiraceae spp OTUs. Data collected at 28 and 35 da showed 
differences in abundance of Lachnospiraceae spp. While for birds on the control 
diet, these were dominated by OTU006 Lactobacillus at 22 da, Ruminococcaceae 
spp OTU0020, Clostridiales_unclassified Otu0037, Eggerthella OTU0036 and 
OTU0043_Blautia at 24 da. The abundance of Lachnospiraceae spp was noted at 
28 da control-fed birds as well as Ruminococcaceae spp at was observed 28 and 
35 da control-fed birds.   
For commercial birds, LEfSe highlights the greater differential abundance 
of Parasutterella OTU0070, Lachnospiraceae_unclassified OTU0045, Butyricicocs 
OTU0076, Bacteria_unclassified OTU0193 and Clostridiales_unclassified 
OTU0136 and Blautia OTU0171 in control birds at 30 da. While the GOS-fed birds 
at 30 da display a greater abundance of Aestuariispira OTU0176, 
Ruminococcaceae_unclassified OTU0107 and Firmcutes_unclassified OTUs 
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(Figures 5.18 A). At 37 da when both control and GOS diet barns were randomly 
colonised by Campylobacter, the  most abundant bacterial OTUs for the GOS fed 
birds were Alistipes OTU0025 and Bacteroides OTU0028 and for birds on the 
control diet  Megamonas OTU0004, Faecalibacterium OTU0005, 





























































Figure 5.15 Comparison of PCoA plots of Beta diversity based on Bray-Curtis dissimilarity between control and GOS supplemented diets fed 
birds microbiota of biosecure birds. The comparison of AMOVA test between control and GOS diets fed birds showing that there was a significant 
different of clustering microbiota between the two barns at 22, 24 and 28 da birds (AMOVA test, p-values: 0.003, 0.001, 0.014) however there was no a 








Figure 5.16 Comparison of PCoA plots of Beta diversity based on Bray-Curtis 
dissimilarity of control and GOS diets of commercial birds. The p-values of control 
diet birds at 30 da and GOS diet birds at 30 da indicates there is a significant difference 
between the two barns (AMOVA test, p-value: 0.004), There was also a significant 
difference with a AMOVA test p-value of 0.001 by comparing control diet birds and GOS 
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Figure 5.17 Histogram of the linear discriminant analysis (LDA) effect size (LEfSe) 
of biosecure housed birds fed control and GOS diets during 4 sampling times. LDA 
scores computed for express the differentially abundant of bacterial communities of birds 
fed control (represented by red bars) and GOS diets (represented by green bars) and reared 
in biosecure conditions. LEfSe illustrates which clades amongst detected OTUs that are 
statistically explain the greatest differences between bacterial population fed the different 
diets and reared in similar conditions. All representative OTUs subject to stringent cut off 
p-value 0.01 and LDA≥ 2.  
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Figure 5.18 A Histogram of the linear discriminant analysis (LDA) effect size 
(LEfSe) of commercial birds at 30 da. LDA scores computed for express the differentially 
abundant between commercial broiler chickens at 30 da fed control diets (control 
represented by Peachy bars) and GOS diets (GOS represented as Tiffany blue bars). LEfSe 
illustrates which clades amongst detected OTUs that are statistically explain the greatest 
differences between bacterial population fed the different diets and reared in similar 
conditions. All representative OTUs subject to stringent cut off p-value 0.01 and LDA≥ 2.  
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Figure 5.18 B Histogram of the linear discriminant analysis (LDA) effect size 
(LEfSe) of commercial birds at 37 da. LDA scores computed for express the differentially 
abundant between GOS and control diets in commercial broiler chickens at 37 da (control 
represented as orange/Peach bars) and control birds (GOS represented by tiffany blue 
bars). LEfSe illustrates which clades amongst detected OTUs that are statistically explain 
the greatest differences between bacterial population fed the different diets and reared in 
similar conditions. All representative OTUs subject to stringent cut off p-value 0.01 and 





5.3 Discussion  
One of the most important medical issues of the twenty-first century is the 
problem of antibiotic resistance. Increased understanding through environmental 
and evolutionary studies are considered as essential to recognize the origins and 
destinations of resistance determinants (Wellington et al., 2013;Gillings, 2018). 
Most of the research on resistance has focused on diagnostics and infection 
control. At the same time many studies on animal feed additives have highlighted 
the potential for prebiotics to promote growth and immunological responses in the 
host. However, the influence of GOS feed on the modulation of gut bacterial 
populations to potentially mitigate antibiotic resistance carriage in the chicken gut 
microbiome has not been investigated. This Chapter attempts to address the issue 
of continuously emerging antibiotic resistance by maintaining a broiler microbiome 
that is less hospitable to the bacteria carrying resistance genes through the use of 
dietary GOS supplementation. Therefore, it focusses on studying the influence of 
GOS dietary inclusion on broiler microbiota supplied from commercial hatcheries 
and reared in either biosecure conditions or in a commercial environment with all 
the incumbent challenges that brings. To gain a greater understanding of the 
microbiota in which the carriers of AMR are embedded, next generation sequencing 
of 16S rRNA amplicons was employed and analysed with regard to the total 
carriage of antibiotic resistance genes (reviewed in Chapter 3) for two different 
diets and rearing conditions. 
A recent study by Braykov et al. (2016) aimed to evaluate phenotypic 
patterns of antibiotic resistance between commercial (broilers and laying hens) 
and household birds, and the study also extended to the collection of 
environmental samples from the corresponding sites. They observed high levels 
of ARGs in both rearing conditions with a distinctive phenotypic pattern of 
antibiotic resistance in production birds compared to what was observed from 
backyard birds, and from this described a typical signature pattern of production 
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birds. The signature pattern was prevalent in poultry coops of production birds, 
but not observed in domestic environments. Similarly, to the current study, they 
found GCs in commercial birds are higher than birds reared in domestic locations. 
This may of course change as antibiotics are marketed in various countries to 
smallholders based on improved production without any control. 
In this study approximately 37% (10/27) of the representative GCs were 
obtained from broiler caecal microbiota of the control diet group birds housed in 
biosecure conditions which were dominated by one type of antibiotic resistance 
configuration (GCs-B-2 containing the genes dfrA1 and aadA1 that confer 
resistance to trimethoprim and streptomycin respectively). Half of them were 
collected at da 22 after which the number decreased with increasing age (Table 
3.4A, Chapter 3). However, only four of 28 samples (14.2%) contained the GCs 
from GOS-fed birds, two of them obtained at 24 da showing similar pattern of 
ARGs detected in the control feed birds (GCs-B-2), while the other two GCs were 
recovered at 35 da and belong to GCs C-1 (aadA1), which is considered a deletion 
of GCs-B (Table 3.4A, Chapter 3). 
  The microbiota of all the commercial birds fed control and GOS diets 
contained GCs (20/20) with 75% (15/20) of the ctl birds containing GC-A, 20% 
(4/20) containing GCs-B-2 and 5% (1/20) containing GCs-C-2. Similarly, 75% 
(15/20) of the GOS fed birds carried GCs-A, and 25% (5/20) carried GCs-B-2 
(Table 3.6, Chapter 3). These findings indicate that the environment in which the 
birds are reared plays an important role in determining the ARG load and 
dissemination in poultry. Although two trials birds were given similar diets the 
level of resistance was higher in commercial birds than those reared in biosecure 
conditions. As  Connerton et al. (2018) justified high densities of birds in 
commercial production facilitate the dispersion of microorganisms throughout the 
flock and creating a source of microbiota for other flocks on the farm. Hence, in 
commercial production, young chicks are exposed to several exogenous sources 
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of bacteria that can readily colonise the immature gut of young chicks such as 
litter materials, feed, water, and ambient air shaping the composition of gut 
microbiota (Wang et al., 2016). Thereby, the association of antibiotic resistant 
strains with poultry production is likely to be originated post hatch through 
environmental sources, suggesting that it might be better to control widespread 
AR from rearing environments. Furthermore, it is noted that the GOS feed showed 
an impact on the GCs present from biosecure birds denoting both factors (GOS 
and biosecure rearing conditions) reduce the carriage of AR genes.  
In order to confirm the effect of GOS diet in reducing the ARG load, first the 
total coliform counts and trimethoprim resistance strains were enumerated to 
emphasise if the GOS diet has influence on trimethoprim resistance or not as 
trimethoprim resistance was more prevalent in biosecure housed birds. The 
experimental findings indicated that the total coliform counts were reduced with 
time, and this reduction was higher in the GOS diet birds than those fed the control 
diet. Over the rearing period the recovery of trimethoprim resistance isolates was 
lower from the GOS diet groups than the control diet. However, the ratio of 
trimethoprim resistance was shown to increase over time, suggesting that the 
trimethoprim resistant coliform bacteria were not displaced to the same extent as 
the general coliform population.  
Erdoğan et al. (2010) reported dietary supplements of synbiotic and 
phytobiotic either alone or in combination significantly decreased the caecal 
coliform count (p < 0.01) in broiler chicken caecal samples. They postulated that 
this effect was due to probiotics and prebiotics providing a balance on the 
microecosystem of the GI by controlling pathogenic bacterial populations via 
competitive exclusion. Furthermore, studies have reported that the administration 
of dietary prebiotics might support the intestinal microbiota of young broiler chicks 
by boosting the abundance of Lactobacilli and Bifidobacteria and reducing the 
counts of coliforms (Yang et al., 2008;Chee et al., 2010a;Shang et al., 2018b). 
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Braykov et al. (2016) reported that the prevalence of resistant phenotypes tended 
to decrease with bird age for all antibiotics tested in the study except for the 
highest resistance levels to the drugs sulfisoxazole, trimethoprim-
sulfamethoxazole, and tetracycline. They suggest that since birds are purchased 
from commercial hatcheries, and resistant strains to some drugs are already in 
the systems of these birds, which may explain why they observe resistance 
carriage to decline with age. Consequently, it suggested that feeding broiler chicks 
GOS could reduce coliform numbers, which will simultaneously reduce the load of 
antibiotic resistance genes carried by Gram-negative bacteria. 
Additional information was sought in support of the suppressive role of 
dietary GOS under biosecure conditions in reducing the spread of ARGs by 
determining the copy numbers of class 1 integrase using q-PCR (Figure 5.4A). 
Interestingly, a significant reduction was found (p-value, 0.015) for the integrase 
copy number at 22 da in the GOS supplemented diet compared to the control diet, 
proposing that GOS can restrict ARGs, and that this effect is eroded in the absence 
of the GOS diet. Generally, the integrase copy number decreased with time in the 
control diet. This finding is consistent with study conducted by Diarra et al. (2007), 
which demonstrated that the prevalence of AR obtained from 197 broilers isolates 
exposed to different antibiotic regimens in a large case-control study in Canada 
showed decreasing resistance levels between 7 and 35 da that correlated with a 
decrease in the carriage of class 1 integrons and the tet resistance gene. Thus, 
the level of AR was higher among younger birds and was associated with the 
conditions of rearing and source of the chicks. Commercial considerations mean 
that GOS is likely to be used in young birds to establish a productive juvenile 
microbiota whist avoiding the increased cost of feeding mature birds (Richards et 
al., 2020).  In this context the suppressive role of GOS was at an early stage of 
chick’s life that is more likely to be enriched in bacteria carrying antibiotic 
resistance. The collective effect of the hatch and rearing environments with early 
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GOS feed could potentially reduce the dissemination of antibiotic resistance and 
reduce the health risk of chickens to be reservoirs for resistance genes. Apajalahti 
et al. (2004) pointed out that both the diet and the environments can manipulate 
the microbial status of the gastrointestinal tract of chickens, which may explain 
why effect of GOS supplemented diets was absent in commercial birds compared 
to the biosecure housed birds. Although the study design differed in both 
experiments, bird to bird variation in integrase copy number even in GOS 
supplemented birds was evident. Several studies have reported that the small 
intestine of chickens can be effected by many factors including the age of the 
birds, the diet and the surrounding environment  (Knarreborg et al., 2002;Lu et 
al., 2003a;Apajalahti et al., 2004;Rehman et al., 2007;Danzeisen et al., 
2011;Torok et al., 2011;Yeoman et al., 2012;Ballou et al., 2016;Shang et al., 
2018b).  
Analysis of 16S rRNA gene sequences at phyla level indicated that Firmicutes 
remained the most predominant phylum in the caecum for all sampling points for 
both diets in the biosecure and commercial birds. The mean abundance data for 
this phylum was similar for the GOS diet compared to the control diet in biosecure 
housed (mean: 92.5% in control vs 92.9% in GOS diets), whereas the control diet 
for the commercial birds recorded a higher percentage than the GOS diet (mean: 
76.92% in control; 70.53% in GOS diets). At phyla level there was variation in the 
abundance of Proteobacteria between two diets for biosecure housed birds (mean: 
3.66% in control compared to 2.46% in GOS), Actinobacteria 0.84% compared to 
3.28% and Bacteria_unclassified 1.3% compared to 1.27%. The second most 
abundant phylum for the commerical birds was the Bacteroidetes, with a mean of 
6.89% in the control birds and 9.98% in the birds given the GOS supplemented 
diet. The Bacteroidetes were followed by Proteobacteria (mean: 5.31% in the 
control and 8.23% in the GOS diet); Actinobacteria (mean: 7.22% in control; 
5.89% in GOS) and Bacteria_unclassified (mean: 3.64% in control, 5.29% in 
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GOS). This agrees with previous reports that Firmicutes, Proteobacteria 
and Bacteroidetes from the dominant phyla of the chicken caecal microbiota (Wei 
et al., 2013;Yan et al., 2017;Shang et al., 2018c). Furthermore, Mesa et al. (2017) 
found similar results in their study of broiler chicken caecal microbiota in birds fed 
either a control diet or supplemented with prebiotics (MOS) and nucleotides, and 
notably only detected the Bacteroidetes phylum at 35 da. However, the current 
study on biosecure housed birds ended by day 35 with less than 1% of 
Bacteroidetes present. Polansky et al. (2016) proposed a role for Bacteroides in 
the metabolism of oligosaccharides and formation of short-chain fatty acids in that 
they expressed xylose isomerase required for polysaccharide degradation and the 
enzymes leading to propionate and butyrate production. However, Jumpertz et al. 
(2011) stated that Bacteroidetes were linked to a decrease in nutrient absorption. 
Kers et al. (2018), proposed that the presence or absence of  Bacteroidetes  in 
various studies is likely to be caused by differences in diet, experimental 
conditions, age or sampling time, variation in sequencing technology and the 
differences in the primers used. 
Analysis at class level of the control and GOS diets from commercial birds 
indicated an increase in abundance of Epsilonproteobacteria (Campylobacter 
OTUs) that seems to have emerged post 30 da and which coincides with increase 
the abundance of Negativecutes in control fed birds only. This suggests 
contamination of both barns followed thinning, and it highlights a possible role for 
humans influencing the composition of the microbiota (discussed in Chapter 4).   
Wielen et al. (2002) stated that each bird has variations in the relative 
abundance of members of the intestinal bacterial community. Previous studies 
have indicated that successional changes within the intestinal microbiota at 5 to 
20 days post hatch can be amended by the provision of exogenous microbial 
communities and suppressed by antimicrobial dietary additives (Hume et al., 
2003;Yin et al., 2010;Torok et al., 2011). Hume et al. (2003) showed shifts in the 
caecal microbiota at 2 days and 5 to 20 days of age. The change in composition 
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of the broiler caecal microbiota was reported with age as well as the complexities 
of bacterial communities in microbiome (Wielen et al., 2002;Hume et al., 
2003;Gong et al., 2008). These age-related alterations in the gut microbiota tend 
to be partially associated to the physiological changes that occur in the chick’s GI 
tract post hatch. The GI tract exhibits a rapid increase in the size in early 
development and is reported to reach maximal relative size of the digestive organs 
at 3 to 8 days post hatch with the intestine continuing to increase in the length 
and diameter until 14 days post hatch (Noy and Sklan, 1997). Therefore, different 
environments settings that bird’s early exposure to with the host’s physiology have 
a direct influence on the development of the gut microbiota in the newly hatched 
chick.  
Analysis of alpha diversity of the inverse Simpson index for biosecure housed 
birds showed a reduction at 28 da old in both diets. This decrease in alpha diversity 
was lower in GOS-fed birds. In the commercial birds a significant decrease was 
observed in the control diet (discussed in Chapter 4) compared to the GOS diet. 
This could be a residual consequence of the GOS supplemented diet to retain 
microbial diversity. This finding suggests that GOS promotes diversity in the 
intestinal microbiota. Gao et al. (2017) studied the influence of feed additives 
including probiotics and antibiotics on the maturation of the intestinal microbiota 
in broiler chickens to conclude that probiotic feed provides a great acceleration in 
the maturation of the intestinal microbiota by 15 days. Contrary, they revealed a 
significant retardation with eventual delay (10 day) on intestinal maturation of the 
broiler chicken microbiota using antibiotic supplemented feed. Therefore, it is 
possible that the structural and functional dynamics of intestinal microbiota can 
be used as a signature to characterize, compare, and evaluate the feeding 
regimens in the poultry industry. 
Estimates of beta diversity using Bray-Curtis dissimilarity indicates that 
significant differences exist between the control and GOS supplemented diet in 
biosecure housed birds at 22, 24 and 28 da but losing this significance at 35 da. 
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Additionally, significant differences in beta diversity were found between control 
and GOS birds at 30 and 37 da in commercial birds with increasing age. Moreover, 
it is illustrated that despite the halting the provision of GOS at day 20, the effect 
of the prebiotic feed persists in the gut microbiota since elements of the microbiota 
become established. Thus, it seems to be GOS retain diversity of gut population 
even though the absence of GOS feeding, which may explain the reason why α-
diversity not affected in GOS 37 da diet. 
The phylum of Proteobacteria have been documented as a reservoir of class 
1 integrons.  The association of class 1 integrons with Enterobacteriaceae has been 
extensively reported since 1973 in various geographical locations of the globe 
(Kaushik et al., 2018). This includes the intestinal microbiota of farm animals such 
as poultry, swine, cattle, and aquatic animals that have been widely associated 
with various classes of integrons (Cocchi et al., 2007;Zhang et al., 2009). 
Especially, when animals are reared for commercial purposes are they frequently 
associated with class 1 integrons, likely due to their exposure to antimicrobial 
agents more frequently than other animals (Cocchi et al., 2007). Primary analysis 
by the phylogenetic tree highlights the distribution of embedded GCs in the 
Proteobacteria of the two rearing environments and the diets provided. The most 
prevalent GCs (GC-B2 and GC-A) in birds from the biosecure and commercial 
housing show higher abundance in the control feed birds over the GOS-fed birds 
(Appendix 3.3 A and B). Resistance to trimethoprim by the dfrA gene (GC-B2) was 
observed to reduce in the biosecure birds with time through the loss of the specific 
gene cassette to form GC-C1 (aadA1). Although, resistance load of commercial 
birds did not decrease with time, it showed an increase in GC diversity.  A study 
by Braykov et al. (2016) reported similar observation compatible with findings for 
the biosecure birds. They proposed that control should be exerted in poultry 
hatcheries and sources along the distribution chain because young birds have 
potential to act as reservoirs of AR bacteria. They also called for monitoring to 
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control the dissemination of AR bacteria in poultry production and to assess AR 
bacteria emerging from external sources. The rearing environment has a role in 
the acquisition and dissemination of ARGs. Wellington et al. (2013) pointed out 
the role of the natural environment in the mobilization of genetic elements from 
environmental bacteria to Gram-negative bacteria, as well as the mobility of these 
elements being associated with responses to selective pressures, induced by 
exposure to antibiotics and pollutants in the environment.  
The distribution of GCs among Proteobacteria OTUs demonstrates high 
frequency of recovered resistance load (GCs) in Gamma-proteobacteria 
(OTU0007) in both trials. Zhang et al. (2018) investigated the phylogenetic 
distribution of integrons using the bacterial whole genome database (WGD) and 
plasmid database to demonstrate out of 2440 integrons, 2295 were identified as 
harboured by the phylum Proteobacteria, mainly by Gamma-proteobacteria 
(93%). They also detected a few examples of integrons in Alpha-proteobacteria 
(5 in 2879 of the available genomes) and Beta-proteobacteria (109 in 3401 
genomes). Several studies have reported that the most frequently identified 
integrons (90%) were obtained from Gamma-Proteobacteria (Schmitz et al. 
(1999);Zhao et al. (2001);Moura et al. (2009). Similarly, the current study 
findings also highlight high contributions of GCs in Beta-Proteobacteria OTUs in 
both trials, while alpha-Proteobacteria OTUs were only observed in the commercial 
birds. The results show high frequency of GCs-A was found to coincide with α-
Proteobacteria OTU0176 with fewer dissemination was detected in both OTU0474 
and in the two feed of commercial birds (Appendix 4.4, Figures 1 and 2). Cury et 
al. (2016) studied the taxonomic distribution of integrons in 243 bacterial genomes 
to find that GCs were absent in α-Proteobacteria if they encoded tyrosine 
recombinases that contributed to the integration of GCs, however they detected 
20% GCs in gamma-proteobacterial and 10 % in beta-proteobacteria.  
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LEfSe identified a relative increase in the abundance of Lachnospiraceae ssp 
(OTU0032 and OTU0030) and Clostridiales_unclassified (OTU0138) as 
differentially abundant OTUs for GOS fed birds compared to those on the control 
diet at 22 da, which could  be acting  as competitors to decrease the expansion of 
GCs in the GOS fed birds. LEfSe analysis also shows that although commercial 
birds fed control and GOS diets became colonised by Campylobacter at 37 da, the 
abundance of Megamonas coincides with Campylobacter colonisation in control-
fed birds but not in the GOS-fed birds. This may be an indicative of the suppressive 
role of the GOS established microbiota (it could be attributed to Alistipes OTU0025 
and Bacteroides OTU0028) that are competing with the growth of Megamonas. 
Duggett (2016) showed that the abundance of Megamonas was determined in 
chicken’s microbiome by feeding a wheat rich diet as the most responsive genus 
with over five times in the number of 16S rRNA gene sequences. 
  
5.4 Conclusion 
To summarise the previous findings, the involvement of a prebiotic GOS has 
been investigated by modulating the broiler caecal microbiota using prebiotic 
dietary intervention. This study used class 1 integrons as an indicator of the 
distribution of antibiotic resistance in the caecal microbiota of broiler chickens 
reared under biosecure or commercial conditions and fed either a control or GOS 
supplemented diet. Based on the study findings, at 22 da when the birds were on 
GOS feed there was a significant decrease in the integrase copy number, a low 
percentage of recovered GCs, and a reduction in trimethoprim resistance 
compared to the control diet. GOS feed shows promise in mitigating the resistance 
load in juvenile chickens. At this age the microbiota of the bird shows a 




The resistance load was high in young birds independent of the rearing 
regime; hence they have the potential to act as reservoirs of AR bacteria. 
Therefore, management practice should focus on first forms of contact with birds 
(hatcheries and the distribution chain) responsible for spreading AR genes in 
poultry production. Hence, GOS not only can positively prevent pathogen 
colonization but also has the potential to mitigate AR containing OTUs. This 
suggests that dietary GOS supplementation combined with biosecurity can restrict 
the expansion ARGs in the early rearing period, where control could reduce the 
dissemination of these genes.  However, this restriction is eroded in the absence 



























IMPACT OF DIETARY GALACTO-OLIGOSACCHARIDE (GOS) ON 
ANTIBIOTIC RESISTANCE IN BROILER CHICKEN CAECAL 

















As reviewed in Chapter 1, Salmonella represents one of the leading causes 
of foodborne illness that is often associated with poultry and poultry products, 
which are considered as a major source of human infection (Hughes et al., 2017). 
Therefore, it is important to control Salmonella within poultry production (meat 
and eggs) to reduce the risk of human consumption. Poultry are a frequently 
symptomatic carriers of Salmonella infection (Kogut and Arsenault, 2017), and are 
therefore a target for research to understand how birds respond to Salmonella 
colonisation and how interventions can reduce Salmonella carriage without 
compromising bird health or production (Hughes et al., 2017). Research in this 
chapter investigates the impact of dietary GOS supplementation to prevent or 
support the removal of Salmonella from broiler chickens and how intervention 
could reduce the dissemination of ARGs.  
The two most common serotypes responsible for approximately 40 to 60% 
of all Salmonella infections associated with foodborne disease emanating from 
poultry are: S. enterica serovar Typhimurium and S. enterica serovar Enteritidis 
(Altekruse et al., 2006;Boore et al., 2015;Azcarate-Peril et al., 2018). Salmonella 
can be detected in various concentrations in all regions of the gastrointestinal tract 
(GIT) of challenged chickens (Fanelli et al., 1971;Snoeyenbos et al., 
1982;Micciche et al., 2018). However, the caecum remains the most frequently 
investigated part of GIT of poultry for Salmonella (Soerjadi et al., 1981;Hargis et 
al., 1995;Heres et al., 2003;Huang et al., 2006). The caecum, as the favoured 
environment for colonisation, harbours relatively high densities of bacterial counts 
with up to 1011 cells/g of digesta at three days post-hatching (Apajalahti et al., 
2004;Stanley et al., 2014). Salmonella could be detected by culture, in the 
duodenum and the small intestines of 5–45% of young birds, 1 day post-infection, 
when challenged with high levels of Salmonella (Fanelli et al., 1971) but not with 
lower levels (Micciche et al., 2018). 
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Recent data propose that Salmonella colonisation factors promote horizontal 
gene transfer of antimicrobial resistance genes by increasing the local density of 
Salmonella in colonised intestines (Yue and Schifferli, 2014). It is proposed there 
is a link between the acquisition of adhesins of Salmonella and AMR as HGT drives 
the acquisition of the elements. This is because ARGs in enterobacteria including 
Salmonella, are frequently harboured on mobile genetic elements such as 
integrons, transposons, plasmids, and integrative conjugative elements (Vo et al., 
2007;Su et al., 2008;Ajiboye et al., 2009;Call et al., 2010;Yue and Schifferli, 
2014). Mobilisation of these DNA elements by HGT occurs in the favourable 
environment of the intestines (Nijsten et al., 1995;Lester et al., 2004;Rowe-
Magnus and Mazel, 2006;Schjørring et al., 2008;Trobos et al., 2009;Faure et al., 
2010). The local inflammatory response of the intestinal mucosa caused by 
Salmonella adhesion and invasion can provoke HGT events and is illustrated in 
Figure 6.1 (Stecher et al., 2012). The cyclical colonisation process in the intestines 
leads to intestinal persistence (Figure 6.1 B) that create favourable conditions for 
HGT events (Figure 6.1 C). This enhances the antibiotic resistance gene pool which 
is further stabilised by clonal expansion and selection if antibiotics are 
administered. Moreover, specific ileum colonisation can increase the rate of intra-
intestinal conjugation (García-Quintanilla et al., 2008). HGT of antibiotic resistance 
genes can promote expression of some adhesins (Sahly et al., 2008), which 
suggests a positive mechanism between intestinal colonisation and HGT leading to 
the accumulation of antimicrobial resistance genes in such strains.  
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Figure 6.1 Intestinal surface colonisation and HGT model (Yue and Schifferli, 
2014). (A) Wide adaptation of Salmonella to multitude of environments and hosts with 
distinctly different anatomies. (B) S. enterica possessing specific adhesins for recognising 
the cognate host intestinal receptors and cellular targets to initiate successful 
colonisation.(C) During intestinal colonisation, Salmonella (red ovals) optimises contact 
(event numbers and time span) with a constant flow of new bacteria (blue ovals) via specific 
allelic adhesins, some encoding ARGs on conjugative or mobilizable elements (small circles 
in ovals), leading to an increase in HGT efficiency and antibiotic resistant.  
 
Farm environments can serve as reservoirs of pathogens that carry 
antibiotic-resistant genes (Kelley et al., 1998;Chen and Jiang, 2014). Recently, 
MDR Salmonella isolates resistant to streptomycin (30.9%), gentamicin (12.6%), 
sulfadimethoxine (20.9%), tetracycline (13.9%), and trimethoprim-
sulfamethoxazole combination (8.6%) were recovered from broiler farms (Nair et 
al., 2018). High prevalence rates of S. Enteritidis were observed in feed, hatching 
eggs, litter, drinkers, bird rinse, and caeca, with 88% of S. Enteritidis found to be 
resistant to multiple antimicrobials including ampicillin, nalidixic acid, and 
tetracycline (Al-Zenki et al., 2007). AMR strains of Salmonella serovars are 
frequently isolated from broiler carcasses including  S. Enteritidis, S. Infantis, S. 
Typhimurium, and S. Heidelberg (Medeiros et al., 2011). 
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Sustainable intervention strategies are in development to control antibiotic-
resistant Salmonella in poultry at the farm level and its dissemination to carcasses 
during processing but progress is slow. Prebiotic applications are a potential 
control strategy for controlling intestinal Salmonella infection. These may be added 
to feed and/or water without any modification required from current production 
procedures (Hughes et al., 2017). Prebiotic diets have been shown to modulate 
the intestinal microbiota, modify transit time, luminal pH, and microbial 
metabolites products in humans and in animal models (Chambers and Lu, 
2002;Kogut et al., 2012;Park et al., 2017b). Prebiotics are proposed to act as 
soluble decoy receptors to prevent the attachment of pathogens to mucosal 
surfaces (Shoaf et al., 2006;Quintero et al., 2011;Azcarate-Peril et al., 2018). 
The prebiotics inulin, fructo-oligosaccharides (FOS), and mannan-
oligosaccharides (MOS) have been ascribed protective roles in chicks during the 
first few days post-Salmonella infection, with a reduction in shedding of the 
colonising pathogen (Fukata et al., 1999;Patterson and Burkholder, 2003;Baurhoo 
et al., 2007). Prebiotic GOS fed to chickens resulted in an increase in the 
abundance of beneficial Bifidobacteria and Lactobacillus (Jung et al., 2008). GOS 
is also reported to reduce the adherence and invasion of Salmonella in human 
enterocytes (Searle et al., 2010). Inclusion of prebiotics in broiler diets therefore 
offer the prospect of reducing Salmonella colonisation through modification of the 
hosts’ immune response and the gut microbiome. It may also reduce the 
expansion of ARGs in co-affected Enterobacteriaceae. 
The work described in this chapter aimed to understand the effectiveness of 
dietary GOS supplementation on the elimination of Salmonella enterica serovar 
Enteritidis 125109 colonising broiler chickens. These studies were also planned to 
determine the effect of GOS on the carriage of AR genes in the presence of 
Salmonella by monitoring the ARG load embedded in class 1 integrons within the 
caecal microbiota. An attempt was also made to detect a colonising Salmonella 
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that might have acquired a trimethoprim gene cassette (dfrA) to assess the 
mobility of AR genes in the microbiome of the chicken caecum.  
  
6.2 Results 
6.2.1 Enumeration of Salmonella in the caecal contents of challenged 
birds fed control and GOS diets 
The enumeration of Salmonella (the strain is trimethoprim sensitive, and it 
does not carry a class 1 integron) from the caecal contents of challenged birds fed 
control diet (G3, named ctl-sal) and GOS diet (G4, named gos-sal) were carried 
out at 2, 4, 8, 15 da post infection (dpi) and the results are presented in Figure 
6.2. Birds infected with Salmonella enterica serovar Enteritidis 125109 at 20 days 
became caecal colonised within 2 days of exposure with median counts of 3.43 
(SD  0.66) and 3.51 (SD  0.84) log10 CFU/g for control and GOS fed birds. The 
level of detection for these experiments was 1.8 log10 CFU/g and by 4 dpi 
Salmonella were only detectable by enrichment from the caeca of specific birds 
<1.8>1.0 log10 CFU/g, and not at all for two members of the GOS-fed group. For 
this reason, the colonisation data for each group were ranked and analysed using 
the Wilcoxon signed-rank test as a non-parametric statistical test. The Wilcoxon 
test revealed that Salmonella counts significantly reduced by 8 dpi in GOS fed 
birds compared to the control diet (p-value = 0.0476). The significance level 
increased by 15 dpi (p = 0.0075). No Salmonella were isolated from the mock 





Figure 6.2 Comparison of Salmonella Enteritidis 125109 numbers recovered from 
the caecal contents of birds fed control diet or GOS diet. Dietary GOS reduced the 
level of Salmonella at 8 days post infection. At 2 dpi GOS feeding was stopped. Bars indicate 
median Salmonella concentration. Each individual bird is marked with corresponding ID. A 
non-parametric Wilcoxon test was used to determine significant differences for each 
sampling time with the level of significance p<0.05. 
 
6.2.2 Screening for Salmonella in the livers and spleens of challenged 
birds fed control and GOS diets 
Detection of Salmonella in the liver and spleen of the challenged groups 
(G3 and G4) was carried out at 2, 4, 8, 15 dpi by direct plating of homogenised 
tissue on selective agar out of 7 birds per treatment and by enrichment. The 
results showed that Salmonella was detected in the livers of three birds in ctl-sal 
group at 2 dpi whereas all seven birds were positive in the gos-sal group. At 4 dpi, 
all livers sampled from both diets were positive. While at 8 dpi, both diets 
displaying a decrease in Salmonella detection (6/7). At the last sampling day (15 
dpi) both control and GOS diet birds recorded a lower number of Salmonella 
positive livers (28.5%). The results are presented in Figure 6.3.  
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Figure 6.3 The comparison of livers Salmonella Enteritidis 125109 positive birds 
fed the control diet or the GOS diet.  Percentage indicating that no significant difference 
was found among two diets. Data expresed as bar charts with red bars represented ctl-sal 
groups and gray bars represented gos-sal groups.  
Salmonella was recovered from the spleens of the infected birds with five 
samples positive in the ctl-sal group compared to 6 positive samples in the gos-
sal group at 2 dpi. All spleen samples were positive at 4 dpi from both groups and 
6/7 for the ctl-sal birds compared to 7/7 samples for gos-sal at 8 dpi. However, a 
15 dpi the number of positive spleen samples in both diets declined (three positive 
samples in ctl and two positives in GOS diets). The results are displayed in Figure 
6.4. No Salmonella were detected in the liver and spleen of birds from Groups 1 


























































Figure 6.4 Comparison of Salmonella positive spleen samples of birds fed control 
diet and the GOS diet (Late challenge). Showing no significant difference in positive 
samples number between two diets colonised by Salmonella (G3 and G4). However, the 
percentage decreased with age in both feeds. 
 
6.2.3 Enumeration of coliform bacteria recovered from the caecal 
contents of Salmonella challenged groups fed control and GOS diets 
Experiments were carried out to investigate the influence of GOS 
supplemented diet on the reduction of coliform total counts and trimethoprim 
resistant bacteria. In this set of experiments, the normal broiler chicken gut 
microbiota was disrupted by Salmonella Enteritidis infection to analyse the effect 
if any on coliform numbers and persistence. As described previously the challenge 
with Salmonella was carried out at 20 da while feeding with GOS was halted at 22 
da (2 dpi). 
The results presented in Figure 6.5 show the total coliform viable count from 
caecal contents of birds sacrificed fed control and GOS diets, infected and non-
infected by Salmonella at 4 sampling ages. A trend of declining coliform counts 















































with age was observed for all groups. The decline in coliform count was greater in 
the GOS-fed birds independent of Salmonella infection but only reached 
significance (p>0.017) at 4 dpi (24 da) comparing the two diets for the Salmonella 
infected birds (G3 and G4). The general observation of reduced coliform counts in 
the GOS-fed birds supports the hypothesis that prebiotic GOS has an impact on 
total coliform counts that could reduce the load of ARGs. Thereby GOS 
supplemented diet retained its ability to reduce total coliform number even when 
challenged with Salmonella Enteritidis. 
The total number of coliform in control diet fed non-colonised birds ranged 
from 7.5 to 8.3 log10 CFU/g (G1), whilst the Salmonella challenged fed control diet 
ranged from 6.5 to 8 log10 CFU/g (G3) with no significant difference was detected 
p value> 0.05. The GOS-diet cohort colonised with Salmonella (G4) ranging from 
5.8 to 8 log10 CFU/g and non-colonised birds ranged between 6.2 and 8.4 log10 





























22 da 24 da 35 da 28 da 
Figure 6.5 Comparison of coliform numbers recovered from the caecal contents at 22, 24, 28 and 35 da of birds non-infected and 
infected by Salmonella Enteritidis 125109, fed control diet (G1) or GOS supplemented diet (G2) or control diet colonised with 
Salmonella (G3) or GOS diet challenged with Salmonella (G4). Data are expressed as standard boxplots with medians (solid black line), 
where n=7.  
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6.2.4 Enumeration of trimethoprim resistant coliforms from caecal 
contents of control and GOS fed birds challenged with Salmonella.  
  
The viable counts of trimethoprim resistant bacteria were enumerated on 
MacConkey agar containing trimethoprim (20 µg /ml). Figure 6.6 shows the counts 
for the various groups ranging from log10 4-7 CFU/g. The results indicate that 
viable counts of trimethoprim resistance coliforms were significantly reduced at 2 
and 4 dpi (p-value = 0.04 and 0.0009 respectively) in the GOS supplemented diet 
birds challenged with Salmonella (G4) compared to control diet fed Salmonella 
infected birds. Although, this significance disappeared at 8 dpi the counts of 
trimethoprim resistance coliforms were still lower in Salmonella-colonised GOS 
diet birds than Salmonella-colonised control diet birds. At 4 dpi the trimethoprim 
resistance counts were reduced in the presence of Salmonella for birds fed GOS 
diet (p-value = 0.045). Generally, the counts of trimethoprim resistant bacteria 
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22 da 24 da 35 da 28 da 
Figure 6.6 Comparison of trimethoprim resistance bacteria collected from the caecal contents at 22, 24, 28 and 35 da of birds 
non-infected and infected by Salmonella Enteritidis 125109, fed control diet (G1) or GOS supplemented diet (G2) or control diet 
colonised with Salmonella (G3) or GOS diet challenged with Salmonella.  Data are expressed as standard boxplots with medians (solid 





6.2.5 Ratio of coliform trimethoprim resistance bacteria obtained from 
the caecal contents of birds reared in biosecure conditions fed control 
and GOS diets, challenged by Salmonella  
The proportion of trimethoprim resistant coliforms was calculated by dividing 
total number of trimethoprim resistant coliform bacteria by the total number of 
coliforms. Figure 6.7 shows that the proportion of the trimethoprim resistant 
bacteria in the total population increases with age. Consistent with the observation 
that the trimethoprim resistant coliforms were reduced in birds fed GOS diet 
(Figure 6.6), a reduced proportion of trimethoprim resistant bacteria at 2 and 4 
dpi in birds fed GOS diet was observed. At 8 dpi the proportion of trimethoprim 
resistant bacteria increased in both GOS diet groups. The ratio of trimethoprim 
resistant bacteria reduced at 22 and 24 da after withdrawing GOS at 22 da but 
this effect did not persist at 28 and 35 da and that may relate to changes in 





























Figure 6.7 Ratios of trimethoprim resistant coliform population in birds fed control and GOS diets, challenged and non-
challenged by Salmonella. Data are expressed as standard boxplots with medians (solid black line), where n=7. The orange boxes indicate 
to control-non colonised birds, tiffany blue boxes represent GOS non-colonised birds, dark red boxes represent control Salmonella colonised 
birds and grey boxes represent GOS Salmonella colonised birds. Outliers are expressed as dots. The top and bottom Whiskers indicate 
maximum and minimum values, unless these values exceed 1.5x the interquartile range.   
22 da 24 da 28 da 35 da 
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6.2.6 Evaluation of class 1 integron integrase copy number of 
Salmonella colonised birds fed control and GOS diets reared in 
biosecure conditions. 
To extend the observations regarding the enumeration the total coliform 
counts and trimethoprim resistant coliform population for the Salmonella colonised 
birds (G3 and G4) and to enable comparison with the non-colonised groups (G1 
and G2, Chapter 4) fed either control or GOS diets, q-PCR experiments was 
preformed to determine the class 1 integron copy number using the integrase gene 
primer described in Chapter4 (Section 4.2.5). The S.Typhimurium U288 was used 
as positive control to quantify the absolute quantification of integrase gene copy 
number per gram of intestinal contents. The results presented in Figure 6.8 show 
at 2 dpi the birds on the GOS diet had significantly less class 1 integrase that the 
control diet with Salmonella colonisation (p-value = 0.004) or without (p-value = 
0.015). Therefore, this finding supports the hypothesis that the GOS 
supplemented diet leads to a class 1 integron population and the incumbent ARGs 
but this effect is lost once the GOS supplementation is halted. 
 
6.2.7 Comparison of the antimicrobial gene cassettes in the caecal 
microbiota of birds with and without Salmonella. 
Table 6.1 shows the class 1 integron GC types present in the caecal 
microbiota of the birds fed control and GOS diets with and without Salmonella 
colonisation across all sampling points. Notably the challenge strain Salmonella 
Enteritidis P125109 does not contain a PCR amplifiable class 1 integron. The total 
representative GC types from broiler caecal microbiota of birds on the control diet 
colonised by Salmonella was 37 from 28 birds (G3), such that all birds contained 
at least one GC. Almost all (27/28) carried the GC with the antibiotic resistance 
type GCs-B-2 (containing the resistance genes dfrA1 and aadA1), followed by GCs-
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C-2 (3/28; characterised by the insertion of the trinucleotide GGG in the integrase 
gene), and 2/28 for GCs-B-1, GCs-F and 1/28 GCs-C-1. Whereas 26 of 28 birds 
carried class 1 integron GCs for the GOS supplemented diet challenged by 
Salmonella (G4). The most frequent GC type detected was GCs-B-2 (17/28), with 
lesser contributions from GCs-C-1 (4/28), GCs-B-1 (2/28) and GCs-F (3/28). 
Using the chi-squared test for all birds colonised by Salmonella the proportion 
exhibiting gene cassettes on the GOS diet was significantly different to those on 
the control diet (χ2 (1, N = 56) = 8.00, p = 0.004). For the non-colonised groups, 
the proportion exhibiting gene cassettes on the GOS diet (G2) compared to those 
on the control diet (G1) marginally failed to meet significance (χ2 (1, N = 55) = 
2.3, p = 0.13). Comparison for all birds exhibiting gene cassettes on the GOS diet 
with control shows a significant difference (χ2 (1, N = 111) = 6.75, p = 0.009). 
Comparison of the proportion of all birds exhibiting gene cassettes with or without 














Table 6.1 Gene cassettes present in the caecal microbiota of chickens 
reared under biosecure conditions. 
 
6.2.8 Salmonella Enteritidis antimicrobial resistance mobility test   
An attempt was made to detect if the colonising Salmonella strain had 
acquired resistance to trimethoprim (dfrA) during the experiment. Caecal contents 
of Salmonella colonised groups were serially decimally diluted and plated on 
trimethoprim XLD plates. No Salmonella isolates resistant to trimethoprim were 























B-1 - - - - - - - - - 0 
B-2 5 3 1 1 10/27=37% - 2 - - 2/28=7.14 
C-1 - - - - - - - - 2 2/28=7.14 
C-2 - - - - - - - - - 0 
F - - - - - - - - - 0 
ND 2 4 6 5 17 7 5 7 5 24 
Total 5 3 1 1 10/27=37% 0 2 0 2 4/28=14.28 
 Control diet with Salmonella (G3) GOS diets with Salmonella (G4) 
B-1 1 - 1 - 2/28=7.14% 1 1 - - 2/28=7.14 
B-2 7 7 7 6 27/28=96.4% 6 5 2 4 17/28=60.71 
C-1 - - - 1 1/28=3.57% 1 - 1 2 4/28=14.2% 
C-2 1 - - 2 3/28=10.71% - - - - 2/28=7.14% 
F - - 1 1 2/28=7.14% - - 1 2 3/28=10.71% 
ND - - - - 0 - 2 3 2 7 










22 da 24 da 28 da 35 da 
Figure 6.8 Comparison of class 1 integrase copy number quantified by qPCR per gram of caecal contents of birds fed both diets 
challenged and nonchallenged by Salmonella. Data are expressed as standard boxplots with medians (solid black line), where n=7. The 
orange boxes indicate to control-non colonised birds, tiffany blue boxes represent GOS non-colonised birds, dark red boxes represent control 
Salmonella colonised birds and grey boxes represent GOS Salmonella colonised birds. Outliers are expressed as dots. The top and bottom 
Whiskers indicate maximum and minimum values, unless these values exceed 1.5x the interquartile range.  
0.015  0.004  
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6.2.9 Development of the caecal microbiota composition fed control 
diets and GOS supplemented diets colonised by Salmonella  
A similar approach to that described earlier was adopted to profile the caecal 
bacterial community by PCR-amplifying the V4 regions of the bacterial 16S rRNA 
genes. All sequences data of the 16S rRNA gene were quality filtered and then 
clustered into operational taxonomic units (OTUs) by Mothur (Schloss et al., 2009)  
using the Schloss lab. MiSeq SOP2 (Kozich et al., 2013). Rarefaction curves were 
plotted to evaluate sampling effort covered sufficient depth (Appendix 5.1 for ctl-
sal and gos-sal birds, for non-colonised 3.1 A).  
A taxonomy-based comparison was performed to determine the differences 
between the microbiota of control fed and GOS supplemented given birds. Figure 
6.9 A and B shows that the dominant phyla, at 2 dpi (22 da) were Firmicutes 
(Clostridiales_unclassified) with similar medians of 89.97% for G3 and 89.73% for 
G4 and an inter quartile range (IQR) of 4.81, 6.43 respectively (Wilcoxon p-value 
=0.7104). The second most numerous phyla were Proteobacteria for both diets 
with a median of 3.90% for G3 and 2.20% for G4 (IQR, 2.61, 0.44; Wilcoxon p-
value= 0.3829). The abundance of the group described as Bacteria_unclassified 
was higher in G3 than G4 with a median of 3.28% and 1.44% respectively (IQR, 
2.23%, 2.63%, Wilcoxon p-value = 0.3829). The abundance of Actinobacteria was 
less than 1% in G3 (median: 0.994%; IQR, 3.18), the abundance for G4 was 
approximately 2% (median: 1.9%; IQR, 3.78). The abundance of Bacteroidetes 
was noted at 22 da olds birds in both diets as variable between individual samples 
with a mean of 3.23% for G3 and 3.85% for G4. Figure 6.9 C and D shows that at 
4 days post-infection (24 da birds), the phyla observed were similar with no 
significant differences between the phyla abundances for G3 and G4. Bird to bird 
variation in the abundance of Bacteroidetes remained a feature of the data. 
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Figure 6.10 A and B show the abundances of phyla at 8 da post Salmonella 
colonisation (28 da old birds), with the control-sal group (G3) displaying an 
increase in abundance of Firmicutes (median: 93.44%, IQR, 8.0) while for the 
GOS diet (G4) caecal abundance of Firmicutes was reduced (83.29%, IQR, 11.24; 
Wilcoxon p-value =0.0973). In contrast, there was a significant increase in the 
abundance of Actinobacteria in gos-sal group (G4) with a median of 10.76% and 
IQR of 9.28, whereas the abundance of Actinobacteria was deceased in control-
sal birds with a median of 0.37% and an IQR of 2.94 (Wilcoxon p-value =0.0262). 
The abundance of Proteobacteria was similar between the two diet groups with 
medians of 3.05%, and 3.22% for G3 and G4 respectively (IQR of 3.88 and 2.79; 
Wilcoxon p-value =0.9015). Figure 6.10 C and D show that at 15 dpi (35 da) the 
abundance of the Firmicutes was reduced in the control-sal (G3) with a median of 
88.38% and IQR of 11.40% but was not significantly different to that recorded for 
the gos-sal group (G4) with a median of 90.14% and an IQR of 3.11% (Wilcoxon 
p-value =0.4557). The proportion of Proteobacteria was reduced in caecal 
contents from birds fed either diet, however its abundance was lower in G3 with a 
median of 0.98% and IQR of 0.52, compared to a median of 2.25% in G4 with and 
IQR of 1.35 (Wilcoxon p-value= 0.0728).  
Figures 6.11 A and B show the class level abundance at 2 dpi where there 
was one significant difference detected between the two diets in conjunction with 
Salmonella colonisation. This was the OTU corresponding to Erysipelotrichia with 
a median of 1.76% and 0.398%, for G3 and G4 respectively (Wilcoxon p-value 
0.0111). There was no significant change detected at 4 dpi (Figure 6.11 C and D). 
At 8 dpi (Figure 6.12 A and B) significant differences were found in the class level 
abundance of Clostridia with a median of 78.07% for G3 and 51.94% for G4 (IQR, 
9.78 and 13.95; Wilcoxon p-value= 0.0262). The abundance of Negativicutes, 
were found to be greater in G4 with a median of 34.33% compared to 9.55% for 
G3 and IQR values of 29.09%, 2.19%, respectively (p-value Wilcoxon 
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test=0.0973). Actinobacteria also showed a significantly greater class level 
abundance in the GOS diet (G4) with a median of 10.76% and IQR of 9.29 
compared to control diet (G3) with a median of 0.37% and IQR of 2.94 (p-value= 
0.0262). At 15 dpi (Figure 6.12 C and D) the abundance of Clostridia was reduced 
in G4 with a median of 27.52% and IQR of 5.61 compared to G3 with a median of 
67.09% and IQR of 11.70 (p-value 0.0012). Negativicutes OTUs displayed a 
significantly greater class level abundance at 15 dpi for the GOS diet (G4) with a 
median of 61.87% and IQR of 17.17 compared to control diet (G3) with a median 
of 9.11% and IQR of 12.30 (p-value Wilcoxon test = 0.0012).  
A group-wise class level comparison combining the individual bird data and 
showing the effects of diet and Salmonella colonisation is shown in Figure 6.13 for 
each sample day. This indicated a significantly lower relative abundance of 
Clostridia in the Salmonella colonised control diet group (G3) compared to non-
colonised control diet (G1) with Wilcoxon p-values of 0.0070, 0.0070, 0.0262, 
0.0023 for 2dpi, 4dpi, 8dpi and 15 dpi respectively. Negativicutes emerged in the 
microbiota of birds fed control diet colonised by Salmonella (G3) at 2 dpi (22 da). 
With a median abundance of 17.81% and IQR of 16.45. In contrast, Negativicutes 
which were all but absent in the non-infected control diet (G1) with a median of 
0.0016% for G1 and IQR of 0.001 (p-value = 0.0006). The difference in 
Negativicutes persisted until the end of the study at 15 dpi with a median of 0.00% 
and IQR of 0.0 compared to a median of 9.118% and IQR of 12.3 for G3, (p-value 
= 0.0006). The relative abundance of the OTU corresponding to Bacilli at 2 dpi 
was significantly higher in G1 with a median of 7.311% and IQR of 3.33 compared 
to G3 with a median of 3.597% and IQR of 2.57 (p-value = 0.0041). The relative 
abundance of Actinobacteria was significantly greater in G3 than G1 at 15 dpi 
(median for Actinobacteria 0.905% for G1 and 7.197% for G3; IQR: 0.57, 5.03; 
p-value = 0.0175) and for Bacteroidia  (median for Bacteroidia 0.00% for G1 and 
3.85% for G3; IQR: 0.0, 7.11;p-value = 0.0373). 
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Comparison between the non-Salmonella colonised birds on the GOS diet 
(gos-nonc, G2) and Salmonella colonised birds (gos-sal, G4) at class level (Figure 
6.13) demonstrated a significant shift (decrease) in the relative abundance of the 
Clostridia recorded at 22 da in GOS-Salmonella cohorts with a median of 87.88% 
and IQR of 4.93 for G2 and a median of 66.67% and IQR of 17.75 for G4 (p-value 
= 0.0175). Negativicutes emerged in the microbiota of birds fed GOS and 
colonised by Salmonella (G4) with a median of 12.35% and IQR of 21.12. In 
contrast, Negativicutes had a low abundance in the microbiota of non-colonised 
GOS diet birds (G2) with a median of 0.002% and IQR of 0.0 (p-value = 0.0012). 
These differences also persisted until the end of the trial at 35 da but with the 
abundance of Negativicutes significantly greater in Salmonella colonised birds with 
a median 61.87% and IQR of 17.1 for G4 compared to a median of 0.04% and 
IQR of 0.02 (p-value = 0.0006). This difference appeared to be largely at the 
expense of Clostridia (median: 78.44% for G2 and 27.53% for G4; IQR: 7.63 and 
11.70; p-value = 0.0006) and Bacilli (median: 13.86% for G2 and 3.63% for G4; 
IQR: 5.81 and 1.7; p-value = 0.0023). Actinobacteria showed significant increases 
in the relative abundance observed for the GOS-challenged birds from 28 da 
(median: 0.72% for G2 and 10.77% for G4; IQR: 0.60 and 9.29; p-value 0.0006). 
No significant change was detected in the proportion of 
Gammaproteobacteria for the GOS diet groups in the presence or absence of 
Salmonella until 15 dpi when Gammaproteobacteria reduced in G4 compared to 
G2 (median: 3.71% for G2 and 0.68 % for G4; IQR: 1.67 and 0.5; p-value = 
0.0530). Similarly, no significant difference was found among 
Gammaproteobacteria in birds fed standard diet colonised or non-colonised by 
































































































































































































































































































































Figure 6.9. Comparison of the relative abundance of dominant bacterial phyla of gut microbiota of birds fed control and 
GOS diets challenged with Salmonella. The data were clustered based on Ribosomal Database Project taxonomy (phylum level). 
The results are presented as a normalised percentage of the total abundance where the taxa representing at least 1% of the caecal 

























































































































































































































































































































































Figure 6.10 Comparison of the relative abundance of dominant bacterial phyla of gut microbiota of CH birds fed control 
and GOS diets challenged with Salmonella. The data were clustered based on Ribosomal Database Project taxonomy (phylum 
level). The results are presented as a normalised percentage of the total abundance where the taxa represent at least 1% of the 














































































































































































































































































































































Figure 6.11 Comparison of the relative abundance of dominant bacterial classes among CH chicken gut microbiota fed control 
and GOS diets challenged with Salmonella. The data were clustered based on Ribosomal Database Project taxonomy (class level). The 
results are presented as a normalised percentage of the total abundance where the taxa represent at least 1% of the caecal community. A) 












































































































































































































































































































































Figure 6.12 Comparison of the relative abundance of dominant bacterial classes among CH chicken gut microbiota fed control 
and GOS diets challenged with Salmonella. The data were clustered based on Ribosomal Database Project taxonomy (class level). The 
results are presented as a percentage of the normalised total abundance where the taxa represent at least 1% of the caecal community. A) 






























































































































Figure 6.13 Summary of the relative abundance of dominant bacterial classes for 
chicken caecal microbiota challenged with Salmonella comparing control and GOS 
diets. The data were clustered based on Ribosomal Database Project taxonomy (class 
level). The results are mean values for each OTU presented as normalised % abundance 
for control and GOS feeds with and without Salmonella challenge. A) 22 da; B) 24 da; C) 











6.2.10 Relative abundance of Proteobacteria among Salmonella 
challenged and non-challenged birds fed control and GOS diets   
The relative abundance of Proteobacteria was investigated at phylum level 
to evaluate if there is any difference between the four groups fed control or GOS 
diets and colonised or non-colonised by Salmonella. The abundance of each group 
was tested by Shapiro–Wilk test for normality indicating that the relative 
abundance of Proteobacteria was not normally distributed at 4 dpi in gos-sal birds  
(Shapiro–Wilk test, p-value= 0.035) as well as for ctl-sal at 15 dpi old birds 
(Shapiro–Wilk test, p-value = 0.030). The relative abundance of Proteobacteria 
was otherwise normally distributed across various sampling days in both groups 
(Appendix 5.2). Therefore, the Mann–Whitney-Wilcoxon test for unpaired data was 
used for determining the significance between groups. Results in Figure 6.14 show 
no significant change was detected between the non-infected control (ctl-nonc) 
and GOS feed groups (gos-nonc) or between the Salmonella colonised groups (ctl-
sal vs gos-sal) across Proteobacteria cohorts through all sampling points (p-
value > 0.05). Moreover, comparison between control diets with and without 
pathogen (G1 vs G3) at 22, 28 and 35 showed no difference (p> 0.05). However, 
a significant difference was indicated at 24 da (median: 6.34% for G1 and 2.98% 
for G3; p-value = 0.053). No difference was observed between the GOS feed 
groups (G2 vs G4) for the abundance of Proteobacteria at any sampling time.  
An attempt was made to investigate the correlation between the relative 
abundance of the Proteobacteria present and the ratio of trimethoprim 
resistant/sensitive coliform populations through four sampling points for G1-G4 
(ctl-nonc, gos-nonc, ctl-sal and gos-sal). The results presented in Appendix 5.3 
indicate a significant negative correlation between the Proteobacteria abundance 
and the proportion of trimethoprim resistant coliforms for the control diet 
Salmonella colonised group (G2) at 22 da (r= -0.78, p = 0.038) and the GOS diet 
Salmonella colonised group (G4) at 28 da (r= -0.83, p = 0.020).  
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Figure 6.14 Comparison of the relative abundance median of the 
Gammaproteobacteria from 4 sampling points for non-infected control and GOS 
diet birds (G1 and G2) and infected control and GOS diets groups (G3 and G4). 
Wilcoxon test p value was used as all Proteobacteria phylum not normally distributed across 
cohorts: ctl-nonc at 22 da, gos-sal at 24 da and ctl-sal at 35 da (Normality test, Appendix 








6.2.11 The distribution of resistance GC arrays within the gut 
microbiota of birds fed control and GOS diets colonised and non-
colonised by Salmonella  
Correlations between integron gene cassettes within broiler caecal 
microbiota was examined with respect to Proteobacteria OTUs. The phylogenetic 
trees presented in Figures 6.15 A, B, C and D show the distribution of different 
type GCs among birds carrying the Proteobacteria OTUs indicated. The results 
demonstrated that at the first sampling point (2 dpi) in control fed birds there 
were 4 main OTUs detected within the phylum whether they were Salmonella 
challenged or not. Birds featuring Enterobacteriaceae_unclassified (OTU007 and 
OTU0324) also frequently feature GCs-B2. Proteobacterial OTUs corresponding to 
Betaproteobacteria_Sutterella (OTU0097) and Gammaproteobacteria_Proteus 
(OTU0169) are less frequently associated with the presence of GCs. Fewer of the 
GOS fed birds contained GCs in their caecal microbiota throughout the rearing 
period but those that did, possessed the most common OTU corresponding to 
Enterobacteriaceae_unclassified (OTU007). At 4 dpi the birds fed the control diet 
displayed a similar pattern of resistance dominated only by GCs-B2 associated 
with OTU0007 and OTU0324. The Betaproteobacteria_Sutterella OTU0097 is lost 
from the control diet birds at 4 dpi and does not feature thereafter, but was present 
throughout for the GOS-fed birds. At 8 dpi (28 da) fewer control birds contained 
GCs, which included those featuring OTU007. A new GC designated GCs-F 
containing the aadA gene appeared at 8 dpi, and at 15 dpi (35da). The expansion 
of GCs may be correlated with the mechanism of excising dfrA1 to create the GCs-
B2C1 and B2F types that are deletions of GCs-B2. The diversity of recovered GCs 




Figure 6.15 Phylogenetic tree of Proteobacteria phylum illustrates the OTUs associated with the distribution of GC groups in broiler chicken 
microbiota fed control and GOS diets challenged and non-challenged by Salmonella. All birds were reared under biosecure conditions. The 
phylogenetic tree was constructed with Bootstrap value ≥ 20 reads. (A) Control fed birds at 22 da Salmonella colonised and non-colonised (B) GOS fed 
birds at 22 da Salmonella colonised and non-colonised. The bacterial OTUs are: OTU 0324 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), 
OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is Gamma-proteobacteria (Proteus), OTU0097 is (Beta-proteobacteria) 
Sutterella. The GCs are named as in Chapter 3 where ND is none detected. 




Figure 6.16 Phylogenetic tree of Proteobacteria phylum illustrates the OTUs associated with the distribution of GC groups in broiler chicken 
microbiota fed control or GOS diets challenged and non-challenged by Salmonella.  All birds were reared under biosecure conditions. The 
phylogenetic tree was constructed with Bootstrap value ≥ 20 reads. (A) Control fed birds at 24 da Salmonella colonised and non-colonised (B) GOS fed 
birds at 24 da Salmonella colonised and non-colonised. The bacterial OTUs are: OTU 0324 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), 
OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is Gamma-proteobacteria (Proteus), OTU0097 is (Beta-proteobacteria) 
Sutterella. The GCs are named as in Chapter 3 where ND is none detected. 




Figure 6.17 Phylogenetic tree of Proteobacteria phylum illustrates the OTUs associated with the distribution of GC groups in broiler 
chicken microbiota fed control or GOS diets challenged and non-challenged by Salmonella.  All birds were reared under biosecure conditions. 
The phylogenetic tree constructed with Bootstrap value ≥ 20 reads. (A) Control fed birds at 28 da Salmonella colonised and non-colonised (B) GOS fed 
birds at 28 da Salmonella colonised and non-colonised. The bacterial OTUs are: OTU 0324 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), 
OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is Gamma-proteobacteria (Proteus), OTU0097 is (Beta-proteobacteria) 
Sutterella. The GCs are named as in Chapter 3 where ND is none detected. 
















Figure 6.18 The phylogenetic tree of Proteobacteria phylum illustrates the OTUs associated with the distribution of GC groups in broiler 
chicken microbiota fed control or GOS diets challenged and non-challenged by Salmonella.  All birds were reared under biosecure conditions. The 
phylogenetic tree constructed with Bootstrap value ≥ 20. (A) Control fed birds at 35 da Salmonella colonised and non-colonised (B) GOS fed birds at 35 
da Salmonella colonised and non-colonised ones. The bacterial OTUs are: OTU 0324 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU0007 
is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is Gamma-proteobacteria (Proteus), OTU0097 is (Beta-proteobacteria) Sutterella. 
The GCs are named as in Chapter 3 where ND is none detected.
A. Control_diet_35 da (15 dpi) B. GOS_diet_35 da (15 dpi) 
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6.2.12 Microbial diversity analysis 
Analysis of the composition of caecal microbiome contents was performed 
by using Mothur (V1.39.5) and for comparison of the diversity indices (alpha and 
beta diversity). As noted previously, the inverse Simpson's index is used for the 
α-diversity or the overall diversity (evenness), whereas the observed OTUs or the 
OTUs richness was calculated using the Chao index. The complete comparison of 
the medians for both indices are presented in Figure 6.19 (A) for inverse Simpson's 
index and (B) for Chao index.  
Normality tests were performed using the Shapiro-Wilks test for all groups 
(ctl-nonc G1, ctl-sal G3, gos-nonc G2, and gos-sal G4) indicating that the inverse 
Simpsons indices was not normally distributed at 24 da for the ctl-nonc group 
(Shapiro-Wilk test, p-value = 0.0279, Appendix 4.5A, Chapter 5) and 15 dpi in 
gos-sal birds (Shapiro-Wilk test, p-value = 0.0064), while all other sampling times 
show normal distributions for the Simpsons indices (p-value >0.05). The fit of the 
data in quantile-quantile plots is represented in Appendix 5.5A for only ctl-sal and 
gos-sal. 
The majority of Chao indices calculated were normally distributed among 
various sampling times for both control and GOS diet cohorts either Salmonella 
challenged or not. The exceptions were gos-sal at 22 da (Shapiro-Wilk test, p-
value = 0.0116), ctl-nonc at 28 da (Shapiro-Wilk test, p-value = 0.0378, Appendix 
4.5B ), and ctl-sal birds at 28 da (Shapiro-Wilk test, p-value = 0.0163). The fit of 
the data in quantile-quantile plots are illustrated in Appendix 5.5 B. 
Based on calculations of alpha diversity and Wilcoxon tests for unpaired data 
there was no significant difference observed between the microbiome in caecal 
contents from birds fed control and GOS diets following Salmonella colonisation 
(G3 and G4) on the overall diversity (evenness) after 2, 4 and 8 dpi (p-value> 
0.05). However, a significant change was noted in alpha diversity at 15 dpi 
between G3 and G4 (p-value = 0.0023). In addition, comparison between ctl-nonc 
birds and control-sal groups (G1 and G3) during four sampling times revealed that 
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no significant difference was evident in the evenness of the OTUs whether these 
groups were colonised or not by Salmonella (p> 0.05). However, there were 
statistically significant differences detected at 2 and 15 dpi in the  Salmonella 
colonisation in gos-sal birds (G4) compared to gos-nonc G2 (inverse Simpson, p-
value= 0.026 at 2 dpi, p-value= 0.001 at 15 dpi). These results are presented in 
Figure 6.19 A. 
There was no significant difference in Chao richness of the two diets (G3 and 
G4) at 2,4, and 8 dpi of Salmonella infection, however at 15 dpi, a significant 
reduction in the Chao index was observed for G4 compared to G3 (p-value = 
0.011). Comparison between the caecal microbiota of control diet groups with and 
without Salmonella colonisation (G1 and G3) indicated that the only significant 
change was detected at the first sampling day (p-value = 0.016) in G1 compared 
to G3, whilst no differences were observed for other sampling points (p >0.05). 
Likewise, no significant changes in richness were determined by comparing G2 

















































































































































































































Figure 6.19 (A) Inverse Simpson indices, (B) Chao indices of caecal microbiota for control and GOS diets with or without Salmonella 
colonisation. Wilcoxon rank significance tests were used to calculate p-values used for identifying significant differences because the inverse Simpson 
indices were not normally distributed at ctl-nonc at 24 da and gos-sal al 35 da (Appendix 5.5A and 3.5A). Whilst for the Chao index data the indices were 
not normally distributed at 22 da for gos-sal and at 28 in ctl-sal groups (Appendix 5.5 B)
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In order to examine the effect of diet and infection interactions, the 
relationship between the compositions of the bacterial communities were analysed 
by calculating Bray-Curtis dissimilarity. Ordination plots were generated that 
included comparisons of dissimilarity between the caecal microbiota for the two 
diets for birds infected or non-infected by Salmonella (Figure 6.20). AMOVA tests 
were also calculated using Mothur (V1.39.5) to detect significant differences 
between groups for the four sampling times. AMOVA test results denoted that no 
significant shift was detected between G3 and G4 at 2 and 4 dpi following 
Salmonella colonisation, however, significant shifts in microbiota composition were 
observed at 8 and 15 dpi between G3 and G4 (AMOVA test, p-value = 0.004 and 
0.001 respectively). However, by comparing microbial composition of the control 
diet cohorts with and without pathogen colonisation (G1 and G3), the AMOVA test 
showed significant changes between bacterial communities at all sampling points 
(AMOVA test, at 22 da p-value = 0.004, while at 24, 28 and 35 da p-value = 
0.001). Similarly, the GOS supplemented diet cohorts displayed significant shifts 
across the sampling times whether they were challenged or not (AMOVA test, at 


















































Figure 6.20 Relationship between bacterial communities’ composition is affected by diet/infection interaction. Communities 
subset by age. R2= 0.56. AMOVA test results showed that no significant shift was detected between G3 and G4 at 2 and 4 dpi following 
Salmonella colonisation, however, significant shifts in microbiota composition were observed at 8 and 15 dpi between G3 and G4 (AMOVA 
test, p-value = 0.004 and 0.001 respectively).
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LEfSe identified the most differentially abundant taxons between control and 
GOS diets for Salmonella colonised or non-colonised caecal microbiota. The results 
are shown in Figures 6.21 (22 and 24 da) and 6.22 (28 and 35 da). At 22 da the 
non-colonised control diet birds (G1) were enriched with a high abundance of 
Lactobacillus (OTU0006, data not shown due to cut-off p-value <0.01 applied) and 
Lachnospiraceae_unclassified (mainly OTU0168). While ctl-sal groups were 
significantly enriched by Acidaminococcaceae_unclassified (OTU0009), 
Clostridiales_unclassified (OTU0081), Oscillibacter (OTU0068) 
Ruminococcaceae_unclassified (OTU0126), Megamonas (OTU0004), 
Lachnospiraceae_unclassified (OTU0230), Olsenella (OTU0109) and 
Bifidobacterium (Otu0010).  
Similarly, GOS diet (nonc) was dominated by a high abundance of 
Lachnospiraceae_unclassified (OTU0012, OTU0030, OTU0031), Eggerthella 
(Otu0036) and Clostridiales_unclassified (Otu0054). However, gos-sal birds were 
dominated by abundance of Acidaminococcaceae_unclassified (OTU0009) and 
Lactobacillus (OTU0039). 
 At 24 da old, non-colonised birds fed control diet (nonc) displayed high 
abundance of Lachnospiraceae_unclassified (OTU0042), Clostridiales_unclassified 
(OTU0037) and Blautia (OTU0043), whereas for Salmonella colonised birds fed 
control diet Acidaminococcaceae_unclassified (OTU0009) still remained dominant 
with the emergence of Bacteroides (OTU0033), Ruminococcaceae_unclassified 
(OTU0038, OTU0126) and Clostridiales_unclassified (OTU0047, OTU0267). The 
GOS fed birds (nonc) were dominated by Subdoligranulum (OTU0015); 
Lachnospiraceae_unclassified (OTU0059, OTU0225), while the gos-sal birds were 
enriched by Acidaminococcaceae_unclassified (OTU0009), 
Ruminococcaceae_unclassified (OTU0038), Oscillibacter (OTU0035); Lactobacillus 
(OTU0039) and Lachnospiraceae_unclassified (OTU0102). 
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At 28 da the microbiota of non-colonised control diet (ctl-nonc) birds showed 
a high abundance of Lachnospiraceae_unclassified (OTU0080) whilst the 
microbiota of Salmonella colonised birds fed control diet (ctl-sal) was dominated 
by Acidaminococcaceae_unclassified (OTU0009), Clostridiales_unclassified 
(OTU0054), Ruminococcaceae_unclassified (OTU0126) and Clostridium_XlVb 
(OTU0252). The microbiota of birds fed GOS diet exhibited a high abundance of 
Lactobacillus (OTU0022 not shown due to p-value >0.01) and 
Lachnospiraceae_unclassified (OTU0002) while Salmonella colonised GOS diet 
birds (gos-sal) groups recorded a higher abundance of Megamonas (OTU0004) 
Acidaminococcaceae_unclassified (OTU0009), Bifidobacterium (OTU0010), 
Bacteroids (OTU0033) and Faecalicoccus (OTU0141).  
At 35 da the caecal microbiota of non-colonised control diet (ctl-nonc) birds 
was dominated by Lachnospiraceae_unclassified (OTU0002, OTU0230, OTU0243), 
Clostridiales_unclassified (OTU0024), Clostridium_XlVb (OTU0067) and 
Clostridium_IV (OTU0181), whilst the microbiota of Salmonella colonised birds fed 
control diet (ctl-sal) demonstrated a high abundance of 
Acidaminococcaceae_unclassified (OTU0009) and Bacteroides (OTU0033). Several 
OTUs showed increases in abundance in the caecal microbiota among the non-
colonised GOS fed birds (nonc), including Anaerostipes (OTU0011), 
Clostridiales_unclassified (OTU0024) and Blautia (OTU0034), while the caecal 
microbiota of Salmonella challenged birds fed GOS diet showed persistence of the 


























































Figure 6.21 Comparison of microbial variations at the genus level, using the LEfSe 
for CH birds fed ctl and GOS diets Salmonella challenged and non-challenged birds 
at 22 and 24 da. LDA scores computed for express the differentially abundant of bacterial 
communities of birds fed ctl-nonc (orange bars), ctl-sal (red bars), GOS-nonc (green bars) 
and GOS-sal (grey bars). LEfSe illustrates which clades amongst detected OTUs that are 
statistically explain the greatest differences between bacterial population fed the different 
diets and reared in similar conditions. All representative OTUs subject to stringent cut off 
p-value 0.01 and LDA≥ 2.  
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Figure 6.22 Comparison of microbial variation at the genus level, using the LEfSe 
for CH birds fed ctl and GOS diets Salmonella challenged and non-challenged birds 
at 28 and 35 da. LDA scores computed for express the differentially abundant of bacterial 
communities of birds fed ctl-nonc (orange bars), ctl-sal (red bars), GOS-nonc (green bars) 
and GOS-sal (grey bars). LEfSe illustrates which clades amongst detected OTUs that are 
statistically explain the greatest differences between bacterial population fed the different 
diets and reared in similar conditions. All representative OTUs subject to stringent cut off 
p-value 0.01 and LDA≥ 2.  
 































































6.3 Discussion  
The prevalence of antibiotic resistance in foodborne pathogens like 
Salmonella is a major concern for public health (Nair et al., 2018). Therefore, more 
attention is required to control this pathogen in the animal food chain. The 
elimination of Salmonella from its hosts and food animals is difficult because they 
often serve as reservoirs of the pathogen, frequently without obvious pathogenic 
effects on the animal (Nair et al., 2018). Thus, preventing early colonisation of 
chicks by Salmonella is a key factor for reducing the incidence of Salmonellosis 
acquired from poultry (Hughes et al., 2017).  
This Chapter aimed to investigate the response of the caecal microbiota of 
birds fed prebiotic GOS to the carriage of Salmonella and antibiotic resistance 
cassettes embedded in class 1 integrons. This study may provide insights into 
using GOS for controlling Salmonella infection by modifying the structure of the 
gut microbiome of the bird and thereby the innate immune response which 
collectively could reduce the load of antibiotic resistance genes. 
It has been demonstrated that the GOS supplemented diet accelerates the 
clearance rate of Salmonella recovered from the caecal contents of birds at 8 days 
post colonisation compared to birds on a matched control diet that had not cleared 
(Figure 6.2). Azcarate-Peril et al. (2018) found that GOS can promote host 
resistance to Salmonella colonisation by promoting an advantageous microbiome 
structure by increasing the abundance of beneficial bacteria that accelerate 
clearance. Pourabedin et al. (2017) reported that diets supplemented with 
prebiotics like mannan-oligosaccharides (MOSs) and xylo-oligosaccharides (XOSs) 
significantly reduced (1.6 and 1.0 log10 CFU/g, respectively) chicken caecal 
colonisation by S. Enteritidis. Another study by Tanner et al. (2014) also found 
that GOS and fructo-oligosaccharides (FOS) reduced S. Typhimurium numbers in 
vitro when cultured in proximal colon conditions of pigs (38 C, pH 6.0, retention 
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time 9 h, and anaerobiosis) in combination with the probiotic Bifidobacterium 
thermophilum RBL67.  
Translocation of Salmonella from the intestine to the liver and spleen is an 
established occurrence in chickens (Turnbull and Snoeyenbos, 1974). The results 
show translocation of Salmonella started by 2 dpi for both diets and its level was 
reduced by 8 dpi in liver and spleen samples with a greater percentage in spleen 
compared to liver. Hughes et al. (2017) demonstrated that S. Typhimurium (S.T) 
was present in chicken liver of a few chickens sampled at 4 and 12 dpi on a GOS 
supplemented diet, with no significant difference (p= 0.05) in the counts of S.T 
positive liver samples between the birds fed the control diet and those fed the 
prebiotic. However, the S. Enteritidis was detected in 7/8 birds at 1 dpi, 3/8 at 4 
dpi, and was undetectable by 7 dpi in birds fed prebiotic GOS, whilst for birds fed 
the control diet S.E was determined in 8/8 birds at 1 dpi, 4/8 at 4 dpi, 2/8 at 7 
dpi, and then undetectable by 12 dpi. 
Relman and Lipsitch (2018) demonstrated that ARGs tend to be more 
transferable than others across ecological niches and habitats, with increasing 
likelihood of sharing these ARGs recovered from animal farms and human food 
with human isolates. In this context, the carriage of AR genes recovered from 
caecal contents of Salmonella colonised birds is significantly greater than non-
colonised birds reared under similar conditions (χ2 p = 0.001). The inclusion of 
dietary GOS significantly reduced the presence of ARGs in the Salmonella 
challenged birds (χ2 p = 0.004). 
HGT adds an important dimension to the transfer of antibiotic resistance 
genes (ARGs) to multiple unrelated pathogens (Lerminiaux and Cameron, 2019) 
elucidated that both transmissible elements and HGT have contributed to the 
emergence of antibiotic resistance originating in the 1960s. Based on model 
laboratory experiments on the dissemination of ARGs it has become clear that 
commensals can become donors, recipients, and reservoirs of ARGs (Shoemaker 
et al., 2001). It was apparent the presence of Salmonella induced the prevalence 
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of ARGs although the colonising Salmonella did not possess the class 1 integron 
or the integrase. 
Trimethoprim resistance coliforms displayed a significant reduction at 2 and 
4 dpi in GOS-sal group (G4) compared to the control Salmonella colonised group 
(G3). This finding was in accordance with the integrase copy number, which 
exhibited a significant reduction at 2 dpi in GOS-Salmonella groups compared to 
the ctl-Salmonella (p-value 0.004). Prebiotic GOS brought about a significant 
reduction in integrase copy number, which was compatible with decrease 
expansion of trimethoprim resistance bacteria achieved at 2 and 4 dpi but these 
differences were not apparent thereafter, likely as a result of removing the GOS 
supplementation at 22 da.  
Surveys suggest 88% of poultry sourced S. Enteritidis are resistant to 
multiple antimicrobials such as ampicillin, nalidixic acid, and tetracycline, with high 
prevalence rates observed in hatching eggs, litter, feed, drinkers, bird rinse and 
caeca (Al-Zenki et al., 2007). However, in the work described here we did not 
observe the trimethoprim resistance gene (dfrA) to be transferred to colonising 
Salmonella despite an increase in the ARG load. There are two possible hypotheses 
that may explain why the trimethoprim resistance gene (dfrA) carried on a class 
1 integron was not transferred to Salmonella. The first hypothesis is simply that 
as most studies report that young birds carry high loads of AR genes and this load 
decreases with age (Diarra et al., 2007;Braykov et al., 2016) so in this study the 
infection occurred too late at 20 da, for lateral gene exchange to occur. 
Nevertheless, at 2 dpi the integrase copy number in the control birds challenged 
with Salmonella was high but declined with age in support of the hypothesis that 
ARGs decrease as the microbiota matures. Ijaz et al. (2018) reported that the 
intestinal contents of early-stage birds were dominated by the Proteobacteria 
phylum (3 da) and showed a general reduction up to 7 da. This finding also could 
suggest that there is a possible association between high level of ARGs in young 
birds and high abundance of Proteobacteria phylum at this stage. Furthermore, 
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Rychlik (2020) elucidated that E. coli is a ubiquitously distributed facultative 
anaerobic bacteria which can readily survive in the environment to colonise newly 
hatched chicks. Hence, the environmental resistome is likely to be involved in the 
dissemination of resistance. In this experiment birds were kept under biosecure 
conditions so environmental exposure was minimised. 
The second possible explanation is based on the observations of Bythwood 
et al. (2019) who explained  that antimicrobial resistance in Salmonella relies on 
resistance genes acquired from the environment. Therefore, transfer of 
antimicrobial resistance genes is dependent on cell contact (Sieckmann et al., 
1969) with another cell provided by a conjugative genetic element with a donor 
because Salmonella are not naturally transformable (Lorenz and Wackernagel, 
1994). Additionally, Bythwood et al. (2019) stated that the antibiotic resistance 
donor’s population size is an important factor, affecting antimicrobial resistance in 
Salmonella. Moreover, they studied the impact of antimicrobial administration on 
prevalence of antimicrobial resistant Salmonella in chickens by colonising chickens 
with Salmonella and E. coli carrying a ceftiofur resistance plasmid for determining 
how the administration antibiotics impacted resistance in E. coli and Salmonella. 
The group found increasing levels of streptomycin resistance in E. coli. However, 
the impact was minimal on Salmonella, leading to the conclusion that other factors 
may significantly govern the prevalence of AMR Salmonella in chickens. 
Nevertheless Salmonella have been isolated from the poultry environment with 
tendency to harbour class 1 integrons (Bass et al., 1999;Goldstein et al., 2001), 
which are associated with diverse resistances genes including those conferring 
resistance to β-lactams, phenicols, sulfonamides, aminoglycosides, and 
quaternary ammonium compounds (Lu et al., 2003b;Nandi et al., 2004;Smith et 
al., 2007). It is possible that the host immune response directed at Salmonella 
and donor organisms may reduce the frequency of integrase mobility in Salmonella 
and reduce the rate of HGT. 
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The metagenomic analysis of 16S RNA at class level revealed that non-
challenged groups were characterised by a relatively high abundance of Clostridia, 
with overall mean of 84.18% in ctl-nonc birds (G1) and 83.27% in GOS-nonc 
group (G2) (Figure 6.13), where most are unclassified species of the family 
Lachnospiraceae. While the Salmonella challenged groups are characterised by 
decline in abundance of Clostridia, with overall mean 69.92% for ctl-sal (G3) and 
55.79% in GOS-sal (G4). The groups feature a high abundance of Negativicutes 
(Megamonas), with an overall mean of 12% for ctl-sal compared to 27.68% for 
GOS-sal. It is hypothesised that the clearance/reduction of Salmonella in GOS-sal 
is associated with the expansion of the Negativicutes, which only emerge in the 
Salmonella challenged groups. The interaction with GOS in the Salmonella 
colonised birds appears to boost Negativicutes abundance and Actinobacteria by 
8 dpi compared to (ctl-sal) control diet challenged by Salmonella. These significant 
increases arise at the expense of Clostridia and Gamma-Proteobacteria, where a 
reduction in the latter may reduce the transfer of ARGs. Polansky et al. (2016) 
pointed out that Megamonas was one of the main propionate producing 
microorganisms in the Firmicute phylum and could encode enzymes that 
contribute to melibiose and alanine metabolism. Megamonas expressing alanine 
dehydrogenase can produce ammonia leading to a rise in the pH of the caecal 
contents and affect the metabolism of host epithelial cells and other members of 
the microbiota (Davila et al., 2013;Polansky et al., 2016). Oakley et al. (2014) 
attributed a high abundance of Megamonas, Helicobacter, and Campylobacter 
bacteria to the presence of hydrogenase, which seems to stimulate the production 
of SCFAs in the caecum. Consequently, SCFAs raise osmosis in the lumen of the 
intestine and indirectly stimulate the response of macrophages to modulate the 
immune system (Patel and Goyal, 2012). Furthermore, Polansky et al. (2016) 
noted that SCFAs negatively influence the expression of the virulence factors of 
bacterial pathogens.  
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Megamonas may decrease the availability of oxygen in the GOS-sal birds 
which will have an effect on the growth of Salmonella and accelerate clearance in 
GOS-sal over ctl-sal. The avian gut plays vital role in the control of the innate 
immune system that can disrupt cell membranes of various enteric pathogens and 
eliminate infection by producing antimicrobial peptides (β-defensins). This 
interaction between gut microbial communities and host innate immune system 
can stimulate adaptive immune response via either be B-cell dependent or T-cell 
dependent (Pan and Yu, 2014), and properly involves in the development and 
homeostasis of immune system (Oakley et al., 2014) that are negatively affected 
by antibiotic growth promotors (Kumar et al., 2018). Consequently, the gut 
microbial community contributes in exclude pathogenic taxa, ferment complex 
polysaccharides, and provide the host energy in the form of metabolizable volatile 
fatty acids. 
Analysis of the α-diversity of the caecal microbiome demonstrates that α-
diversity was significantly reduced at 35 da in gos-sal birds compared to ctl-sal 
(Inverse Simpson index: p-value =0.0023; Figure 6.19A), and similarly compared 
to gos-nonc at 22 and 35 da (Inverse Simpson index: p < 0.026, 0.0011 
respectively; Figure 6.19A). Community richness (Chao index) was not 
significantly different through to 28 da between the infected groups fed control or 
GOS diet. However, at 35 da the richness was reduced in GOS-sal group (Chao 
index p-value 0.011, Figure 6.19B). This observation could be accomplishing by 
interaction between GOS and Salmonella that changing in the intestinal microbiota 
due to overgrowth of Negativicutes and reduction of Clostridia.  
Analysis of microbiota composition among the different groups using LEfSe 
demonstrated a high abundance of Acidaminococcaceae_unclassified (OTU0009) 
across all sampling points in ctl-sal birds with Clostridiales _unclassified OTU and 
Bacteroides (OTU0033). Acidaminococcaceae _unclassified dominated at 2 and 4 
dpi while Megamonas dominated at 8 and 15 dpi. Veillonellaceae (Megamonas) 
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and Acidaminococcaceae (Acidaminococcaceae _unclassified) belong to the class 
Negativicutes. These families belong to Gram-positive Firmicutes but have 
acquired genes responsible for the biosynthesis of cell wall components similar to 
Gram-negative bacteria, and are strict anaerobes non-spore forming bacteria 
(Rychlik, 2020). Therefore, the predominant growth of representative members of 
the Negativicutes maintains the environment strictly anaerobic free of alternative 
electron acceptors like nitrogen or sulfate, which could prevent the overgrowth of 
E. coli or Salmonella by limiting the availability of the substrates for effective 
anaerobic metabolism (Rychlik, 2020). 
 
6.4 Conclusion 
By investigating the conditions that produce mobility and horizontal transfer 
of ARGs in the gut microbiota, new approaches could be adopted aimed at reducing 
AMR (Hegde et al., 2016). However, the dynamics of transferring genes that confer 
antibiotic resistance are still not well understood (Lerminiaux and Cameron, 2019). 
Manipulation of gut microbiota by administration or selection of probiotic 
organisms may reduce antibiotic resistant populations via displacement or 
exclusion of the resistant organisms. In this context, galacto-oligosaccharides 
(GOS) may modify the structure of the gut microbiome and contribute to control 
the impact of pathogen (Salmonella) colonisation and mitigate the spread ARGs. 
At 2 and 4 dpi the count of trimethoprim resistant coliforms recovered from 
the microbiota of gos-sal (G4) were significantly reduced compared to ctl-sal (G3). 
This reduction did not persist in birds older than 24 da since the GOS 
supplemented feed was halted at 20 da due to the relative commercial cost of 
feeding larger birds. The integrase copy number for gos-sal also exhibited a 
significant reduction at 2 dpi suggesting at least one mechanism by which ARGs 
are disseminated. Examination of the GCs recovered from the caecal contents of 
Salmonella colonised birds demonstrated a significantly greater prevalence than 
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non-colonised birds. Dietary GOS significantly reduced the presence of ARGs in 
the Salmonella challenged birds 
The study has demonstrated that both Salmonella and GOS diets influence 
the structure of the gut microbiome. Prebiotic GOS enhances the abundance of 
specific taxonomic OTUs. These important changes result in faster clearance of 
Salmonella infection in GOS-fed birds over control birds and in doing so displaces 
Proteobacteria that carry class 1 integrons and have the potential to disseminate 
ARGs. Specifically, treatment with the GOS resulted in a significant increase of 
Negativicutes on expense of Clostridiales thereby restricting the abundance of 











































7.1 introduction  
Recently, developments in next-generation DNA sequencing technologies 
have facilitated the tracking of outbreak resistant organisms and revolutionised 
the number of bacterial whole-genome sequences. Analysing these data has 
enabled the fundamental characterisation of bacterial pathogens and provided 
opportunities to study the evolution of resistance. Molecular analyses of multi-
drug resistant bacteria indicate the spread of resistance can be attributed to the 
acquisition of pre-existing determinants followed by amplification as a response to 
selection. Furthermore, sequences of many mobile genetic elements (MGEs) and 
plasmid backbone segments are highly conserved with low sequence errors. This 
feature has enabled the identification of variation between analogous plasmids 
that are epidemiologically or functionally important (Partridge et al., 2018).  
Horizontal gene transfer plays vital role in the acquisition of new features, 
such as pathogenicity, antibiotic resistance and support the tremendous adaptive 
potential of bacteria (Partridge et al., 2018).  The horizontal transfer of resistance 
genes can arise from plasmids or from within the bacterial chromosome. 
Resistance gene transfer mediated by plasmids is the most effective type of 
transmission that can occur at high frequency and involve the simultaneous 
transfer of multiple resistance genes (Carattoli, 2003). The process of capturing, 
accumulating, and disseminating resistance genes often features mobile genetic 
elements (MGE) in promoting intracellular DNA mobility such as mobility from the 
chromosome to a plasmid or between plasmids.  
Insertion sequences (IS) and transposons (Tn) are discrete DNA modules 
that are capable of randomly migrating themselves (and associated resistance 
genes) to new locations in the same or different DNA segments within a single 
cell. Integrons use site-specific recombination to transfer resistance genes 
between defined sites. The frequent presence of these MGE types in many copies 
and at various positions in genomes, can facilitate homologous recombination. 
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Thus, interactions between the different types of MGE promoting the rapid 
evolution of different multi-resistant pathogens that the encounter of antimicrobial 
chemotherapy (Partridge et al., 2018). 
Metagenomics have helped to understand the drivers behind the functional 
selection of ARGs in genetic exchanges between various microbial species (De la 
Cruz and Davies, 2000;Shoemaker et al., 2001;Lester et al., 2006) and have also 
recognized that ARGs exist in bacteria obtained from the environment that have 
not been exposed to antibiotics (D’Costa et al., 2011;Moore et al., 2013). Ongoing 
work has revealed the mechanistic features of emerging antibiotic resistance in 
bacteria, and their reservoirs from diverse microbial communities (Danzeisen et 
al., 2011;Durso et al., 2011;Andersson and Hughes, 2012). These studies have 
facilitated tracking of new antimicrobial resistance from their origins to pathogenic 
bacteria (Solberg et al., 2006;Van Hoek et al., 2011;Hegde et al., 2016). 
The aim of this Chapter is to characterise the types of mobile genetic 
elements as vehicles of class 1 integrons, and to associate OTUs observed in the 
chicken gut microbiota with the prevalence of the integrons. Finally, to compare 
the observations made from plasmid sequences with pure bacterial cultures of 













7.2 Results  
In order to study the boundaries of class 1 integrons and the types of mobile 
genetic elements they are located in, individual bacterial isolates carrying class 1 
integrons with an embedded dfrA1 gene (GCs-B) were selected. The process of 
selecting single cell colonies from trimethoprim resistance plates was carried out 
during viable counting of trimethoprim resistant bacterial populations in Trial 1 
throughout all sampling points (22, 24, 28 and 35 da). Approximately 200 
bacterial isolates were collected from biosecure housed birds that were infected 
and non-infected by Salmonella and fed either the control or GOS diet. From these 
35 isolates were randomly selected (Table 7.1), single colony purified and then 
the DNA extracted using the GenElute bacterial Genomic DNA kit (Chapter 2, 
section 2.5.2.1). Three different PCRs were performed to characterise the isolates: 
first, 16S rRNA gene amplification and sequencing was carried out to avoid picking 
similar bacteria (Figure7.1), second the detection of class 1 integrons (Figure 7.2), 
and third long range PCR aimed to detect the GC sequence environment (Figure 
7.3). Based on these results 6 isolates were selected and subjected to whole 
genome sequencing using the illumina MiSeq platform. Plasmid DNA sequences 
were identified from isolate numbers 19 and 24 carrying GC-B-2 (dfrA1 and 
aadA1), while bacterial isolate 38 encoded GC-B-1 (dfrA1, hypothetical protein 
and aadA1). Isolates AA_2 and 6 contained different GCs. The results are 









































Sample No ID Trial IntI1 GCs 
1      G4 pooled samples biosecure positive negative 
2 G4-01 biosecure positive negative 
3 G3-04 biosecure positive negative 
4 G4-12 biosecure positive negative 
5 G4-13 biosecure negative negative 
6 G3-03 biosecure positive negative 
7 G4-06 biosecure positive negative 
8 G1-26 biosecure negative negative 
9 G3-21 biosecure negative negative 
10 G4-22 biosecure negative negative 
12 G4-21 biosecure negative negative 
13 G1-14 biosecure positive negative 
14-01 G3-01 biosecure negative negative 
14-02 G3-01 biosecure negative negative 
16 G2-12-1 biosecure negative negative 
17 G2-12-2 biosecure positive negative 
18 G4-22-2 biosecure positive positive 
19 G1-22-4 biosecure positive positive 
20 G2-35-1 biosecure negative negative 
21 G1-35-4 biosecure negative negative 
22 G4-22-4 biosecure positive positive 
23 G3-35-4 biosecure positive negative 
24 G3-24-6 biosecure positive positive 
25 G3-28-6 biosecure negative negative 
26 G1-35-3 biosecure negative negative 
27 G3-24-1 biosecure positive positive 
28 G3-35-6 biosecure negative negative 
29 G4-35-6 biosecure negative negative 
30 G3-28-1 biosecure negative negative 
31 G3-28-3 biosecure negative negative 
32 G4-24-5 biosecure negative negative 
36 G3-22-3 biosecure positive negative 
37 G2-28-4 biosecure negative negative 
38 G4-28-6 biosecure positive positive 














Figure 7.1 PCR amplicon products of 16S RNA genes obtained from trimethoprim 
resistant bacterial isolates. Specific primers (Hugerth et al., 2014) were used to target 
V3-V4 region in chicken caecal DNA samples electrophoresed on 1% TAE agarose gel. 
Row 1: Lane 1 100 bp ladder (BioLab), Lane 2 int1 Ravi sample 01, Lane 3 16S RNA sample 
02, Lane 4 16S RNA sample 03, Lane 5 16S RNA sample 04, Lane 6 16S RNA sample 05, 
Lane 7 16S RNA sample 06, Lane 8 16S RNA sample 07, Lane 9 16S RNA sample 08, Lane 
10 16S RNA sample 09, Lane 11 16S RNA sample 10, Lane 12 16S RNA sample 12, Lane 
13 16S RNA sample 13, Lane 14 int1 Ravi sample 14-1, Lane 15 16S RNA sample 14-2, 
Lane 16 16S RNA 16, Lane 17 16S RNA sample 17, Lane 18 16S RNA sample 18, Lane 19 
16S RNA sample 19, Lane 20 16S RNA -ve control.     
                                                             
Row 2: Lane 100 bp ladder (BioLab), Lane 2 16S RNA sample 20, Lane 3 16S RNA sample 
21, Lane 4 16S RNA sample 22, Lane 5 16S RNA sample 23, Lane 6 16S RNA sample 24, 
Lane 7 16S RNA sample 25, Lane 8 16S RNA sample 26, Lane 9 16S RNA sample 27, Lane 
10 16S RNA sample 28, Lane 11 16S RNA sample 29, Lane 12 16S RNA sample 30, Lane 
13 16S RNA sample 31, Lane 14 16S RNA sample 32, Lane 15 16S RNA sample 36, Lane 
16 16S RNA 37, Lane 17 16S RNA sample 38, Lane 18 16S RNA sample 39, Lane 19 16S 
RNA +ve control, Lane 20 int1 Ravi -ve control.                                                                             
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Figure 7.2 Agarose gel of amplification products of PCRs using Ravi primers. The 
Figure shows PCRs products of the 546 bp target genes of class 1 integrase gene (intl1 
Ravi) obtained from DNA of selected coliforms colonies that picked from broiler caecal DNA 
samples reared in bio-secure condition and electrophoresed on a 1 % TAE gel. 
Row 1: Lane 100 bp ladder (BioLab), Lane 2 int1 Ravi sample 01, Lane 3 int1 Ravi sample 
02, Lane 4 int1 Ravi sample 03, Lane 5 int1 Ravi sample 04, Lane 6 int1 Ravi  sample 05, 
Lane 7 int1 Ravi  sample 06, Lane 8 int1 Ravi  sample 07, Lane 9 int1 Ravi  sample 08, 
Lane 10 int1 Ravi  sample 09, Lane 11 int1 Ravi  sample 10, Lane 12 int1 Ravi sample 13, 
Lane 13 int1 Ravi  sample 13, Lane 14 int1  Ravi  sample 14-1, Lane 15 int1 Ravi  sample 
14-2, Lane 16 int1 Ravi  16, Lane 17 int1 Ravi sample 17, Lane 18 int1 Ravi sample 18, 
Lane 19-ve control, Lane 20 int1 Ravi +ve control.                                                                         
Row 2: Lane 100 bp ladder (BioLab), Lane 2 int1 Ravi  sample 19, Lane 3 int1 Ravi sample 
20, Lane 4 int1 Ravi  sample 21, Lane 5 int1 Ravi  sample 22, Lane 6 int1 Ravi  sample 23, 
Lane 7 int1 Ravi  sample 24, Lane 8 int1 Ravi  sample 25, Lane 9 int1 Ravi  sample 26, 
Lane 10 int1 Ravi sample 27, Lane 11 int1 Ravi  sample 28, Lane 12 int1 Ravi  sample 29, 
Lane 13 int1 Ravi  sample 30, Lane 14 int1 Ravi  sample 31, Lane 15 int1 Ravi  sample 32, 
Lane 16 int1 Ravi  36, Lane 17 int1 Ravi sample 37, Lane 18 int1 Ravi sample 38, Lane 19 
int1 Ravi sample 39, Lane 20 int1 Ravi -ve control.   
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Figure 7.3 Agarose gel of PCR amplification of GCs using primer ntf2/qcr2. The 
primer pair targets gene cassettes isolated from DNA of selected coliforms colonies picked 
from biosecure condition chicken caecal DNA samples electrophoresed on 0.8% TAE 
agarose gel with 3 min annealing time. 
Row 1: Lane 1 KB bp ladder (BioLab), Lane 2 GCs sample 01, Lane 3 GCs sample 02, Lane 
4 GCs sample 03, Lane 5 GCs sample 04, Lane 6 GCs sample 05, Lane 7 GCs sample 06, 
Lane 8 GCs sample 07, Lane 9 GCs sample 08, Lane 10 GCs sample 09, Lane 11 GCs sample 
10, Lane 12 GCs sample 13, Lane 13 GCs sample 13, Lane 14 GCs sample 14-1, Lane 15 
GCs sample 14-2, Lane 16 GCs 16, Lane 17 GCs sample 17, Lane 18 sample 18, Lane 19-
ve control, Lane 20+ve control.                                                                            
 
Row 2: Lane 1 KB bp ladder (BioLab), Lane 2 GCs sample 19, Lane 3 GCs sample 20, Lane 
4 GCs sample 21, Lane 5 GCs sample 22, Lane 6 GCs sample 23, Lane 7 GCs sample 24, 
Lane 8 GCs sample 25, Lane 9 GCs sample 26, Lane 10 GCs sample 27, Lane 11 GCs sample 
28, Lane 12 GCs sample 29, Lane 13 GCs sample 30, Lane 14 GCs sample 31, Lane 15 GCs 
sample 32, Lane 16 GCs 36, Lane 17 GCs sample 37, Lane 18 sample 38, Lane 19 sample 
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BlastN analysis of the plasmid sequence data revealed that a 148,956 bp 
plasmid of isolate AA_2_contig_2 showed 99.99% sequence identity to Escherichia 
coli strain G749 plasmid pG749_1 (Genbank Acc. No. CP014489.1) and 100.00% 
sequence identity to E. coli strain 2009-52 plasmid pSDJ2009-52F (Genbank Acc. 
No. MH195200.1). While a 45,609 bp plasmid of isolate AA_6 exhibited 99.89% 
sequence identity to plasmids from multiple Salmonella Typhi and the 
chromosomes of Proteus mirabilis (Genbank Acc. No. CP015347.1) and E. coli 
(Genbank Acc. No. CP057176.1). The 139,294bp plasmid of AA_19 _contig_103 
showed 100.00% sequence identity to E. coli strain CFS3273 plasmid pCFS3273-
1(Genbank Acc. No. CP026933.2). Similarly, the 175,545 bp of isolate 
AA_24_contig_1 showed high sequence similarity (99.99%) to E. coli isolate 2-
101 plasmid p2-101(Genbank Acc. No. CP053786.1) and E. coli plasmid 
pESBL20150178 (Genbank Acc. No.MK181568.1), as well as the 105,518 bp of 
the bacterial isolate AA_25_contig_35 also displayed sequence similarity 99.99% 
and 100% to E. coli strain 13KWH46 plasmid p13KWH46-2 and Escherichia coli 
strain CFS3313 plasmid pCFS3313-2 respectively (Genbank Acc. No. CP019252.1 
and CP026941.2). Whilst the 49,958 bp plasmid of isolate  AA_38 contig_5 is 
showing high similarity to Klebsiella pneumoniae TUM14373 pMTY14343_IncN 
DNA, with 99.92% sequence identity (Genbank Acc. No. AP018557.1) and 
Klebsiella pneumoniae strain C16KP0065 plasmid pC16KP0065-1 (Genbank Acc. 
No. CP052452) with 99.96% sequence identity. These data are summarised in 
Table 7.2. 
Annotated circular maps of all the plasmids found in the six bacterial isolates 




































































































Figure 7.4 A schematic circular representation map of plasmids found in six bacterial 
isolates carrying class 1 integrons. Dark green arrow highlighting conjugative genes, light 
green arrows pil genes, dark pink arrows mercury resistance genes, red and brown arrows 
transposons, light purple arrows class 1 integron gene, dark blue arrows antibiotic resistance 
genes, orange arrows colicin resistance gene. All grey arrows hypothetical protein (HP) and other 





The plasmid isolated from E. coli (AA_2) encodes two class1 integrase 
sequences at different locations (127,769-128,782 and 140,116-141,420). 
Upstream of the first integrase gene there is a member of the Tn3 transposase 
family and colicin transporter. While downstream of this integrase gene there are 
trimethoprim resistance dfrA5 gene, two IS6 family transposases flanking class A 
beta-lactamase resistance, and two aminoglycoside resistance genes. These are 
followed by the second integrase sequence and several virulence associated genes 
including mercury resistance genes, tra and pili genes involved in the conjugal 
transfer of resistance genes, and antimicrobial resistance Mig_14 genes, macrolide 
transporter and resistance-nodulation-division (RND) transporter. This plasmid 
belongs to the IncFIB group (Genbank Acc. No. AP001918) with 98.39% identity 
identified by plasmid finder 2.1. 
BlastN analysis of the 45,609bp plasmid isolated from Proteus mirabilis 
(AA_6) contains one copy of a class 1 integron. Upstream of this structure there 
are two IS6 family transposases flanked by beta lactamase resistance, strA and 
strB (streptomycin resistance) and sul2. Downstream of intI1 there are genes for 
dfrA1, emrE (Ethidium bromide-methyl viologen resistance) and sul1. Followed by 
many mobilizable elements such as Tn21 module (transposon Tn21 modulator 
protein, Tn21 resolvase and transposase Tn21), IS1 transposase and IS5 
transposase and cat gene (chloramphenicol resistance). However, the plasmid 
does not carry conjugative apparatus and belongs to IncQ1 with 100% sequence 
identity (Genbank Acc. No. M28829). 
BlastN analysis of the plasmid sequence from AA_19 revealed a class 1 
integron (2597/3610) containing GC-B-2 is embedded between IS1 transposase 
family upstream and IS21 family transposase (IS1326) downstream of the 
integrase system. This is followed by a mercury resistance module, tetA gene 
(tetracycline resistance) and Tn3 family transposase. The plasmid encodes several 
transposase genes, however only two conjugative genes were identified (traH and 
incomplete gene encoding a putative conjugative transfer protein). The plasmid 
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could be categorised as p0111 with 98.53% identity (Genbank Acc. No. AP010962) 
by plasmid finder 2.1.  
The boundaries of the class 1 integron that encodes GC-B-2 from 
AA_24_conting_1 feature a Tn21 modulator protein and IS110-like element 
ISEc32 family transposase upstream and IS21-like element IS1326 family 
transposase downstream. The integrase system is followed by mercury resistance 
genes and several conjugative (tra and trb operons) and pili encoding genes. This 
plasmid also possesses colicin 1B and V encoding genes (cvaA, cvaB and cvaC) 
and belongs to IncFII (Genbank Acc. No. AY458016).    
While the plasmid isolated from AA_25 carries a class 2 integron (39,959-
40,936 bp) with a different arrangement in the gene cassettes. This GC contains 
dfrA1 (trimethoprim resistance), sat2, aadA (streptomycin resistance) and bla_1 
(Beta-lactamase) genes. Upstream of this structure are a Tn3 transposase 
(32,613-35,618) and sul2 gene (30,885-31,781). This plasmid contains colicin E1 
and tra and trb conjugative genes. The plasmid also features a phage integrase 
XerC gene with no imbedded GCs (14,017-14,796). The plasmid is IncI1-
I(Gamma) with 99.3% sequence identity (Genbank Acc. No. AP005147). 
Klebsiella pneumonia AA38 contains a plasmid of 49,958 bp, which encodes 
GCsB-1(dfrA1, ORF1, aadA24). Downstream of the class 1 integron is IRT of 
Tn402-like transposon tni module inserted in a IS6100 family transposase. The 
IRT ends of Tn 402-like transposons were identified in KY020154.1 (100% 
identity). The 765 bp at 8946-9710 bp of contig 5 shown similarity to transposable 
element IS6100 that was identified in BlastN with 100% coverage in CP052359.1 
and KY020154.1. Moreover, there was another 267 bp nucleotide sequence of the 
transposable element IS1 (12,757-13,023)  with 100% identity in CP052359.1. 
This conjugative plasmid encodes cluster of conjugative elements and can be 
ascribed to the IncN plasmid group based on with 99.81% identity (Genbank Acc. 
No. AY046276). The plasmid also encodes tetracycline resistance and several tra 




Table 7.2 Summary and comparative plasmid sequence analysis by BlastN of bacterial isolates picked from broiler caecal content reared in 























AA_2 E. coli 148,956 IncFIB conjugative dfrA5/bla_1/ /sul1/aadA/merC 2 intI1 CP014489.1 99.99% 
AA_6 P. mirabilis 45,609 IncQ1 mobilizable  bla/strA/strB/sul2/dfrA1/EmrE/ sul1/cat 1 intI1 CP015347.1 99.89% 
AA_19 E. coli 139,294 p0111 mobilizable 
GC_B2(dfrA1/aadA1/qacEΔ1/sul1) 
merC/tetA 
1 intI1 CP026933.2 100% 
AA_24 E. coli 175,545 IncFII conjugative GC_B2(dfrA1/aadA1/qacEΔ1/sul1)/merC 1 intI1 CP053786.1 99.99% 





AA_38 K.pneumonia 49,958 IncN conjugative 
GC-B-1 
(dfrA1/HP/aadA1/qacEΔ1/sul1)/tetA 













Figure 7.5  Boundaries of integrase genes detected in plasmids from E.coli, P.mirabilis and K.pneumonia.  
Red arrows are transposons and IS sequences and transposon like elements, light purple class 1 integron while dark purple is class 2 integron, blue arrows 
are beta-lactamase resistance, light green tetracycline resistance, grey arrows are resistance genes embed in gene cassettes and dark pink are mercury 
resistance genes. Plasmid order 1- IncFIB (E. coli), 2- IncQ1 (P. mirabilis),3- p0111 (E. coli), 4- IncFII (E. coli), 5- IncI1-I (E. coli), 6- IncN (K. pneumonia). 
 
 
Tn3 intI1 dfrA5 IS6 bla_TEM_1 IS6 sul2 aadA TR aadA TR intI1 mer module  1 
IS1 IS6 sul2 strB   strA IS6 bla_TEM_1 IS6 sul1 dfrA1 intI1 Tn21 IS1 IS5 IS5 cat 2 
IS5 IS30 IS1 intI1 GC-B-2 IS21 mer module  tetA Tn3 3 
IS110 Tn21 intI1 GC-B-2 IS21 mer module  IS1 4 
bla_TEM_1 intI2 dfrA1 sat2 aadA     Tn3 sul2 TR 5 
Tn402 Tn402 IS6 GC-B-1 intI1 IS1 6 
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7. 3 Discussion  
The vital role of plasmids has been highlighted in the evolution and 
dissemination of bacterial ARGs among the most clinically important pathogens 
(Alekshun and Levy, 2007;Carattoli, 2013;San Millan, 2018). The main drivers of 
the spread ARGs in bacterial families such as Enterobacteriaceae and 
Enterococcaceae including some of the most important nosocomial pathogens, are 
conjugative plasmids (Vincent, 2003;Boucher et al., 2009;Rozwandowicz et al., 
2018). Analysis using BlastN of the six plasmids from caecal contents  cultured on 
Mac-03 medium supplemented with 20 mg/ml of trimethoprim revealed that four 
plasmids (AA_2, AA_24, AA_25, AA_38) that possessed a set of common genes 
that are predicted to play a role in plasmid replication, conjugative transfer, 
stability, and partition control clustered in functional modules. While two plasmids 
isolated from AA_6 and AA_19 are likely to be mobilizable (non-conjugative) 
plasmids as they do not encode conjugative genes however they do encode 
mobilizable and mobile genetic elements (transposase and IS). All plasmids carry 
genes encoding replication initiation protein (RepA or RepB or RepC or RepN) 
required for plasmid replication. Conjugative plasmids isolated from AA_2 and 
AA_24 contain more than 20 tra genes with  trb, pil genes and feature more than 
one rep genes per replicon. These plasmid are likely belonging to IncF plasmid 
group. Rozwandowicz et al. (2018) described IncF plasmid as the most common 
plasmid type from human and animal that it is frequently found in E. coli. Similarly, 
the current study found both plasmids were isolated from E.coli. They are also 
highlighted global association of IncF plasmid with the spread of ESBL genes 
(blaCTX-M-15) in human E. coli isolates of the ST131 and ST405 groups which 
was observed in the AA_2 plasmid.  
While AA_25 encodes 17 tra genes, 2 trb and 12 pil genes, AA_38 encodes 
only 11 conjugative tra genes. Plasmid AA_25 does not carry a class 1 integron, 
however it encodes dfrA1 embedded in a class 2 integron that belongs to the IncI1-
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I incompatibility group. This plasmid group are described by Carattoli (2009) as 
plasmids that produce type I pili making them susceptible to phage. Garcillán-
Barcia et al. (2011) stated that this group consist of low copy number, narrow-
host-range, and conjugative plasmids. The IncI1 plasmids are commonly detected 
in enteric bacteria from food animal sources and are linked to clinically relevant 
strains (Kaldhone et al., 2019). They are also known for their potential carriage 
and dissemination of ARGs among enteric pathogens (Wong et al., 2016;Mo et al., 
2017). For instance, several of the plasmids that showed association with the 
dissemination of resistance to ceftriaxone (an antimicrobial agent used for the 
control of severe Salmonella infections) have been reported to be IncI1 plasmids 
(Smith et al., 2015). 
Plasmid AA_38 found in K. pneumoniae could be placed in the IncN group 
and was found to encode GC-B-1 in addition to the tetA gene. A study conducted 
by Eikmeyer et al. (2012) isolated four novel plasmids, pRSB201, pRSB203, 
pRSB205 and pRSB206 from the final effluent of a municipal wastewater treatment 
plant, which were demonstrated to belong to the IncN incompatibility group. 
Plasmid AA_38 shows sequence similarity to the plasmid module present in 
pRSB201. Eikmeyer et al. (2012) indicated that IncN plasmids although possessing 
a limited host range are widespread. They pointed out that IncN plasmids need to 
be considered as important genetic elements involved in the dissemination of 
clinically relevant ARGs. They further highlighted the large variety of antibiotic 
resistance determinants associated with IncN plasmids include fluoroquinolones 
(nalidixic acid, ciprofloxacin, norfloxacin, ofloxacin, moxifloxacin), cephalosporins 
(cefotiam, cefotaxime, ceftazidime, cefepim), carbapenems (imipenem, 
meropenem), monobactams (aztreonam), fosfomycin, chloramphenicol and 
aminoglycosides (amikacin, tobramycin, netilmicin, gentamicin), indicating the 
plasmids of this incompatibility group are suitable vehicles for the incorporation of 
various resistance transposons, insertion sequences and integron gene cassettes 
containing resistance genes. However, Garcillán-Barcia et al. (2011) noted that 
274 
 
IncN plasmids are known as a broad-host range plasmids and that their copy 
number is controlled by iterons. Although IncN plasmids have ability to replicate 
in various Enterobacteriaceae, they are most frequently found in E. 
coli and Klebsiella pneumonia, where they are involve in  the dissemination of 
cephalosporin and carbapenem resistance (Carattoli, 2013;Blau et al., 2018). In 
the current study it found in Klebsiella pneumoniae with an identical GCs-B-1 that 
emerged from Salmonella infected birds.  
Plasmid AA_6 belongs to IncQ and for which conjugative genes are absent 
within the sequence. Rozwandowicz et al. (2018) described IncQ plasmid as a 
group of mobilizable elements with a medium-range copy number (4–12 
copies/cell). Even though, IncQ plasmids do not possess conjugation genes, they 
can be transmitted at a high frequency in the presence of a helper plasmid and 
have been successfully mobilized to a large number of gram-negative bacterial 
hosts (Rozwandowicz et al., 2018). Similarly, plasmid isolate AA_19 seems to be 
mobilizable plasmid.   
The association of antibiotic resistance and mercury resistance has been 
previously reported (Wireman et al., 1997). The current study indicated that 
plasmids AA_2, AA_19 and AA_24 isolated from E. coli carried mercury resistance 
loci with antibiotic resistance gene. Nguyen et al. (2019) stated that Pseudomonas 
aeruginosa and E. coli were the most frequently studied bacteria that showed co-
occurrence of resistance to many heavy metals and antibiotic classes. They also, 
proposed that the prevalence of heavy metals in the environment is likely to 
increase resistance to both heavy metals and antibiotics through co-resistance and 
cross-resistance mechanism.  
Sunde et al. (2015) indicated that class 1 integrons are usually considered 
as a component of transposons that allows them to move between different 
plasmids and between plasmids and the chromosome. Transposition into various 
plasmids groups may contribute to a further dissemination of the integron 
structure in the bacterial mapping that flanking DNA of integrons in the isolates. 
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The analysis of class 1 integrons boundaries show that three plasmids (IncFIB, 
p0111 and IncI1-I) carried different gene cassettes harboured integrase genes 
flaked by the Tn3 transposon family, while the integrase gene in the IncQ1 and 
IncFII plasmids were integrated in to a Tn21 transposon family member. Pal et al. 
(2017) described Tn21 as a Tn3 subfamily of transposable element embedded 
between the mercury resistance genes and the transposition genes (Pal et al., 
2017). Therefore, the association between the Tn3 transposon family and mercury 
resistance (often Tn21 or Tn1696 family), and the carriage of integrons has been 
widely detected (Gaze et al., 2011;Gillings et al., 2015). There are several reports 
of mercury-resistant Tn21 or Tn1696-related transposons which encode integrons, 
that themselves carry antibiotic and biocide resistance genes (Partridge et al., 
2001;Rosewarne et al., 2010;Pal et al., 2017). 
However, the integrase gene found in the IncN plasmid showed the presence 
of an IS6 transposon that flanked by IRt of the Tn402 module downstream of the 
integrase structure. Additionally, downstream of this structure another IS1 
transposon is present. It seems that the structure of Tn402 is incomplete. Stokes 
et al. (2006) reported that the presence of a complete structure is relatively rare, 
however, most of most class 1 integrons are associated with an incomplete 
transposition (tni) module.  Many studies on the origin of class 1 integrons 
highlight the possible early association between the ancestor of the Tn402 
transposon with a class 1 integrase and an attI1 site. This early association was 
raised because of the observation of the majority of class 1 integrons carry the 5'-
CS region at the same position (Toleman and Walsh, 2011;Domingues et al., 
2012). While the 3'-CS region has been proposed to be as consequence of a fusion 
of the qacE gene of the Tn402 transposon with the sul1 gene leading to partial 
deletion of the qacE gene; which happened at the same time as a deletion event 
in the transposition functions of the Tn402 transposon, causing a loss in self-
mobilization for this structure (Toleman and Walsh, 2011). Therefore, most class 
1 integrons are defective transposons (Brown et al., 1996;Domingues et al., 
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2012). Additionally, insertion sequences also play an important role in the 
dissemination of antibiotic resistance genes (Domingues et al., 2012). Several 
studies have reported class 1 integrons bounded on each side by an IS, which are 
mainly elements of the IS6 family (Domingues et al., 2012). In this study ISs were 
present in the plasmids featuring IS6, IS5, IS1 and IS3, as well as IS110 and 
IS21-like elements. The configuration of IS6 surrounding the blaTEM_1 was found 
in plasmids of incompatibility groups IncFIB and IncQ1 that were isolated from 
similar trial. Hendrickx et al. (2020) stated that the IS1 and IS3 transposase 
families are commonly detected in the K. pneumoniae plasmids. They found that 
IS1 family transposase was the most predominant among the plasmids and in 
multiple copies within plasmids. Likewise, IS1 was the most frequently detect in 
the current study. 
  
7.4 Conclusion  
Plasmids carry multidrug resistance determinants and the machineries 
required to transfer genes between bacteria. Therefore, the identification of 
plasmid characteristics in different bacterial hosts may provide fundamental 
knowledge regarding the historical and potential for transmission of ARGs. 
Molecular identification of plasmid and strain genotypes can distinguish whether 
the spread of ARGs are driven by an epidemic plasmid to different bacterial hosts 
or by clonal spread of bacterial organisms harbouring these plasmids with ARGs 
(Rozwandowicz et al., 2018). 
This study showed that all the plasmids recovered from broiler chickens 
harboured various GC types with E. coli a frequent carrier of plasmids could be 
categorised to the IncFIB, IncFII, IncI1-I, IncQ1, pO111, and IncN compatibility 
groups. The most representative GCs (B-2) type in identified in two isolates from 
biosecure housed. Most of the plasmids belong to incompatibly groups that have 
the potential to be major contributors to the propagation of ARGs within enteric 
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bacteria. Transposases and IS sequences are likely to play a major role in of the 













































GENERAL DISCUSSION AND FUTURE WORK
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8.1 General discussion  
The aims of this study, outlined in Chapter 1, were to increase knowledge of 
the prevalence and type of antibiotic-resistant bacteria in broiler chicken intestinal 
contents and to understand the effects of the prebiotic GOS on these populations.  
 
8.1.1 Prevalence of ARGs in during rearing in biosecure or commercial 
conditions 
The work described in Chapter 3 was to evaluate the prevalence of ARGs in 
broiler chickens reared under biosecure conditions and compare this to the 
prevalence in broiler chickens reared under commercial production conditions. 
Class 1 integrons were used as biomarkers for this purpose. The types of GCs 
present in the microbiota were determined by obtaining sequences of the 
conserved genes in the integron-integrase system. This showed that 99% of the 
bacterial populations in caecal contents samples from birds reared under biosecure 
conditions were positive for the IntI1 gene while 92.5% were positive for the same 
gene in birds reared under commercial conditions. Similar results were obtained 
by Che et al. (2019) who reported a 97% prevalence for the IntI1 gene in faeces 
from commercially farmed birds. For the qacEΔ1 gene that generally marks the 
opposite end of the integron to IntI1, 93.7% of birds reared under biosecure 
conditions were positive while 100% of birds reared under commercial conditions 
were positive. A high prevalence of this gene (100%) was reported by Enany et 
al. (2019) in E. coli isolates from diseased commercial birds and from 
environmental samples in Egypt. In this study 94.5% of the DNA samples from 
caecal microbiota was positive for sul1 resistance in biosecure housed birds to 
97.5% of commercial birds. Sulfonamide resistance genes (sul1 and sul2) are 
common in E. coli and Salmonella isolated from commercial pig and poultry 
sources (Kozak et al., 2009). 
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Having established a high prevalence of AMR genes in both groups of birds, 
the second stage of the work described in chapter 3 was the molecular 
characterisation of the GCs. Five different GC arrangements were discovered 
among birds reared under biosecure conditions whilst three GC arrangements were 
identified from commercial birds (Figure 3.7 and 3.11). Comparing the patterns 
between the two types of rearing conditions revealed that only two GCs shared a 
similar pattern of resistance (GCs-B-2 and GCs-C-1). The predominant 
discriminatory resistance GC in commercial birds was GCs-A (lincosamides, linF) 
with 75% prevalence, where no difference was observed in prevalence between 
the GOS and control diets. Interestingly the linF resistance gene was completely 
absent in the microbiota of birds reared under biosecure conditions. This finding 
suggests that mobility of this gene could potentially be attributed to selective 
pressure of antibiotics used for veterinary purposes in the commercial 
environment that is not encountered by birds reared under biosecure conditions. 
The use of lincosamides may be historic but resistance determinant persistent due 
to carriage in highly adapted bacteria colonising successive flocks. The GC B-2 
(dfrA1 and aadA1) type was frequently detected in the microbiota of birds reared 
under biosecure conditions (21.81%). Birds fed prebiotic GOS and infected with 
Salmonella were less likely to have the GC B-2 type in their microbiota (7.14%) 
than birds infected with Salmonella and fed control diet (96.4%). Non-infected 
birds also showed a difference in this type between GOS diet (60%) and standard 
diet (37%). The concept that prebiotic diets could diminish the gut “resistome” in 
humans is a relatively recent idea (Wu et al., 2016). The work described in this 
chapter highlights the potential of applying this strategy to chickens. However, the 
pattern for this particular GC type was not observed in commercially reared birds 
with the GC B-2 type being more prevalent in GOS fed birds (25%) than birds fed 
standard diet (20%). It was clear that the role of prebiotics in influencing the type 
and frequency of GCs was complex and required further study. Other differences 
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in GC types found between different diet and rearing conditions are discussed in 
Chapter 3. 
 
8.1.2 To what extend can the prebiotic GOS mitigate the load of ARGs 
present in the broiler chicken microbiome? 
To answer of this question, it was first necessary to estimate the base-line 
resistance of broiler caecal microbiota from birds fed standard diets. This was 
achieved using with trimethoprim resistance as a marker in populations of 
coliforms and the relative copy number of integrase genes in the population across 
time. Metagenomics was also applied to identify changes in the overall caecal 
microbiota composition with time. The results detailed in Chapter 4 follow the 
developmental changes of the broiler chicken caecal microbiota from birds fed 
standard control diet and reared under biosecure or commercial conditions. This 
revealed that resistance load was highest in young biosecure housed birds. 
Integrase copy number decreased with time. However, the ratio of trimethoprim 
resistance to sensitive members of the population increased with age. This 
suggests that dfrA gene may or may not embedded in integrase system. The 
diversity of representative OTUs in the caecal microbiota was higher in commercial 
birds than biosecure reared birds, which was probably due to their greater 
exposure to the environment.  
The work described in Chapter 5 focussed on the impact on antibiotic 
resistance by feeding prebiotic GOS diet. This was assessed using metagenomics 
to compare the microbiota of birds fed prebiotic with control birds fed a standard 
control diet. To focus on prevalence of antibiotic resistance, the abundance of 
Proteobacteria (Enterobacteriaceae) was specifically targeted. The effect of rearing 
system (biosecure or commercial) was also assessed. In addition to the 
metagenomic approach, trimethoprim resistance and total coliforms were 
enumerated, and the ratio of resistance in the population estimated. Integrase 
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copy number was also assessed and showed a significant reduction at 22 da (p 
value = 0.015) in birds fed GOS diet compared to those fed control diet when the 
direct impact of GOS supplementation would be most effective as the GOS 
supplementation was halted at 20 da.  
The abundance of Proteobacteria in birds fed GOS diet and reared under 
biosecure conditions was reduced compared to those fed the control diet at 22-24 
da. However, this effect did not continue in later sampling points. It suggests that 
dietary GOS supplementation in a biosecure environment may suppress AR in early 
life, which may reduce dissemination of these genes even though the effect did 
not persist. Metagenomic analysis of the microbiota of GOS fed birds compared to 
that of birds fed the control diet at 22 da displayed differential abundance 
dominated by members of the Firmicutes phylum that included Lachnospiraceae 
ssp OTU0032 and OTU0030, Enterococcus OTU0078 and members of the 
Clostridiales_unclassified OTU0138. The increased abundance of these OTUs may 
contribute to the decrease in Proteobacteria, and as a consequence the prevalence 
of GCs. Further work would be required to identify exactly which members of the 
population were responsible for the reduction in GC at 22 da. Yang et al. (2008) 
and Chee et al. (2010) reported that administration of dietary prebiotics might 
support young broilers intestinal microbiota by boosting the abundance of 
Lactobacilli and Bifidobacteria and reducing the coliform titres. The work described 
here supports the idea that targeting young birds with prebiotic could be an 
effective measure for reducing AMR. 
The proportion of Proteobacteria was higher in commercial birds than 
biosecure birds. Comparison of alpha-diversity showed that both inverse-
Simpsons and richness indices were higher in commercial than biosecure housed 





8.1.3 Does the beneficial effect of GOS persist if the gut is colonised 
by a pathogen such as Salmonella?  
The work in Chapter 6 described the impact of Salmonella colonisation on 
the composition of the broiler gut microbiota. It also reports the prevalence ARGs 
carried by caecal community members from birds fed the GOS diet compared to 
control diet for Salmonella colonised and non-colonised birds.  
The data collected indicated that the GOS diet accelerates the clearance rate 
of Salmonella from the caecal contents of birds by 8 days post colonisation 
compared to control diets. Correlation between abundance of Proteobacteria and 
ratio of trimethoprim resistance indicated that the decreasing abundance of 
Proteobacteria coincided with increased resistance to trimethoprim. Interestingly, 
there was a significant reduction in class 1 integron copy number (p-value = 
0.004) at 2 dpi in GOS supplemented diet for birds challenged with Salmonella or 
mock challenged. The integrase copy number remained relatively stable until the 
end of the study at 15 dpi in the Salmonella infected GOS diet group but not for 
the non-colonised GOS diet group. This finding coincided with day that the GOS 
prebiotic was removed from the diet. Comparing viable counts of trimethoprim 
resistant isolates in caecal contents between Salmonella infected birds fed GOS 
diet and those Salmonella infected and fed the control diet indicated a significant 
reduction at 2 and 4 dpi associated with the GOS diet. Total coliform viable counts 
showed a gradual decline with age in the caecal contents from GOS diet Salmonella 
infected birds compared to Salmonella infected birds on the control diet. The 
results of metagenomic analysis indicated that the presence of Salmonella 
increased the proportions of Negativicutes OTUs in both diet groups. The effect 
was more pronounced in the GOS diet group. There was an increase in the 
abundance of Negativicutes (Megamonas) with age at the expense of Clostridia 
(Lachnospiraceae) that was potentially restricting abundance of Proteobacteria. It 
is possible that the expansion of this OTU influenced oxygen availability leading to 
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accelerated clearance of Salmonella. Colonisation of chickens with Salmonella has 
been shown to require a virulence-factor-dependent increase in gut epithelial 
oxygenation (Litvak et al., 2019). Both Veillonellaceae (Megamonas) and 
Acidaminococcaceae (Acidaminococcaceae _unclassified) belong to class 
Negativicutes which includes strictly anaerobic and non-spore forming bacteria 
that maintain an anaerobic environment free of alternative electron acceptors 
(Rychlik, 2020). Other possible explanations for the reduction in Salmonella 
numbers coinciding with increased Negativicutes in birds fed GOS diet include 
changes in competition for certain nutrients or production of organic acids which 
decrease the expression of virulence factors from pathogens like Salmonella(Van 
Immerseel et al., 2003). LEfSe analysis highlighted the high abundance of 
Acidaminococcaceae_unclassified (OTU0009) within microbiota compositions of 
Salmonella colonised groups which have the potential to produce butyrate  
(Rychlik, 2020). A combined effect of the prebiotic GOS feed and invasion by 
Salmonella may have stimulated the avian immune system to promote the 
elimination of Salmonella. 
The presence of Salmonella increased the proportion of birds carrying class 
1 integron ARGs unrelated to the colonising organism in the caecal microbiota of 
the chickens reared under biosecure conditions (χ2 p = 0.001). However, the 
provision of dietary GOS up to day 20 reduced ARG carriage in the Salmonella 
colonised birds (χ2 p = 0.004). Zhang et al. (2018) reported the host species of 
class 1 integrons were highly conserved with 96% of the database class 1 
integrons lodged in Gammaproteobacteria with the family Enterobacteriaceae 
dominant. Stecher et al. (2012) indicated that the normal gut harboured low 
densities (<108 cfu/g) of Enterobacteriaceae. Having low densities of both donor 
and recipient bacteria may reduce the frequency of direct bacterial encounters and 
thus decrease the chance of conjugation-mediated HGT. Stecher et al. (2012) also 
showed that conjugative HGT of the colicin-plasmid p2 from Salmonella enterica 
serovar Typhimurium to E. coli happened at unprecedented rates when the gut 
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(mouse model) was colonised by the pathogen. The mechanism was suggested to 
be driven by inflammatory responses that increased transient enterobacterial 
blooms. This transconjugation efficiency of approximately 100% in vivo, were 
attributed to the high intrinsic p2-transfer rates. Yue and Schifferli (2014) 
demonstrated that Salmonella colonisation factors promote horizontal gene 
transfer of antimicrobial resistance genes by increasing the local density of 
Salmonella in colonised intestines (reviewed in Chapter 6). Types of mobile genetic 
elements that act as vehicles of class 1 integrons and associated OTUs were 
investigated in the chicken gut microbiota in Chapter7. Six trimethoprim 
resistance isolates selected for the whole genome sequence analysis showed that 
the most frequent carrier of plasmids carry multidrug resistance determinants and 
the machineries required to transfer resistance genes between bacteria is E.coli. 
Plasmids observed could be categorised to the IncFIB, IncFII, IncI1-I, IncQ1, 
pO111, and IncN compatibility groups discussed in more details in Chapter 7. The 
most representative GCs (B-2) type in identified in two isolates from biosecure 
housed birds. The presence of this plasmid in this commensal bacterial isolate in 
the chicken intestine indicates how easily the GCs can spread in the Proteobacterial 
population by HGT including transmission to human pathogens such as 
Salmonella.  
 
8.2 Conclusion  
This study has highlighted broiler chickens as one of the most important food 
animal reservoirs involved in transmission of antibiotic resistance genes to human 
pathogens and the wider environment. A possible control strategy by manipulating 
the broiler chicken microbiota via dietary intervention using a prebiotic GOS diet 
was investigated. This resulted in early elimination of Salmonella colonization and 
modification of caecal bacterial communities.  
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The involvement of class 1 integrons in the spread of antibiotic resistance 
was assessed. It was shown that acquisition of GCs was influenced by the rearing 
environment and that GCs can acquire or lose ARGs with time. Moreover, 
regardless of antibiotic pressure, they can persist without selection pressure as 
result of robustness of the integration mechanism via intI1 and attC. Hence, they 
can act as reservoirs for disseminating various resistance genes in every 
environment.  
Metagenomic analysis of the microbiomes of birds fed prebiotic GOS or 
standard diets and either colonised or non-colonised with Salmonella has increased 
our understanding of how prebiotic compounds such as GOS achieve the beneficial 
effects that have been observed empirically. Studying resistance in these same 
birds has increased our understanding of the way in which AMR spreads at the 
molecular level. 
Collectively, the results obtained in this thesis confirm the study hypothesis 
that feeding GOS to chickens is a possible approach for restricting expansion of 
Salmonella and other Proteobacteria that are known to be associated with high 
prevalent of ARGs in Gram-ve bacteria belonging to the Enterobacteriaceae family. 
 
8.3 Future work 
Besides breeding and selection, nutritional optimisation of broiler chickens is 
a fundamental component of efficient poultry production. Hence, effective control 
strategies are needed to make the cecum less hospitable for zoonotic pathogens 
colonisation. Prebiotics are a promising approach for mitigating antibiotic 
resistance gene loads, and by optimising the avian microbiome, improvements in 
zootechnical performance with a reduction in the risk of transmitting pathogenic 
species. The model experiments established here could be applied to different 
prebiotics and synbiotics. The study could be extended to include other classes of 
integrons and gram-positive bacteria to investigate the impact of GOS. Correlation 
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of resistance patterns fond in the broiler gut microbiota with their surrounding 
environment could give insights into the sources of the GCs. Extending the work 
to include laying hens would provide more valuable information because of their 
longer life and resistance patterns may different as the microbiome matures. 
Collectively, it may provide insights into important players in the dissemination of 
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Appendix 1: preparation of media 
1.1 Media preparation 
The suppliers for all media used and chemicals substances in this thesis are listed 
in Table 2.1. All media used in this thesis were prepared using reverse osmosis 
(RO) water followed by sterilization cycle by autoclaving at 121 °C for 15 min, in 
case if the components of media were heat labile the frequent agitation was used 
until the medium boiled. The antibiotics were added to the molten agar after 
sterilizing, once it had cooled to approximately 50 °C. The media was poured into 
sterile Petri dishes (Sarstedt, Leicester, UK) in a laminar flow cabinet. Liquid media 
was generally stored at room temperature (unless specified) and prepared agar 
plates was stored at 4 °C. 
All media used in this thesis for culturing and storing bacterial growth were 
prepared in reverse osmosis (RO) water and then sterilised via autoclaving on 
liquid cycle at 121°C and 15 psi for twenty minutes. Required antibiotics were 
added to agar media after it cooled to 50°C in a water bath, and then poured into 
sterile Petri dishes (Sarstedt, Leicester, UK) in a laminar flow cabinet. Broth media 
were stored at room temperature whereas agar plates were stored at 4°C for a 
maximum of four weeks. 
1.1.1 Modified Xylose-Lysine-Desoxycholate (mXLD) agar 
The media was prepared by dissolving 53 g of XLD medium (Oxoid; CM0469; 
UK) into 1 litre of RO water and then, heated by stirrer hotplates (Stuart; CB162; 
UK) with frequent agitation until the medium boiled (over boiled should be 
avoided). It was cooled to 50 °C in water bath before addition of 1 µg/ml of 
Novobiocin (Sigma-Aldrich) and 12.5 µg/ml Nalidixic acid (Sigma-Aldrich), mixed 
well then poured into sterile Petri dishes (Sarstedt, Leicester, UK) in a laminar flow 
cabinet and agar media were stored at 4°C for a maximum of four weeks. 
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1.1.2 Xylose-Lysine-Desoxycholate (XLD) agar 
XLD medium was prepared as above without antibiotics. 
1.1.3 Modified Semi-solid Rappaport Vassiliadis (MSRV) agar 
Approximately 15.8 g of MSRV Medium Base (Oxoid; CM1112; UK) was 
suspended in 1 litre of RO water, heated with frequent agitation until the medium 
boiled and then It was cooled to 50°C before addition of Novobiocin (20 µg/ml) 
Mix well and poured into sterile Petri dishes. The plates were air dried at room 
temperature for at least one hour and kept right way up because it is semi-solid 
media.  
1.1.4 MacConkey agar No 3 (Mac_03) 
51.5g of MacConkey no 3 (Oxoid; CM115; UK) was suspended in 1 litre of 
RO water and sterilised by autoclaving at 121°C for 15 minutes, cooled in water 
bath and then poured into sterile Petri dishes for control plates whereas 
trimethoprim plates were prepared by inoculated medium with 20 ug/ml of 
trimethoprim after medium was tempered to 50 °C, mixed well and poured into 
marked Petri dishes. 
1.1.5 De man, Rogosa and Sharpe (MRS) agar 
MRS medium (31 g; Oxoid; CM0361) was suspended in 1 litre of RO water 
and sterilised by autoclaving at 121°C for 15 minutes, cooled then poured into 
sterile Petri dishes.  
1.1.6 Luria-Bertani (LB) agar  
LB medium was prepared by adding 10 g tryptone (BiTek™; USA), 5 g yeast 
extract (BiTek™; USA), 5 g sodium chloride (Sigma-Aldrich; UK) and 15 g 
bacteriological agar No. 1 (Oxoid; LP0011 UK) was prepped in 1 L of RO water. 
The medium was autoclaved for sterility at 15 psi, 121 °C for 15-20 minutes. 
Sterile LB Petri dishes were stored at room temperature or 4°C until required. 
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1.1.7 LB broth  
LB broth was prepared as mentioned previously in 1.1.6 without adding 
bacteriological agar no.1 autoclaved and LB broth was stored at room temperature 
for a maximum of eight weeks.  
1.1.8 Nutrient Agar (NA) 
Nutrient agar (Oxoid; CM0003; UK) was prepared by dissolving 28g of 
Nutrient agar into 1 litre of RO water. After autoclaving, Nutrient agar was cooled 
in water bath, poured in Petri dishes and stored at room temperature for a 
maximum of eight weeks.  
1.1.9 Nutrient broth No. 2  
Nutrient broth No. 2 (Oxoid; CM0067; UK) was prepared by dissolving 25g 
of Nutrient broth No. 2 into 1 litre of RO water. After autoclaving, Nutrient Broth 
No. 2 broth was stored at room temperature for a maximum of eight weeks. 
1.1.10 YT broth 
YT broth was prepared by adding 0.5% Difco Bacto yeast extract, 0.5% NaCl, 
0.8% Difco Bacto tryptone and was adjusted to pH 7.5. YT broth was autoclaved 
for sterility at 15 psi, 121 °C for 15-20 minutes and stored at room temperature 
until required. 
1.2 Buffers and solutions  
1.2.1 Buffered peptone water  
Buffered Peptone Water (20 g; Oxoid; CM509) was suspended in 1 litre of 
RO water and sterilised by autoclaving at 121°C for 15 minutes. 
1.2.2 Maximum recovery diluent (MRD)  
MRD was prepared by adding 9.5g of maximum recovery diluent (Oxoid; 
CM0733; UK) in 1 litre of RO water. After autoclaving, MRD was stored at room 
temperature for a maximum of eight weeks. 
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1.2.3 Phosphate buffered saline (PBS) 
To prepare PBS, one phosphate buffered saline tablet (ThermoFisher) was 
dissolved in 200 ml of RO water. After autoclaving, PBS buffer was stored at room 
temperature. 
1.2.4 Long-term bacterial storage medium  
 
Glycerol stock was prepared to maintain and store bacterial growth by adding 
300 µl of sterile glycerol (50 % v v) to 700 µl nutrient broth No.2 (1.1.9) to a final 
concentration of 30% v/v. After autoclaving, the bacterial storage medium was 
stored at room temperature for a maximum of eight weeks. 
1.2.5 Antibiotics  
Selected antibiotics were prepared in appropriate solvent according to 
manufacturer’s instructions. After preparation, antibiotics were sterilised by 0.22 
µm filter (Sartorius Stedim Biotech; Germany) and aliquoted as 1ml stock 
solutions and stored at -20°C. Stock concentrations for antibiotics used in this 
thesis are listed in Table 1.1. 
Table 1. 1 Antibiotics used in this thesis. 





Trimethoprim Sigma-Aldrich 100% Ethanol 
/DMSO 
20 mg/ml 20 μg/ml 
Novobiocin Sigma-Aldrich RO water 1 mg/ml 1 μg/ml 
Nalidixic acid Sigma-Aldrich RO water 12.5 mg/ml 12.5 μg/ml 







1.1.13 Proteinase kinase  
Approximately 0.1 g of proteinase K (Sigma-Aldrich) was dissolved in 5 ml 
of RO water (20 mg/ml) for GenElute Bacterial Genomic DNA kit, sterilised by filter 
(0.22 µm) then aliquoted as 60 µl stock solutions and stored at -20°C. It 
commonly used to digest protein and remove contamination from DNA because it 
inactivates nucleases that might degrade the DNA or RNA during purification.  
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Appendix 2.1 Table 2.1.1 The PCR ampilicon product results of three 
conserved genes of class 1 integrons of broiler caecal samples biosecure 
birds 
Sample feed type age intI1 Ravi intI1 EB intI1 H intl1 C sul1 qacEΔ1 
1.22.1 ctl-nonc 22 + neq + + + + 
1.22.2 ctl-nonc 22 + neq + + + + 
1.22.3 ctl-nonc 22 + neq + + + + 
1.22.4 ctl-nonc 22 + neq + + + + 
1.22.5 ctl-nonc 22 + neq + + + + 
1.22.6 ctl-nonc 22 + neq + + + + 
1.22.7 ctl-nonc 22 + neq + + + + 
1.24.1 ctl-nonc 24 + neq + + + + 
1.24.2 ctl-nonc 24 + neq + + + + 
1.24.3 ctl-nonc 24 + neq + + + + 
1.24.4 ctl-nonc 24 + neq + + + + 
1.24.5 ctl-nonc 24 + neq neg neg neg + 
1.24.6 ctl-nonc 24 + neq + + + + 
1.24.7 ctl-nonc 24 + neq + + + + 
1.28.1 ctl-nonc 28 + neq + + + + 
1.28.2 ctl-nonc 28 + neq + + neg + 
1.28.3 ctl-nonc 28 + neq + + + + 
1.28.4 ctl-nonc 28 + neq + neg + + 
1.28.5 ctl-nonc 28 + neq + + + + 
1.28.6 ctl-nonc 28 + neq + neg neg + 
1.28.7 ctl-nonc 28 + neq + + + + 
1.35.1 ctl-nonc 35 + neq + + + + 
1.35.2 ctl-nonc 35 + neq + + + + 
1.35.4 ctl-nonc 35 + neq + + + + 
1.35.5 ctl-nonc 35 + neq + + + + 
1.35.6 ctl-nonc 35 + neq + + + + 
1.35.7 ctl-nonc 35 + neq + neg + + 
2.22.1 GOS-nonc 22 + neq + + + + 
2.22.2 GOS-nonc 22 + neq + + + + 
2.22.3 GOS-nonc 22 + neq + neg + neg 
2.22.4 GOS-nonc 22 + neq + + + neg 
2.22.5 GOS-nonc 22 + neq + + + neg 
2.22.6 GOS-nonc 22 + neq + + + + 
2.22.7 GOS-nonc 22 + neq + + + + 
2.24.1 GOS-nonc 24 + neq + + + + 
2.24.2 GOS-nonc 24 + neq + + + + 
2.24.3 GOS-nonc 24 + neq + + + + 
2.24.4 GOS-nonc 24 + neq + + + + 
2.24.5 GOS-nonc 24 + neq + + neg neg 
2.24.6 GOS-nonc 24 + neq + + + + 
2.24.7 GOS-nonc 24 + neq + + neg + 
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Continued. Table 2.1 The PCR ampilicon product results of three 
conserved genes of class 1 integrons of broiler caecal samples biosecure 
birds 
 





intI1 H intl1 C sul1 qacEΔ1 
2.28.1 GOS-nonc 28 + neq + + + + 
2.28.2 GOS-nonc 28 + neq + + + + 
2.28.3 GOS-nonc 28 + neq + + + + 
2.28.4 GOS-nonc 28 + neq + + + + 
2.28.5 GOS-nonc 28 + neq + + + + 
2.28.6 GOS-nonc 28 + neq + + + + 
2.28.7 GOS-nonc 28 + neq + + + + 
2.35.1 GOS-nonc 35 + neq + + + + 
2.35.2 GOS-nonc 35 + neq + + + + 
2.35.3 GOS-nonc 35 + neq + + + + 
2.35.4 GOS-nonc 35 + neq + + + + 
2.35.5 GOS-nonc 35 + neq + + + + 
2.35.6 GOS-nonc 35 + neq + neg neg neg 
2.35.7 GOS-nonc 35 + neq + + + + 
3.22.1 ctl-sal 22 + neq + + + + 
3.22.2 ctl-sal 22 + neq + + + + 
3.22.3 ctl-sal 22 + neq + + + + 
3.22.4 ctl-sal 22 + neq + + + + 
3.22.5 ctl-sal 22 + neq + + + + 
3.22.6 ctl-sal 22 + neq + + + + 
3.22.7 ctl-sal 22 + neq + + + + 
3.24.1 ctl-sal 24 + neq + neg + + 
3.24.2 ctl-sal 24 + neq + + + + 
3.24.3 ctl-sal 24 + neq + + + + 
3.24.4 ctl-sal 24 + neq + + + + 
3.24.5 ctl-sal 24 + neq + + + + 
3.24.6 ctl-sal 24 + neq + + + + 
3.24.7 ctl-sal 24 + neq + + + + 
3.28.1 ctl-sal 28 + neq + + + + 
3.28.2 ctl-sal 28 + neq + + + + 
3.28.3 ctl-sal 28 + neq + + + + 
3.28.4 ctl-sal 28 + neq + + + + 
3.28.5 ctl-sal 28 + neq + + + + 
3.28.6 ctl-sal 28 + neq + + + + 
3.28.7 ctl-sal 28 + neq + + + + 
3.35.1 ctl-sal 35 + neq + neg + + 
3.35.2 ctl-sal 35 + neq + + + + 
3.35.3 ctl-sal 35 + neq + + + + 
3.35.4 ctl-sal 35 + neq + + + + 
3.35.5 ctl-sal 35 + neq + + + + 
3.35.6 ctl-sal 35 + neq + + + neg 
3.35.7 ctl-sal 35 + neq + neg + + 
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Continued. Table 2.1 The PCR ampilicon product results of three 










intI1 H intl1 C sul1 qacEΔ1 
4..22.1 GOS-sal 22 + neq + neg + + 
4..22.2 GOS-sal 22 + neq + neg + + 
4..22.3 GOS-sal 22 + neq + neg + + 
4..22.4 GOS-sal 22 + neq + + + + 
4..22.5 GOS-sal 22 + neq + + + + 
4..22.6 GOS-sal 22 + neq + + + + 
4..22.7 GOS-sal 22 + neq + + + + 
4.24.1 GOS-sal 24 + neq + neg + + 
4.24.2 GOS-sal 24 + neq + neg + + 
4.24.3 GOS-sal 24 + neq + neg + + 
4.24.4 GOS-sal 24 + neq + + + + 
4.24.5 GOS-sal 24 neg neq + neg + neg 
4.24.6 GOS-sal 24 + neq + neg + + 
4.24.7 GOS-sal 24 + neq + + + + 
4.28.1 GOS-sal 28 + neq + neg + + 
4.28.2 GOS-sal 28 + neq + neg + + 
4.28.3 GOS-sal 28 + neq + neg + + 
4.28.4 GOS-sal 28 + neq + + + + 
4.28.5 GOS-sal 28 + neq + neg + + 
4.28.6 GOS-sal 28 + neq + + + + 
4.28.7 GOS-sal 28 + neq + + + + 
4.35.1 GOS-sal 35 + neq + neg + + 
4.35.2 GOS-sal 35 + neq + + + + 
4.35.3 GOS-sal 35 + neq + neg + + 
4.35.4 GOS-sal 35 + neq + + + + 
4.35.5 GOS-sal 35 + neq + + + + 
4.35.6 GOS-sal 35 + neq + + + + 






Appendix 2.2 The PCR ampilicon product of class 1 integron (intl1 Ravi 





Figure 2.2.1  Agarose gels amplification products of PCRs by using Ravi primers 
showing target genes the 546 bp PCRs products of class 1 integrase gene (intl1 
Ravi, Chapter 2 Table 2.4) obtained from biosecure condition chicken caecal DNA 
samples of control group (G1) electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 1.22.1, Lane 3 IntI1 Ravi sample 
1.22.2, Lane 4 IntI1 Ravi sample 1.22.3, Lane 5 IntI1 Ravi sample 1.22.4, Lane 6 IntI1 
Ravi sample 1.22.5, Lane 7 IntI1 Ravi sample 1.22.6, Lane 8 IntI1 Ravi sample 1.22.7, 
Lane 9 IntI1 Ravi sample 1.24.1, Lane 10 IntI1 Ravi sample 1.24.2, Lane 11 IntI1 Ravi 
sample 1.24.3, Lane 12 IntI1 Ravi sample 1.24.4, Lane 13 IntI1 Ravi sample 1.24.5, Lane 
14 IntI1 Ravi sample 1.24.6, Lane 15 IntI1 Ravi sample 1.24.7, Lane 16 IntI1 Ravi -ve 
control Lane 17 IntI1 Ravi +ve control, Lane 18 100 bp ladder (BioLab).   





Figure 2.2.2 Agarose gels amplification products of PCRs by using Ravi primers 
showing target genes the 546 bp PCRs products of class 1 integrase gene (intl1 
Ravi, Chapter 2 Table 2.4) obtained from biosecure condition chicken caecal DNA 
samples of G1 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 1.28.1, Lane 3 IntI1 Ravi sample 
1.28.2, Lane 4 IntI1 Ravi sample 1.28.3, Lane 5 IntI1 Ravi sample 1.28.4, Lane 6 IntI1 
Ravi sample 1.28.5, Lane 7 IntI1 Ravi sample 1.28.6,  Lane 8 IntI1 Ravi sample 1.28.7, 
Lane 9 IntI1 Ravi sample 1.35.1, Lane 10 IntI1 Ravi sample 1.35.2, Lane 11 IntI1 Ravi 
sample 1.35.4, Lane 12 IntI1 Ravi sample 1.35.5, Lane 13 IntI1 Ravi sample 1.35.6, Lane 
14 IntI1 Ravi sample 1.35.7. Lane 15 IntI1 Ravi -ve control, Lane 16 IntI1 Ravi +ve control, 
Lane 17 100 bp ladder (BioLab).      
 1    2    3     4    5    6    7    8    9   10  11  12  13   14  15  16   17  18  









Figure 2.2.3 Agarose gels amplification products of PCRs by using Ravi primers 
showing target genes the 546 bp PCRs products of class 1 integrase gene (intl1 
Ravi, Chapter 2 Table 2.4) obtained from biosecure condition chicken caecal DNA 
samples of GOS supplemented diet (G2) electrophoresed on a 1 % TAE gel 
Lane 1 100 bp ladder (BioLab), Lane 2 intl1 Ravi sample 2.22.1, Lane 3 IntI1 Ravi sample 
2.22.2 , Lane 4 intl1 Ravi sample 2.22.3, Lane 5 IntI1 Ravi sample 2.22.4, Lane 6 intl1 Ravi 
sample 2.22.5, Lane 7 IntI1 Ravi sample 2.22.6, Lane 8 intl1 Ravi sample 2.22.7, Lane 9 
IntI1 Ravi sample 2.24.1, Lane 10 IntI1 Ravi sample 2.24.2, Lane 11 IntI1 Ravi sample 
2.24.3, Lane 12 IntI1 Ravi sample 2.24.4, Lane 13 IntI1 Ravi sample 2.24.5, Lane 14 intl1 
Ravi sample 2.24.6, Lane 15 IntI1 Ravi sample 2.24.7, Lane 16 intl1 Ravi -ve control, Lane 









Figure 2.2.4 Agarose gels amplification products of PCRs by using Ravi primers 
showing target genes the 546 bp PCRs products of class 1 integrase gene (intl1 
Ravi, Chapter 2 Table 2.4) obtained from biosecure condition chicken caecal DNA 
samples of G2 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 2.28.1, Lane 3 IntI1 Ravi sample 
2.28.2, Lane 4 IntI1 Ravi sample 2.28.3, Lane 5 IntI1 Ravi sample 2.28.4, Lane 6 IntI1 
Ravi sample 2.28.5, Lane 7 IntI1 Ravi sample 2.28.6, Lane 8 IntI1 Ravi sample 2.28.7, 
Lane 9 IntI1 Ravi sample 2.35.1, Lane 10 IntI1 Ravi sample 2.35.2, Lane 11 IntI1 Ravi 
sample 2.35.3, Lane 12 IntI1 Ravi sample 2.35.4, Lane 13 IntI1 Ravi sample 2.35.5, Lane 
14 IntI1 Ravi sample 2.35.6, Lane 15 IntI1 Ravi sample 2.35.7, Lane 17 IntI1 Ravi -ve 
control, Lane 18 100 bp ladder (BioLab).  
1     2    3    4    5    6    7    8    9   10  11  12   13  14  15   16   17  18  











Figure 2.2.5 Agarose gels amplification products of PCRs by using Ravi primers 
exhibiting target genes the 546 bp PCRs products of class 1 integrase gene (intl1 
Ravi, Chapter 2 Table 2.4) obtained from biosecure condition chicken caecal DNA 
samples of control group challenged with Salmonella (G3) electrophoresed on a 1 
% TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 3.22.1, Lane 3 IntI1 Ravi sample 
3.22.2, Lane 4 IntI1 Ravi sample 3.22.3, Lane 5 IntI1 Ravi sample 3.22.4, Lane 6 IntI1 
Ravi sample 3.22.5, Lane 7 IntI1 Ravi sample 3.22.6, Lane 8 IntI1 Ravi sample 3.22.7, 
Lane 9 IntI1 Ravi sample 3.24.1, Lane 10 IntI1 Ravi sample 3.24.2, Lane 11 IntI1 Ravi 
sample 3.24.3, Lane 12 IntI1 Ravi sample 3.24.4, Lane 13 IntI1 Ravi sample 3.24.5, Lane 
14 IntI1 Ravi sample 3.24.6, Lane 15 IntI1 Ravi sample 3.24.7, Lane 16 IntI1 Ravi -ve 
control, Lane 17 IntI1 Ravi +ve control, Lane 18 100 bp ladder (BioLab). 







Figure 2.2.6 Agarose gels amplification products of PCRs by using Ravi primers 
showing target genes the 546 bp PCRs products of class 1 integrase gene (intl1 
Ravi, Chapter 2 Table 2.4) obtained from biosecure condition chicken caecal DNA 
samples of G3 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 3.28.1, Lane 3 IntI1 Ravi sample 
3.28.2, Lane 4 IntI1 Ravi sample 3.28.3, Lane 5 IntI1 Ravi sample 3.28.4, Lane 6 IntI1 
Ravi sample 3.28.5, Lane 7 IntI1 Ravi sample 3.28.6, Lane 8 IntI1 Ravi sample 3.28.7, 
Lane 9 IntI1 Ravi sample 3.35.1, Lane 10 IntI1 Ravi sample 3.35.2, Lane 11 IntI1 Ravi 
sample 3.35.3, Lane 12 IntI1 Ravi sample 3.35.4, Lane 13 IntI1 Ravi sample 3.35.5, Lane 
14 IntI1 Ravi sample 3.35.6, Lane 15 IntI1 Ravi sample 3.35.7, Lane 17 IntI1 Ravi -ve 
control, Lane 17 IntI1 Ravi +ve control. 
1    2    3    4     5    6    7    8    9   10   11  12  13   14  15  16  17   18  










Figure 2.2.7 Agarose gels amplification products of PCRs by using Ravi primers 
showing target genes the 546 bp PCRs products of class 1 integrase gene (intl1 
Ravi, Chapter 2 Table 2.4) obtained from biosecure condition chicken caecal DNA 
samples of GOS supplementary dietary challenged by Salmonella (G4) 
electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 4.22.1, Lane 3 IntI1 Ravi sample 
4.22.2, Lane 4 IntI1 Ravi sample 4.22.3, Lane 5 IntI1 Ravi sample 4.22.4, Lane 6 IntI1 
Ravi sample 4.22.5, Lane 7 IntI1 Ravi sample 4.22.6, Lane 8 IntI1 Ravi sample 4.22.7, 
Lane 9 IntI1 Ravi sample 4.24.1, Lane 10 IntI1 Ravi sample 4.24.2, Lane 11 IntI1 Ravi 
sample 4.24.3, Lane 12 IntI1 Ravi sample 4.24.4, Lane 13 IntI1 Ravi sample 4.24.5, Lane 
14 IntI1 Ravi sample 4.24.6, Lane 15 IntI1 Ravi sample 4.24.7, Lane 16 IntI1 Ravi -ve 








Figure 2.2.8 Agarose gels amplification products of PCRs by using Ravi primers 
showing target genes the 546 bp PCRs products of class 1 integrase gene (intl1 
Ravi, Chapter 2 Table 2.4) obtained from biosecure condition chicken caecal DNA 
samples of G4 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 4.28.1, Lane 3 IntI1 Ravi sample 
4.28.2, Lane 4 IntI1 Ravi sample 4.28.3, Lane 5 IntI1 Ravi sample 4.28.4, Lane 6 IntI1 
Ravi sample 4.28.5, Lane 7 IntI1 Ravi sample 4.28.6, Lane 8 IntI1 Ravi sample 4.28.7 , 
Lane 9 IntI1 Ravi sample 4.35.1, Lane 10 IntI1 Ravi sample 4.35.2, Lane 11 IntI1 Ravi 
sample 4.35.3, Lane 12 IntI1 Ravi sample 4.35.4, Lane 13 IntI1 Ravi sample 4.35.5, Lane 
14 IntI1 Ravi sample 4.35.6, Lane 15 IntI1 Ravi sample 4.35.7, Lane 16 IntI1 Ravi -ve 
control, Lane 17 IntI1 Ravi +ve control, Lane 18 100 bp ladder (BioLab).   
1    2    3   4    5    6   7     8   9   10  11  12  13  14  15  16  17  18  
1    2    3    4    5    6    7    8    9   10  11  12   13   14        15   16  17  18  
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Appendix 2.3 The PCR ampilicon product of class 1 integron (intl1 H 





Figure 2.3.1 Agarose gels amplification products of PCRs by using intl1 
HS464/HS463a primers (Chapter 2 Table 2.4) showing target genes the 471 bp 
PCRs products of class 1 integrase gene obtained from biosecure condition 
chicken caecal DNA samples of G1 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 H sample 1.22.1, Lane 3 IntI1 H sample 1.22.2, 
Lane 4 IntI1 H sample 1.22.3, Lane 5 IntI1 H sample 1.22.4, Lane 6 IntI1 H sample 1.22.5, 
Lane 7 IntI1 H sample 1.22.6, Lane 8 IntI1 H sample 1.22.7, Lane 9 IntI1 H sample 1.24.1, 
Lane 10 IntI1 H sample 1.24.2, Lane 11 IntI1 H sample 1.24.3, Lane 12 IntI1 H sample 
1.24.4, Lane 13 IntI1 H sample 1.24.5, Lane 14 IntI1 H sample 1.24.6, Lane 15 IntI1 H 






Figure 2.3.2 Agarose gels amplification products of PCRs by using intl1 
HS464/HS463a primers showing target genes the 471 bp PCRs products of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
of G1 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 H sample 1.28.1, Lane 3 IntI1 H sample 1.28.2, 
Lane 4 IntI1 H sample 1.28.3, Lane 5 IntI1 H sample 1.28.4, Lane 6 IntI1 H sample 1.28.5, 
Lane 7 IntI1 H sample 1.28.6, Lane 8 IntI1 H sample 1.28.7, Lane 9 IntI1 H sample 1.35.1, 
Lane 10 IntI1 H sample 1.35.2, Lane 11 IntI1 H sample 1.35.4,  Lane 12, IntI1 H sample 
1.35.5, Lane 13 IntI1 H sample 1.35.6, Lane 14 IntI1 H sample 1.35.7, Lane 15 IntI1 H -
ve control, Lane 16 IntI1 H +ve control, Lane 17100 bp ladder (BioLab).  
 
 
1    2    3   4    5    6   7   8    9  10  11  12 13  14  15  16  17  18  











Figure 2.3.3 Agarose gels amplification products of PCRs by using intl1 
HS464/HS463a primers showing target genes the 471 bp PCRs products of class 
1 integrase gene (obtained from biosecure condition chicken caecal DNA samples 
of G2 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 H sample 2.22.1, Lane 3 IntI1 H sample 2.22.2, 
Lane 4 IntI1 H sample 2.22.3, Lane 5 IntI1 H sample 2.22.4, Lane 6 IntI1 HS464 sample 
2.22.5, Lane 7 IntI1 H sample 2.22.6, Lane 8 IntI1 H sample 2.22.7, Lane 9 IntI1 H sample 
2.24.1, Lane 10 IntI1 H sample 2.24.2, Lane 11 IntI1 H sample 2.24.3, Lane 12 IntI1 H 
sample 2.24.4, Lane 13 IntI1 H sample 2.24.5, Lane 14 IntI1 H sample 2.24.6, Lane 15 
IntI1 H sample 2.24.7, Lane 16 IntI1 H -ve control, Lane 17 IntI1 H +ve control, Lane 18 
100 bp ladder (BioLab).  




Figure 2.3.4 Agarose gels amplification products of PCRs by using intl1 
HS464/HS463a primers showing target genes the 471 bp PCRs products of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
of G2 electrophoresed on a 1 % TAE gel.  
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 H sample 2.28.1, Lane 3 IntI1 H sample 2.28.2, 
Lane 4 IntI1 H sample 2.28.3, Lane 5 IntI1 H sample 2.28.4, Lane 6 IntI1 H sample 2.28.5, 
Lane 7 IntI1 H sample 2.28.6, Lane 8 IntI1 H sample 2.28.7, Lane 9 IntI1 H sample 2.35.1, 
Lane 10 IntI1 H sample 2.35.2, Lane 11 IntI1 H sample 2.35.3, Lane 12 IntI1 H  sample 
2.35.4, Lane 13 IntI1 H sample 2.35.5, Lane 14 IntI1 H sample 2.35.6, Lane 15 IntI1 H 
sample 2.35.7, Lane 16 IntI1 H -ve control, Lane 17 IntI1 H +ve control, Lane 18 100 bp 
ladder (BioLab). 
 
1    2    3     4   5     6     7     8    9   10  11   12  13   14  15   16   17  18  









Figure 2.3.5 Agarose gels amplification products of PCRs by using intl1 
HS464/HS463a primers showing target genes the 471 bp PCRs products of class 
1 integrase gene (obtained from biosecure condition chicken caecal DNA samples 
G3 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 H sample 3.22.1, Lane 3 IntI1 H sample 3.22.2, 
Lane 4 IntI1 H sample 3.22.3, Lane 5 IntI1 H sample 3.22.4, Lane 6 IntI1 H sample 3.22.5, 
Lane 7 IntI1 H sample 3.22.6, Lane 8 IntI1 H sample 3.22.7, Lane 9 IntI1 H sample 3.24.1  
Lane 10 IntI1 H sample 3.24.2, Lane 11 IntI1 H sample 3.24.3, Lane 12 IntI1 H sample 
3.24.4, Lane 13 IntI1 H sample 3.24.5, Lane 14 IntI1 H sample 3.24.6, Lane 15 IntI1 H 
sample 3.24.7, Lane 16 IntI1 H -ve control, Lane 17 IntI1 H +ve control, Lane 18 100 bp 
ladder (BioLab).      




Figure 2.3.6 Agarose gels amplification products of PCRs by using intl1 
HS464/HS463a primers showing target genes the 471 bp PCRs products of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
of G3 electrophoresed on a 1 % TAE gel 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 H sample 3.28.1, Lane 3 IntI1 H sample 3.28.2, 
Lane 4 IntI1 H sample 3.28.3, Lane 5 IntI1 H sample 3.28.4, Lane 6 IntI1 H sample 3.28.5, 
Lane 7 IntI1 H sample 3.28.6, Lane 8 IntI1 H sample 3.28.7, Lane 9 IntI1 H sample 3.35.1   
Lane 10 IntI1 H sample 3.35.2, Lane 11 IntI1 H sample 3.35.3, Lane 12 IntI1 H sample 
3.35.4, Lane 13 IntI1 H sample 3.35.5, Lane 14 IntI1 H sample 3.35.6, Lane 15 IntI1 H 
sample 3.35.7, Lane 16 IntI1 H -ve control, Lane 17 IntI1 H +ve control, Lane 18 100 bp 




1    2    3   4    5    6    7   8    9  10  11  12  13  14  15  16  17  18  









Figure 2.3.7 Agarose gels amplification products of PCRs by using intl1 
HS464/HS463a primers showing target genes the 471 bp PCRs products of class 
1 integrase gene (obtained from biosecure condition chicken caecal DNA samples 
G4 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 HS464 sample 4.22.1, Lane 3 IntI1 H sample 
4.22.2, Lane 4 IntI1 H sample 4.22.3, Lane 5 IntI1 H sample 4.22.4, Lane 6 IntI1 H sample 
4.22.5, Lane 7 IntI1 H sample 4.22.6, Lane 8 IntI1 H sample 4.22.7, Lane 9 IntI1 H sample 
4.24.1, Lane 10 IntI1 H sample 4.24.2, Lane 11 IntI1 H sample 4.24.3, Lane 12 IntI1 H 
sample 4.24.4, Lane 13 IntI1 H sample 4.24.5, Lane 14 IntI1 H sample 4.24.6, Lane 15 
IntI1 H sample 4.24.7, Lane 16 IntI1 H -ve control, Lane 17 IntI1 H +ve control, Lane 18 
100 bp ladder (BioLab).    
Figure 2.3.8 Agarose gels amplification products of PCRs by using intl1 
HS464/HS463a primers showing target genes the 471 bp PCRs products of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
of G4 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 H sample 4.28.1, Lane 3 IntI1 H sample 4.28.2, 
Lane 4 IntI1 H sample 4.28.3, Lane 5 IntI1 H sample 4.28.4, Lane 6 IntI1 H sample 4.28.5, 
Lane 7 IntI1 H sample 4.28.6, Lane 8 IntI1 H sample 4.28.7, Lane 9 IntI1 H sample 4.35.1 
Lane 10 IntI1 H sample 4.35.2, Lane 11 IntI1 H sample 4.35.3, Lane 12 IntI1 H sample 
4.35.4, Lane 13 IntI1 H sample 4.35.5, Lane 14 IntI1 H sample 4.35.6, Lane 15 IntI1 H 
sample 1.35.7, Lane 16 IntI1 H -ve control, Lane 17 IntI1 H +ve control, Lane 18 100 bp 
ladder (BioLab). 
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Appendix 2.4 The PCR ampilicon product of class 1 integron (Clinical 





Figure 2.4.1 Agarose gels amplification products of PCRs by using intl1 clinical 
primers (F165/R476, Chapter 2, Table 2.4) showing target genes the 311 bp PCRs 
products of class 1 integrase gene (obtained from biosecure condition chicken 
caecal DNA samples G1 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 C sample 1.22.1, Lane 3 IntI1 C sample 1.22.2, 
Lane 4 IntI1 C sample 1.22.3, Lane 5 IntI1 C sample 1.22.4, Lane 6 IntI1 C sample 1.22.5, 
Lane 7 IntI1 C sample 1.22.6, Lane 8 IntI1 C sample 1.22.7, Lane 9 IntI1 C sample 1.24.1, 
Lane 10 IntI1 C sample 1.24.2, Lane 11 IntI1 C sample 1.24.3, Lane 12 IntI1 C sample 
1.24.4, Lane 13 IntI1 C sample 1.24.5, Lane 14 IntI1 C sample 1.24.6, Lane 15 IntI1 C 







Figure 2.4.2 Agarose gels amplification products of PCRs by using intl1 clinical 
primers (F165/R476, Chapter 2, Table 2.4) showing target genes the 311 bp PCRs 
products of class 1 integrase gene (obtained from biosecure condition chicken 
caecal DNA samples of G1 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 C sample 1.28.1, Lane 3 IntI1 C sample 1.28.2, 
Lane 4 IntI1 C sample 1.28.3, Lane 5 IntI1 C sample 1.28.4,  Lane 6 IntI1 C sample 1.28.5, 
Lane 7 IntI1 C sample 1.28.6, Lane 8 IntI1 C sample 1.28.7, Lane 9 IntI1 C sample 1.35.1, 
Lane 10 IntI1 C sample 1.35.2, Lane 11 IntI1 C sample 1.35.4, Lane 12 IntI1 C sample 
1.35.5, Lane 13 IntI1 C sample 1.35.6, Lane 14 IntI1 C sample 1.35.7, Lane 15 IntI1 C+ve 
control, Lane 16 IntI1 C-ve control, Lane 17 100 bp ladder (BioLab).                   
 
1   2   3    4   5   6    7   8   9  10  11 12 13  14 15 16  17 18  







Figure 2.4.3 Agarose gels amplification products of PCRs by using intl1 clinical 
primers (F165/R476, Chapter 2, Table 2.4) showing target genes the 311 bp PCRs 
products of class 1 integrase gene (obtained from biosecure condition chicken 
caecal DNA samples of G2 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 C sample 2.22.1, Lane 3 IntI1 C sample 2.22.2, 
Lane 4 IntI1 C sample 2.22.3, Lane 5 IntI1 C sample 2.22.4, Lane 6 IntI1 C sample 2.22.5, 
Lane 7 IntI1 C sample 2.22.6, Lane 8 IntI1 C sample 2.22.7, Lane 9 IntI1 C sample 2.24.1, 
Lane 10 IntI1 C sample 2.24.2, Lane 11 IntI1 C sample 2.24.3, Lane 12 IntI1 C sample 
2.24.4, Lane 13 IntI1 C sample 2.24.5, Lane 14 IntI1 C sample 2.24.6, Lane 15 IntI1 C 









Figure 2.4.4 Agarose gels amplification products of PCRs by using intl1 clinical 
primers (F165/R476, Chapter 2, Table 2.4) showing target genes the 311 bp PCRs 
products of class 1 integrase gene (obtained from biosecure condition chicken 
caecal DNA samples of G2 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 C sample 2.28.1, Lane 3 IntI1 C sample 2 
.28.2, Lane 4 IntI1 C sample 2.28.3, Lane 5 IntI1 C sample 2.28.4, Lane 6 IntI1 C sample 
2.28.5, Lane 7 IntI1 C sample 2.28.6, Lane 8 IntI1 C sample 2.28.7, Lane 9 IntI1 C sample 
2.35.1, Lane 10 IntI1 C sample 2.35.2, Lane 11 IntI1 C sample 2.35.4, Lane 12 IntI1 C 
sample 2.35.5, Lane 13 IntI1 C sample 2.35.6, Lane 14 IntI1 C sample 2.35.7, Lane 15 
IntI1 C+ve control, Lane 16 IntI1 C-ve control, Lane 17 100 bp ladder (BioLab).                   
1   2   3   4   5    6   7   8   9  10  11 12 13  14 15 16 17 18  





Figure 2.4.5 Agarose gels amplification products of PCRs by using intl1 clinical 
primers (F165/R476, Chapter 2, Table 2.4) showing target genes the 311 bp PCRs 
products of class 1 integrase gene (obtained from biosecure condition chicken 
caecal DNA samples G3 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 C sample 3.22.1, Lane 3 IntI1 C sample 3.22.2, 
Lane 4 IntI1 C sample 3.22.3, Lane 5 IntI1 C sample 3.22.4, Lane 6 IntI1 C sample 3.22.5, 
Lane 7 IntI1 C sample 3.22.6, Lane 8 IntI1 C sample 3.22.7, Lane 9 IntI1 C sample 3.24.1, 
Lane 10 IntI1 C sample 3.24.2, Lane 11 IntI1 C sample 3.24.3, Lane 12 IntI1 C sample 
3.24.4, Lane 13 IntI1 C sample 3.24.5, Lane 14 IntI1 C sample 3.24.6, Lane 15 IntI1 C 
sample 3.24.7,  Lane 16 IntI1 C-ve control, Lane 17 IntI1 C +ve control, Lane 18 100 bp 
ladder (BioLab). 
 
Figure 2.4.6 Agarose gels amplification products of PCRs by using intl1 clinical 
primers showing target genes the 311 bp PCRs products of class 1 integrase gene 
(obtained from biosecure condition chicken caecal DNA samples G3 
electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 C sample 3.28.1, Lane 3 IntI1 C sample 3.28.2, 
Lane 4 IntI1 C sample 3.28.3, Lane 5 IntI1 C sample 3.28.4, Lane 6 IntI1 C sample 3.28.5, 
Lane 7 IntI1 C sample 3.28.6, Lane 8 IntI1 C sample 3.28.7, Lane 9 IntI1 C sample 3.35.1, 
Lane 10 IntI1 C sample 3.35.2, Lane 11 IntI1 C sample 3.35.4, Lane 12 IntI1 C sample 
3.35.5, Lane 13 IntI1 C sample 3.35.6, Lane 14 IntI1 C sample 3.35.7, Lane 15 IntI1 C+ve 
control, Lane 16 IntI1 C-ve control, Lane 17 100 bp ladder (BioLab).                   
1    2    3     4   5    6     7   8     9   10  11 12   13   14  15  16   17  18    




Figure 2.4.7 Agarose gels amplification products of PCRs by using intl1 clinical 
primers showing target genes the 311 bp PCRs products of class 1 integrase gene 
(obtained from biosecure condition chicken caecal DNA samples G4 
electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 C sample 4.22.1, Lane 3 IntI1 C sample 4.22.2, 
Lane 4 IntI1 C sample 4.22.3, Lane 5 IntI1 C sample 4.22.4, Lane 6 IntI1 C sample 4.22.5, 
Lane 7 IntI1 C sample 4.22.6, Lane 8 IntI1 C sample 4.22.7, Lane 9 IntI1 C sample 4.24.1, 
Lane 10 IntI1 C sample 4.24.2, Lane 11 IntI1 C sample 4.24.3, Lane 12 IntI1 C sample 
4.24.4, Lane 13 IntI1 C sample 4.24.5, Lane 14 IntI1 C sample 4.24.6, Lane 15 IntI1 C 
sample 4.24.7, Lane 16 IntI1 C-ve control, Lane 17 IntI1 C +ve control, Lane 18 100 bp 
ladder (BioLab). 
Figure 2.4.8 Agarose gels amplification products of PCRs by using intl1 clinical 
primers showing target genes the 311 bp PCRs products of class 1 integrase gene 
(obtained from Biosecure condition chicken caecal DNA samples G4 
electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 C sample 4.28.1, Lane 3 IntI1 C sample 4.28.2, 
Lane 4 IntI1 C sample 4.28.3, Lane 5 IntI1 C sample 4.28.4, Lane 6 IntI1 C sample 4.28.5, 
Lane 7 IntI1 C sample 4.28.6, Lane 8 IntI1 C sample 4.28.7, Lane 9 IntI1 C sample 4.35.1, 
Lane 10 IntI1 C sample 4.35.2,  Lane 11 IntI1 C sample 4.35.4, Lane 12 IntI1 C sample 
4.35.5, Lane 13 IntI1 C sample 4.35.6, Lane 14 IntI1 C sample 4.35.7, Lane 15 IntI1 C+ve 
control, Lane 16 IntI1 C-ve control, Lane 17 100 bp ladder (BioLab).              
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Figure 2.5.1 Agarose gel shows PCRs amplification products of sulphonamides 
resistance gene at 3 conserved regions. The target gene was 364 bp PCR products 
of class 1 integrase gene obtained from biosecure condition chicken caecal DNA 
samples G1 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 1.22.1, Lane 3 sul1 sample 1.22.2, Lane 
4 sul1 sample 1.22.3, Lane 5 sul1 sample 1.22.4, Lane 6 sul1 sample 1.22.5, Lane 7 sul1 
sample 1.22.6, Lane 8 sul1 sample 1.22.7, Lane 9 sul1 sample 1.24.1, Lane 10 sul1 sample 
1.24.2,  Lane 11 sul1 sample 1.24.3, Lane 12 sul1 sample 1.24.4, Lane 13 sul1 sample 
1.24.5, Lane 14 sul1 sample 1.24.6, Lane 15 sul1 sample 1.24.7, Lane 16 sul1-ve control, 
Lane 17 sul1+ve control, Lane 18 100 bp ladder (BioLab).   





Figure 2.5.2 Agarose gel shows PCRs amplification products of sulphonamides 
resistance gene at 3 conserved regions. The target gene was 364 bp PCR products 
of class 1 integrase gene obtained from biosecure condition chicken caecal DNA 
samples G1 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 1.28.1, Lane 3 sul1 sample 1.28.2, Lane 
4 sul1 sample 1.28.3, Lane 5 sul1 sample 1.28.4, Lane 6 sul1 sample 1.28.5, Lane 7 sul1 
sample 1.28.6, Lane 8 sul1 sample 1.28.7, Lane 9 sul1 sample 1.35.1, Lane 10 sul1 sample 
1.35.2, Lane 11 sul1 sample 1.35.4, Lane 12 sul1 sample 1.35.5, Lane 13 sul1 sample 
1.35.6, Lane 14 sul1 sample 1.35.7, Lane 15 sul1+ve control, Lane 16 sul1-ve control, 
Lane 17 100 bp ladder (BioLab). 
 
1     2   3   4    5    6    7   8    9  10  11  12  13  14  15 16   17  18  









Figure 2.5.3 Agarose gel shows PCRs amplification products of sulphonamides 
resistance gene at 3 conserved regions. The target gene was 364 bp PCR products 
of class 1 integrase gene obtained from biosecure condition chicken caecal DNA 
samples G2 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 2.22.1, Lane 3 sul1 sample 2.22.2, Lane 
4 sul1 sample 2.22.3, Lane 5 sul1 sample 2.22.4, Lane 6 sul1 sample 2.22.5, Lane 7 sul1 
sample 2.22.6, Lane 8 sul1 sample 2.22.7, Lane 9 sul1 sample 2.24.1, Lane 10 sul1 sample 
2.24.2, Lane 11 sul1 sample 2.24.3, Lane 12 sul1 sample 2.24.4, Lane 13 sul1 sample 
2.24.5, Lane 14 sul1 sample 2.24.6, Lane 15 sul1 sample 2.24.7, Lane 16 sul1-ve control, 






Figure 2.5.4 Agarose gel shows PCRs amplification products of sulphonamides 
resistance gene at 3 conserved regions. The target gene size was 364 bp of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
G2 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 2.28.1, Lane 3 sul1 sample 2.28.2, Lane 
4 sul1 sample 2.28.3, Lane 5 sul1 sample 2.28.4, Lane 6 sul1, sample 2.28.5, Lane 7 sul1 
sample 2.28.6, Lane 8 sul1 sample 2.28.7, Lane 9 sul1 sample 2.35.1, Lane 10 sul1 sample 
2.35.2, Lane 11 sul1 sample 2.35.3, Lane 12 sul1 sample 2.35.4, Lane 13 sul1 sample 
2.35.5, Lane 14 sul1 sample 2.35.6, Lane 15 sul1 sample 1.35.7, Lane 16 sul1-ve control, 
Lane 17 sul1+ve control, Lane 18 100 bp ladder (BioLab).    
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Figure 2.5.5 Agarose gel shows PCRs amplification products of sulphonamides 
resistance gene at 3 conserved regions. The target gene size was 364 bp of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
G3 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 3.22.1, Lane 3 sul1 sample 3.22.2, Lane 
4 sul1 sample 3.22.3, Lane 5 sul1 sample 3.22.4, Lane 6 sul1, sample 3.22.5, Lane 7 sul1 
sample 3.22.6, Lane 8 sul1 sample 3.22.7, Lane 9 sul1 sample 3.24.1, Lane 10 sul1 sample 
3.24.2, Lane 11 sul1 sample 3.24.3, Lane 12 sul1 sample 3.24.4. Lane 13 sul1 sample 
3.24.5, Lane 14 sul1 sample 3.24.6, Lane 15 sul1 sample 3.24.7, Lane 16 sul1-ve control, 







Figure 2.5.6 Agarose gel shows PCRs amplification products of sulphonamides 
resistance gene at 3 conserved regions. The target gene size was 364 bp of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
G3 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 3.28.1, Lane 3 sul1 sample 3.28.2, Lane 
4 sul1 sample 3.28.3, Lane 5 sul1 sample 3.28.4, Lane 6 sul1 sample 3.28.5, Lane 7 sul1 
sample 3.28.6, Lane 8 sul1 sample 3.28.7, Lane 9 sul1 sample 3.35.1, Lane 10 sul1 sample 
3.35.2, Lane 11 sul1 sample 3.35.3, Lane 12 sul1 sample 3.35.4 Lane 13 sul1 sample 
3.35.5, Lane 14 sul1 sample 3.35.6, Lane 15 sul1 sample 3.35.7, Lane 16 sul1-ve control, 
Lane 17 sul1+ve control.   
  1    2    3   4    5    6    7    8    9   10  11  12  13  14  15  16  17  18  




Figure 2.5.7 Agarose gel shows PCRs amplification products of sulphonamides 
resistance gene at 3 conserved regions. The target gene size was 364 bp of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
G4 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 4.22.1, Lane 3 sul1 sample 4.22.2, Lane 
4 sul1 sample 4.22.3, Lane 5 sul1 sample 4.22.4, Lane 6 sul1 sample 4.22.5, Lane 7 sul1 
sample 4.22.6, Lane 8 sul1 sample 4.22.7, Lane 9 sul1 sample 4.24.1, Lane 10 sul1 sample 
4.24.2, Lane 11 sul1 sample 4.24.3, Lane 12 sul1 sample 4.24.4, Lane 13 sul1 sample 
4.24.5, Lane 14 sul1 sample 4.24.6, Lane 15 sul1 sample 4.24.7, Lane 16 sul1-ve control, 
Lane 17 sul1+ve control, Lane 18 100 bp ladder (BioLab).                   
 
Figure 2.5.8 Agarose gel shows PCRs amplification products of sulphonamides 
resistance gene at 3 conserved regions. The target gene size was 364 bp of class 
1 integrase gene obtained from biosecure condition chicken caecal DNA samples 
G4 electrophoresed on a 1 % TAE gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 4.28.1, Lane 3 sul1 sample 4.28.2, Lane 
4 sul1 sample 4.28.3, Lane 5 sul1 sample 4.28.4, Lane 6 sul1 sample 4.28.5, Lane 7 sul1 
sample 4.28.6, Lane 8 sul1 sample 4.28.7, Lane 9 sul1 sample 4.35.1, Lane 10 sul1 sample 
4.35.2, Lane 11 sul1 sample 4.35.3, Lane 12 sul1 sample 4.35.4, Lane 13 sul1 sample 
4.35.5, Lane 14 sul1 sample 4.35.6, Lane 15 sul1 sample 4.35.7, Lane 16 sul1-ve control, 
Lane 17 sul1+ve control, Lane 18 100 bp ladder (BioLab).  
                  
 
 
1    2    3    4    5    6    7    8    9   10  11  12  13  14  15  16  17   18  
1    2    3    4    5    6    7    8    9   10 11  12   13  14  15  16  17  18  
343 
 







Figure 2.6.1 Agarose gel shows PCRs amplification products of quaternary 
ammonium compound resistance gene (qacE∆1) at 3 conserved region of class 1 
integrase gene obtained from biosecure condition chicken caecal DNA samples G1 
electrophoresed on a 1 % TAE gel. The target gene size is 200 bp.  
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 1.22.1, Lane 3 qacE∆1 sample 
1.22.2, Lane 4 qacE∆1 sample 1.22.3, Lane 5 qacE∆1 sample 1.22.4, Lane 6 qacE∆1 sample 
1.22.5, Lane 7 qacE∆1 sample 1.22.6, Lane 8 qacE∆1, sample 1.22.7, Lane 9 qacE∆1 
sample 1.24.1, Lane 10 qacE∆1 sample 1.24.2, Lane 11 qacE∆1 sample 1.24.3, Lane 12 
qacE∆1 sample 1.24.4, Lane 13 qacE∆1 sample 1.24.5, Lane 14 qacE∆1 sample 1.24.6, 
Lane 15 qacE∆1 sample 1.24.7 Lane 16 qacE∆1 -ve control, Lane 17 qacE∆1 +ve control, 





Figure 2.6.2 Agarose gel shows PCRs amplification products of quaternary 
ammonium compound resistance gene (qacE∆1) at 3 conserved region of class 1 
integrase gene obtained from biosecure condition chicken caecal DNA samples 
G1electrophoresed on a 1 % TAE gel. The target gene size is 200 bp.  
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 1.28.1, Lane 3 qacE∆1 sample 
1.28.2, Lane 4 qacE∆1 sample 1.28.3, Lane 5 qacE∆1 sample 1.28.4 , Lane 6 qacE∆1 
sample 1.28.5, Lane 7 qacE∆1 sample 1.28.6, Lane 8 qacE∆1 sample 1.28.7, Lane 9 qacE∆1 
sample 1.35.1, Lane 10 qacE∆1 sample 1.35.2, Lane 11 qacE∆1 sample 1.35.4, Lane 12 
qacE∆1 sample 1.35.5, Lane 13 qacE∆1 sample 1.35.6, Lane 14 qacE∆1 sample 1.35.7, 
Lane 15 qacE∆1 -ve control, Lane 16 qacE∆1 -ve control, Lane 17 100 bp ladder (BioLab). 
 
1    2    3   4     5    6    7    8    9   10  11  12   13   14  15  16   17   18  








Figure 2.6.3 Agarose gel shows PCRs amplification products of quaternary 
ammonium compound resistance gene (qacE∆1) at 3 conserved region of class 1 
integrase gene obtained from biosecure condition chicken caecal DNA samples G2 
electrophoresed on a 1 % TAE gel. The target gene size is 200 bp.  
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 2.22.1, Lane 3 qacE∆1 sample 
2.22.2, Lane 4 qacE∆1 sample 2.22.3, Lane 5 qacE∆1 sample 2.22.4 Lane 6 qacE∆1 sample 
2.22.5, Lane 7 qacE∆1 sample 2.22.6, Lane 8 qacE∆1 sample 2.22.7, Lane 9 qacE∆1 sample 
2.24.1, Lane 10 qacE∆1 sample 2.24.2, Lane 11 qacE∆1 sample 2.24.3, Lane 12 qacE∆1 
sample 2.24.4, Lane 13 qacE∆1 sample 2.24.5, Lane 14 qacE∆1 sample 2.24.6, Lane 15 
qacE∆1 sample 2.24.7, Lane 16 qacE∆1 -ve control, Lane 17 qacE∆1 +ve control, Lane 18 
100 bp ladder (BioLab).      
Figure 2.6.4 Agarose gel shows PCRs amplification products of quaternary 
ammonium compound resistance gene (qacE∆1) at 3 conserved region of class 1 
integrase gene obtained from biosecure condition chicken caecal DNA samples G2 
electrophoresed on a 1 % TAE gel. The target gene size is 200 bp 
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 2.28.1, Lane 3 qacE∆1 sample 
2.28.2, Lane 4 qacE∆1 sample 2.28.3, Lane 5 qacE∆1 sample 2.28.4, Lane 6 qacE∆1 sample 
2.28.5, Lane 7 qacE∆1 sample 2.28.6, Lane 8 qacE∆1, sample 2.28.7, Lane 9 qacE∆1 
sample 2.35.1, Lane 10 qacE∆1 sample 2.35.2, Lane 11 qacE∆1 sample 2.35.3, Lane 12 
qacE∆1 sample 2.35.4, Lane 13 qacE∆1 sample 2.35.5, Lane 14 qacE∆1 sample 2.35.6, 
Lane 15 qacE∆1 sample 2.35.7, Lane 16 qacE∆1 -ve control, Lane 18 100 bp ladder 
(BioLab). 
 
1    2    3    4    5   6     7    8    9   10  11  12   13  14   15  16  17   18  







Figure 2.6.5 Agarose gel shows PCRs amplification products of quaternary 
ammonium compound resistance gene (qacE∆1) at 3 conserved region of class 1 
integrase gene obtained from biosecure condition chicken caecal DNA samples G3 
electrophoresed on a 1 % TAE gel. The target gene size is 200 bp. 
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 3.22.1, Lane 3 qacE∆1 sample 
3.22.2, Lane 4 qacE∆1 sample 3.22.3, Lane 5 qacE∆1 sample 3.22.4, Lane 6 qacE∆1 sample 
3.22.5, Lane 7 qacE∆1 sample 3.22.6, Lane 8 qacE∆1 sample 3.22.7, Lane 9 qacE∆1 sample 
3.24.1, Lane 10 qacE∆1 sample 3.24.2, Lane 11 qacE∆1 sample 3.24.3, Lane 12 qacE∆1 
sample 3.24.4, Lane 13 qacE∆1 sample 3.24.5, Lane 14 qacE∆1 sample 3.24.6, Lane 15 
qacE∆1 sample 3.24.7, Lane 16 qacE∆1-ve control, Lane 17 qacE∆1+ve control, Lane 18 
100 bp ladder (BioLab).  






Figure 2.6.6 Agarose gel shows PCRs amplification products of quaternary 
ammonium compound resistance gene (qacE∆1) at 3 conserved region of class 1 
integrase gene obtained from biosecure condition chicken caecal DNA samples G3 
electrophoresed on a 1 % TAE gel. The target gene size is 200 bp. 
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 3.28.1, Lane 3 qacE∆1 sample 
3.28.2, Lane 4 qacE∆1 sample 3.28.3, Lane 5 qacE∆1 sample 3.28.4, Lane 6 qacE∆1 sample 
3.28.5, Lane 7 qacE∆1 sample 3.28.6, Lane 8 qacE∆1 sample 3.28.7, Lane 9 qacE∆1 sample 
3.35.1, Lane 10 qacE∆1 sample 3.35.2, Lane 11 qacE∆1 sample 3.35.3, Lane 12 qacE∆1 
sample 3.35.4, Lane 13 qacE∆1 sample 3.35.5, Lane 14 qacE∆1 sample 3.35.6, Lane 15 
qacE∆1 sample 3.35.7, Lane 16 qacE∆1 -ve control, Lane 18 100 bp ladder (BioLab).   
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Figure 2.6.7 Agarose gel shows PCRs amplification products of quaternary 
ammonium compound resistance gene (qacE∆1) at 3 conserved region of class 1 
integrase gene obtained from biosecure condition chicken caecal DNA samples G4 
electrophoresed on a 1 % TAE gel. The target gene size is 200 bp. 
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 4.22.1, Lane 3 qacE∆1 sample 
4.22.2, Lane 4 qacE∆1 sample 4.22.3, Lane 5 qacE∆1 sample 4.22.4, Lane 6 qacE∆1 sample 
4.22.5, Lane 7 qacE∆1 sample 4.22.6, Lane 8 qacE∆1 sample 4.22.7, Lane 9 qacE∆1 sample 
4.24.1, Lane 10 qacE∆1 sample 4.24.2, Lane 11 qacE∆1 sample 4.24.3, Lane 12 qacE∆1 
sample 4.24.4, Lane 13 qacE∆1 sample 4.24.5, Lane 14 qacE∆1 sample 4.24.6, Lane 15 
qacE∆1 sample 4.24.7 Lane 16 qacE∆1 -ve control, Lane 17 qacE∆1 +ve control, Lane 18 






Figure 2.6.8 Agarose gel shows PCRs amplification products of quaternary 
ammonium compound resistance gene (qacE∆1) at 3 conserved region of class 1 
integrase gene obtained from biosecure condition chicken caecal DNA samples G4 
electrophoresed on a 1 % TAE gel. The target gene size is 200 bp. 
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 4.28.1, Lane 3 qacE∆1 sample 
4.28.2, Lane 4 qacE∆1 sample 4.28.3, Lane 5 qacE∆1 sample 4.28.4, Lane 6 qacE∆1 sample 
4.28.5, Lane 7 qacE∆1 sample 4.28.6, Lane 8 qacE∆1 sample 4.28.7, Lane 9 qacE∆1 sample 
4.35.1, Lane 10 qacE∆1 sample 4.35.2, Lane 11 qacE∆1 sample 4.35.3, Lane 12 qacE∆1 
sample 4.35.4, Lane 13 qacE∆1 sample 4.35.5, Lane 14 qacE∆1 sample 4.35.6, Lane 15 
qacE∆1 sample 4.35.7, Lane 16 qacE∆1 -ve control, Lane 17 qacE∆1 +ve control, Lane 18 
100 bp ladder (BioLab). 
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Appendix 2.7 Table 2.7.1 The prevalence of conserved genes of class 1 
integrons of caecal contents of commercial birds 
Sample feed type age 
intI1 
Ravi 
intI1 EB intI1 H intl1 C sul1 qacEΔ1 
1 ctl 30 ￚ ￚ ￚ ￚ ￚ ₊ 
2 ctl 30 ₊ ￚ ₊ ₊ ₊ ₊ 
3 ctl 30 ₊ ￚ ₊ ₊ ₊ ₊ 
4 ctl 30 ￚ ￚ ₊ ￚ ₊ ₊ 
5 ctl 30 ₊ ₊ ₊ ₊ ₊ ₊ 
6 ctl 30 ₊ ￚ ₊ ￚ ₊ ₊ 
7 ctl 30 ₊ ￚ ₊ ￚ ₊ ₊ 
8 ctl 30 ₊ ₊ ₊ ₊ ₊ ₊ 
9 ctl 30 ₊ ￚ ₊ ₊ ₊ ₊ 
10 ctl 30 ₊ ￚ ₊ ₊ ₊ ₊ 
11 GOS 30 ₊ ￚ ₊ ₊ ₊ ₊ 
12 GOS 30 ₊ ￚ ₊ ₊ ₊ ₊ 
13 GOS 30 ₊ ￚ ￚ ￚ ₊ ₊ 
14 GOS 30 ₊ ₊ ￚ ₊ ₊ ₊ 
15 GOS 30 ₊ ￚ ₊ ₊ ₊ ₊ 
16 GOS 30 ₊ ₊ ₊ ₊ ₊ ₊ 
17 GOS 30 ₊ ￚ ₊ ￚ ₊ ₊ 
18 GOS 30 ₊ ₊ ₊ ₊ ₊ ₊ 
19 GOS 30 ₊ ￚ ₊ ₊ ₊ ₊ 
20 GOS 30 ₊ ₊ ₊ ₊ ₊ ₊ 
21 GOS 37 ₊ ₊ ₊ ₊ ₊ ₊ 
22 GOS 37 ₊ ￚ ₊ ￚ ₊ ₊ 
23 GOS 37 ₊ ₊ ₊ ₊ ₊ ₊ 
24 GOS 37 ₊ ₊ ₊ ₊ ₊ ₊ 
25 GOS 37 ₊ ₊ ₊ ₊ ₊ ₊ 
26 GOS 37 ￚ ￚ ₊ ₊ ₊ ₊ 
27 GOS 37 ₊ ₊ ₊ ₊ ₊ ₊ 
28 GOS 37 ₊ ₊ ₊ ₊ ₊ ₊ 
29 GOS 37 ₊ ₊ ₊ ₊ ₊ ₊ 
30 GOS 37 ₊ ₊ ₊ ₊ ₊ ₊ 
31 ctl 37 ₊ ￚ ₊ ₊ ₊ ₊ 
32 ctl 37 ₊ ￚ ₊ ₊ ₊ ₊ 
33 ctl 37 ₊ ￚ ₊ ₊ ₊ ₊ 
34 ctl 37 ₊ ￚ ₊ ₊ ₊ ₊ 
35 ctl 37 ₊ ￚ ₊ ₊ ₊ ₊ 
36 ctl 37 ₊ ￚ ₊ ￚ ₊ ₊ 
37 ctl 37 ₊ ￚ ₊ ₊ ₊ ₊ 
38 ctl 37 ₊ ￚ ₊ ₊ ₊ ₊ 
39 ctl 37 ₊ ￚ ₊ ￚ ₊ ₊ 
40 ctl 37 ₊ ₊ ₊ ￚ ₊ ₊ 
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Appendix 2.8 The PCR ampilicon product of class 1 integron (intl1 Ravi, 






Figure 2.8.1 The PCR amplification using the IntI1 Ravi (546 bp), IntI1 EB (254 
bp) and sul1 (346 bp) primers to examine the presence of resistance genes in 
commercial chicken’s caecal DNA (sample 1-7). 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 1, Lane 3 IntI1 Ravi sample 2, 
Lane 4 IntI1 Ravi sample 3, Lane 5 IntI1 Ravi sample 4, Lane 6 IntI1 Ravi sample 5, Lane 
7 IntI1 Ravi sample 6, Lane 8 IntI1 Ravi sample 7, Lane 9 IntI1 Ravi –ve control, Lane 10 
IntI1 EB sample 1, Lane 11 IntI1 EB sample 2, Lane 12 IntI1 EB sample 3, Lane 13 IntI1 
EB sample 4, Lane 14 IntI1 EB sample 5, Lane 15 IntI1 EB sample 6, Lane 16 IntI1 EB 
sample 7, Lane 17 IntI1 EB +ve control, Lane 18 sul1 sample 1, Lane 19 sul1 sample 2, 
Lane 20 sul1 sample 3. 
 
 
   
 
Figure 2.8.2 PCR amplification using the sul1 (346 bp) and intl1 H primer (471 
bp) to examine the presence of sulphonamides and integrase resistance genes in 
commercial chicken’s caecal DNA (sample 1-7). 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 4, Lane 3 sul1 sample 5, Lane 4 sul1 
sample 6, Lane 5 sul1 sample 7, Lane 6 sul1 S.T.U288, Lane 7 sul1 –ve control, Lane 8 
intl1 H sample 1, Lane 9 intl1 H sample 2, Lane 10 intl1 H sample 3, Lane 11 intl1 H sample 
4, Lane 12 intl1 H sample 5, Lane 13 intl1 H sample 6, Lane 14 intl1 H sample 7, Lane 15 
intl1 H –ve control, Lane 16 intl1 H S.T.U288, Lane 17 intl1 Ravi +ve, Lane 18 +ve EB, 
Lane 19 –ve qacE∆1, Lane 20 +ve control  
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Figure 2.8.3 The PCR amplification using the intl1 C (311 bp) and qacE∆1 (200 
bp) to examine the presence of integrase resistance genes in commercial 
chicken’s caecal DNA (sample 1-7). 
Lane 1 100 bp ladder (BioLab), Lane 2 intl1 C sample 1, Lane 3 intl C sample 2, Lane 4 
intl1 C sample 3, Lane 5 intl1 C sample 4, Lane 6 intl1 C sample 5, Lane 7 intl C sample 6, 
Lane 8 intl1 C sample 7 Lane 9 intl1 C –ve, Lane 10 intl1 C +ve, Lane 11 qacE∆ sample 1, 
Lane 12 qacE∆1 sample 2, Lane 13 qacE∆1 sample 3, Lane 14 qacE∆1 sample 4, Lane 15 
qacE∆1 sample 5, Lane 16 qacE∆1 sample 6, Lane 17 qacE∆1 sample 7, Lane 18 qacE∆1 
S.T U288, Lane 19 qacE∆1 -ve control,  Lane 20 100 bp ladder DNA. 
Appendix 2.9 The PCR ampilicon product of class 1 integron (intl1 Ravi, 






Figure 2.9.1 The PCR amplification using the IntI1 Ravi (546 bp) and IntI1 EB 
(254 bp) primers to examine the presence of resistance genes in commercial 
chicken’s caecal DNA (sample 8-16). 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 8, Lane 3 IntI1 Ravi sample 9,  
Lane 4 IntI1 Ravi sample 10, Lane 5 IntI1 Ravi sample 11, Lane 6 IntI1 Ravi sample 12, 
Lane 7 IntI1 Ravi sample 13, Lane 8 IntI1 Ravi sample 14, Lane 9 IntI1 Ravi sample 15, 
Lane 10 IntI1 Ravi sample 16, Lane 11 IntI1 Ravi +ve control, Lane 12 IntI1 –ve control, 
Lane 13 IntI1 EB sample 8, Lane 14 IntI1 EB sample 9, Lane 15 IntI1 EB sample 10, Lane 
16 IntI1 EB sample 11, Lane 17 IntI1 EB sample 12,  Lane 18 IntI1 EB sample 13, Lane 19 
IntI1 EB sample 14, Lane 20 100 bp ladder (BioLab). 
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Figure 2.9.2 The PCR amplification using the IntI1 EB (254 bp), sul1 (346 bp) and 
intl1 H (471 bp) primers to examine the presence resistance genes in commercial 
chicken’s caecal DNA (sample 8-16). 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 EB sample 15, Lane 3 IntI1 EB sample 16, 
Lane 4 IntI1 EB +ve control, Lane 5 IntI1 EB -ve control, Lane 6 sul1 sample 8, Lane 7 sul1 
sample 9, Lane 8 sul1 sample 10, Lane 9 sul1 sample 11 Lane 10 sul1 sample 12, Lane 11 
sul1 sample 13, Lane 12 sul1 sample 14, Lane 13 sul1 sample 15, Lane 14 sul1 sample 16, 
Lane 15 sul1 S.T.U 288, Lane 16 sul1 –ve, Lane 17 intl1 H sample 8, Lane 18 intl1 H sample 
9, Lane 19 intl1 H sample 10, Lane 20 100 bp ladder (BioLab).                            
Figure 2.9.3 The PCR amplification using the intl1 H (471 bp) and intl1 C (311 bp) 
to examine the presence of integrase resistance genes in commercial chicken’s 
caecal DNA (sample 8-16). 
Lane 1 100 bp ladder (BioLab), Lane 2 intl1 H sample 11, Lane 3 intl1 H sample 12, Lane 
4 intl1 H sample 13, Lane 5 intl1 H sample 14, Lane 6 intl1 H sample 15, Lane 7 intl1 H 
sample 16, Lane 8 intl1 H S.T.U288 (+ve control ), Lane 9 intl1 H  -ve control, 10 empty, 
Lane 11 intl C sample 8, Lane 12 intl C sample 9,  Lane 13 intl C sample 10, Lane 14 int1l 
C sample 11, Lane 15 intl C sample 12, Lane 16 intl C sample 13, Lane 17 int1l C sample 
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Figure 2.9.4 The PCR amplification using the intl1 C (311 bp) and qacE∆1 (200 
bp) to examine the presence of integrase resistance genes in commercial 
chicken’s caecal DNA (sample 8-16). 
Lane 1 100 bp ladder (BioLab), Lane 2 intl C +ve , Lane 3 intl C –ve, Lane 4 qacE∆ sample 
8, Lane 5 qacE∆1sample 9, Lane 6 qacE∆1 sample 10, Lane 7 qacE∆1 sample 11, Lane 8 
qacE∆1 sample 12, Lane 9 qacE∆1 sample 13, Lane 10 qacE∆1 sample 14, Lane 11 qacE∆1  
sample 15, Lane 12 qacE∆1 sample 16, Lane 13 qacE∆1 S.T U288,  Lane 14 qacE∆1 -ve 
control, Lane 15 100 bp Ladder DNA.  
Appendix 2.10 The PCR ampilicon product of class 1 integron (intl1 ravi, 
intl1 EB, sul1 and qacE∆1) of commerical birds (Samples 17-26)  
 
Figure 2.10.1 The PCR amplification using the IntI1 Ravi (546 bp) and IntI1 EB 
(254 bp) primers to examine the presence of resistance genes in commercial 
chicken’s caecal DNA (sample 17-26). 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 17, Lane 3 IntI1 Ravi sample 18, 
Lane 4 IntI1 Ravi sample 19, Lane 5 IntI1 Ravi sample 20, Lane 6 IntI1 Ravi sample 21, 
Lane 7 IntI1 Ravi sample 22, Lane 8 IntI1 Ravi sample 23, Lane 9 IntI1 Ravi sample 24, 
Lane 10 IntI1 Ravi sample 25, Lane 11 IntI1 Ravi sample 26, Lane 12 IntI1 +ve control, 
Lane 13 IntI1 Ravi -ve control, Lane 14 IntI1 EB sample 17, Lane 15 IntI1 EB sample 18, 
Lane 16 IntI1 EB sample 19, Lane 17 IntI1 EB sample 20,  Lane 18 IntI1 EB sample 21, 
Lane 19 IntI1 EB sample 22, Lane 20 100 bp ladder (BioLab). 
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Figure 2.10.2 The PCR amplification using the IntI1 EB (254 bp) and sul1 (346 
bp) to examine the presence resistance genes in commercial chicken’s caecal DNA 
(sample 17-26). 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 EB sample 23, Lane 3 IntI1 EB sample 24, 
Lane 4 IntI1 EB sample 25, Lane 5 IntI1 EB sample 26, Lane 6 IntI1 EB +ve control, Lane 
7 IntI1 EB –ve control, Lane 8 sul1 sample 17, Lane 9 sul1 sample 18, Lane 10 sul1 sample 
19, Lane 11 sul1 sample 20, Lane 12 sul1 sample 21, Lane 13 sul1 sample 22, Lane 14 
sul1 sample 23, Lane 15 sul1 sample 24, Lane 16 sul1 sample 25, Lane 17 sul1 sample 26, 




Figure 2.10.3 The PCR amplification using the intl1 H (471 bp) and intl1 C (311 
bp) to examine the presence of integrase resistance genes in commercial 
chicken’s caecal DNA (sample 17-26). 
Lane 1 100 bp ladder, Lane 2 intl1 H sample 17, Lane 3 intl1 H sample 18, Lane 4 intl1 H 
sample 19, Lane 5 intl1 H sample 20, Lane 6 intl1 H sample 21,  Lane 7 intl1 H sample 22, 
Lane 8 intl1 H sample 23, Lane 9 intl1 H sample 24  Lane 10 intl1 H sample 25, Lane 11 
intl1 H sample 26, Lane 12 intl1 H S.T.U288 (+ve control )Lane 13 int1l H –ve, Lane 14 
intl1 C sample 17, Lane 15 intl1 C, sample 18,  Lane 16 intl1 C sample 19, Lane 17 intl1 C 
sample 20, Lane 18 intl1 C sample 21, Lane 19 intl1 C sample 22, Lane 20 100 bp ladder 
DNA.   
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Figure 2.10.4 The PCR amplification using the intl1 C (311 bp) and qacE∆1 (200 
bp) to examine the presence of integrase resistance genes in commercial chickens 
caecal DNA (sample 17-26). 
Lane 1 100 bp ladder, Lane 2 intl1 C sample 23, Lane 3 intl1 C sample 24,  Lane 4 intl1 C 
sample 25, Lane 5 intl1 C sample 26, Lane 6 intl1 C +ve, Lane 7 intl1 C –ve, Lane 8 qacE∆1 
sample17, Lane 9 qacE∆1 sample 18,  Lane 10 qacE∆1 sample 19, Lane 11 qacE∆1 sample 
20 , Lane 12 qacE∆1 sample 21, Lane 13 qacE∆1 sample 22, Lane 14 qacE∆1 sample 23, 
Lane 15 qacE∆1 sample 24, Lane 16 qacE∆1 sample 25, Lane 17 qacE∆1 sample 26, Lane 
18 qacE∆1 E∆1-ve. 
Appendix 2.11 The PCR ampilicon product of class 1 integron (intl1 ravi, 




Figure 2.11.1 The PCR amplification using the IntI1 Ravi (546 bp) and IntI1 EB 
(254 bp) primers to examine the presence of resistance genes in commercial 
chickens caecal DNA (sample 27-40). 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 Ravi sample 27, Lane 3 IntI1 Ravi sample 28, 
Lane 4 IntI1 Ravi sample 29, Lane 5 IntI1 Ravi sample 30, Lane 6 IntI1 Ravi sample 31, 
Lane 7 IntI1 Ravi sample 32, Lane 8 IntI1 Ravi sample 33, Lane 9 IntI1 Ravi sample 34, 
Lane 10 IntI1 Ravi sample 35, Lane 11 IntI1 Ravi sample 36, Lane 12 IntI1 Ravi sample 
37, Lane 13 IntI1 Ravi sample 38, Lane 14 IntI1 Ravi sample 39, Lane 15 IntI1 Ravi sample 
40 Lane 16 IntI1 +ve control, Lane 17 IntI1 Ravi -ve control, Lane 18 IntI1 EB sample 27, 
Lane 19 IntI1 EB sample 28, Lane 20 100 bp ladder (BioLab).  
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Figure 2.11.2 The PCR amplification using the IntI1 EB (254 bp) and sul1 (346 
bp) to examine the presence resistance genes in commercial chickens caecal DNA 
(sample 27-40). 
Lane 1 100 bp ladder (BioLab), Lane 2 IntI1 EB sample 29, Lane 3 IntI1 EB sample 30, 
Lane 4 IntI1 EB sample 31, Lane 5 IntI1 EB sample 32, Lane 6 IntI1 EB sample 33, Lane 7 
IntI1 EB sample 34, Lane 8 IntI1 EB sample 35, Lane 9 IntI1 EB sample 36, Lane 10 IntI1 
EB sample 37, Lane 11 IntI1 EB sample 38, Lane 12 IntI1 EB sample 39, Lane 13 IntI1 EB 
sample 40, Lane 14 IntI1 EB +ve control, Lane 15 IntI1 EB–ve control, Lane 16 sul1 sample 
27, Lane 17 sul1 sample 28, Lane 18 sul1 sample 29, Lane 19 sul1 sample 30, Lane 20 100 






Figure 2.11.3 The PCR amplification using the sul1 (346 bp) and intl1 H (471 bp) 
to examine the presence of integrase resistance genes in commercial chickens 
caecal DNA (sample 27-40). 
Lane 1 100 bp ladder (BioLab), Lane 2 sul1 sample 31, Lane 3 sul1 sample 32 Lane 4 sul1 
sample 33, Lane 5 sul1 sample 34, Lane 6 sul1 sample 35, Lane 7 sul1 sample 36, Lane 8 
sul1 sample 37, Lane 9 sul1 sample 38,Lane 10 sul1 sample 39, Lane 11 sul1 sample 40, 
Lane 12 sul1 S.T.U 288, Lane 13 sul1–ve, Lane 14 intl1 H sample 27, Lane 15 intl1 H 
sample 28, Lane 16 intl1 H sample 29, Lane 17 intl1 H sample 30, Lane 18 intl1 H sample 
31, Lane 19 intl1 H sample 32, Lane 20 100 bp ladder (BioLab).   
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Figure 2.11.4 The PCR amplification using the intl1 C (311 bp) and qacE∆1 (200 
bp) to examine the presence of integrase resistance genes in commercial chickens 
caecal DNA (sample 27-40). 
Lane 1 100 bp ladder (BioLab), Lane 2 intl1 H sample 33, Lane 3 intl1 H sample 34,  Lane 
4 intl1 H sample 35, Lane 5 intl1 H sample 36, Lane 6 intl1 H sample 37, Lane 7 intl1 H 
sample 38, Lane 8 intl1 H sample 39, Lane 9 intl1 H sample 40,  Lane 10 intl1 H S.T.U288, 
Lane 11 intl1 H –ve control, Lane 12 qacE∆1 sample 27, Lane 13 qacE∆1 sample 28, Lane 
14 qacE∆1 sample 29, Lane 15 qacE∆1 sample 30,  Lane 16 qacE∆1 sample 31, Lane 17 
qacE∆1 sample 32, Lane 18 qacE∆1 sample 33,Lane 19 qacE∆1 sample 34,Lane 20 100 bp 





Figure 2.11.5 The PCR amplification using the intl1 C (311 bp) and qacE∆1 (200 
bp) to examine the presence of integrase resistance genes in commercial chickens 
caecal DNA (sample 27-40). 
Lane 1 100 bp ladder (BioLab), Lane 2 qacE∆1 sample 35, Lane 3 qacE∆1 sample 36, Lane 
4 qacE∆1 sample 37, Lane 5 qacE∆1 sample 38, Lane 6 qacE∆1 sample 39, Lane 7 qacE∆1 
sample 40, Lane 8 qacE∆1 S.T U288, Lane 9 qacE∆1 -ve control, Lane 10 intl1 C sample 
27, Lane 11 intl1 C sample 28, Lane 12 intl1 C sample 29, Lane 13 intl1 C sample 30, Lane 
14 intl1 C sample 31,Lane 15 intl1 C sample 32, Lane 16 intl1 C sample 33, Lane 17 intl1 
C sample 34 , Lane 18 int1l C sample 35, Lane 19 intl1 C sample 36, Lane 20 100 bp ladder         
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Figure 2.11.6 The PCR amplification using the intl1 C (311 bp) to examine 
the presence of integrase resistance genes in commercial chickens caecal 
DNA (sample 27-40). 
Lane 1 100 bp ladder (BioLab), Lane 2 intl1 C sample 37, Lane 3 intl1 C sample 
38 Lane 4 intl1 C sample 39, Lane 5 intl1 C sample 40, Lane 6 int1l C +ve, Lane 
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Figure 2.12. 1A The PCR amplification of GCs of broiler caecal DNA by using four 
different primers (Table 2.5, Chapter 2) for selecting optimum primers (1 min 
extension time) electrophoresed on 0.8% TAE agarose gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 long range Ravi sample 1, Lane 3 long range Ravi 
sample 2, Lane 4 long range Ravi sample 3, Lane 5 long range Ravi sample 4, Lane 6 long 
range Ravi sample 5, Lane 7 long range Ravi +ve control, Lane 8 long range Ravi -ve 
control. Lane 9 MRG 284/285 sample 1, Lane 10 MRG 284/285 sample 2, Lane 11 MRG 
284/285 sample 3, Lane 12 MRG 284/285 sample 4, Lane 13 MRG 284/285 sample 5, Lane 
14 MRG 284/285 +ve, Lane 15 MRG 284/285 –ve, Lane 16 ntf2/qcr2 sample 1, Lane 17 
ntf2/qcr2 sample 2, Lane 18 ntf2/qcr2 sample 3, Lane 19 ntf2/qcr2 sample 4, Lane 20 1 







Figure 2.12.2A The PCR amplification of GCs of broiler caecal DNA by using four 
different primers (Table 2.5, Chapter 2) for selecting optimum primers (1 min 
extension time) electrophoresed on 0.8% TAE agarose gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 ntf2/qcr2 sample 5, Lane 3 ntf2/qcr2 -ve, Lane 4 
ntf2/qcr2 +ve control, Lane 5 F-Ravi/R-qacEΔ1 sample 1, Lane 6 F-Ravi/R- qacEΔ1 sample 
2, Lane 7 F-Ravi/R-qacEΔ1 sample 3, Lane 8 F-Ravi/R-qacEΔ1 sample 4, Lane 9 F-Ravi/R-
qacEΔ1, sample 5, Lane 10 F-Ravi/R-qacEΔ1 +ve control, Lane 11 F-Ravi/R-qacEΔ1 -ve 
control, Lane 12 1 kb ladder (BioLab).    
 
   1       2       3      4       5       6      7      8      9     10     11    12    13   14     15    16    17    18    19   20 
long range Ravi MRG 284/285 ntf2/qcr2 













Figure 2.12.1B The PCR amplification of GCs of broiler caecal DNA by using four 
different primers (Table 2.5, Chapter 2) for selecting optimum primers (3 min 
extension time) electrophoresed on 0.8% TAE agarose gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 long range Ravi sample 1, Lane 3 long range Ravi 
sample 1 (Replicate), Lane 4 long range Ravi sample 2, Lane 5 long range Ravi sample 2, 
Lane 6 long range Ravi sample 3, Lane 7 long range Ravi sample 3, Lane 8 long range Ravi 
sample 4, Lane 9 long range Ravi sample 4, Lane 10 long range Ravi +ve control,  Lane 11 
long range Ravi -ve control, Lane 12 MRG 284/285 sample 1, Lane 13 MRG 284/285 sample 
1, Lane 14 MRG 284/285 sample 2, Lane 15 MRG 284/285 sample 2, Lane 16 MRG 284/285 
sample 3, Lane 17 MRG 284/285 sample 3, Lane 18 MRG 284/285 sample 4, Lane 19 MRG 






Figure 2.12.2B The PCR amplification of GCs of broiler caecal DNA by using four 
different primers (Table 2.5, Chapter 2) for selecting optimum primers (3 min 
extension time) electrophoresed on 0.8% TAE agarose gel. 
Lane 1 100 bp ladder (BioLab), Lane 2 MRG 284/285 +ve, Lane 3 MRG 284/285 –ve, Lane 
4 ntf2/qcr2 sample 1, Lane 5 ntf2/qcr2 sample 2, Lane 6 ntf2/qcr2 sample 3, Lane 7 
ntf2/qcr2 sample 4, Lane 8 ntf2/qcr2 sample 5, Lane 9 ntf2/qcr2 sample 6, Lane 10 
ntf2/qcr2 sample 7,  Lane 11 ntf2/qcr2 sample 8, Lane 12 ntf2/qcr2 sample 9, Lane 20  
1 kb ladder (BioLab). 
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Appendix 2.13 The gene cassettes sequence data 












































Figure 2.13.2 Class_ 1 _integron group_B-1 (dfrA1), hypothetical protein, and 
































































































































































Appendix 2.14 The insertion of three Gs in integrase gene sequence found 
in commercial flock samples compared with the same GC components in 

























Figure 3.1 Rarefactions curves of observed OTUs of caecal samples 
microbiota collected from A biosecure birds and B commercial birds. 
A-biosecured birds 



















































































































































Figure 3.2 The relative abundance of Proteobacteria phylum in control 
diet groups. 
A-biosecure birds  


















Data not normally distributed at 22 da (Shapiro-Wilk normality test= 0.0215), 
however other sampling points show data normally distributed across cohorts (p-
value 0.0957, 0.05, 0.0807 respectively).  
 
B-commercial birds   
















The abundance of Proteobacteria was not normally distributed at 30 da (Shapiro-
Wilk normality test= 0.0001), while this abundance of Proteobacteria was normally 
distributed at 37 da (p-value=0.2762)
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The phylogenetic tree of Proteobacteria phylum shows the OTUs associated with distribution of GCs groups in broiler chicken microbiota 




The phylogenetic tree of Proteobacteria phylum shows the OTUs associated with distribution of GCs groups in broiler chicken microbiota 






Figure 3.4 QQ plot of control fed birds (all sampling days) reared in 
controlled housed conditions 
A-inverse-Simpson index 
 

















Normality test for invsimpson index CH birds
 
Data not normally distributed (Shapiro-Wilk normality test) mainly at 24 da (p-
value 0.0279) however other sampling days are normally distributed p-value 
>0.05 as it passes normality tests. 

















Normality test for Chao index CH birds
 
Data not normally distributed based Shapiro-Wilk normality test indicated that at 
day 28 data not normally distributed but the other sampling days are normally 
distributed as it passes both normality tests (p-value respectively of all Sampling 
da are: 0.8737, 0.7649, 0.0378 and 0.4811. 
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Figure 3.5 QQ plot of control fed birds (all sampling days) reared in 
commercial conditions  
A-inverse-Simpson index 
















Normality test for invsimpson index commberical birds
 
Data normally distributed at 30 and 37 da (Shapiro-Wilk normality test= 0.7348, 
0.2637 respectively) therefore it passes normality tests.  
 
B-Chao index  
 

















Normality test for Chao index commberical birds
 
Data normally distributed at 30 and 37 da (Shapiro-Wilk normality test= 0.4431, 





Figure 4.1 Rarefactions curves of observed OTUs of caecal samples 
microbiota collected from A biosecure birds and B commercial birds. 
A-biosecure birds  






























































































































































































































































































Figure 4.2 The relative abundance of Proteobacteria phylum in control and 



























































The data were not normally distributed in control diet at 22 da (Shapiro-Wilk 
normality test= 0.0215), however other sampling points show the data are 


















ctl-com-37 da gos-com-37 da
Normal QQ plot













ctl-com-30 da gos-com-30 da
 
The abundance of Proteobacteria was not normally distributed at control-30 da 
(Shapiro-Wilk normality test= 0.0001), while all other sampling points for both 




Appendix 4.3.1 The coincidence of resistance GCs arrays in Proteobacteria phylum of biosecure birds. Figure A shows distribution of GCs 
and Figure B demonstrates feed type 
 1-Biosecured birds-22 da  
 
 
The scale bar represents a sequence divergence of 3%. The bacterial OTUs are: OTU 0324 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), 
OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is Gamma-proteobacteria (Proteus). 
* ND not detected. 
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 Appendix 4.3.2 The abundance of resistance GCs arrays in Proteobacteria phylum in biosecure housing birds. Figure A shows distribution 
of GCs and Figure B demonstrates feed type 
 2-Biosecure birds-24 da 
 
The scale bar represents a sequence divergence of 3%. The bacterial OTUs are: OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), 
OTU 0169 is Gamma-proteobacteria (Proteus). 
 * ND not detected. 
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Appendix 4.3.3 The abundance of resistance GCs arrays in Proteobacteria phylum in biosecure housing birds. Figure A shows distribution 
of GCs and Figure B demonstrates feed type 










The scale bar represents a sequence divergence of 3%. The bacterial OTUs are: OTU 0324 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), 
OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is Gamma-proteobacteria (Proteus). 
* ND not detected. 
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Appendix 4.3.4 The abundance of resistance GCs arrays in Proteobacteria phylum in biosecure housing birds. Figure A shows distribution 
of GCs and Figure B demonstrates feed type 










The scale bar represents a sequence divergence of 3%. The bacterial OTUs are: OTU 0324 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), 
OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU 0169 is Gamma-proteobacteria (Proteus). 
* ND not detected. 
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Appendix 4.4.1 The abundance of resistance GCs arrays in Proteobacteria phylum in commercial birds. Figure A shows distribution of GCs 
and Figure B demonstrates feed type 
1-Commerical birds-30 da 
 
 
The scale bar represents a sequence divergence of 3%. The bacterial OTUs are: OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), 
OTU 0169 is Gamma-proteobacteria (Proteus), OTU0176 is Alpha-proteobacteria (Aestuariispira), OTU0070 is Beta-proteobacteria (Parasutterella), 
OTU0276 is Proteobacteria_unclassified. 
* ND not detected. 
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Appendix 4.4.2 The abundance of resistance GCs arrays in Proteobacteria phylum in commercial birds. Figure A shows distribution of GCs 
and Figure B demonstrates feed type 














The scale bar represents a sequence divergence of 3%. The bacterial OTUs are: OTU0041 is Epsilonproteobacteria (Campylobacter), OTU0176 is Alpha-
proteobacteria (Aestuariispira), OTU0474 is Alpha-proteobacteria_unclassified, OTU0471 is Alpha-proteobacteria (Alphaproteobacteria_unclassified 
OTU0007 is Gamma-proteobacteria (Enterobacteriaceae_unclassified), OTU0070 is Beta-proteobacteria  (Parasutterella), OTU0276 is 





Appendix 4.5 QQ plot of normality test of control and GOS diets (all 
sampling days) for controlled housed birds or biosecure reading birds 
A-inverse-Simpson index 












ctl-bio-22 da gos-bio-22 da












ctl-bio-24 da gos-bio-24 da















Normal QQ plot 28 da














ctl-bio-35 da gos-bio-35 da
Normal QQ plot 35 da
 
The Shapiro-Wilk normality test shows that inverse Simpson data were not not 
normally distributed at control-24 da (p-value 0.0279) however other sampling 






B-Chao index  















Normal QQ plot Chao index 22da








































Normal QQ plot Chao index 35 da
 
The Shapiro-Wilk normality test shows that Chao index data were not normally 
distributed at control-28 da (p-value 0.0378) however other sampling days are of 









Appendix 4.6 QQ plot of normality test of control and GOS diets (all 
sampling days) for commercial birds 
A-inverse-Simpson index 













Normal QQ plot inv-Simpson index 30 da














Normal QQ plot inv-Simpson index 37 da
 
The Shapiro-Wilk normality test shows that data normally distributed at 30 and 
37 da (p-value = 0.7348, 0.8189 for control-com vs GOS-com 30da; p-value 
0.2637, 0.1736 among control-com vs GOS -com at 37 da). 
B-Chao index 













ctl-bio-30 da gos-bio-30 da
Normal QQ plot Chao index 30 da













Normal QQ plot Chao index 37 da
 
The Shapiro-Wilk normality test shows that data normally distributed across 




Appendix 5.1 Rarefactions curves of observed OTUs of caecal samples 
microbiota collected from challenged groups fed both control and GOS 
diets reared in controlled housing condition 


































































































































































































Appendix 5.2 The relative abundance of Proteobacteria phylum in control 


























Normal QQ plot 24 da






























The Shapiro–Wilk test of normality displayed that the data of abundance 
Proteobacteria were not normally distributed at 24 da in gos-sal barns(p-
value=0.0358) as well as in ctl-sal barns at 35 da old birds (p-value=0.0304) 








 Appendix 5.3 Correlation coefficient between the relative abundance of Proteobacteria and proportional of trimethoprim 
resistance population (Ratio). Significance calculated by using Pearson’s correlation coefficient method.   
















































































































































































































































































































































































































































































































































































































Appendix 5.4 A The abundance of resistance GCs arrays in Proteobacteria phylum in control fed birds colonised and non-colonised birds 

















1. ctl_nonc and ctl_sal groups_ at 22 da 
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Appendix 5.4 B The abundance of resistance GCs arrays in Proteobacteria phylum in control fed birds colonised and non-colonised birds 

















2. gos_nonc and gos_sal groups_ at 22 da 
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Appendix 5.4 C The abundance of resistance GCs arrays in Proteobacteria phylum in control fed birds colonised and non-colonised birds 
housing in controlled condition. Figure A shows distribution of GCs and Figure B demonstrates feed type 

















Appendix 5.4 D The abundance of resistance GCs arrays in Proteobacteria phylum in control fed birds colonised and non-colonised birds 








Appendix 5.4 E The abundance of resistance GCs arrays in Proteobacteria phylum in control fed birds colonised and non-colonised birds 




















Appendix 5.4 F The abundance of resistance GCs arrays in Proteobacteria phylum in control fed birds colonised and non-colonised birds 




6. gos_nonc and gos_sal groups_ at 28 da 
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Appendix 5.4 G The abundance of resistance GCs arrays in Proteobacteria phylum in control fed birds colonised and non-colonised birds 
housing in controlled condition. Figure A shows distribution of GCs and Figure B demonstrates feed type 





















Appendix 5.4 H The abundance of resistance GCs arrays in Proteobacteria phylum in control fed birds colonised and non-colonised birds 
housing in controlled condition. Figure A shows distribution of GCs and Figure B demonstrates feed type 





Appendix 5.5 QQ plot of normality test of control and GOS diets (all 
sampling days) for controlled housed birds or biosecure reading birds 
A-inverse Simpson 












ctl-sal-22 da gos-sal-22 da
Normal QQ plot 22 da












ctl-sal-24 da gos-sal-24 da
Normal QQ plot 24 da













ctl-sal-28 da gos-sal-28 da













ctl-sal-35 da gos-sal-35 da
 
The Shapiro–Wilk test of normality displayed that the data of inverse Simpson 
indices were not normally distributed at 35 da in gos-sal barns (p-value= 0.0064) 





















ctl-sal-22 da gos-sal-22 da














ctl-sal-24 da gos-sal-24 da














ctl-sal-28 da gos-sal-28 da













ctl-sal-35 da gos-sal-35 da
The Shapiro–Wilk test of normality displayed that the data of Chao indices were 
not normally distributed at 22 da in gos-sal barns (p-value= 0.0116) as well as at 
28 da in ctl-sal groups (p-value=0.0163) otherwise all data showed normal 
distribution (p-value >0.05). 
 
 
 
